[{"entities":{"hashtags":[{"start":123,"end":139,"tag":"AnnualReportEMA"}],"urls":[{"start":140,"end":163,"url":"https://t.co/RMNBhwIIK9","expanded_url":"http://bit.ly/2rl0X9M","display_url":"bit.ly/2rl0X9M"},{"start":164,"end":187,"url":"https://t.co/RByM49vzrH","expanded_url":"https://twitter.com/EMA_News/status/1002204303988273152/photo/1","display_url":"pic.twitter.com/RByM49vzrH"}],"annotations":[{"start":24,"end":26,"probability":0.5208,"type":"Organization","normalized_text":"HTA"}],"mentions":{}},"text":"Representatives of EMA, HTA bodies and payers discuss the challenges and benefits of fostering mutual understanding in our #AnnualReportEMA https://t.co/RMNBhwIIK9 https://t.co/RByM49vzrH","attachments":{"media_keys":["3_1002201297813196800"],"poll_ids":{}},"created_at":"2018-05-31T15:05:00.000Z","author_id":"116716199","lang":"en","conversation_id":"1002204303988273152","possibly_sensitive":false,"id":"1002204303988273152","source":"TweetDeck","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":11,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":28,"end":32,"tag":"EMA"},{"start":66,"end":87,"tag":"PaediatricRegulation"},{"start":265,"end":276,"tag":"Paediatric"}],"urls":[{"start":241,"end":264,"url":"https://t.co/fQ6eNpfEIq","expanded_url":"http://bit.ly/2Jid3eV","display_url":"bit.ly/2Jid3eV"},{"start":277,"end":300,"url":"https://t.co/lYduZXFp2f","expanded_url":"https://twitter.com/EMA_News/status/1002144980637552640/video/1","display_url":"pic.twitter.com/lYduZXFp2f"}],"annotations":{},"mentions":{}},"text":"Patients, doctors and other #EMA stakeholders talk about what the #PaediatricRegulation has achieved in the last 10 years, and most importantly, about the challenges that need to be tackled from now on. Hear their opinions in a short video: https://t.co/fQ6eNpfEIq #Paediatric https://t.co/lYduZXFp2f","attachments":{"media_keys":["7_1002143926625751040"],"poll_ids":{}},"created_at":"2018-05-31T11:09:16.000Z","author_id":"116716199","lang":"en","conversation_id":"1002144980637552640","possibly_sensitive":false,"id":"1002144980637552640","source":"Twitter Web Client","public_metrics":{"retweet_count":18,"reply_count":0,"like_count":8,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":46,"end":56,"tag":"medicines"},{"start":131,"end":142,"tag":"paediatric"},{"start":143,"end":164,"tag":"PaediatricRegulation"}],"urls":[{"start":107,"end":130,"url":"https://t.co/zjakvcwGWg","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Report/2018/05/WC500249618.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"},{"start":165,"end":188,"url":"https://t.co/64x4nXMTku","expanded_url":"https://twitter.com/EMA_News/status/1002112449292587008/photo/1","display_url":"pic.twitter.com/64x4nXMTku"}],"annotations":{},"mentions":{}},"text":"Do you know what percentage of total approved #medicines are indicated for use in children? Find out here: https://t.co/zjakvcwGWg\n#paediatric #PaediatricRegulation https://t.co/64x4nXMTku","attachments":{"media_keys":["3_1001846184296828931"],"poll_ids":{}},"created_at":"2018-05-31T09:00:00.000Z","author_id":"116716199","lang":"en","conversation_id":"1002112449292587008","possibly_sensitive":false,"id":"1002112449292587008","source":"TweetDeck","public_metrics":{"retweet_count":46,"reply_count":0,"like_count":44,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":84,"end":94,"tag":"medicines"},{"start":211,"end":232,"tag":"PaediatricRegulation"},{"start":259,"end":270,"tag":"paediatric"}],"urls":[{"start":235,"end":258,"url":"https://t.co/zjakvcwGWg","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Report/2018/05/WC500249618.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"},{"start":271,"end":294,"url":"https://t.co/IBVDfampds","expanded_url":"https://twitter.com/EMA_News/status/1002097351392022531/photo/1","display_url":"pic.twitter.com/IBVDfampds"}],"annotations":{},"mentions":{}},"text":"Did you know that, in the infectious diseases therapeutic area, new indications for #medicines have led to positive changes in the way children are treated? More facts available in our latest infographic on the #PaediatricRegulation:  https://t.co/zjakvcwGWg #paediatric https://t.co/IBVDfampds","attachments":{"media_keys":["3_1001844978824433665"],"poll_ids":{}},"created_at":"2018-05-31T08:00:01.000Z","author_id":"116716199","lang":"en","conversation_id":"1002097351392022531","possibly_sensitive":false,"id":"1002097351392022531","source":"TweetDeck","public_metrics":{"retweet_count":21,"reply_count":1,"like_count":16,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":38,"end":59,"tag":"PaediatricRegulation"},{"start":84,"end":94,"tag":"medicines"},{"start":137,"end":148,"tag":"Paediatric"}],"urls":[{"start":170,"end":193,"url":"https://t.co/H327jQDvXu","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Report/2018/05/WC500249617.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"},{"start":194,"end":217,"url":"https://t.co/XakQkeEXaX","expanded_url":"https://twitter.com/EMA_News/status/1001841474642808832/photo/1","display_url":"pic.twitter.com/XakQkeEXaX"}],"annotations":{},"mentions":{}},"text":"Interested in how to better apply the #PaediatricRegulation to boost development of #medicines for children? Check out our report on the #Paediatric Regulation workshop: https://t.co/H327jQDvXu https://t.co/XakQkeEXaX","attachments":{"media_keys":["3_1001841454497529857"],"poll_ids":{}},"created_at":"2018-05-30T15:03:15.000Z","author_id":"116716199","lang":"en","conversation_id":"1001841474642808832","possibly_sensitive":false,"id":"1001841474642808832","source":"Twitter Web Client","public_metrics":{"retweet_count":26,"reply_count":0,"like_count":25,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":46,"end":60,"tag":"StopSuperbugs"}],"urls":{},"annotations":{},"mentions":[{"start":3,"end":12,"username":"DrTedros","id":"189868631"},{"start":91,"end":95,"username":"FAO","id":"19649135"},{"start":96,"end":112,"username":"OIEAnimalHealth","id":"2826426188"}]},"text":"RT @DrTedros: It’s a good day in the fight to #StopSuperbugs. We are strengthening our WHO-@FAO-@OIEAnimalHealth partnership by signing an…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-05-30T13:15:34.000Z","author_id":"116716199","lang":"en","conversation_id":"1001814373097267200","possibly_sensitive":false,"id":"1001814373097267200","source":"Twitter Web Client","public_metrics":{"retweet_count":71,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"1001755905590026240"}]},{"entities":{"hashtags":[{"start":24,"end":28,"tag":"EMA"}],"urls":[{"start":92,"end":115,"url":"https://t.co/ZGZ3ns2g1u","expanded_url":"https://clinicaldata.ema.europa.eu/web/cdp/home","display_url":"clinicaldata.ema.europa.eu/web/cdp/home"}],"annotations":{},"mentions":{}},"text":"Transparency milestone! #EMA publishes 100th clinical dossier on its clinical data website: https://t.co/ZGZ3ns2g1u","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-05-30T08:01:00.000Z","author_id":"116716199","lang":"en","conversation_id":"1001735211816636416","possibly_sensitive":false,"id":"1001735211816636416","source":"TweetDeck","public_metrics":{"retweet_count":23,"reply_count":0,"like_count":23,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":30,"end":52,"tag":"PersonalisedMedicines"},{"start":117,"end":133,"tag":"AnnualReportEMA"}],"urls":[{"start":134,"end":157,"url":"https://t.co/RMNBhwIIK9","expanded_url":"http://bit.ly/2rl0X9M","display_url":"bit.ly/2rl0X9M"},{"start":158,"end":181,"url":"https://t.co/qwiTNjPO7j","expanded_url":"https://twitter.com/EMA_News/status/1001455623031148545/photo/1","display_url":"pic.twitter.com/qwiTNjPO7j"}],"annotations":{},"mentions":{}},"text":"What are the latest trends in #PersonalisedMedicines? The Agency’s experts and stakeholders share their views in our #AnnualReportEMA https://t.co/RMNBhwIIK9 https://t.co/qwiTNjPO7j","attachments":{"media_keys":["3_1001453779789799424"],"poll_ids":{}},"created_at":"2018-05-29T13:30:01.000Z","author_id":"116716199","lang":"en","conversation_id":"1001455623031148545","possibly_sensitive":false,"id":"1001455623031148545","source":"TweetDeck","public_metrics":{"retweet_count":21,"reply_count":0,"like_count":15,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":28,"end":32,"tag":"EMA"}],"urls":[{"start":68,"end":91,"url":"https://t.co/TN54McF17s","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2018/05/news_detail_002963.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"},{"start":92,"end":115,"url":"https://t.co/f6i4grgRak","expanded_url":"https://twitter.com/EMA_News/status/1001424521499480064/photo/1","display_url":"pic.twitter.com/f6i4grgRak"}],"annotations":[{"start":45,"end":53,"probability":0.9962,"type":"Place","normalized_text":"Amsterdam"}],"mentions":{}},"text":"The construction of the new #EMA building in Amsterdam is on track: https://t.co/TN54McF17s https://t.co/f6i4grgRak","attachments":{"media_keys":["3_1001424484891549696"],"poll_ids":{}},"created_at":"2018-05-29T11:26:26.000Z","author_id":"116716199","lang":"en","conversation_id":"1001424521499480064","possibly_sensitive":false,"id":"1001424521499480064","source":"Twitter Web Client","public_metrics":{"retweet_count":20,"reply_count":1,"like_count":46,"quote_count":4},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":{},"annotations":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":54,"end":63,"username":"EMA_News","id":"116716199"},{"start":65,"end":80,"username":"RareDiseasesEU","id":"1430840870"},{"start":85,"end":95,"username":"EU_Health","id":"606325697"}]},"text":"RT @EU_Health: Happening today at 10:00 AM CET: joint @EMA_News, @RareDiseasesEU and @EU_Health workshop on how to work together with #Euro…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-05-29T08:46:15.000Z","author_id":"116716199","lang":"en","conversation_id":"1001384213508251648","possibly_sensitive":false,"id":"1001384213508251648","source":"Twitter Web Client","public_metrics":{"retweet_count":20,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"1001366297857462272"}]},{"entities":{"hashtags":[{"start":16,"end":42,"tag":"EuropeanReferenceNetworks"},{"start":85,"end":98,"tag":"rarediseases"}],"urls":[{"start":125,"end":148,"url":"https://t.co/iAZRJfYXA7","expanded_url":"https://bit.ly/2s55Cgx","display_url":"bit.ly/2s55Cgx"},{"start":176,"end":199,"url":"https://t.co/pnnB1l4SAO","expanded_url":"https://twitter.com/EMA_News/status/1001372576004956160/photo/1","display_url":"pic.twitter.com/pnnB1l4SAO"}],"annotations":{},"mentions":[{"start":149,"end":164,"username":"RareDiseasesEU","id":"1430840870"},{"start":165,"end":175,"username":"EU_Health","id":"606325697"}]},"text":"How can EMA and #EuropeanReferenceNetworks work together in the field of complex and #rarediseases? Watch the workshop live: https://t.co/iAZRJfYXA7 @RareDiseasesEU @EU_Health https://t.co/pnnB1l4SAO","attachments":{"media_keys":["16_1001138823059959810"],"poll_ids":{}},"created_at":"2018-05-29T08:00:01.000Z","author_id":"116716199","lang":"en","conversation_id":"1001372576004956160","possibly_sensitive":false,"id":"1001372576004956160","source":"TweetDeck","public_metrics":{"retweet_count":12,"reply_count":1,"like_count":9,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":61,"end":72,"tag":"Veterinary"},{"start":79,"end":84,"tag":"CVMP"}],"urls":[{"start":205,"end":228,"url":"https://t.co/5KIreD9TRk","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2018/05/news_detail_002962.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"annotations":{},"mentions":{}},"text":"At its May meeting, our Committee for Medicinal Products for #Veterinary Use - #CVMP - recommended for approval a new vaccine to reduce the incidence of intramammary infections in cows/heifers. Read more: https://t.co/5KIreD9TRk","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-05-28T15:13:37.000Z","author_id":"116716199","lang":"en","conversation_id":"1001119308687306752","possibly_sensitive":false,"id":"1001119308687306752","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":3,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":95,"end":100,"tag":"CHMP"},{"start":101,"end":111,"tag":"medicines"}],"urls":[{"start":112,"end":135,"url":"https://t.co/XFpv8S5Muw","expanded_url":"http://bit.ly/2LASRmE","display_url":"bit.ly/2LASRmE"}],"annotations":{},"mentions":{}},"text":"What's on the agenda of the May meeting of our Committee for medicinal products for human use? #CHMP #medicines https://t.co/XFpv8S5Muw","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-05-28T09:14:14.000Z","author_id":"116716199","lang":"en","conversation_id":"1001028867094667264","possibly_sensitive":false,"id":"1001028867094667264","source":"Twitter Web Client","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":6,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":33,"end":45,"tag":"antibiotics"},{"start":60,"end":64,"tag":"EMA"}],"urls":[{"start":207,"end":230,"url":"https://t.co/zIrFRm73ap","expanded_url":"http://bit.ly/2s5qSnj","display_url":"bit.ly/2s5qSnj"},{"start":231,"end":254,"url":"https://t.co/abBucEtmBQ","expanded_url":"https://twitter.com/EMA_News/status/999673684485910528/photo/1","display_url":"pic.twitter.com/abBucEtmBQ"}],"annotations":{},"mentions":[{"start":133,"end":140,"username":"US_FDA","id":"208120290"}]},"text":"Interested in the development of #antibiotics for children? #EMA, the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) and @US_FDA are co-organising a workshop to discuss this topic. Register now: https://t.co/zIrFRm73ap https://t.co/abBucEtmBQ","attachments":{"media_keys":["16_999673517749645312"],"poll_ids":{}},"created_at":"2018-05-24T15:29:14.000Z","author_id":"116716199","lang":"en","conversation_id":"999673684485910528","possibly_sensitive":false,"id":"999673684485910528","source":"Twitter Web Client","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":12,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":126,"end":149,"url":"https://t.co/e4ctFxXhjc","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/about_us/landing/ask_ema_landing_page.jsp&mid=","display_url":"ema.europa.eu/ema/index.jsp?…"}],"annotations":[{"start":70,"end":75,"probability":0.5106,"type":"Person","normalized_text":"AskEMA"}],"mentions":[{"start":0,"end":10,"username":"sesiegler","id":"26573545"}]},"text":"@sesiegler We are happy to answer your questions. Please send them to AskEMA and we will get back to you as soon as possible: https://t.co/e4ctFxXhjc","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-05-24T12:45:44.000Z","author_id":"116716199","lang":"en","conversation_id":"999322778431115264","possibly_sensitive":false,"id":"999632539743551488","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":4,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"999322778431115264"}],"in_reply_to_user_id":"26573545"},{"entities":{"hashtags":[{"start":18,"end":29,"tag":"EUAgencies"}],"urls":{},"annotations":{},"mentions":[{"start":3,"end":11,"username":"Frontex","id":"3305994758"}]},"text":"RT @Frontex: \"The #EUAgencies add value through their expertise, advice and \nactivities in areas with an overwhelming impact on the lives o…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-05-23T11:56:37.000Z","author_id":"116716199","lang":"en","conversation_id":"999257793189285889","possibly_sensitive":false,"id":"999257793189285889","source":"Twitter Web Client","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"999253558422892544"}]},{"entities":{"hashtags":[{"start":99,"end":104,"tag":"CVMP"},{"start":105,"end":116,"tag":"veterinary"},{"start":117,"end":127,"tag":"medicines"}],"urls":[{"start":128,"end":151,"url":"https://t.co/QyaxPo02PV","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Agenda/2018/05/WC500249266.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"}],"annotations":{},"mentions":{}},"text":"Check out the agenda of the May meeting of our Committee for Medicinal Products for Veterinary Use #CVMP #veterinary #medicines https://t.co/QyaxPo02PV","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-05-23T09:59:44.000Z","author_id":"116716199","lang":"en","conversation_id":"999228378359259136","possibly_sensitive":false,"id":"999228378359259136","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":4,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":80,"end":106,"tag":"EuropeanReferenceNetworks"},{"start":135,"end":148,"tag":"rarediseases"}],"urls":[{"start":186,"end":209,"url":"https://t.co/RcojSuhy6G","expanded_url":"https://bit.ly/2rVB2GX","display_url":"bit.ly/2rVB2GX"},{"start":210,"end":233,"url":"https://t.co/QEeLuFsMaq","expanded_url":"https://twitter.com/EMA_News/status/998969739048243200/photo/1","display_url":"pic.twitter.com/QEeLuFsMaq"}],"annotations":{},"mentions":[{"start":11,"end":26,"username":"RareDiseasesEU","id":"1430840870"},{"start":31,"end":41,"username":"EU_Health","id":"606325697"}]},"text":"Joint EMA, @RareDiseasesEU and @EU_Health workshop on how to work together with #EuropeanReferenceNetworks in the field of complex and #rarediseases – Watch the live broadcast on 29 May https://t.co/RcojSuhy6G https://t.co/QEeLuFsMaq","attachments":{"media_keys":["16_998968440722370560"],"poll_ids":{}},"created_at":"2018-05-22T16:52:00.000Z","author_id":"116716199","lang":"en","conversation_id":"998969739048243200","possibly_sensitive":false,"id":"998969739048243200","source":"TweetDeck","public_metrics":{"retweet_count":19,"reply_count":0,"like_count":23,"quote_count":3},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":181,"end":190,"tag":"CARTcell"},{"start":192,"end":210,"tag":"patientregistries"}],"urls":[{"start":157,"end":180,"url":"https://t.co/2uqhk8lbSn","expanded_url":"http://bit.ly/2IBT0Zj","display_url":"bit.ly/2IBT0Zj"},{"start":211,"end":234,"url":"https://t.co/zIqcjKpXou","expanded_url":"https://twitter.com/EMA_News/status/998925003595898881/photo/1","display_url":"pic.twitter.com/zIqcjKpXou"}],"annotations":{},"mentions":{}},"text":"What are the opportunities and challenges in using patient registries for the benefit-risk evaluations of CAR T-cell therapies? Consult our workshop report: https://t.co/2uqhk8lbSn #CARTcell  #patientregistries https://t.co/zIqcjKpXou","attachments":{"media_keys":["3_998924915506987008"],"poll_ids":{}},"created_at":"2018-05-22T13:54:14.000Z","author_id":"116716199","lang":"en","conversation_id":"998925003595898881","possibly_sensitive":false,"id":"998925003595898881","source":"Twitter Web Client","public_metrics":{"retweet_count":20,"reply_count":1,"like_count":14,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":24,"end":42,"tag":"Pharmacovigilance"},{"start":169,"end":173,"tag":"HIV"},{"start":183,"end":196,"tag":"dolutegravir"},{"start":222,"end":227,"tag":"PRAC"}],"urls":[{"start":198,"end":221,"url":"https://t.co/l3qrPagOo1","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2018/05/news_detail_002954.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"annotations":{},"mentions":{}},"text":"At its May meeting, our #Pharmacovigilance Committee concluded two referrals, maintained recommendation on HES solutions for infusion and issued precautionary advice on #HIV medicine #dolutegravir: https://t.co/l3qrPagOo1 #PRAC","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-05-18T11:16:40.000Z","author_id":"116716199","lang":"en","conversation_id":"997435798378176512","possibly_sensitive":false,"id":"997435798378176512","source":"Twitter Web Client","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":4,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":82,"end":105,"url":"https://t.co/UWCemkBmXf","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2018/05/news_detail_002957.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"annotations":[{"start":75,"end":79,"probability":0.2394,"type":"Organization","normalized_text":"Esmya"}],"mentions":[{"start":0,"end":13,"username":"AniB75383019","id":"951070515506036736"}]},"text":"@AniB75383019 @Bleat_Babble Please find our communication on the review of Esmya: https://t.co/UWCemkBmXf","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-05-18T11:12:33.000Z","author_id":"116716199","lang":"en","conversation_id":"997418127922167813","possibly_sensitive":false,"id":"997434761068056577","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"997418700427837441"}],"in_reply_to_user_id":"951070515506036736"},{"entities":{"hashtags":[{"start":4,"end":20,"tag":"AnnualReportEMA"},{"start":47,"end":58,"tag":"veterinary"},{"start":59,"end":69,"tag":"medicines"}],"urls":[{"start":87,"end":110,"url":"https://t.co/RMNBhx0jBH","expanded_url":"http://bit.ly/2rl0X9M","display_url":"bit.ly/2rl0X9M"},{"start":111,"end":134,"url":"https://t.co/MioEE1rmTP","expanded_url":"https://twitter.com/EMA_News/status/997395616417304576/photo/1","display_url":"pic.twitter.com/MioEE1rmTP"}],"annotations":{},"mentions":{}},"text":"The #AnnualReportEMA offers an overview of the #veterinary #medicines approved in 2017 https://t.co/RMNBhx0jBH https://t.co/MioEE1rmTP","attachments":{"media_keys":["3_997393293011927041"],"poll_ids":{}},"created_at":"2018-05-18T08:37:00.000Z","author_id":"116716199","lang":"en","conversation_id":"997395616417304576","possibly_sensitive":false,"id":"997395616417304576","source":"TweetDeck","public_metrics":{"retweet_count":9,"reply_count":1,"like_count":9,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":120,"end":129,"tag":"Oncology"},{"start":130,"end":141,"tag":"Immunology"},{"start":142,"end":157,"tag":"AntiInfectives"},{"start":158,"end":169,"tag":"Cardiology"},{"start":170,"end":184,"tag":"Endocrinology"},{"start":185,"end":195,"tag":"Neurology"},{"start":233,"end":240,"tag":"EUjobs"},{"start":241,"end":253,"tag":"sciencejobs"}],"urls":[{"start":208,"end":231,"url":"https://t.co/SGcFN8ZaXr","expanded_url":"http://bit.ly/2wP0Rxk","display_url":"bit.ly/2wP0Rxk"},{"start":254,"end":277,"url":"https://t.co/FiVZPZhVRU","expanded_url":"https://twitter.com/EMA_News/status/997094208858046467/photo/1","display_url":"pic.twitter.com/FiVZPZhVRU"}],"annotations":[{"start":0,"end":2,"probability":0.5276,"type":"Organization","normalized_text":"EMA"}],"mentions":{}},"text":"EMA is looking to recruit scientific specialists for its scientific divisions covering the following therapeutic areas: #Oncology #Immunology #AntiInfectives #Cardiology #Endocrinology #Neurology. Apply now: https://t.co/SGcFN8ZaXr  #EUjobs #sciencejobs https://t.co/FiVZPZhVRU","attachments":{"media_keys":["3_997094140549783552"],"poll_ids":{}},"created_at":"2018-05-17T12:39:19.000Z","author_id":"116716199","lang":"en","conversation_id":"997094208858046467","possibly_sensitive":false,"id":"997094208858046467","source":"Twitter Web Client","public_metrics":{"retweet_count":15,"reply_count":1,"like_count":19,"quote_count":3},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":27,"end":37,"tag":"medicines"},{"start":77,"end":95,"tag":"pharmacovigilance"},{"start":103,"end":119,"tag":"AnnualReportEMA"}],"urls":[{"start":125,"end":148,"url":"https://t.co/Ah40V9scoS","expanded_url":"https://bit.ly/2rl0X9M","display_url":"bit.ly/2rl0X9M"},{"start":149,"end":172,"url":"https://t.co/y0wODetZxP","expanded_url":"https://twitter.com/EMA_News/status/996754643337146368/photo/1","display_url":"pic.twitter.com/y0wODetZxP"}],"annotations":{},"mentions":{}},"text":"EMA monitors the safety of #medicines on the EU market. Check out figures on #pharmacovigilance in our #AnnualReportEMA 2017 https://t.co/Ah40V9scoS https://t.co/y0wODetZxP","attachments":{"media_keys":["3_996751113427800070"],"poll_ids":{}},"created_at":"2018-05-16T14:10:00.000Z","author_id":"116716199","lang":"en","conversation_id":"996754643337146368","possibly_sensitive":false,"id":"996754643337146368","source":"TweetDeck","public_metrics":{"retweet_count":33,"reply_count":0,"like_count":29,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":223,"end":246,"url":"https://t.co/Fe97fRcnN5","expanded_url":"http://bit.ly/2rGiWbX","display_url":"bit.ly/2rGiWbX"},{"start":247,"end":270,"url":"https://t.co/OyhgpYGvbc","expanded_url":"https://twitter.com/cochranecollab/status/994327189083623426","display_url":"twitter.com/cochranecollab…"}],"annotations":[{"start":159,"end":160,"probability":0.3857,"type":"Place","normalized_text":"EU"}],"mentions":{}},"text":"We welcome the publication of new data that can support public confidence in vaccines. EMA continuously monitors the safety of all medicines authorised in the EU. Find out about our 2015 safety review of HPV vaccines here: https://t.co/Fe97fRcnN5 https://t.co/OyhgpYGvbc","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-05-15T09:01:36.000Z","author_id":"116716199","lang":"en","conversation_id":"996314645584588800","possibly_sensitive":false,"id":"996314645584588800","source":"Twitter Web Client","public_metrics":{"retweet_count":66,"reply_count":0,"like_count":71,"quote_count":1},"referenced_tweets":[{"type":"quoted","id":"994327189083623426"}]},{"entities":{"hashtags":[{"start":32,"end":50,"tag":"Pharmacovigilance"}],"urls":[{"start":93,"end":116,"url":"https://t.co/TukDcsdOBl","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Agenda/2018/05/WC500248947.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"}],"annotations":{},"mentions":{}},"text":"See what's on the agenda of the #Pharmacovigilance Risk Assessment Committee meeting in May: https://t.co/TukDcsdOBl","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-05-14T14:41:38.000Z","author_id":"116716199","lang":"en","conversation_id":"996037828927807489","possibly_sensitive":false,"id":"996037828927807489","source":"Twitter Web Client","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":5,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":0,"end":4,"tag":"EMA"},{"start":223,"end":230,"tag":"EUjobs"}],"urls":[{"start":171,"end":194,"url":"https://t.co/ZsduRNm2CA","expanded_url":"http://bit.ly/2rG6B7y","display_url":"bit.ly/2rG6B7y"},{"start":199,"end":222,"url":"https://t.co/T7DYgpzSUW","expanded_url":"http://bit.ly/2IjlHKE","display_url":"bit.ly/2IjlHKE"},{"start":231,"end":254,"url":"https://t.co/h1GKl7meNR","expanded_url":"https://twitter.com/EMA_News/status/996014405354688512/photo/1","display_url":"pic.twitter.com/h1GKl7meNR"}],"annotations":[{"start":17,"end":42,"probability":0.5406,"type":"Organization","normalized_text":"Head of Finance Department"}],"mentions":{}},"text":"#EMA is hiring a Head of Finance Department and Financial Assistants to provide support to the financial activities of the Agency. Find out more by accessing these links: https://t.co/ZsduRNm2CA and https://t.co/T7DYgpzSUW #EUjobs https://t.co/h1GKl7meNR","attachments":{"media_keys":["3_996014084469518336"],"poll_ids":{}},"created_at":"2018-05-14T13:08:33.000Z","author_id":"116716199","lang":"en","conversation_id":"996014405354688512","possibly_sensitive":false,"id":"996014405354688512","source":"Twitter Web Client","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":5,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":68,"end":78,"tag":"EuropeDay"},{"start":88,"end":99,"tag":"EUAgencies"}],"urls":[{"start":100,"end":123,"url":"https://t.co/bcjcNR2WZr","expanded_url":"https://twitter.com/EMA_News/status/994150741840420864/video/1","display_url":"pic.twitter.com/bcjcNR2WZr"}],"annotations":[{"start":7,"end":12,"probability":0.9262,"type":"Place","normalized_text":"Europe"}],"mentions":{}},"text":"Making Europe a better place to live today and every day. Celebrate #EuropeDay with the #EUAgencies https://t.co/bcjcNR2WZr","attachments":{"media_keys":["7_994148392333987840"],"poll_ids":{}},"created_at":"2018-05-09T09:43:01.000Z","author_id":"116716199","lang":"en","conversation_id":"994150741840420864","possibly_sensitive":false,"id":"994150741840420864","source":"Twitter Web Client","public_metrics":{"retweet_count":26,"reply_count":0,"like_count":36,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":42,"end":65,"url":"https://t.co/RDoPeeaHr8","expanded_url":"http://bit.ly/2KHRVg1","display_url":"bit.ly/2KHRVg1"},{"start":66,"end":89,"url":"https://t.co/VgpMcKELSh","expanded_url":"https://twitter.com/EMA_News/status/993525463640346624/photo/1","display_url":"pic.twitter.com/VgpMcKELSh"}],"annotations":[{"start":10,"end":12,"probability":0.4087,"type":"Organization","normalized_text":"EMA"}],"mentions":{}},"text":"Check out EMA’s two-year report on PRIME: https://t.co/RDoPeeaHr8 https://t.co/VgpMcKELSh","attachments":{"media_keys":["3_993525219175337985"],"poll_ids":{}},"created_at":"2018-05-07T16:18:23.000Z","author_id":"116716199","lang":"en","conversation_id":"993525463640346624","possibly_sensitive":false,"id":"993525463640346624","source":"Twitter Web Client","public_metrics":{"retweet_count":20,"reply_count":0,"like_count":25,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":85,"end":92,"tag":"AskEMA"}],"urls":[{"start":94,"end":117,"url":"https://t.co/rMxJXL615X","expanded_url":"http://bit.ly/X4lXwT","display_url":"bit.ly/X4lXwT"}],"annotations":{},"mentions":{}},"text":"@SALedlie We are happy to address your concerns and questions. Please contact us via #AskEMA (https://t.co/rMxJXL615X) and send us your views. We will look into this.","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-05-04T12:18:01.000Z","author_id":"116716199","lang":"en","conversation_id":"991168770671595527","possibly_sensitive":false,"id":"992377806595219457","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"991168770671595527"}],"in_reply_to_user_id":"2260435939"},{"entities":{"hashtags":[{"start":10,"end":20,"tag":"EuropeDay"},{"start":35,"end":46,"tag":"EUAgencies"},{"start":78,"end":82,"tag":"EMA"},{"start":92,"end":105,"tag":"PublicHealth"}],"urls":[{"start":131,"end":154,"url":"https://t.co/K5sP1Q0UV6","expanded_url":"http://bit.ly/2JOaH47","display_url":"bit.ly/2JOaH47"},{"start":166,"end":189,"url":"https://t.co/BZKeDzWa4f","expanded_url":"https://twitter.com/EMA_News/status/992354199479480321/video/1","display_url":"pic.twitter.com/BZKeDzWa4f"}],"annotations":{},"mentions":[{"start":155,"end":165,"username":"EU_Health","id":"606325697"}]},"text":"Celebrate #EuropeDay on 9 May with #EUAgencies and learn more about our work. #EMA protects #PublicHealth across all EU countries: https://t.co/K5sP1Q0UV6 @EU_Health https://t.co/BZKeDzWa4f","attachments":{"media_keys":["7_992353486158401536"],"poll_ids":{}},"created_at":"2018-05-04T10:44:12.000Z","author_id":"116716199","lang":"en","conversation_id":"992354199479480321","possibly_sensitive":false,"id":"992354199479480321","source":"Twitter Web Client","public_metrics":{"retweet_count":25,"reply_count":0,"like_count":28,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":72,"end":80,"tag":"BigData"}],"urls":[{"start":148,"end":171,"url":"https://t.co/9GKMtK0Emo","expanded_url":"http://bit.ly/2HVnWPG","display_url":"bit.ly/2HVnWPG"},{"start":172,"end":195,"url":"https://t.co/u3WS82qjOi","expanded_url":"https://twitter.com/EMA_News/status/992329379895218177/photo/1","display_url":"pic.twitter.com/u3WS82qjOi"}],"annotations":{},"mentions":{}},"text":"Watch the live broadcast of the Heads of Medicines Agencies / EMA Joint #BigData Task Force meeting: identifying solutions for big data challenges. https://t.co/9GKMtK0Emo https://t.co/u3WS82qjOi","attachments":{"media_keys":["16_992329319535071232"],"poll_ids":{}},"created_at":"2018-05-04T09:05:35.000Z","author_id":"116716199","lang":"en","conversation_id":"992329379895218177","possibly_sensitive":false,"id":"992329379895218177","source":"Twitter Web Client","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":8,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":{},"annotations":[{"start":213,"end":228,"probability":0.4917,"type":"Organization","normalized_text":"EU Member States"}],"mentions":[{"start":0,"end":13,"username":"AniB75383019","id":"951070515506036736"}]},"text":"@AniB75383019 [2] The PRAC’s final recommendations will be forwarded to the CHMP. The final stage of the review procedure is the adoption by the European Commission of a legally binding decision applicable in all EU Member States. Assessment report will be published then.","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-05-03T16:59:05.000Z","author_id":"116716199","lang":"en","conversation_id":"991992426654044160","possibly_sensitive":false,"id":"992086153464565762","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"992006271900381185"}],"in_reply_to_user_id":"951070515506036736"},{"entities":{"hashtags":{},"urls":[{"start":169,"end":192,"url":"https://t.co/7qSeVS6ZYc","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/about_us/document_listing/document_listing_000353.jsp&mid=WC0b01ac05805a21cf","display_url":"ema.europa.eu/ema/index.jsp?…"}],"annotations":[{"start":67,"end":109,"probability":0.8292,"type":"Organization","normalized_text":"Pharmacovigilance Risk Assessment Committee"}],"mentions":[{"start":0,"end":13,"username":"AniB75383019","id":"951070515506036736"}]},"text":"@AniB75383019 [1] The review is currently being carried out by the Pharmacovigilance Risk Assessment Committee (PRAC). PRAC’s decision will be published on our website: https://t.co/7qSeVS6ZYc","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-05-03T16:58:33.000Z","author_id":"116716199","lang":"en","conversation_id":"991992426654044160","possibly_sensitive":false,"id":"992086018596585472","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"992006271900381185"}],"in_reply_to_user_id":"951070515506036736"},{"entities":{"hashtags":[{"start":128,"end":134,"tag":"PRIME"},{"start":160,"end":165,"tag":"CHMP"}],"urls":[{"start":136,"end":159,"url":"https://t.co/B9nFhmnHGO","expanded_url":"http://bit.ly/2HJFeDr","display_url":"bit.ly/2HJFeDr"},{"start":166,"end":189,"url":"https://t.co/ywaGrntXVy","expanded_url":"https://twitter.com/EMA_News/status/991992426654044160/photo/1","display_url":"pic.twitter.com/ywaGrntXVy"}],"annotations":{},"mentions":{}},"text":"During its April 2018 meeting, our Committee for Medicinal Products for Human Use reviewed 3 recommendations for eligibility to #PRIME: https://t.co/B9nFhmnHGO #CHMP https://t.co/ywaGrntXVy","attachments":{"media_keys":["3_991992403614715905"],"poll_ids":{}},"created_at":"2018-05-03T10:46:39.000Z","author_id":"116716199","lang":"en","conversation_id":"991992426654044160","possibly_sensitive":false,"id":"991992426654044160","source":"Twitter Web Client","public_metrics":{"retweet_count":10,"reply_count":2,"like_count":7,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":202,"end":218,"tag":"AnnualReportEMA"}],"urls":[{"start":178,"end":201,"url":"https://t.co/nXti2Zaztx","expanded_url":"https://bit.ly/2rb1Kdo","display_url":"bit.ly/2rb1Kdo"},{"start":219,"end":242,"url":"https://t.co/jOn6e2ZL89","expanded_url":"https://twitter.com/EMA_News/status/991683226660831232/photo/1","display_url":"pic.twitter.com/jOn6e2ZL89"}],"annotations":[{"start":0,"end":2,"probability":0.5106,"type":"Organization","normalized_text":"EMA"}],"mentions":{}},"text":"EMA’s annual report 2017 is now published! Read about the Agency’s key achievements and figures in 2017, including statistics on its regulatory procedures, activities and trends https://t.co/nXti2Zaztx #AnnualReportEMA https://t.co/jOn6e2ZL89","attachments":{"media_keys":["3_991682269512372225"],"poll_ids":{}},"created_at":"2018-05-02T14:18:00.000Z","author_id":"116716199","lang":"en","conversation_id":"991683226660831232","possibly_sensitive":false,"id":"991683226660831232","source":"TweetDeck","public_metrics":{"retweet_count":60,"reply_count":0,"like_count":48,"quote_count":4},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":31,"end":49,"tag":"Pharmacovigilance"}],"urls":[{"start":99,"end":122,"url":"https://t.co/BeUGeHCcZ5","expanded_url":"http://bit.ly/2HJm0Ko","display_url":"bit.ly/2HJm0Ko","status":429,"unwound_url":"https://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2018/04/news_detail_002949.jsp&mid=WC0b01ac058004d5c1"}],"annotations":{},"mentions":{}},"text":"Join EMA's Management Board or #Pharmacovigilance Risk Assessment Committee. Apply by 8 June 2019. https://t.co/BeUGeHCcZ5","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-04-30T14:47:48.000Z","author_id":"116716199","lang":"en","conversation_id":"990965949032431623","possibly_sensitive":false,"id":"990965949032431623","source":"Twitter Web Client","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":10,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":0,"end":4,"tag":"EMA"}],"urls":[{"start":116,"end":139,"url":"https://t.co/953xQwbBXK","expanded_url":"http://bit.ly/2jiZ1Lk","display_url":"bit.ly/2jiZ1Lk"},{"start":140,"end":163,"url":"https://t.co/s7lCv74AYJ","expanded_url":"https://twitter.com/EMA_News/status/990945722706120705/photo/1","display_url":"pic.twitter.com/s7lCv74AYJ"}],"annotations":[{"start":105,"end":113,"probability":0.9892,"type":"Place","normalized_text":"Amsterdam"}],"mentions":{}},"text":"#EMA has updated the tracking tool showing the main milestones and deliverables for the Agency’s move to Amsterdam: https://t.co/953xQwbBXK https://t.co/s7lCv74AYJ","attachments":{"media_keys":["3_990945537426944001"],"poll_ids":{}},"created_at":"2018-04-30T13:27:25.000Z","author_id":"116716199","lang":"en","conversation_id":"990945722706120705","possibly_sensitive":false,"id":"990945722706120705","source":"Twitter Web Client","public_metrics":{"retweet_count":32,"reply_count":1,"like_count":26,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":0,"end":5,"tag":"CHMP"},{"start":19,"end":29,"tag":"medicines"}],"urls":[{"start":69,"end":92,"url":"https://t.co/11vjT3jTt0","expanded_url":"https://bit.ly/2r3tWjb","display_url":"bit.ly/2r3tWjb"},{"start":93,"end":116,"url":"https://t.co/amHbC5gx5x","expanded_url":"https://twitter.com/EMA_News/status/989829010883395584/photo/1","display_url":"pic.twitter.com/amHbC5gx5x"}],"annotations":{},"mentions":{}},"text":"#CHMP recommends 3 #medicines for approval at its April 2018 meeting https://t.co/11vjT3jTt0 https://t.co/amHbC5gx5x","attachments":{"media_keys":["3_989826512261206018"],"poll_ids":{}},"created_at":"2018-04-27T11:30:00.000Z","author_id":"116716199","lang":"en","conversation_id":"989829010883395584","possibly_sensitive":false,"id":"989829010883395584","source":"TweetDeck","public_metrics":{"retweet_count":23,"reply_count":0,"like_count":16,"quote_count":3},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":80,"end":89,"tag":"vaccines"}],"urls":[{"start":91,"end":114,"url":"https://t.co/d5WmqJ3805","expanded_url":"http://bit.ly/2r4GAgX","display_url":"bit.ly/2r4GAgX"}],"annotations":[{"start":0,"end":2,"probability":0.7262,"type":"Organization","normalized_text":"EMA"}],"mentions":{}},"text":"EMA launches public consultation on revised guideline on clinical evaluation of #vaccines: https://t.co/d5WmqJ3805","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-04-27T08:00:02.000Z","author_id":"116716199","lang":"en","conversation_id":"989776167707267072","possibly_sensitive":false,"id":"989776167707267072","source":"TweetDeck","public_metrics":{"retweet_count":33,"reply_count":0,"like_count":25,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":155,"end":172,"tag":"EMAPublicHearing"}],"urls":[{"start":131,"end":154,"url":"https://t.co/bDzkO1Pa3S","expanded_url":"https://youtu.be/l5y2Qrlo8mI","display_url":"youtu.be/l5y2Qrlo8mI"},{"start":173,"end":196,"url":"https://t.co/HJR5YQXFOJ","expanded_url":"http://bit.ly/2GNfMsg","display_url":"bit.ly/2GNfMsg"}],"annotations":{},"mentions":{}},"text":"You can watch this video to better understand what a public hearing is and what role it can have in EMA's decision-making process: https://t.co/bDzkO1Pa3S #EMAPublicHearing https://t.co/HJR5YQXFOJ","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-04-26T13:01:00.000Z","author_id":"116716199","lang":"en","conversation_id":"989489522823004160","possibly_sensitive":false,"id":"989489522823004160","source":"TweetDeck","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":13,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":31,"end":48,"tag":"EMAPublicHearing"},{"start":52,"end":63,"tag":"quinolones"},{"start":68,"end":85,"tag":"fluoroquinolones"},{"start":224,"end":236,"tag":"antibiotics"},{"start":237,"end":255,"tag":"pharmacovigilance"}],"urls":[{"start":200,"end":223,"url":"https://t.co/HJR5YQXFOJ","expanded_url":"http://bit.ly/2GNfMsg","display_url":"bit.ly/2GNfMsg"},{"start":256,"end":279,"url":"https://t.co/iRvrAX4ijH","expanded_url":"https://twitter.com/EMA_News/status/989459574842384384/photo/1","display_url":"pic.twitter.com/iRvrAX4ijH"}],"annotations":[{"start":0,"end":1,"probability":0.5591,"type":"Organization","normalized_text":"EU"}],"mentions":{}},"text":"EU citizens can participate in #EMAPublicHearing on #quinolones and #fluoroquinolones either as speakers or observers. In their interventions, the speakers will need to address a list of 3 questions: https://t.co/HJR5YQXFOJ #antibiotics #pharmacovigilance https://t.co/iRvrAX4ijH","attachments":{"media_keys":["3_989444008417034240"],"poll_ids":{}},"created_at":"2018-04-26T11:02:00.000Z","author_id":"116716199","lang":"en","conversation_id":"989459574842384384","possibly_sensitive":false,"id":"989459574842384384","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":1,"like_count":9,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":67,"end":70,"tag":"EU"}],"urls":{},"annotations":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}]},"text":"RT @EU_Health: Today we issue a set of recommendations for how the #EU can strengthen cooperation in the fight against vaccine-preventable…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-04-26T10:18:30.000Z","author_id":"116716199","lang":"en","conversation_id":"989448625456599040","possibly_sensitive":false,"id":"989448625456599040","source":"Twitter Web Client","public_metrics":{"retweet_count":20,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"989447633902194689"}]},{"entities":{"hashtags":[{"start":66,"end":74,"tag":"measles"}],"urls":{},"annotations":[{"start":87,"end":88,"probability":0.5895,"type":"Place","normalized_text":"EU"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":16,"end":31,"username":"V_Andriukaitis","id":"575269517"},{"start":108,"end":118,"username":"JunckerEU","id":"169426475"}]},"text":"RT @EU_Health: .@V_Andriukaitis: We are witnessing an increase in #measles epidemic in EU. I echo President @JunckerEU: It is unacceptable…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-04-26T10:15:33.000Z","author_id":"116716199","lang":"en","conversation_id":"989447883127689217","possibly_sensitive":false,"id":"989447883127689217","source":"Twitter Web Client","public_metrics":{"retweet_count":31,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"989445816065642496"}]},{"entities":{"hashtags":{},"urls":{},"annotations":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":75,"end":90,"username":"V_Andriukaitis","id":"575269517"}]},"text":"RT @EU_Health: Follow 🔴live today from 12:00 CET the press conference with @V_Andriukaitis announcing our set of recommendations on vaccine…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-04-26T09:52:47.000Z","author_id":"116716199","lang":"en","conversation_id":"989442153620402176","possibly_sensitive":false,"id":"989442153620402176","source":"Twitter Web Client","public_metrics":{"retweet_count":20,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"989438248622620673"}]},{"entities":{"hashtags":[{"start":57,"end":70,"tag":"FacebookLive"},{"start":79,"end":91,"tag":"vaccination"}],"urls":{},"annotations":{},"mentions":[{"start":3,"end":18,"username":"V_Andriukaitis","id":"575269517"}]},"text":"RT @V_Andriukaitis: So exited and looking forward to the #FacebookLive chat on #vaccination today @ 14:00 !\nDon't hesitate to send your que…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-04-26T09:48:08.000Z","author_id":"116716199","lang":"en","conversation_id":"989440984000983040","possibly_sensitive":false,"id":"989440984000983040","source":"Twitter Web Client","public_metrics":{"retweet_count":26,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"989413942559760384"}]},{"entities":{"hashtags":[{"start":118,"end":122,"tag":"EMA"},{"start":257,"end":270,"tag":"VaccinesWork"}],"urls":[{"start":233,"end":256,"url":"https://t.co/1TwnWTlSia","expanded_url":"http://bit.ly/2JoROnV","display_url":"bit.ly/2JoROnV"},{"start":271,"end":294,"url":"https://t.co/jNJ4YQa6Pa","expanded_url":"https://twitter.com/EMA_News/status/989401189447098368/photo/1","display_url":"pic.twitter.com/jNJ4YQa6Pa"}],"annotations":[{"start":4,"end":28,"probability":0.5298,"type":"Organization","normalized_text":"European Medicines Agency"},{"start":88,"end":93,"probability":0.9845,"type":"Place","normalized_text":"Europe"}],"mentions":{}},"text":"The European Medicines Agency has strict rules for the authorisation of vaccines across Europe. Once they are in use, #EMA continuously monitors their safety so any adverse effects can be promptly detected, investigated and managed. https://t.co/1TwnWTlSia #VaccinesWork https://t.co/jNJ4YQa6Pa","attachments":{"media_keys":["3_988731946128891904"],"poll_ids":{}},"created_at":"2018-04-26T07:10:00.000Z","author_id":"116716199","lang":"en","conversation_id":"989401189447098368","possibly_sensitive":false,"id":"989401189447098368","source":"TweetDeck","public_metrics":{"retweet_count":28,"reply_count":2,"like_count":33,"quote_count":5},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":98,"end":106,"tag":"measles"}],"urls":{},"annotations":[{"start":14,"end":39,"probability":0.5785,"type":"Other","normalized_text":"European Immunisation Week"},{"start":120,"end":125,"probability":0.9964,"type":"Place","normalized_text":"Europe"}],"mentions":[{"start":3,"end":12,"username":"ECDC_VPD","id":"186471638"},{"start":56,"end":64,"username":"ECDC_EU","id":"204752573"}]},"text":"RT @ECDC_VPD: European Immunisation Week is next week – @ECDC_EU will launch data and analysis on #measles situation in Europe to support a…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-04-25T14:33:18.000Z","author_id":"116716199","lang":"en","conversation_id":"989150362018942978","possibly_sensitive":false,"id":"989150362018942978","source":"Twitter Web Client","public_metrics":{"retweet_count":82,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"985852445384470528"}]},{"entities":{"hashtags":[{"start":63,"end":74,"tag":"Paediatric"},{"start":87,"end":91,"tag":"EMA"}],"urls":[{"start":119,"end":142,"url":"https://t.co/SG3MkXRzwn","expanded_url":"http://bit.ly/2qZNZ0T","display_url":"bit.ly/2qZNZ0T"},{"start":143,"end":166,"url":"https://t.co/BCCnr0lO0A","expanded_url":"https://twitter.com/EMA_News/status/989131726654930944/photo/1","display_url":"pic.twitter.com/BCCnr0lO0A"}],"annotations":{},"mentions":{}},"text":"Registration opens for the workshop of the European Network of #Paediatric Research at #EMA (Enpr-EMA), 7–8 June 2018: https://t.co/SG3MkXRzwn https://t.co/BCCnr0lO0A","attachments":{"media_keys":["3_989131701476569088"],"poll_ids":{}},"created_at":"2018-04-25T13:19:15.000Z","author_id":"116716199","lang":"en","conversation_id":"989131726654930944","possibly_sensitive":false,"id":"989131726654930944","source":"Twitter Web Client","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":4,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":199,"end":210,"tag":"quinolones"},{"start":215,"end":232,"tag":"fluoroquinolones"},{"start":258,"end":275,"tag":"EMAPublicHearing"}],"urls":[{"start":234,"end":257,"url":"https://t.co/HJR5YQXFOJ","expanded_url":"http://bit.ly/2GNfMsg","display_url":"bit.ly/2GNfMsg"},{"start":276,"end":299,"url":"https://t.co/TaQvic7ILn","expanded_url":"https://twitter.com/EMA_News/status/989081590625169408/photo/1","display_url":"pic.twitter.com/TaQvic7ILn"}],"annotations":{},"mentions":{}},"text":"Less than one week to register for EMA's next public hearing which will give a voice to patients, doctors, nurses, pharmacists, researchers and everyone else who wants to share their experience with #quinolones and #fluoroquinolones: https://t.co/HJR5YQXFOJ #EMAPublicHearing https://t.co/TaQvic7ILn","attachments":{"media_keys":["3_988796933144793088"],"poll_ids":{}},"created_at":"2018-04-25T10:00:02.000Z","author_id":"116716199","lang":"en","conversation_id":"989081590625169408","possibly_sensitive":false,"id":"989081590625169408","source":"TweetDeck","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":8,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":90,"end":113,"url":"https://t.co/Ilyyc80Wjb","expanded_url":"https://wef.ch/2Hp0yhC","display_url":"wef.ch/2Hp0yhC"},{"start":114,"end":137,"url":"https://t.co/UBk3mQky49","expanded_url":"https://twitter.com/wef/status/988797121020166145/video/1","display_url":"pic.twitter.com/UBk3mQky49"}],"annotations":{},"mentions":[{"start":3,"end":7,"username":"wef","id":"5120691"}]},"text":"RT @wef: Did you know an infant could respond to 10,000 vaccines at one time? Learn more: https://t.co/Ilyyc80Wjb https://t.co/UBk3mQky49","attachments":{"media_keys":["7_988794550025154562"],"poll_ids":{}},"created_at":"2018-04-25T08:50:41.000Z","author_id":"116716199","lang":"en","conversation_id":"989064138356912128","possibly_sensitive":false,"id":"989064138356912128","source":"Twitter Web Client","public_metrics":{"retweet_count":152,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"988797121020166145"}]},{"entities":{"hashtags":[{"start":163,"end":176,"tag":"VaccinesWork"},{"start":177,"end":192,"tag":"ImmunizeEurope"},{"start":193,"end":201,"tag":"EIW2018"}],"urls":[{"start":139,"end":162,"url":"https://t.co/1TwnWTlSia","expanded_url":"http://bit.ly/2JoROnV","display_url":"bit.ly/2JoROnV"},{"start":202,"end":225,"url":"https://t.co/TTEejY4xns","expanded_url":"https://twitter.com/EMA_News/status/989043836637900801/photo/1","display_url":"pic.twitter.com/TTEejY4xns"}],"annotations":{},"mentions":{}},"text":"Vaccines eradicated smallpox. They stopped polio, a dreadful disease affecting millions of children, in almost all countries in the world: https://t.co/1TwnWTlSia\n#VaccinesWork #ImmunizeEurope #EIW2018 https://t.co/TTEejY4xns","attachments":{"media_keys":["3_988728273596289025"],"poll_ids":{}},"created_at":"2018-04-25T07:30:00.000Z","author_id":"116716199","lang":"en","conversation_id":"989043836637900801","possibly_sensitive":false,"id":"989043836637900801","source":"TweetDeck","public_metrics":{"retweet_count":40,"reply_count":0,"like_count":39,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":27,"end":35,"tag":"vaccine"}],"urls":{},"annotations":[{"start":81,"end":86,"probability":0.9874,"type":"Place","normalized_text":"Europe"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":95,"end":110,"username":"V_Andriukaitis","id":"575269517"}]},"text":"RT @EU_Health: Deaths from #vaccine preventable diseases must no longer occur in Europe.\n\nJoin @V_Andriukaitis for a live chat on #vaccinat…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-04-24T15:26:02.000Z","author_id":"116716199","lang":"en","conversation_id":"988801246873210881","possibly_sensitive":false,"id":"988801246873210881","source":"Twitter Web Client","public_metrics":{"retweet_count":19,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"988800696450535424"}]},{"entities":{"hashtags":[{"start":64,"end":73,"tag":"vaccines"},{"start":122,"end":135,"tag":"VaccinesWork"},{"start":136,"end":151,"tag":"ImmunizeEurope"},{"start":152,"end":160,"tag":"EIW2018"}],"urls":[{"start":161,"end":184,"url":"https://t.co/IePkQpxAEV","expanded_url":"https://twitter.com/EMA_News/status/988741846011703299/photo/1","display_url":"pic.twitter.com/IePkQpxAEV"}],"annotations":[{"start":15,"end":39,"probability":0.9013,"type":"Organization","normalized_text":"European Medicines Agency"}],"mentions":{}},"text":"Our job at the European Medicines Agency is to ensure that only #vaccines that are safe and effective are used in the EU.\n#VaccinesWork #ImmunizeEurope #EIW2018 https://t.co/IePkQpxAEV","attachments":{"media_keys":["3_988729578750390273"],"poll_ids":{}},"created_at":"2018-04-24T11:30:00.000Z","author_id":"116716199","lang":"en","conversation_id":"988741846011703299","possibly_sensitive":false,"id":"988741846011703299","source":"TweetDeck","public_metrics":{"retweet_count":49,"reply_count":0,"like_count":66,"quote_count":4},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":0,"end":4,"tag":"EMA"}],"urls":[{"start":50,"end":73,"url":"https://t.co/9TLMQZK5do","expanded_url":"http://bit.ly/2Hn4mf7","display_url":"bit.ly/2Hn4mf7"}],"annotations":[{"start":13,"end":23,"probability":0.9745,"type":"Place","normalized_text":"Netherlands"},{"start":121,"end":123,"probability":0.6021,"type":"Place","normalized_text":"EMA"},{"start":130,"end":135,"probability":0.99,"type":"Place","normalized_text":"London"},{"start":140,"end":148,"probability":0.9714,"type":"Place","normalized_text":"Amsterdam"}],"mentions":{}},"text":"#EMA and the Netherlands agree on Seat Agreement: https://t.co/9TLMQZK5do\nThis is an important step in the relocation of EMA from London to Amsterdam.","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-04-24T09:50:34.000Z","author_id":"116716199","lang":"en","conversation_id":"988716821619576832","possibly_sensitive":false,"id":"988716821619576832","source":"Twitter Web Client","public_metrics":{"retweet_count":23,"reply_count":1,"like_count":21,"quote_count":3},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":14,"end":22,"tag":"Measles"},{"start":85,"end":98,"tag":"vaccineswork"},{"start":99,"end":107,"tag":"EIW2018"},{"start":108,"end":123,"tag":"immunizeEurope"}],"urls":{},"annotations":{},"mentions":[{"start":3,"end":12,"username":"ECDC_VPD","id":"186471638"}]},"text":"RT @ECDC_VPD: #Measles affects all ages. Close the vaccination gap – get vaccinated! #vaccineswork #EIW2018 #immunizeEurope https://t.co/7Q…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-04-24T09:11:31.000Z","author_id":"116716199","lang":"en","conversation_id":"988706994264649728","possibly_sensitive":false,"id":"988706994264649728","source":"Twitter Web Client","public_metrics":{"retweet_count":47,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"988706612838838272"}]},{"entities":{"hashtags":[{"start":151,"end":164,"tag":"VaccinesWork"},{"start":165,"end":180,"tag":"ImmunizeEurope"},{"start":181,"end":189,"tag":"EIW2018"}],"urls":[{"start":190,"end":213,"url":"https://t.co/R37MLkjipY","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2018/04/news_detail_002943.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"},{"start":214,"end":237,"url":"https://t.co/opA8qoWRRL","expanded_url":"https://twitter.com/EMA_News/status/988696880111652864/photo/1","display_url":"pic.twitter.com/opA8qoWRRL"}],"annotations":{},"mentions":{}},"text":"Yearly, vaccines prevent 2.7 million people from contracting measles, 1 million from getting whooping cough and 2 million babies from getting tetanus. #VaccinesWork #ImmunizeEurope #EIW2018 https://t.co/R37MLkjipY https://t.co/opA8qoWRRL","attachments":{"media_keys":["16_988696615002300416"],"poll_ids":{}},"created_at":"2018-04-24T08:31:19.000Z","author_id":"116716199","lang":"en","conversation_id":"988696880111652864","possibly_sensitive":false,"id":"988696880111652864","source":"Twitter Web Client","public_metrics":{"retweet_count":45,"reply_count":0,"like_count":41,"quote_count":5},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":39,"end":43,"tag":"EMA"},{"start":182,"end":195,"tag":"VaccinesWork"},{"start":196,"end":211,"tag":"ImmunizeEurope"}],"urls":[{"start":212,"end":235,"url":"https://t.co/R37MLkjipY","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2018/04/news_detail_002943.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"},{"start":236,"end":259,"url":"https://t.co/QOd93EOGxT","expanded_url":"https://twitter.com/EMA_News/status/988443374414909442/video/1","display_url":"pic.twitter.com/QOd93EOGxT"}],"annotations":[{"start":11,"end":36,"probability":0.4304,"type":"Other","normalized_text":"European Immunization Week"}],"mentions":{}},"text":"To support European Immunization Week, #EMA produced a video together with the community of patients, consumers, doctors, nurses, and pharmacists to explain why vaccination matters. #VaccinesWork #ImmunizeEurope https://t.co/R37MLkjipY https://t.co/QOd93EOGxT","attachments":{"media_keys":["7_988441760971018241"],"poll_ids":{}},"created_at":"2018-04-23T15:43:59.000Z","author_id":"116716199","lang":"en","conversation_id":"988443374414909442","possibly_sensitive":false,"id":"988443374414909442","source":"Twitter Web Client","public_metrics":{"retweet_count":82,"reply_count":2,"like_count":64,"quote_count":8},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":69,"end":79,"tag":"medicines"},{"start":105,"end":110,"tag":"CHMP"}],"urls":[{"start":81,"end":104,"url":"https://t.co/ihnRsGRNwd","expanded_url":"https://bit.ly/2qSx1S4","display_url":"bit.ly/2qSx1S4"}],"annotations":{},"mentions":{}},"text":"What’s on the agenda of the April meeting of our committee for human #medicines? https://t.co/ihnRsGRNwd #CHMP","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-04-23T15:00:01.000Z","author_id":"116716199","lang":"en","conversation_id":"988432308238663680","possibly_sensitive":false,"id":"988432308238663680","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":19,"end":23,"tag":"SME"},{"start":27,"end":36,"tag":"research"},{"start":76,"end":91,"tag":"pharmaceutical"},{"start":129,"end":133,"tag":"EMA"}],"urls":[{"start":206,"end":229,"url":"https://t.co/VcjTO8N4yy","expanded_url":"http://bit.ly/2K0HpjD","display_url":"bit.ly/2K0HpjD"},{"start":230,"end":253,"url":"https://t.co/TnhHMK8htP","expanded_url":"https://twitter.com/EMA_News/status/987277240311468032/video/1","display_url":"pic.twitter.com/TnhHMK8htP"}],"annotations":[{"start":142,"end":162,"probability":0.9069,"type":"Organization","normalized_text":"EU Innovation Network"}],"mentions":{}},"text":"Are you a European #SME or #research institute with innovative ideas in the #pharmaceutical sector? Find out from other SMEs how #EMA and the EU Innovation Network can support you to implement these ideas: https://t.co/VcjTO8N4yy https://t.co/TnhHMK8htP","attachments":{"media_keys":["7_987276289731121154"],"poll_ids":{}},"created_at":"2018-04-20T10:30:11.000Z","author_id":"116716199","lang":"en","conversation_id":"987277240311468032","possibly_sensitive":false,"id":"987277240311468032","source":"Twitter Web Client","public_metrics":{"retweet_count":19,"reply_count":1,"like_count":23,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":30,"end":40,"tag":"quinolone"},{"start":45,"end":61,"tag":"fluoroquinolone"},{"start":62,"end":74,"tag":"antibiotics"}],"urls":[{"start":191,"end":214,"url":"https://t.co/HJR5YQG4q9","expanded_url":"http://bit.ly/2GNfMsg","display_url":"bit.ly/2GNfMsg"},{"start":271,"end":294,"url":"https://t.co/cBPalBzYIw","expanded_url":"https://twitter.com/EMA_News/status/986880077110456320/photo/1","display_url":"pic.twitter.com/cBPalBzYIw"}],"annotations":{},"mentions":{}},"text":"Citizens will be consulted on #quinolone and #fluoroquinolone #antibiotics in a new public hearing at EMA. Those with relevant experience are invited to register no later than 30 April 2018: https://t.co/HJR5YQG4q9. For questions contact us: publichearings@ema.europa.eu https://t.co/cBPalBzYIw","attachments":{"media_keys":["3_986618515393273857"],"poll_ids":{}},"created_at":"2018-04-19T08:12:00.000Z","author_id":"116716199","lang":"en","conversation_id":"986880077110456320","possibly_sensitive":false,"id":"986880077110456320","source":"TweetDeck","public_metrics":{"retweet_count":11,"reply_count":1,"like_count":9,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":18,"end":27,"tag":"patients"},{"start":32,"end":56,"tag":"HealthcareProfessionals"}],"urls":[{"start":127,"end":150,"url":"https://t.co/T2RjE4b1Ey","expanded_url":"http://bit.ly/2J7kNNh","display_url":"bit.ly/2J7kNNh"},{"start":188,"end":211,"url":"https://t.co/zfrfo3f4hN","expanded_url":"http://bit.ly/265b5Si","display_url":"bit.ly/265b5Si"},{"start":212,"end":235,"url":"https://t.co/PLK9xpUza2","expanded_url":"https://twitter.com/EMA_News/status/986567519870730240/photo/1","display_url":"pic.twitter.com/PLK9xpUza2"}],"annotations":{},"mentions":{}},"text":"Did you know that #patients and #HealthcareProfessionals are involved in our decision-making process? See the full infographic https://t.co/T2RjE4b1Ey and how you can be part of our work: https://t.co/zfrfo3f4hN https://t.co/PLK9xpUza2","attachments":{"media_keys":["3_986554447877861376"],"poll_ids":{}},"created_at":"2018-04-18T11:30:00.000Z","author_id":"116716199","lang":"en","conversation_id":"986567519870730240","possibly_sensitive":false,"id":"986567519870730240","source":"TweetDeck","public_metrics":{"retweet_count":26,"reply_count":1,"like_count":26,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":16,"end":25,"tag":"patients"},{"start":38,"end":62,"tag":"HealthcareProfessionals"},{"start":67,"end":77,"tag":"academics"},{"start":93,"end":97,"tag":"EMA"}],"urls":[{"start":208,"end":231,"url":"https://t.co/T2RjE4sD38","expanded_url":"http://bit.ly/2J7kNNh","display_url":"bit.ly/2J7kNNh"},{"start":232,"end":255,"url":"https://t.co/t20EpQm0un","expanded_url":"https://twitter.com/EMA_News/status/986551324467712000/photo/1","display_url":"pic.twitter.com/t20EpQm0un"}],"annotations":{},"mentions":{}},"text":"Engagement with #patients, consumers, #HealthcareProfessionals and #academics is crucial for #EMA. In 2017, we had more than 900 activities involving patients and 445 activities for healthcare professionals: https://t.co/T2RjE4sD38 https://t.co/t20EpQm0un","attachments":{"media_keys":["3_986551232180445184"],"poll_ids":{}},"created_at":"2018-04-18T10:25:39.000Z","author_id":"116716199","lang":"en","conversation_id":"986551324467712000","possibly_sensitive":false,"id":"986551324467712000","source":"Twitter Web Client","public_metrics":{"retweet_count":52,"reply_count":0,"like_count":56,"quote_count":9},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":116,"end":123,"tag":"cancer"}],"urls":{},"annotations":[{"start":21,"end":34,"probability":0.9021,"type":"Person","normalized_text":"K. Apostolidis"}],"mentions":[{"start":3,"end":19,"username":"RafalSwierzewsk","id":"807251123254034432"},{"start":37,"end":43,"username":"kgapo","id":"187453356"},{"start":104,"end":113,"username":"EMA_News","id":"116716199"}]},"text":"RT @RafalSwierzewsk: K. Apostolidis (@kgapo) during her presentation in PCWP/HCPWP joint meeting in the @EMA_News: \"#cancer patients do not…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-04-17T14:38:18.000Z","author_id":"116716199","lang":"en","conversation_id":"986252515653115904","possibly_sensitive":false,"id":"986252515653115904","source":"TweetDeck","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"986248808064540672"}]},{"entities":{"hashtags":[{"start":86,"end":101,"tag":"WorldHealthDay"}],"urls":[{"start":58,"end":81,"url":"https://t.co/diw9q1EQDz","expanded_url":"http://data.europa.eu/euodp/","display_url":"data.europa.eu/euodp/"}],"annotations":{},"mentions":[{"start":3,"end":15,"username":"EU_opendata","id":"115660120"},{"start":123,"end":132,"username":"EMA_News","id":"116716199"}]},"text":"RT @EU_opendata: Growing number of datasets every year on https://t.co/diw9q1EQDz for #WorldHealthDay! Check datasets from @EMA_News, @ECDC…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-04-17T09:46:10.000Z","author_id":"116716199","lang":"en","conversation_id":"986178997947117568","possibly_sensitive":false,"id":"986178997947117568","source":"Twitter Web Client","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"981767158286954496"}]},{"entities":{"hashtags":[{"start":0,"end":8,"tag":"mHealth"}],"urls":[{"start":202,"end":225,"url":"https://t.co/500KK79UVg","expanded_url":"http://bit.ly/2JU0cwT","display_url":"bit.ly/2JU0cwT"}],"annotations":{},"mentions":{}},"text":"#mHealth, social media, real-world evidence and electronic product information are on the agenda of our meeting with patients’ and consumers’ organisations  and healthcare professionals’ organisations: https://t.co/500KK79UVg","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-04-17T09:39:48.000Z","author_id":"116716199","lang":"en","conversation_id":"986177397404897286","possibly_sensitive":false,"id":"986177397404897286","source":"Twitter Web Client","public_metrics":{"retweet_count":24,"reply_count":0,"like_count":34,"quote_count":3},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":91,"end":96,"tag":"ERNs"}],"urls":{},"annotations":[{"start":30,"end":35,"probability":0.6674,"type":"Place","normalized_text":"Europe"}],"mentions":[{"start":3,"end":15,"username":"_rarecancer","id":"2301430153"},{"start":55,"end":64,"username":"EMA_News","id":"116716199"}]},"text":"RT @_rarecancer: Rare Cancers Europe &amp; JARC at the @EMA_News today discussing the role #ERNs have to play in licensing process of new #rare…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-04-16T15:37:57.000Z","author_id":"116716199","lang":"en","conversation_id":"985905141588033538","possibly_sensitive":false,"id":"985905141588033538","source":"Twitter Web Client","public_metrics":{"retweet_count":18,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"985904697772003335"}]},{"entities":{"hashtags":{},"urls":[{"start":217,"end":240,"url":"https://t.co/k7LetizzbF","expanded_url":"http://bit.ly/2qBVIlX","display_url":"bit.ly/2qBVIlX"}],"annotations":{},"mentions":[{"start":0,"end":8,"username":"amm1036","id":"226290200"},{"start":9,"end":20,"username":"NovartisUK","id":"712956128284524544"}]},"text":"@amm1036 @NovartisUK Generally, Cosentyx should be stored in a refrigerator. If necessary, some preparations of the product can be left out. Detailed instructions for each presentation are in the product information: https://t.co/k7LetizzbF","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-04-16T13:27:54.000Z","author_id":"116716199","lang":"en","conversation_id":"983649296653471745","possibly_sensitive":false,"id":"985872412217618432","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"983649296653471745"}],"in_reply_to_user_id":"226290200"},{"entities":{"hashtags":[{"start":4,"end":22,"tag":"Pharmacovigilance"},{"start":56,"end":69,"tag":"methotrexate"},{"start":95,"end":100,"tag":"PRAC"}],"urls":[{"start":71,"end":94,"url":"https://t.co/YusIS9Jdyr","expanded_url":"http://bit.ly/2GTP6dj","display_url":"bit.ly/2GTP6dj"}],"annotations":{},"mentions":{}},"text":"Our #Pharmacovigilance Committee starts new referral on #methotrexate: https://t.co/YusIS9Jdyr #PRAC","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-04-13T11:22:56.000Z","author_id":"116716199","lang":"en","conversation_id":"984753798273957888","possibly_sensitive":false,"id":"984753798273957888","source":"Twitter Web Client","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":6,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":211,"end":234,"url":"https://t.co/pANbsIL6Wq","expanded_url":"http://bit.ly/2Hh8mRt","display_url":"bit.ly/2Hh8mRt"}],"annotations":{},"mentions":[{"start":10,"end":24,"username":"MHRAmedicines","id":"960436586"}]},"text":"@SALedlie @MHRAmedicines Alopecia is a common side effect of breast cancer for TAXOTERE, but evidence suggests that non-reversible alopecia is very rare. Check out the information about Taxotere on our website: https://t.co/pANbsIL6Wq","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-04-13T10:40:51.000Z","author_id":"116716199","lang":"en","conversation_id":"984728505563926528","possibly_sensitive":false,"id":"984743209313210369","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"984728505563926528"}],"in_reply_to_user_id":"2260435939"},{"entities":{"hashtags":[{"start":7,"end":11,"tag":"EMA"},{"start":75,"end":90,"tag":"pharmaceutical"}],"urls":[{"start":131,"end":154,"url":"https://t.co/qvln2orkxN","expanded_url":"http://bit.ly/2qs0diB","display_url":"bit.ly/2qs0diB"}],"annotations":{},"mentions":[{"start":155,"end":165,"username":"edqm_news","id":"2242197968"},{"start":166,"end":175,"username":"TGAgovau","id":"3800463014"},{"start":176,"end":183,"username":"US_FDA","id":"208120290"},{"start":184,"end":197,"username":"GovCanHealth","id":"36375825"},{"start":198,"end":202,"username":"WHO","id":"14499829"}]},"text":"How do #EMA and its partners increase oversight of manufacturing of active #pharmaceutical ingredients worldwide? Read the report: https://t.co/qvln2orkxN @edqm_news @TGAgovau @US_FDA @GovCanHealth @WHO","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-04-12T13:44:39.000Z","author_id":"116716199","lang":"en","conversation_id":"984427076106313729","possibly_sensitive":false,"id":"984427076106313729","source":"Twitter Web Client","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":10,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":175,"end":198,"url":"https://t.co/NiQIbYOx3Q","expanded_url":"http://bit.ly/2IMxIUB","display_url":"bit.ly/2IMxIUB"}],"annotations":[{"start":18,"end":19,"probability":0.6772,"type":"Place","normalized_text":"UK"}],"mentions":{}},"text":"Redistribution of UK’s portfolio of centrally authorised products: over 370 medicines have been transferred to new rapporteurs and co-rapporteurs from the EU27 Member States: https://t.co/NiQIbYOx3Q","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-04-11T13:27:37.000Z","author_id":"116716199","lang":"en","conversation_id":"984060401473253376","possibly_sensitive":false,"id":"984060401473253376","source":"Twitter Web Client","public_metrics":{"retweet_count":20,"reply_count":0,"like_count":9,"quote_count":11},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":82,"end":100,"tag":"pharmacovigilance"}],"urls":{},"annotations":{},"mentions":[{"start":3,"end":14,"username":"DIA_Europe","id":"271864727"}]},"text":"RT @DIA_Europe: \"We all have a responsibility to support development of effective #pharmacovigilance systems globally to protect patients a…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-04-11T08:58:40.000Z","author_id":"116716199","lang":"en","conversation_id":"983992718018973696","possibly_sensitive":false,"id":"983992718018973696","source":"Twitter Web Client","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"968084508129005568"}]},{"entities":{"hashtags":{},"urls":[{"start":218,"end":241,"url":"https://t.co/auXuay8uyT","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/003729/WC500183129.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"}],"annotations":{},"mentions":[{"start":0,"end":8,"username":"amm1036","id":"226290200"},{"start":9,"end":20,"username":"NovartisUK","id":"712956128284524544"},{"start":21,"end":36,"username":"MedicinesOrgUK","id":"35272047"}]},"text":"@amm1036 @NovartisUK @MedicinesOrgUK Generally, Cosentyx should be stored in a refrigerator. If necessary, some preparations of the product can be left out. Check out the product information for detailed instructions: https://t.co/auXuay8uyT","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-04-10T15:08:28.000Z","author_id":"116716199","lang":"en","conversation_id":"982773709428723714","possibly_sensitive":false,"id":"983723393169190912","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"982773709428723714"}],"in_reply_to_user_id":"226290200"},{"entities":{"hashtags":[{"start":31,"end":41,"tag":"quinolone"},{"start":46,"end":62,"tag":"fluoroquinolone"},{"start":63,"end":75,"tag":"antibiotics"},{"start":101,"end":118,"tag":"EMAPublicHearing"}],"urls":[{"start":77,"end":100,"url":"https://t.co/HJR5YQXFOJ","expanded_url":"http://bit.ly/2GNfMsg","display_url":"bit.ly/2GNfMsg"},{"start":119,"end":142,"url":"https://t.co/hiJhtbgWaX","expanded_url":"https://twitter.com/EMA_News/status/983321538391953408/photo/1","display_url":"pic.twitter.com/hiJhtbgWaX"}],"annotations":{},"mentions":{}},"text":"EU Citizens to be consulted on #quinolone and #fluoroquinolone #antibiotics: https://t.co/HJR5YQXFOJ #EMAPublicHearing https://t.co/hiJhtbgWaX","attachments":{"media_keys":["3_983321373551546369"],"poll_ids":{}},"created_at":"2018-04-09T12:31:38.000Z","author_id":"116716199","lang":"en","conversation_id":"983321538391953408","possibly_sensitive":false,"id":"983321538391953408","source":"Twitter Web Client","public_metrics":{"retweet_count":40,"reply_count":0,"like_count":28,"quote_count":7},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":{},"annotations":[{"start":19,"end":20,"probability":0.5875,"type":"Organization","normalized_text":"EU"},{"start":91,"end":96,"probability":0.9762,"type":"Place","normalized_text":"Europe"}],"mentions":[{"start":3,"end":17,"username":"EU_Commission","id":"157981564"}]},"text":"RT @EU_Commission: EU funding for research: €653 million for 269 senior researchers across Europe!\nMore on the projects, which include inno…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-04-06T11:53:33.000Z","author_id":"116716199","lang":"en","conversation_id":"982224791754043394","possibly_sensitive":false,"id":"982224791754043394","source":"TweetDeck","public_metrics":{"retweet_count":98,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"982199304323387392"}]},{"entities":{"hashtags":{},"urls":{},"annotations":{},"mentions":[{"start":3,"end":15,"username":"EU_opendata","id":"115660120"},{"start":89,"end":99,"username":"EU_Health","id":"606325697"},{"start":100,"end":109,"username":"EMA_News","id":"116716199"},{"start":110,"end":118,"username":"ECDC_EU","id":"204752573"},{"start":119,"end":127,"username":"EU_OSHA","id":"23600999"}]},"text":"RT @EU_opendata: Can't find what you want? Let us know! We're making EU health data from @EU_Health @EMA_News @ECDC_EU @EU_OSHA @EU_Eurosta…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-04-06T07:51:17.000Z","author_id":"116716199","lang":"en","conversation_id":"982163820851245058","possibly_sensitive":false,"id":"982163820851245058","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"982163032871600129"}]},{"entities":{"hashtags":[{"start":41,"end":53,"tag":"antibiotics"},{"start":85,"end":89,"tag":"AMR"}],"urls":{},"annotations":{},"mentions":[{"start":3,"end":16,"username":"HAImedicines","id":"429122255"}]},"text":"RT @HAImedicines: The unnecessary use of #antibiotics and associated rapid growth of #AMR is a widely acknowledged crisis and threat to glo…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-04-05T12:42:35.000Z","author_id":"116716199","lang":"en","conversation_id":"981874743837184000","possibly_sensitive":false,"id":"981874743837184000","source":"TweetDeck","public_metrics":{"retweet_count":34,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"981873957531013120"}]},{"entities":{"hashtags":[{"start":224,"end":228,"tag":"AMR"}],"urls":[{"start":229,"end":252,"url":"https://t.co/whXI3SSf19","expanded_url":"http://bit.ly/1RWYdTr","display_url":"bit.ly/1RWYdTr"},{"start":253,"end":276,"url":"https://t.co/ZebdAFwNVw","expanded_url":"https://twitter.com/EMA_News/status/981843896379629568/photo/1","display_url":"pic.twitter.com/ZebdAFwNVw"}],"annotations":[{"start":203,"end":208,"probability":0.9968,"type":"Place","normalized_text":"Europe"}],"mentions":{}},"text":"The European Surveillance of Veterinary Antimicrobial Consumption (ESVAC) project had its annual meeting. 30 countries working together to collect robust data on consumption of antibiotics in animals in Europe to help fight #AMR https://t.co/whXI3SSf19 https://t.co/ZebdAFwNVw","attachments":{"media_keys":["3_981832776981893121"],"poll_ids":{}},"created_at":"2018-04-05T10:40:01.000Z","author_id":"116716199","lang":"en","conversation_id":"981843896379629568","possibly_sensitive":false,"id":"981843896379629568","source":"TweetDeck","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":13,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":{},"annotations":{},"mentions":[{"start":3,"end":12,"username":"EUnetHTA","id":"56493220"},{"start":123,"end":132,"username":"EMA_News","id":"116716199"}]},"text":"RT @EUnetHTA: Learn about EUnetHTA Early Dialogues Multi-HTA and Parallel Consultations with the European Medicines Agency @EMA_News @HAS_s…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-03-27T09:47:23.000Z","author_id":"116716199","lang":"en","conversation_id":"978569161495515136","possibly_sensitive":false,"id":"978569161495515136","source":"TweetDeck","public_metrics":{"retweet_count":26,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"978568569729507328"}]},{"entities":{"hashtags":[{"start":15,"end":24,"tag":"EUbudget"}],"urls":{},"annotations":[{"start":59,"end":64,"probability":0.9912,"type":"Place","normalized_text":"Europe"}],"mentions":[{"start":3,"end":13,"username":"EU_Budget","id":"392741474"}]},"text":"RT @EU_Budget: #EUbudget finances research &amp; innovation in Europe with almost EUR 75 billion (2014-2020).Take a view on the playlist of #Ho…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-03-27T07:54:15.000Z","author_id":"116716199","lang":"en","conversation_id":"978540691168079872","possibly_sensitive":false,"id":"978540691168079872","source":"TweetDeck","public_metrics":{"retweet_count":23,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"978539835802750978"}]},{"entities":{"hashtags":[{"start":35,"end":56,"tag":"DigestiveHealthMonth"}],"urls":{},"annotations":{},"mentions":[{"start":3,"end":10,"username":"my_ueg","id":"487344065"}]},"text":"RT @my_ueg: Join us in celebrating #DigestiveHealthMonth this May 2018! UEG is promoting a range of activities to raise awareness of a vari…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-03-26T13:37:58.000Z","author_id":"116716199","lang":"en","conversation_id":"978264802995908609","possibly_sensitive":false,"id":"978264802995908609","source":"Twitter Web Client","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"978174734490796032"}]},{"entities":{"hashtags":{},"urls":{},"annotations":{},"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}]},"text":"RT @eurordis: One week left tell us what you think about the protection and sharing of your personal health information! Join the #RareBaro…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-03-26T10:13:30.000Z","author_id":"116716199","lang":"en","conversation_id":"978213343931654144","possibly_sensitive":false,"id":"978213343931654144","source":"Twitter Web Client","public_metrics":{"retweet_count":28,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"977530666249269248"}]},{"entities":{"hashtags":[{"start":14,"end":17,"tag":"EU"},{"start":57,"end":68,"tag":"FluVaccine"}],"urls":[{"start":82,"end":105,"url":"https://t.co/YuDJ7hYvEM","expanded_url":"http://bit.ly/2IV02oG","display_url":"bit.ly/2IV02oG"}],"annotations":{},"mentions":{}},"text":"Check out the #EU recommendations for 2018/2019 seasonal #FluVaccine composition: https://t.co/YuDJ7hYvEM","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-03-26T09:43:46.000Z","author_id":"116716199","lang":"en","conversation_id":"978205863390433280","possibly_sensitive":false,"id":"978205863390433280","source":"Twitter Web Client","public_metrics":{"retweet_count":13,"reply_count":1,"like_count":9,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":78,"end":101,"url":"https://t.co/b8TVM0VLLA","expanded_url":"https://twitter.com/EASA/status/976734980243107841","display_url":"twitter.com/EASA/status/97…"}],"annotations":{},"mentions":{}},"text":"Take a look at what our sister Agency is doing to ensure that flying is safe. https://t.co/b8TVM0VLLA","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-03-24T11:30:00.000Z","author_id":"116716199","lang":"en","conversation_id":"977507820777156609","possibly_sensitive":false,"id":"977507820777156609","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":1,"like_count":14,"quote_count":2},"referenced_tweets":[{"type":"quoted","id":"976734980243107841"}]},{"entities":{"hashtags":[{"start":16,"end":21,"tag":"WPIW"},{"start":87,"end":113,"tag":"primaryimmunodeficiencies"}],"urls":{},"annotations":{},"mentions":[{"start":3,"end":14,"username":"ipopi_info","id":"1117085011"},{"start":122,"end":134,"username":"WorldPIWeek","id":"1068116664"}]},"text":"RT @ipopi_info: #WPIW video is out! Share widely &amp; spread the word! \nEducate about #primaryimmunodeficiencies on this @worldpiweek  https:/…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-03-23T15:41:12.000Z","author_id":"116716199","lang":"en","conversation_id":"977208649826357248","possibly_sensitive":false,"id":"977208649826357248","source":"Twitter Web Client","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"977205585476247553"}]},{"entities":{"hashtags":[{"start":60,"end":70,"tag":"valproate"},{"start":178,"end":182,"tag":"EMA"}],"urls":[{"start":199,"end":222,"url":"https://t.co/4Bh3zmcIvv","expanded_url":"http://bit.ly/2IMq3X8","display_url":"bit.ly/2IMq3X8"}],"annotations":{},"mentions":{}},"text":"Member State representatives agree on new measures to avoid #valproate exposure in pregnancy. These measures took into account views expressed by the general public in the first #EMA public hearing: https://t.co/4Bh3zmcIvv","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-03-23T13:32:35.000Z","author_id":"116716199","lang":"en","conversation_id":"977176283770707968","possibly_sensitive":false,"id":"977176283770707968","source":"Twitter Web Client","public_metrics":{"retweet_count":36,"reply_count":1,"like_count":30,"quote_count":9},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":0,"end":5,"tag":"CHMP"},{"start":19,"end":29,"tag":"medicines"}],"urls":[{"start":69,"end":92,"url":"https://t.co/GUWZw6WRBd","expanded_url":"https://bit.ly/2G0h1YI","display_url":"bit.ly/2G0h1YI"},{"start":93,"end":116,"url":"https://t.co/v3ERejrJ4b","expanded_url":"https://twitter.com/EMA_News/status/977164307245903872/photo/1","display_url":"pic.twitter.com/v3ERejrJ4b"}],"annotations":{},"mentions":{}},"text":"#CHMP recommends 6 #medicines for approval at its March 2018 meeting https://t.co/GUWZw6WRBd https://t.co/v3ERejrJ4b","attachments":{"media_keys":["3_977162914292527104"],"poll_ids":{}},"created_at":"2018-03-23T12:45:00.000Z","author_id":"116716199","lang":"en","conversation_id":"977164307245903872","possibly_sensitive":false,"id":"977164307245903872","source":"TweetDeck","public_metrics":{"retweet_count":28,"reply_count":0,"like_count":18,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":23,"end":35,"tag":"SideEffects"},{"start":39,"end":50,"tag":"veterinary"},{"start":51,"end":61,"tag":"medicines"},{"start":146,"end":164,"tag":"pharmacovigilance"}],"urls":[{"start":177,"end":200,"url":"https://t.co/supnZXhpfe","expanded_url":"http://bit.ly/2pxsFzf","display_url":"bit.ly/2pxsFzf"},{"start":201,"end":224,"url":"https://t.co/NtWgXl1e39","expanded_url":"https://twitter.com/EMA_News/status/976846288988917760/photo/1","display_url":"pic.twitter.com/NtWgXl1e39"}],"annotations":{},"mentions":{}},"text":"Increased reporting of #SideEffects of #veterinary #medicines helps to protect animal and human health. See our annual bulletin on the veterinary #pharmacovigilance activities: https://t.co/supnZXhpfe https://t.co/NtWgXl1e39","attachments":{"media_keys":["3_976845530541297665"],"poll_ids":{}},"created_at":"2018-03-22T15:41:18.000Z","author_id":"116716199","lang":"en","conversation_id":"976846288988917760","possibly_sensitive":false,"id":"976846288988917760","source":"Twitter Web Client","public_metrics":{"retweet_count":14,"reply_count":1,"like_count":11,"quote_count":5},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":24,"end":36,"tag":"raredisease"}],"urls":{},"annotations":{},"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}]},"text":"RT @eurordis: Are you a #raredisease patient, family member or carer? Help us understand your views on the sharing and protection of your h…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-03-22T15:04:15.000Z","author_id":"116716199","lang":"en","conversation_id":"976836963914387456","possibly_sensitive":false,"id":"976836963914387456","source":"Twitter Web Client","public_metrics":{"retweet_count":22,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"976836056560668672"}]},{"entities":{"hashtags":[{"start":55,"end":69,"tag":"CallForTender"},{"start":95,"end":106,"tag":"consultant"}],"urls":{},"annotations":{},"mentions":[{"start":3,"end":19,"username":"eupatientsforum","id":"545343465"}]},"text":"RT @eupatientsforum: CALL FOR TENDER! 📢\nEPF launched a #CallForTender to select a professional #consultant to conduct research, analyse dat…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-03-22T11:45:25.000Z","author_id":"116716199","lang":"en","conversation_id":"976786925536325637","possibly_sensitive":false,"id":"976786925536325637","source":"Twitter Web Client","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"976779068023672834"}]},{"entities":{"hashtags":[{"start":28,"end":37,"tag":"pharmacy"},{"start":70,"end":90,"tag":"HospitalPharmacists"}],"urls":{},"annotations":{},"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"},{"start":94,"end":98,"username":"WHO","id":"14499829"}]},"text":"RT @EAHPtweet: The ghost of #pharmacy future highlighting the role of #HospitalPharmacists in @WHO's medication without harm challenge #EAH…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-03-22T11:13:25.000Z","author_id":"116716199","lang":"en","conversation_id":"976778871218503686","possibly_sensitive":false,"id":"976778871218503686","source":"TweetDeck","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"976769672791183360"}]},{"entities":{"hashtags":[{"start":100,"end":104,"tag":"AMR"},{"start":113,"end":116,"tag":"EU"},{"start":117,"end":124,"tag":"Health"}],"urls":{},"annotations":[{"start":53,"end":66,"probability":0.5089,"type":"Organization","normalized_text":"EPHA-led Joint"}],"mentions":[{"start":3,"end":11,"username":"EPHA_EU","id":"184756856"}]},"text":"RT @EPHA_EU: Over 40 organisations have endorsed the EPHA-led Joint statement and Call to Action on #AMR for the #EU #Health Policy platfor…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-03-22T09:44:13.000Z","author_id":"116716199","lang":"en","conversation_id":"976756423702056961","possibly_sensitive":false,"id":"976756423702056961","source":"Twitter Web Client","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"976737810601398272"}]},{"entities":{"hashtags":[{"start":51,"end":60,"tag":"patients"},{"start":66,"end":79,"tag":"rarediseases"}],"urls":{},"annotations":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}]},"text":"RT @EU_Health: Committed to improving the lives of #patients with #rarediseases: today we are reaching a total of 2000 designations of orph…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-03-21T18:08:24.000Z","author_id":"116716199","lang":"en","conversation_id":"976520916640428034","possibly_sensitive":false,"id":"976520916640428034","source":"Twitter Web Client","public_metrics":{"retweet_count":39,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"976499318092857344"}]},{"entities":{"hashtags":[{"start":128,"end":136,"tag":"cancers"}],"urls":{},"annotations":{},"mentions":[{"start":3,"end":18,"username":"V_Andriukaitis","id":"575269517"}]},"text":"RT @V_Andriukaitis: When we consider the advances in adult oncology, I feel that we have not made the same progress in treating #cancers th…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-03-21T14:16:29.000Z","author_id":"116716199","lang":"en","conversation_id":"976462553621594112","possibly_sensitive":false,"id":"976462553621594112","source":"Twitter Web Client","public_metrics":{"retweet_count":19,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"976435780389363712"}]},{"entities":{"hashtags":{},"urls":{},"annotations":{},"mentions":[{"start":3,"end":12,"username":"cancereu","id":"140344419"}]},"text":"RT @cancereu: Nutrition and Physical Activity are crucial components of cancer treatment and rehabilitation! Always ask your cancer care te…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-03-20T14:06:32.000Z","author_id":"116716199","lang":"en","conversation_id":"976097660905099265","possibly_sensitive":false,"id":"976097660905099265","source":"Twitter Web Client","public_metrics":{"retweet_count":19,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"976096032038666242"}]},{"entities":{"hashtags":[{"start":38,"end":46,"tag":"Ireland"},{"start":72,"end":83,"tag":"biomarkers"},{"start":112,"end":122,"tag":"Alzheimer"}],"urls":{},"annotations":{},"mentions":[{"start":3,"end":19,"username":"AlzheimerEurope","id":"1536274003"},{"start":48,"end":57,"username":"RCSI_Irl","id":"45535365"}]},"text":"RT @AlzheimerEurope: Researchers from #Ireland (@RCSI_Irl) identify new #biomarkers, that could help to improve #Alzheimer’s disease diagno…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-03-20T10:47:55.000Z","author_id":"116716199","lang":"en","conversation_id":"976047679217205249","possibly_sensitive":false,"id":"976047679217205249","source":"Twitter Web Client","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"976017299491745792"}]},{"entities":{"hashtags":[{"start":19,"end":28,"tag":"children"},{"start":31,"end":41,"tag":"medicines"},{"start":117,"end":120,"tag":"EU"},{"start":121,"end":132,"tag":"Paediatric"}],"urls":{},"annotations":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}]},"text":"RT @EU_Health: 260 #children's #medicines developed in the past 10 ys - key findings of our report on progress since #EU #Paediatric Regula…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-03-20T10:12:32.000Z","author_id":"116716199","lang":"en","conversation_id":"976038773891923968","possibly_sensitive":false,"id":"976038773891923968","source":"Twitter Web Client","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"976035572224438273"}]},{"entities":{"hashtags":[{"start":83,"end":93,"tag":"medicines"}],"urls":[{"start":108,"end":131,"url":"https://t.co/lxorBmvkfo","expanded_url":"http://bit.ly/2FUULeL","display_url":"bit.ly/2FUULeL"},{"start":132,"end":155,"url":"https://t.co/HnPTfYwpbm","expanded_url":"https://twitter.com/EMA_News/status/976025585452503040/photo/1","display_url":"pic.twitter.com/HnPTfYwpbm"}],"annotations":{},"mentions":{}},"text":"Follow the live broadcast of our workshop today on how to boost the development of #medicines for children: https://t.co/lxorBmvkfo https://t.co/HnPTfYwpbm","attachments":{"media_keys":["16_976025332515033088"],"poll_ids":{}},"created_at":"2018-03-20T09:20:07.000Z","author_id":"116716199","lang":"en","conversation_id":"976025585452503040","possibly_sensitive":false,"id":"976025585452503040","source":"TweetDeck","public_metrics":{"retweet_count":16,"reply_count":0,"like_count":14,"quote_count":3},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":69,"end":79,"tag":"medicines"},{"start":105,"end":110,"tag":"CHMP"}],"urls":[{"start":81,"end":104,"url":"https://t.co/FUCZFosagu","expanded_url":"http://bit.ly/2HNINnT","display_url":"bit.ly/2HNINnT"}],"annotations":{},"mentions":{}},"text":"What’s on the agenda of the March meeting of our committee for human #medicines? https://t.co/FUCZFosagu #CHMP","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-03-19T13:55:00.000Z","author_id":"116716199","lang":"en","conversation_id":"975732372145606657","possibly_sensitive":false,"id":"975732372145606657","source":"TweetDeck","public_metrics":{"retweet_count":11,"reply_count":3,"like_count":11,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":102,"end":125,"url":"https://t.co/c3ZRJNNBYX","expanded_url":"http://bit.ly/2ppye3q","display_url":"bit.ly/2ppye3q"},{"start":170,"end":193,"url":"https://t.co/5rPpgl72kX","expanded_url":"http://bit.ly/2tR3A7S","display_url":"bit.ly/2tR3A7S"},{"start":195,"end":218,"url":"https://t.co/BK6dldXvY2","expanded_url":"https://twitter.com/EMA_News/status/975688866698027013/photo/1","display_url":"pic.twitter.com/BK6dldXvY2"}],"annotations":{},"mentions":{}},"text":"Follow the discussion on how to boost development of medicines for children at our workshop tomorrow: https://t.co/c3ZRJNNBYX. The live broadcast will be available here: https://t.co/5rPpgl72kX. https://t.co/BK6dldXvY2","attachments":{"media_keys":["3_975688594185695232"],"poll_ids":{}},"created_at":"2018-03-19T11:02:07.000Z","author_id":"116716199","lang":"en","conversation_id":"975688866698027013","possibly_sensitive":false,"id":"975688866698027013","source":"Twitter Web Client","public_metrics":{"retweet_count":18,"reply_count":0,"like_count":26,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":74,"end":97,"url":"https://t.co/qddYmTE6G9","expanded_url":"http://data.europa.eu/euodp","display_url":"data.europa.eu/euodp"}],"annotations":{},"mentions":[{"start":3,"end":15,"username":"EU_opendata","id":"115660120"}]},"text":"RT @EU_opendata: Question! From which of the following data publishers on https://t.co/qddYmTE6G9 can you find the highest number of datase…","attachments":{"media_keys":{},"poll_ids":["974599014447550464"]},"created_at":"2018-03-16T17:25:29.000Z","author_id":"116716199","lang":"en","conversation_id":"974698177852051456","possibly_sensitive":false,"id":"974698177852051456","source":"Twitter Web Client","public_metrics":{"retweet_count":32,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"974599016058097664"}]},{"entities":{"hashtags":{},"urls":[{"start":72,"end":95,"url":"https://t.co/gCa7cSarna","expanded_url":"http://bit.ly/2tRUx6D","display_url":"bit.ly/2tRUx6D"}],"annotations":{},"mentions":{}},"text":"Check out the highlights of this week's meeting of our Management Board https://t.co/gCa7cSarna","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-03-16T10:55:24.000Z","author_id":"116716199","lang":"en","conversation_id":"974600010238189570","possibly_sensitive":false,"id":"974600010238189570","source":"TweetDeck","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":13,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":19,"end":29,"tag":"chemicals"},{"start":41,"end":50,"tag":"products"},{"start":113,"end":122,"tag":"diseases"},{"start":128,"end":138,"tag":"allergies"}],"urls":{},"annotations":{},"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}]},"text":"RT @EU_ECHA: Which #chemicals are in the #products you buy? What are their \nbenefits? Are some chemicals causing #diseases like #allergies…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-03-15T13:27:20.000Z","author_id":"116716199","lang":"en","conversation_id":"974275858168012800","possibly_sensitive":false,"id":"974275858168012800","source":"Twitter Web Client","public_metrics":{"retweet_count":92,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"974236194585407490"}]},{"entities":{"hashtags":[{"start":36,"end":54,"tag":"Pharmacovigilance"},{"start":112,"end":121,"tag":"Zinbryta"},{"start":126,"end":133,"tag":"Xofigo"},{"start":190,"end":200,"tag":"quinolone"},{"start":205,"end":221,"tag":"fluoroquinolone"},{"start":222,"end":234,"tag":"antibiotics"}],"urls":[{"start":235,"end":258,"url":"https://t.co/z2hKidnYzW","expanded_url":"http://bit.ly/2Ft8qcI","display_url":"bit.ly/2Ft8qcI"}],"annotations":{},"mentions":{}},"text":"See the meeting highlights from our #Pharmacovigilance Risk Assessment Committee: immediate measures agreed for #Zinbryta and #Xofigo while reviews are ongoing; a public hearing decided for #quinolone and #fluoroquinolone #antibiotics https://t.co/z2hKidnYzW","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-03-09T13:31:09.000Z","author_id":"116716199","lang":"en","conversation_id":"972102491184779265","possibly_sensitive":false,"id":"972102491184779265","source":"Twitter Web Client","public_metrics":{"retweet_count":18,"reply_count":0,"like_count":11,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":210,"end":227,"tag":"EMAInternational"}],"urls":[{"start":248,"end":271,"url":"https://t.co/1Y9O15l6XW","expanded_url":"http://bit.ly/2DgMYHt","display_url":"bit.ly/2DgMYHt"},{"start":272,"end":295,"url":"https://t.co/R8dmxLrZ4b","expanded_url":"https://twitter.com/EMA_News/status/972034177565642752/photo/1","display_url":"pic.twitter.com/R8dmxLrZ4b"}],"annotations":{},"mentions":{}},"text":"The first day of the international awareness session for NGOs, academia and international regulators was a success! Do not miss the live broadcast of the second day and get involved in discussions by using the #EMAInternational hashtag to comment. https://t.co/1Y9O15l6XW https://t.co/R8dmxLrZ4b","attachments":{"media_keys":["3_972033932098142208"],"poll_ids":{}},"created_at":"2018-03-09T08:59:42.000Z","author_id":"116716199","lang":"en","conversation_id":"972034177565642752","possibly_sensitive":false,"id":"972034177565642752","source":"Twitter Web Client","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":22,"quote_count":3},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":3,"end":26,"tag":"InternationalWomensDay"},{"start":28,"end":39,"tag":"EUagencies"},{"start":63,"end":80,"tag":"sexualharassment"}],"urls":[{"start":125,"end":148,"url":"https://t.co/wi5Ewgzb87","expanded_url":"http://bit.ly/2I8ahFy","display_url":"bit.ly/2I8ahFy"},{"start":149,"end":172,"url":"https://t.co/4OhQ7j1fTY","expanded_url":"https://twitter.com/EMA_News/status/971698472435974145/photo/1","display_url":"pic.twitter.com/4OhQ7j1fTY"}],"annotations":{},"mentions":{}},"text":"On #InternationalWomensDay, #EUagencies stand together against #sexualharassment in the workplace. Read the joint statement: https://t.co/wi5Ewgzb87 https://t.co/4OhQ7j1fTY","attachments":{"media_keys":["3_971697378851020801"],"poll_ids":{}},"created_at":"2018-03-08T10:45:43.000Z","author_id":"116716199","lang":"en","conversation_id":"971698472435974145","possibly_sensitive":false,"id":"971698472435974145","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":10,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":198,"end":215,"tag":"EMAInternational"}],"urls":[{"start":137,"end":160,"url":"https://t.co/1Y9O15l6XW","expanded_url":"http://bit.ly/2DgMYHt","display_url":"bit.ly/2DgMYHt"},{"start":225,"end":248,"url":"https://t.co/wQ7vlIMc34","expanded_url":"https://twitter.com/EMA_News/status/971669882738806784/photo/1","display_url":"pic.twitter.com/wQ7vlIMc34"}],"annotations":{},"mentions":{}},"text":"Don’t forget to follow the live broadcast of the second international awareness session for NGOs, academia and international regulators: https://t.co/1Y9O15l6XW. Engage in conversation by using the #EMAInternational hashtag. https://t.co/wQ7vlIMc34","attachments":{"media_keys":["3_971669696679464960"],"poll_ids":{}},"created_at":"2018-03-08T08:52:07.000Z","author_id":"116716199","lang":"en","conversation_id":"971669882738806784","possibly_sensitive":false,"id":"971669882738806784","source":"Twitter Web Client","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":16,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":50,"end":68,"tag":"MultipleSclerosis"}],"urls":[{"start":108,"end":131,"url":"https://t.co/BDClORWtyU","expanded_url":"http://bit.ly/2oWAUEF","display_url":"bit.ly/2oWAUEF"}],"annotations":[{"start":0,"end":2,"probability":0.5801,"type":"Organization","normalized_text":"EMA"}],"mentions":{}},"text":"EMA recommends immediate suspension and recall of #MultipleSclerosis medicine Zinbryta. Find out more here: https://t.co/BDClORWtyU","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-03-07T14:04:55.000Z","author_id":"116716199","lang":"en","conversation_id":"971386214241718278","possibly_sensitive":false,"id":"971386214241718278","source":"Twitter Web Client","public_metrics":{"retweet_count":57,"reply_count":0,"like_count":21,"quote_count":8},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":196,"end":213,"tag":"EMAInternational"}],"urls":[{"start":112,"end":135,"url":"https://t.co/1Y9O15l6XW","expanded_url":"http://bit.ly/2DgMYHt","display_url":"bit.ly/2DgMYHt"},{"start":253,"end":276,"url":"https://t.co/vv2PUBay5V","expanded_url":"https://twitter.com/EMA_News/status/971040910409650178/photo/1","display_url":"pic.twitter.com/vv2PUBay5V"}],"annotations":{},"mentions":{}},"text":"The second international awareness session is taking place on 8-9 March. You can watch the live broadcast here: https://t.co/1Y9O15l6XW. The agenda is available under the ‘Documents’ tab. Use the #EMAInternational hashtag to engage in the conversation. https://t.co/vv2PUBay5V","attachments":{"media_keys":["3_971039969753133059"],"poll_ids":{}},"created_at":"2018-03-06T15:12:48.000Z","author_id":"116716199","lang":"en","conversation_id":"971040910409650178","possibly_sensitive":false,"id":"971040910409650178","source":"Twitter Web Client","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":7,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":29,"end":47,"tag":"Pharmacovigilance"},{"start":127,"end":132,"tag":"PRAC"}],"urls":[{"start":103,"end":126,"url":"https://t.co/H6f8H7cg20","expanded_url":"http://bit.ly/2FcemuO","display_url":"bit.ly/2FcemuO"}],"annotations":{},"mentions":{}},"text":"What is on the agenda of our #Pharmacovigilance Committee's meeting in March? You can consult it here: https://t.co/H6f8H7cg20 #PRAC","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-03-05T13:59:14.000Z","author_id":"116716199","lang":"en","conversation_id":"970660006352826368","possibly_sensitive":false,"id":"970660006352826368","source":"Twitter Web Client","public_metrics":{"retweet_count":23,"reply_count":0,"like_count":17,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":10,"end":14,"tag":"EMA"}],"urls":[{"start":68,"end":91,"url":"https://t.co/Ww7qDkijeW","expanded_url":"http://bit.ly/2Fgt1EY","display_url":"bit.ly/2Fgt1EY"},{"start":92,"end":115,"url":"https://t.co/uqXjzgOgS6","expanded_url":"https://twitter.com/EMA_News/status/970608221772754949/photo/1","display_url":"pic.twitter.com/uqXjzgOgS6"}],"annotations":[{"start":58,"end":66,"probability":0.9927,"type":"Place","normalized_text":"Amsterdam"}],"mentions":{}},"text":"Check out #EMA 's new tracking tool for its relocation to Amsterdam https://t.co/Ww7qDkijeW https://t.co/uqXjzgOgS6","attachments":{"media_keys":["3_970607611048493056"],"poll_ids":{}},"created_at":"2018-03-05T10:33:27.000Z","author_id":"116716199","lang":"en","conversation_id":"970608221772754949","possibly_sensitive":false,"id":"970608221772754949","source":"TweetDeck","public_metrics":{"retweet_count":92,"reply_count":1,"like_count":79,"quote_count":15},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":126,"end":132,"tag":"PRIME"},{"start":191,"end":196,"tag":"CHMP"}],"urls":[{"start":167,"end":190,"url":"https://t.co/d3woq9PFHN","expanded_url":"http://bit.ly/2oKBGol","display_url":"bit.ly/2oKBGol"},{"start":197,"end":220,"url":"https://t.co/BAZJsKFRB1","expanded_url":"https://twitter.com/EMA_News/status/969598578057506816/photo/1","display_url":"pic.twitter.com/BAZJsKFRB1"}],"annotations":{},"mentions":{}},"text":"During its Feb 2018 meeting, our Committee for Medicinal Products for Human Use reviewed 6 recommendations for eligibility to #PRIME: 1 was granted and 5 were denied: https://t.co/d3woq9PFHN #CHMP https://t.co/BAZJsKFRB1","attachments":{"media_keys":["3_969598430644498432"],"poll_ids":{}},"created_at":"2018-03-02T15:41:29.000Z","author_id":"116716199","lang":"en","conversation_id":"969598578057506816","possibly_sensitive":false,"id":"969598578057506816","source":"Twitter Web Client","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":7,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":0,"end":4,"tag":"EMA"},{"start":8,"end":18,"tag":"NowHiring"},{"start":50,"end":53,"tag":"HR"},{"start":76,"end":88,"tag":"recruitment"},{"start":254,"end":261,"tag":"EUjobs"},{"start":262,"end":269,"tag":"HRjobs"}],"urls":[{"start":230,"end":253,"url":"https://t.co/ByhOGRYYip","expanded_url":"http://bit.ly/2GWfbE7","display_url":"bit.ly/2GWfbE7"},{"start":270,"end":293,"url":"https://t.co/mJHwvFpMdL","expanded_url":"https://twitter.com/EMA_News/status/969575836969029633/photo/1","display_url":"pic.twitter.com/mJHwvFpMdL"}],"annotations":{},"mentions":{}},"text":"#EMA is #NowHiring! We are looking for a talented #HR expert specialised in #recruitment processes and resourcing models. Read more if you want to work in a stimulating environment with equal opportunities and attractive rewards: https://t.co/ByhOGRYYip\n#EUjobs #HRjobs https://t.co/mJHwvFpMdL","attachments":{"media_keys":["16_969575352979910657"],"poll_ids":{}},"created_at":"2018-03-02T14:11:08.000Z","author_id":"116716199","lang":"en","conversation_id":"969575836969029633","possibly_sensitive":false,"id":"969575836969029633","source":"Twitter Web Client","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":8,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":15,"end":18,"tag":"EU"},{"start":19,"end":22,"tag":"US"},{"start":64,"end":74,"tag":"medicines"}],"urls":{},"annotations":[{"start":23,"end":25,"probability":0.8071,"type":"Organization","normalized_text":"FDA"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}]},"text":"RT @EU_Health: #EU-#US FDA mutual recognition of inspections of #medicines manufacturers enters operational phase - so far drug manufacturi…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-03-02T11:51:42.000Z","author_id":"116716199","lang":"en","conversation_id":"969540751100203010","possibly_sensitive":false,"id":"969540751100203010","source":"Twitter Web Client","public_metrics":{"retweet_count":18,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"969266498551369728"}]},{"entities":{"hashtags":[{"start":7,"end":10,"tag":"EU"},{"start":114,"end":118,"tag":"GMP"}],"urls":[{"start":90,"end":113,"url":"https://t.co/rExR6bNjwE","expanded_url":"http://bit.ly/2CQ9Iwf","display_url":"bit.ly/2CQ9Iwf"}],"annotations":[{"start":38,"end":42,"probability":0.4273,"type":"Organization","normalized_text":"EU-US"}],"mentions":[{"start":119,"end":126,"username":"US_FDA","id":"208120290"},{"start":127,"end":137,"username":"EU_Health","id":"606325697"}]},"text":"4 more #EU Member States benefit from EU-US mutual recognition agreement for inspections: https://t.co/rExR6bNjwE #GMP @US_FDA @EU_Health","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-03-01T15:42:10.000Z","author_id":"116716199","lang":"en","conversation_id":"969236358647701504","possibly_sensitive":false,"id":"969236358647701504","source":"Twitter Web Client","public_metrics":{"retweet_count":10,"reply_count":1,"like_count":12,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":47,"end":58,"tag":"Veterinary"},{"start":59,"end":69,"tag":"Medicines"},{"start":95,"end":99,"tag":"EMA"}],"urls":[{"start":71,"end":94,"url":"https://t.co/guGyrMRB8M","expanded_url":"http://bit.ly/2F5zX84","display_url":"bit.ly/2F5zX84"}],"annotations":[{"start":0,"end":24,"probability":0.8383,"type":"Organization","normalized_text":"European Medicines Agency"}],"mentions":{}},"text":"European Medicines Agency welcomes new Head of #Veterinary #Medicines: https://t.co/guGyrMRB8M\n#EMA","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-03-01T13:15:00.000Z","author_id":"116716199","lang":"en","conversation_id":"969199324650291200","possibly_sensitive":false,"id":"969199324650291200","source":"TweetDeck","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":2,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":61,"end":65,"tag":"EMA"}],"urls":[{"start":106,"end":129,"url":"https://t.co/VMn7q4hkZm","expanded_url":"http://bit.ly/2CPGY6W","display_url":"bit.ly/2CPGY6W"}],"annotations":[{"start":95,"end":103,"probability":0.9917,"type":"Place","normalized_text":"Amsterdam"}],"mentions":{}},"text":"Our Management Board initiates building approval process for #EMA ’s new permanent premises in Amsterdam: https://t.co/VMn7q4hkZm","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-03-01T11:41:24.000Z","author_id":"116716199","lang":"en","conversation_id":"969175769795710977","possibly_sensitive":false,"id":"969175769795710977","source":"Twitter Web Client","public_metrics":{"retweet_count":21,"reply_count":2,"like_count":12,"quote_count":5},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":84,"end":94,"tag":"NowHiring"},{"start":243,"end":250,"tag":"EUjobs"},{"start":251,"end":260,"tag":"Techjobs"},{"start":261,"end":268,"tag":"ITjobs"}],"urls":[{"start":156,"end":179,"url":"https://t.co/dS0bCbnh2t","expanded_url":"http://bit.ly/2oHTxML","display_url":"bit.ly/2oHTxML"},{"start":217,"end":240,"url":"https://t.co/zDg4T9onns","expanded_url":"http://bit.ly/2ovW3Gh","display_url":"bit.ly/2ovW3Gh"},{"start":269,"end":292,"url":"https://t.co/YtcQyLpRWT","expanded_url":"https://twitter.com/EMA_News/status/969158586885656577/photo/1","display_url":"pic.twitter.com/YtcQyLpRWT"}],"annotations":{},"mentions":{}},"text":"Do you have a strong background in IT? EMA's IT Services and Delivery department is #NowHiring. Two job vacancies are available: Senior IT Service Manager (https://t.co/dS0bCbnh2t) and IT Security Operations Officer (https://t.co/zDg4T9onns) \n#EUjobs #Techjobs #ITjobs https://t.co/YtcQyLpRWT","attachments":{"media_keys":["16_969158412872404992"],"poll_ids":{}},"created_at":"2018-03-01T10:33:07.000Z","author_id":"116716199","lang":"en","conversation_id":"969158586885656577","possibly_sensitive":false,"id":"969158586885656577","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":3,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":36,"end":52,"tag":"OrphanMedicines"},{"start":175,"end":190,"tag":"RareDiseaseDay"},{"start":191,"end":204,"tag":"ShowYourRare"}],"urls":[{"start":151,"end":174,"url":"https://t.co/pzp9EO1i6b","expanded_url":"http://bit.ly/2FFv1E3","display_url":"bit.ly/2FFv1E3"},{"start":205,"end":228,"url":"https://t.co/i1H3mgMy3Z","expanded_url":"https://twitter.com/EMA_News/status/968903208482607104/photo/1","display_url":"pic.twitter.com/i1H3mgMy3Z"}],"annotations":{},"mentions":{}},"text":"Misunderstandings often arise about #OrphanMedicines and how orphan designation is given. The question-and-answer document addresses some common ones: https://t.co/pzp9EO1i6b #RareDiseaseDay #ShowYourRare https://t.co/i1H3mgMy3Z","attachments":{"media_keys":["3_968903167999176704"],"poll_ids":{}},"created_at":"2018-02-28T17:38:20.000Z","author_id":"116716199","lang":"en","conversation_id":"968903208482607104","possibly_sensitive":false,"id":"968903208482607104","source":"Twitter Web Client","public_metrics":{"retweet_count":58,"reply_count":0,"like_count":49,"quote_count":4},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":80,"end":96,"tag":"OrphanMedicines"},{"start":164,"end":172,"tag":"patient"},{"start":185,"end":200,"tag":"RareDiseaseDay"},{"start":201,"end":214,"tag":"ShowYourRare"}],"urls":[{"start":215,"end":238,"url":"https://t.co/fL5OTPMCI7","expanded_url":"https://twitter.com/EMA_News/status/968887665016954880/photo/1","display_url":"pic.twitter.com/fL5OTPMCI7"}],"annotations":[{"start":51,"end":62,"probability":0.4602,"type":"Organization","normalized_text":"Chair of EMA"},{"start":125,"end":146,"probability":0.4172,"type":"Other","normalized_text":"Black Pearl Award 2018"}],"mentions":[{"start":31,"end":45,"username":"bruno_sepodes","id":"3801997829"},{"start":115,"end":124,"username":"eurordis","id":"26993786"}]},"text":"Once again, congratulations to @bruno_sepodes, the Chair of EMA’s committee for #OrphanMedicines, who received the @eurordis Black Pearl Award 2018 for outstanding #patient engagement. #RareDiseaseDay #ShowYourRare https://t.co/fL5OTPMCI7","attachments":{"media_keys":["3_968887327312498691"],"poll_ids":{}},"created_at":"2018-02-28T16:36:35.000Z","author_id":"116716199","lang":"en","conversation_id":"968887665016954880","possibly_sensitive":false,"id":"968887665016954880","source":"Twitter Web Client","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":29,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":78,"end":89,"tag":"Alzheimers"},{"start":161,"end":171,"tag":"medicines"}],"urls":[{"start":209,"end":232,"url":"https://t.co/y4uuypu8oP","expanded_url":"http://bit.ly/2CoNHsV","display_url":"bit.ly/2CoNHsV"}],"annotations":[{"start":0,"end":2,"probability":0.5917,"type":"Organization","normalized_text":"EMA"}],"mentions":{}},"text":"EMA adopted a revised guideline on clinical studies for medicines that target #Alzheimers disease. This document aims to provide guidance for the development of #medicines across all stages of this condition: https://t.co/y4uuypu8oP","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-02-28T14:31:42.000Z","author_id":"116716199","lang":"en","conversation_id":"968856239617736707","possibly_sensitive":false,"id":"968856239617736707","source":"Twitter Web Client","public_metrics":{"retweet_count":33,"reply_count":0,"like_count":25,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":{},"annotations":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}]},"text":"RT @EU_Health: 'As a medical doctor, I have too often been witness to tragic stories from patients with rare or complex diseases.' \n\n@V_And…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-02-28T12:24:12.000Z","author_id":"116716199","lang":"en","conversation_id":"968824153380974592","possibly_sensitive":false,"id":"968824153380974592","source":"Twitter Web Client","public_metrics":{"retweet_count":50,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"968808919727575040"}]},{"entities":{"hashtags":[{"start":91,"end":104,"tag":"RareDiseases"}],"urls":[{"start":230,"end":253,"url":"https://t.co/Rmyl7uNwUQ","expanded_url":"http://bit.ly/2CQBNDW","display_url":"bit.ly/2CQBNDW"},{"start":270,"end":293,"url":"https://t.co/Ig75c5Z6FT","expanded_url":"https://twitter.com/EMA_News/status/968817242740875264/photo/1","display_url":"pic.twitter.com/Ig75c5Z6FT"}],"annotations":[{"start":9,"end":24,"probability":0.7942,"type":"Other","normalized_text":"Rare Disease Day"}],"mentions":[{"start":254,"end":269,"username":"rarediseaseday","id":"19982434"}]},"text":"Today is Rare Disease Day! Finding effective treatment for a patient with one of the 6,000 #RareDiseases can be very difficult. The EU’s orphan designation programme encourages the development of medicines to help these patients: https://t.co/Rmyl7uNwUQ @rarediseaseday https://t.co/Ig75c5Z6FT","attachments":{"media_keys":["3_968817130220281858"],"poll_ids":{}},"created_at":"2018-02-28T11:56:45.000Z","author_id":"116716199","lang":"en","conversation_id":"968817242740875264","possibly_sensitive":false,"id":"968817242740875264","source":"Twitter Web Client","public_metrics":{"retweet_count":181,"reply_count":4,"like_count":178,"quote_count":11},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":60,"end":73,"tag":"ShowYourRare"}],"urls":{},"annotations":[{"start":29,"end":44,"probability":0.7462,"type":"Other","normalized_text":"Rare Disease Day"}],"mentions":[{"start":3,"end":18,"username":"rarediseaseday","id":"19982434"}]},"text":"RT @rarediseaseday: TODAY is Rare Disease Day! How will you #ShowYourRare today in solidarity with rare disease patients all over the world…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-02-28T11:41:01.000Z","author_id":"116716199","lang":"en","conversation_id":"968813286127960064","possibly_sensitive":false,"id":"968813286127960064","source":"Twitter Web Client","public_metrics":{"retweet_count":1013,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"968760230166360064"}]},{"entities":{"hashtags":{},"urls":{},"annotations":{},"mentions":[{"start":3,"end":11,"username":"Food_EU","id":"2874880006"},{"start":95,"end":103,"username":"EFSA_EU","id":"84582815"},{"start":110,"end":118,"username":"ECDC_EU","id":"204752573"}]},"text":"RT @Food_EU: Bacteria from humans and animals continue to show resistance  to antimicrobials - @EFSA_EU &amp; @ECDC_EU report.\n\nWe must continu…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-02-27T18:34:08.000Z","author_id":"116716199","lang":"en","conversation_id":"968554862345637888","possibly_sensitive":false,"id":"968554862345637888","source":"Twitter Web Client","public_metrics":{"retweet_count":52,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"968444573314961409"}]},{"entities":{"hashtags":{},"urls":[{"start":102,"end":125,"url":"https://t.co/3fzkl4iYTr","expanded_url":"http://bit.ly/2os2cn9","display_url":"bit.ly/2os2cn9"},{"start":126,"end":149,"url":"https://t.co/HoDzV9at1K","expanded_url":"https://twitter.com/EMA_News/status/968147458000900096/photo/1","display_url":"pic.twitter.com/HoDzV9at1K"}],"annotations":[{"start":25,"end":27,"probability":0.4701,"type":"Organization","normalized_text":"EMA"}],"mentions":{}},"text":"Read the first report on EMA’s actions to replace, reduce, refine use of animals in medical research: https://t.co/3fzkl4iYTr https://t.co/HoDzV9at1K","attachments":{"media_keys":["3_968147029695303680"],"poll_ids":{}},"created_at":"2018-02-26T15:35:15.000Z","author_id":"116716199","lang":"en","conversation_id":"968147458000900096","possibly_sensitive":false,"id":"968147458000900096","source":"Twitter Web Client","public_metrics":{"retweet_count":37,"reply_count":0,"like_count":30,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":15,"end":25,"tag":"EUfunding"},{"start":73,"end":76,"tag":"EU"},{"start":77,"end":84,"tag":"Health"},{"start":124,"end":136,"tag":"raredisease"}],"urls":{},"annotations":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}]},"text":"RT @EU_Health: #EUfunding Call for proposals for projects within the 3rd #EU #Health Programme. Priorities in 2018:\n\n- ERNs #raredisease #E…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-02-23T17:06:39.000Z","author_id":"116716199","lang":"en","conversation_id":"967083294973145088","possibly_sensitive":false,"id":"967083294973145088","source":"Twitter Web Client","public_metrics":{"retweet_count":46,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"967078463910838273"}]},{"entities":{"hashtags":[{"start":0,"end":5,"tag":"CHMP"},{"start":19,"end":29,"tag":"medicines"}],"urls":[{"start":72,"end":95,"url":"https://t.co/DU6gRLMKtK","expanded_url":"http://bit.ly/2CfvXA2","display_url":"bit.ly/2CfvXA2"},{"start":96,"end":119,"url":"https://t.co/VF4BHSz9Bv","expanded_url":"https://twitter.com/EMA_News/status/967013680658333701/photo/1","display_url":"pic.twitter.com/VF4BHSz9Bv"}],"annotations":{},"mentions":{}},"text":"#CHMP recommends 5 #medicines for approval at its February 2018 meeting https://t.co/DU6gRLMKtK https://t.co/VF4BHSz9Bv","attachments":{"media_keys":["3_967011820883070976"],"poll_ids":{}},"created_at":"2018-02-23T12:30:02.000Z","author_id":"116716199","lang":"en","conversation_id":"967013680658333701","possibly_sensitive":false,"id":"967013680658333701","source":"TweetDeck","public_metrics":{"retweet_count":24,"reply_count":0,"like_count":15,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":6,"end":15,"tag":"medicine"},{"start":34,"end":43,"tag":"diabetes"},{"start":94,"end":99,"tag":"CHMP"}],"urls":[{"start":70,"end":93,"url":"https://t.co/KNqU6BzqoM","expanded_url":"http://bit.ly/2CHewnS","display_url":"bit.ly/2CHewnS"}],"annotations":{},"mentions":{}},"text":"First #medicine to treat neonatal #diabetes recommended for approval: https://t.co/KNqU6BzqoM #CHMP","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-02-23T12:25:00.000Z","author_id":"116716199","lang":"en","conversation_id":"967012414746054656","possibly_sensitive":false,"id":"967012414746054656","source":"TweetDeck","public_metrics":{"retweet_count":14,"reply_count":0,"like_count":10,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":144,"end":149,"tag":"CHMP"},{"start":150,"end":164,"tag":"StillsDisease"}],"urls":[{"start":120,"end":143,"url":"https://t.co/rcHrL3Z0LL","expanded_url":"http://bit.ly/2sPJj20","display_url":"bit.ly/2sPJj20"}],"annotations":{},"mentions":{}},"text":"New treatment option for rare inflammatory condition Still’s disease, in children and adults, recommended for approval: https://t.co/rcHrL3Z0LL #CHMP #StillsDisease","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-02-23T12:20:00.000Z","author_id":"116716199","lang":"en","conversation_id":"967011156043890689","possibly_sensitive":false,"id":"967011156043890689","source":"TweetDeck","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":6,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":69,"end":83,"tag":"OlderPatients"}],"urls":[{"start":114,"end":137,"url":"https://t.co/in7VpmMt8H","expanded_url":"http://bit.ly/2opy5vF","display_url":"bit.ly/2opy5vF"},{"start":138,"end":161,"url":"https://t.co/I4BBuasQV1","expanded_url":"https://twitter.com/EMA_News/status/966963844588425216/photo/1","display_url":"pic.twitter.com/I4BBuasQV1"}],"annotations":{},"mentions":{}},"text":"We have published a guideline on the evaluation of frailty status of #OlderPatients enrolled in clinical studies: https://t.co/in7VpmMt8H https://t.co/I4BBuasQV1","attachments":{"media_keys":["3_966726777287725057"],"poll_ids":{}},"created_at":"2018-02-23T09:12:00.000Z","author_id":"116716199","lang":"en","conversation_id":"966963844588425216","possibly_sensitive":false,"id":"966963844588425216","source":"TweetDeck","public_metrics":{"retweet_count":22,"reply_count":0,"like_count":17,"quote_count":3},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":15,"end":18,"tag":"EU"},{"start":19,"end":29,"tag":"OneHealth"},{"start":41,"end":45,"tag":"AMR"}],"urls":{},"annotations":[{"start":79,"end":87,"probability":0.4508,"type":"Place","normalized_text":"Brusssels"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":57,"end":71,"username":"EU_Commission","id":"157981564"}]},"text":"RT @EU_Health: #EU #OneHealth Network on #AMR chaired by @EU_Commission met in Brusssels on February 5. \n\nWe have now published the present…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-02-22T17:21:10.000Z","author_id":"116716199","lang":"en","conversation_id":"966724560547713025","possibly_sensitive":false,"id":"966724560547713025","source":"Twitter Web Client","public_metrics":{"retweet_count":44,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"966722991387181056"}]},{"entities":{"hashtags":[{"start":72,"end":82,"tag":"medicines"},{"start":108,"end":113,"tag":"CHMP"}],"urls":[{"start":84,"end":107,"url":"https://t.co/RI17pELiwA","expanded_url":"http://bit.ly/2oazpmW","display_url":"bit.ly/2oazpmW"}],"annotations":{},"mentions":{}},"text":"What’s on the agenda of the February meeting of our committee for human #medicines? https://t.co/RI17pELiwA #CHMP","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-02-19T13:44:58.000Z","author_id":"116716199","lang":"en","conversation_id":"965582987034177536","possibly_sensitive":false,"id":"965582987034177536","source":"Twitter Web Client","public_metrics":{"retweet_count":11,"reply_count":1,"like_count":5,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":52,"end":66,"tag":"DIAEurope2018"},{"start":67,"end":78,"tag":"Regulatory"}],"urls":{},"annotations":{},"mentions":[{"start":3,"end":14,"username":"DIA_Europe","id":"271864727"},{"start":125,"end":134,"username":"EMA_News","id":"116716199"}]},"text":"RT @DIA_Europe: Valuable, must-attend discussion at #DIAEurope2018 #Regulatory Town Hall  A focus on the future direction of @EMA_News @EU_…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-02-19T11:59:43.000Z","author_id":"116716199","lang":"en","conversation_id":"965556499169849344","possibly_sensitive":false,"id":"965556499169849344","source":"Twitter Web Client","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"965542790485733376"}]},{"entities":{"hashtags":[{"start":26,"end":34,"tag":"measles"},{"start":61,"end":73,"tag":"vaccination"}],"urls":{},"annotations":[{"start":56,"end":57,"probability":0.5341,"type":"Place","normalized_text":"EU"}],"mentions":[{"start":3,"end":12,"username":"ECDC_VPD","id":"186471638"}]},"text":"RT @ECDC_VPD: Significant #measles outbreaks ongoing in EU - #vaccination is most effective way to stop spread of the disease. Read more: h…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-02-16T09:35:26.000Z","author_id":"116716199","lang":"en","conversation_id":"964433024862511104","possibly_sensitive":false,"id":"964433024862511104","source":"Twitter Web Client","public_metrics":{"retweet_count":97,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"964418226493865984"}]},{"entities":{"hashtags":[{"start":125,"end":132,"tag":"EUjobs"}],"urls":[{"start":101,"end":124,"url":"https://t.co/gNSx9vU76x","expanded_url":"http://bit.ly/2EKpRs4","display_url":"bit.ly/2EKpRs4"},{"start":133,"end":156,"url":"https://t.co/Wn1bzY5tDu","expanded_url":"https://twitter.com/EMA_News/status/964144209589620736/photo/1","display_url":"pic.twitter.com/Wn1bzY5tDu"}],"annotations":[{"start":0,"end":2,"probability":0.6231,"type":"Organization","normalized_text":"EMA"}],"mentions":{}},"text":"EMA is hiring. Check out the Jobs@EMA portal to create your profile and apply for our job vacancies: https://t.co/gNSx9vU76x #EUjobs https://t.co/Wn1bzY5tDu","attachments":{"media_keys":["3_964144122897498112"],"poll_ids":{}},"created_at":"2018-02-15T14:27:47.000Z","author_id":"116716199","lang":"en","conversation_id":"964144209589620736","possibly_sensitive":false,"id":"964144209589620736","source":"Twitter Web Client","public_metrics":{"retweet_count":32,"reply_count":0,"like_count":29,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":28,"end":39,"tag":"veterinary"},{"start":129,"end":138,"tag":"vaccines"}],"urls":[{"start":155,"end":178,"url":"https://t.co/AQ0HhMvRBu","expanded_url":"http://bit.ly/2nZDBWr","display_url":"bit.ly/2nZDBWr"},{"start":179,"end":202,"url":"https://t.co/od8AE9JUCj","expanded_url":"https://twitter.com/EMA_News/status/963405049459363841/photo/1","display_url":"pic.twitter.com/od8AE9JUCj"}],"annotations":{},"mentions":{}},"text":"In 2017, EMA recommended 18 #veterinary medicines for marketing authorisation. Of these, 7 had a new active substance and 10 are #vaccines. Find out more: https://t.co/AQ0HhMvRBu https://t.co/od8AE9JUCj","attachments":{"media_keys":["3_963404958111551489"],"poll_ids":{}},"created_at":"2018-02-13T13:30:37.000Z","author_id":"116716199","lang":"en","conversation_id":"963405049459363841","possibly_sensitive":false,"id":"963405049459363841","source":"Twitter Web Client","public_metrics":{"retweet_count":9,"reply_count":2,"like_count":19,"quote_count":6},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":131,"end":145,"tag":"EUtraineeship"}],"urls":[{"start":107,"end":130,"url":"https://t.co/otZtO6UU37","expanded_url":"http://bit.ly/Uc0JfN","display_url":"bit.ly/Uc0JfN"},{"start":146,"end":169,"url":"https://t.co/Vwck8zcPnW","expanded_url":"https://twitter.com/EMA_News/status/963382922890956802/photo/1","display_url":"pic.twitter.com/Vwck8zcPnW"}],"annotations":{},"mentions":{}},"text":"Hurry up, apply for our traineeship programme that starts in April 2018. The deadline is 19 February 2018: https://t.co/otZtO6UU37\n#EUtraineeship https://t.co/Vwck8zcPnW","attachments":{"media_keys":["3_963382672088354817"],"poll_ids":{}},"created_at":"2018-02-13T12:02:42.000Z","author_id":"116716199","lang":"en","conversation_id":"963382922890956802","possibly_sensitive":false,"id":"963382922890956802","source":"Twitter Web Client","public_metrics":{"retweet_count":17,"reply_count":3,"like_count":18,"quote_count":3},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":44,"end":48,"tag":"EMA"},{"start":105,"end":109,"tag":"AMR"},{"start":111,"end":122,"tag":"paediatric"}],"urls":{},"annotations":[{"start":27,"end":36,"probability":0.9768,"type":"Person","normalized_text":"Guido Rasi"}],"mentions":[{"start":3,"end":18,"username":"V_Andriukaitis","id":"575269517"}]},"text":"RT @V_Andriukaitis: Thanks Guido Rasi &amp; #EMA staff for a warm welcome yesterday. Good discussions on #AMR, #paediatric medicines, #vaccinat…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-02-13T11:49:39.000Z","author_id":"116716199","lang":"en","conversation_id":"963379638696382464","possibly_sensitive":false,"id":"963379638696382464","source":"Twitter Web Client","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"963315500225884160"}]},{"entities":{"hashtags":[{"start":4,"end":22,"tag":"Pharmacovigilance"},{"start":59,"end":69,"tag":"valproate"},{"start":71,"end":82,"tag":"flupirtine"},{"start":84,"end":94,"tag":"retinoids"},{"start":118,"end":124,"tag":"Esmya"}],"urls":[{"start":126,"end":149,"url":"https://t.co/mm30g0Wwg4","expanded_url":"http://bit.ly/2Bl0Amr","display_url":"bit.ly/2Bl0Amr"}],"annotations":{},"mentions":{}},"text":"Our #Pharmacovigilance Committee gives recommendations for #valproate, #flupirtine, #retinoids and interim advice for #Esmya: https://t.co/mm30g0Wwg4","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-02-09T12:19:53.000Z","author_id":"116716199","lang":"en","conversation_id":"961937698599686144","possibly_sensitive":false,"id":"961937698599686144","source":"Twitter Web Client","public_metrics":{"retweet_count":32,"reply_count":2,"like_count":15,"quote_count":6},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":39,"end":48,"tag":"Diabetes"}],"urls":[{"start":105,"end":128,"url":"https://t.co/Ooy5hNz2Uw","expanded_url":"http://bit.ly/2nQnOcD","display_url":"bit.ly/2nQnOcD"}],"annotations":[{"start":0,"end":2,"probability":0.379,"type":"Organization","normalized_text":"EMA"}],"mentions":{}},"text":"EMA’s guideline on clinical studies on #Diabetes is now out for public consultation. Find out more here: https://t.co/Ooy5hNz2Uw. Deadline for comments: 15/08/2018.","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-02-08T13:44:24.000Z","author_id":"116716199","lang":"en","conversation_id":"961596579252785152","possibly_sensitive":false,"id":"961596579252785152","source":"Twitter Web Client","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":10,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":31,"end":35,"tag":"EMA"}],"urls":[{"start":86,"end":109,"url":"https://t.co/antQFILEwn","expanded_url":"http://bit.ly/2GSoCFH","display_url":"bit.ly/2GSoCFH"}],"annotations":[{"start":75,"end":83,"probability":0.9943,"type":"Place","normalized_text":"Amsterdam"}],"mentions":{}},"text":"Our Management Board discussed #EMA 's temporary and permanent premises in Amsterdam: https://t.co/antQFILEwn","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-02-07T11:00:38.000Z","author_id":"116716199","lang":"en","conversation_id":"961192975282987008","possibly_sensitive":false,"id":"961192975282987008","source":"Twitter Web Client","public_metrics":{"retweet_count":17,"reply_count":0,"like_count":13,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":83,"end":93,"tag":"medicines"}],"urls":[{"start":244,"end":267,"url":"https://t.co/iK1NQO15NE","expanded_url":"http://bit.ly/2BeGfza","display_url":"bit.ly/2BeGfza"},{"start":268,"end":291,"url":"https://t.co/OR9QXw01W0","expanded_url":"https://twitter.com/EMA_News/status/961170671345774593/photo/1","display_url":"pic.twitter.com/OR9QXw01W0"}],"annotations":{},"mentions":[{"start":18,"end":32,"username":"EU_Commission","id":"157981564"}]},"text":"Together with the @EU_Commission, we aim to improve the product information for EU #medicines. Get involved by letting us know about the initiatives on digital formats for the product information that you are aware of or working on. Read more: https://t.co/iK1NQO15NE https://t.co/OR9QXw01W0","attachments":{"media_keys":["3_960894062990647297"],"poll_ids":{}},"created_at":"2018-02-07T09:32:00.000Z","author_id":"116716199","lang":"en","conversation_id":"961170671345774593","possibly_sensitive":false,"id":"961170671345774593","source":"TweetDeck","public_metrics":{"retweet_count":26,"reply_count":1,"like_count":16,"quote_count":3},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":34,"end":38,"tag":"EMA"},{"start":51,"end":64,"tag":"transparency"},{"start":146,"end":156,"tag":"medicines"}],"urls":[{"start":158,"end":181,"url":"https://t.co/UV3wNiKvWI","expanded_url":"http://bit.ly/2E4tLIP","display_url":"bit.ly/2E4tLIP"}],"annotations":[{"start":11,"end":23,"probability":0.5635,"type":"Organization","normalized_text":"General Court"}],"mentions":[{"start":182,"end":195,"username":"EUCourtPress","id":"1343714233"}]},"text":"Good news! General Court confirms #EMA approach to #transparency. 3 rulings clarify the scope of commercial confidentiality as regards authorised #medicines: https://t.co/UV3wNiKvWI @EUCourtPress","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-02-06T11:22:36.000Z","author_id":"116716199","lang":"en","conversation_id":"960836116260835328","possibly_sensitive":false,"id":"960836116260835328","source":"Twitter Web Client","public_metrics":{"retweet_count":51,"reply_count":1,"like_count":47,"quote_count":9},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":13,"end":16,"tag":"EU"},{"start":17,"end":27,"tag":"OneHealth"},{"start":39,"end":43,"tag":"AMR"}],"urls":{},"annotations":[{"start":85,"end":93,"probability":0.4088,"type":"Place","normalized_text":"Brusssels"}],"mentions":[{"start":3,"end":11,"username":"Food_EU","id":"2874880006"},{"start":55,"end":69,"username":"EU_Commission","id":"157981564"}]},"text":"RT @Food_EU: #EU #OneHealth Network on #AMR chaired by @EU_Commission meets today in Brusssels. \n\nNetwork members include representatives o…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-02-05T14:30:15.000Z","author_id":"116716199","lang":"en","conversation_id":"960520951543853057","possibly_sensitive":false,"id":"960520951543853057","source":"Twitter Web Client","public_metrics":{"retweet_count":40,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"960519175142825985"}]},{"entities":{"hashtags":[{"start":66,"end":71,"tag":"data"},{"start":116,"end":128,"tag":"researchers"}],"urls":{},"annotations":{},"mentions":[{"start":3,"end":17,"username":"TNavracsicsEU","id":"2599249849"}]},"text":"RT @TNavracsicsEU: Pleased to see launch of new tool that gathers #data on cancer, supporting decision-makers &amp; #researchers in the EU and…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-02-05T12:25:20.000Z","author_id":"116716199","lang":"en","conversation_id":"960489515512156160","possibly_sensitive":false,"id":"960489515512156160","source":"Twitter Web Client","public_metrics":{"retweet_count":24,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"960475187341914119"}]},{"entities":{"hashtags":[{"start":114,"end":119,"tag":"ATMP"}],"urls":[{"start":132,"end":155,"url":"https://t.co/w1YLqPom1t","expanded_url":"http://bit.ly/2BKcP8q","display_url":"bit.ly/2BKcP8q"}],"annotations":{},"mentions":{}},"text":"We have just published for public consultation a revised guideline to better address the specific requirements of #ATMP developers. https://t.co/w1YLqPom1t","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-02-01T14:41:16.000Z","author_id":"116716199","lang":"en","conversation_id":"959074173560659968","possibly_sensitive":false,"id":"959074173560659968","source":"Twitter Web Client","public_metrics":{"retweet_count":19,"reply_count":1,"like_count":19,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":23,"end":27,"tag":"EMA"},{"start":31,"end":37,"tag":"PRIME"}],"urls":[{"start":60,"end":83,"url":"https://t.co/MJWkjPTFbm","expanded_url":"http://bit.ly/1RNe7kK","display_url":"bit.ly/1RNe7kK"},{"start":84,"end":107,"url":"https://t.co/6Tkn3208Nm","expanded_url":"https://twitter.com/EMA_News/status/959013165752356864/photo/1","display_url":"pic.twitter.com/6Tkn3208Nm"}],"annotations":{},"mentions":{}},"text":"See the key figures on #EMA 's #PRIME eligibility requests: https://t.co/MJWkjPTFbm https://t.co/6Tkn3208Nm","attachments":{"media_keys":["3_959013143866433536"],"poll_ids":{}},"created_at":"2018-02-01T10:38:50.000Z","author_id":"116716199","lang":"en","conversation_id":"959013165752356864","possibly_sensitive":false,"id":"959013165752356864","source":"Twitter Web Client","public_metrics":{"retweet_count":19,"reply_count":1,"like_count":12,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":188,"end":211,"url":"https://t.co/tNnlztgg8g","expanded_url":"http://bit.ly/2noYb25","display_url":"bit.ly/2noYb25"},{"start":212,"end":235,"url":"https://t.co/JtpxXOTW5k","expanded_url":"https://twitter.com/EMA_News/status/958708970813669376/photo/1","display_url":"pic.twitter.com/JtpxXOTW5k"}],"annotations":[{"start":180,"end":185,"probability":0.9953,"type":"Place","normalized_text":"Europe"}],"mentions":[{"start":22,"end":36,"username":"EU_Commission","id":"157981564"}]},"text":"Register for this EMA-@EU_Commission joint workshop to support the development of a concrete action plan to address challenges identified with medicine development for children in Europe: https://t.co/tNnlztgg8g https://t.co/JtpxXOTW5k","attachments":{"media_keys":["16_958708684443521024"],"poll_ids":{}},"created_at":"2018-01-31T14:30:05.000Z","author_id":"116716199","lang":"en","conversation_id":"958708970813669376","possibly_sensitive":false,"id":"958708970813669376","source":"Twitter Web Client","public_metrics":{"retweet_count":16,"reply_count":0,"like_count":15,"quote_count":5},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":130,"end":136,"tag":"EUHTA"}],"urls":[{"start":149,"end":172,"url":"https://t.co/athgIFfLuW","expanded_url":"https://twitter.com/EU_Commission/status/958662824275914754","display_url":"twitter.com/EU_Commission/…"}],"annotations":[{"start":74,"end":89,"probability":0.7139,"type":"Organization","normalized_text":"EU Member States"}],"mentions":[{"start":1,"end":15,"username":"EU_Commission","id":"157981564"},{"start":138,"end":148,"username":"EU_Health","id":"606325697"}]},"text":".@EU_Commission just launched a proposal to reinforce cooperation amongst EU Member States in the assessment of health technology #EUHTA. @EU_Health https://t.co/athgIFfLuW","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-01-31T11:48:34.000Z","author_id":"116716199","lang":"en","conversation_id":"958668323859914752","possibly_sensitive":false,"id":"958668323859914752","source":"Twitter Web Client","public_metrics":{"retweet_count":30,"reply_count":0,"like_count":20,"quote_count":0},"referenced_tweets":[{"type":"quoted","id":"958662824275914754"}]},{"entities":{"hashtags":[{"start":85,"end":89,"tag":"EMA"}],"urls":[{"start":105,"end":128,"url":"https://t.co/TYHXMqtLS5","expanded_url":"http://bit.ly/2EhhyBn","display_url":"bit.ly/2EhhyBn","status":403,"unwound_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2018/01/news_detail_002894.jsp&mid=WC0b01ac058004d5c1"},{"start":129,"end":152,"url":"https://t.co/jtAILZR01S","expanded_url":"https://twitter.com/MinVWS/status/957964042882240513","display_url":"twitter.com/MinVWS/status/…"}],"annotations":[{"start":43,"end":52,"probability":0.9819,"type":"Person","normalized_text":"Guido Rasi"}],"mentions":{}},"text":"Read the statement our Executive Director, Guido Rasi, has just made in the Hague on #EMA ’s relocation: https://t.co/TYHXMqtLS5 https://t.co/jtAILZR01S","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-01-29T13:29:41.000Z","author_id":"116716199","lang":"en","conversation_id":"957968996611035137","possibly_sensitive":false,"id":"957968996611035137","source":"Twitter Web Client","public_metrics":{"retweet_count":30,"reply_count":5,"like_count":21,"quote_count":5},"referenced_tweets":[{"type":"quoted","id":"957964042882240513"}]},{"entities":{"hashtags":[{"start":23,"end":27,"tag":"EMA"}],"urls":[{"start":229,"end":252,"url":"https://t.co/UCP2z9697x","expanded_url":"http://bit.ly/EMApressconf","display_url":"bit.ly/EMApressconf","status":403,"unwound_url":"http://bit.ly/EMApressconf"},{"start":253,"end":276,"url":"https://t.co/My6OPfAozL","expanded_url":"https://twitter.com/MinVWS/status/957946440596127745","display_url":"twitter.com/MinVWS/status/…"}],"annotations":[{"start":45,"end":53,"probability":0.9902,"type":"Place","normalized_text":"Amsterdam"},{"start":80,"end":89,"probability":0.9664,"type":"Person","normalized_text":"Guido Rasi"},{"start":112,"end":119,"probability":0.6146,"type":"Place","normalized_text":"12h45 UK"},{"start":171,"end":188,"probability":0.6744,"type":"Organization","normalized_text":"Ministry of Health"},{"start":216,"end":226,"probability":0.9766,"type":"Place","normalized_text":"Netherlands"}],"mentions":{}},"text":"What are the plans for #EMA ’s relocation to Amsterdam? Our Executive Director, Guido Rasi, will participate at 12h45 UK time today in a press conference organised by the Ministry of Health, Welfare and Sport in the Netherlands: https://t.co/UCP2z9697x https://t.co/My6OPfAozL","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-01-29T12:20:20.000Z","author_id":"116716199","lang":"en","conversation_id":"957951541494894592","possibly_sensitive":false,"id":"957951541494894592","source":"Twitter Web Client","public_metrics":{"retweet_count":17,"reply_count":4,"like_count":12,"quote_count":1},"referenced_tweets":[{"type":"quoted","id":"957946440596127745"}]},{"entities":{"hashtags":[{"start":24,"end":28,"tag":"EMA"},{"start":53,"end":65,"tag":"sideeffects"},{"start":75,"end":91,"tag":"clinicalstudies"},{"start":159,"end":168,"tag":"patients"},{"start":177,"end":187,"tag":"medicines"}],"urls":[{"start":194,"end":217,"url":"https://t.co/1k5evZdANv","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2018/01/news_detail_002889.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"},{"start":218,"end":241,"url":"https://t.co/FNW9RNp8Yu","expanded_url":"https://twitter.com/EMA_News/status/957922254725279744/video/1","display_url":"pic.twitter.com/FNW9RNp8Yu"}],"annotations":{},"mentions":{}},"text":"Find out more about how #EMA collects information on #sideeffects from new #clinicalstudies, scientific publications and reports from doctors, pharmacists and #patients to keep #medicines safe.\nhttps://t.co/1k5evZdANv https://t.co/FNW9RNp8Yu","attachments":{"media_keys":["7_957921836041416705"],"poll_ids":{}},"created_at":"2018-01-29T10:23:57.000Z","author_id":"116716199","lang":"en","conversation_id":"957922254725279744","possibly_sensitive":false,"id":"957922254725279744","source":"Twitter Web Client","public_metrics":{"retweet_count":71,"reply_count":1,"like_count":71,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":94,"end":117,"url":"https://t.co/h9gTQdoO2y","expanded_url":"http://bit.ly/2o3tja7","display_url":"bit.ly/2o3tja7","status":200,"unwound_url":"https://ted.europa.eu/TED/notice/udl?uri=TED:NOTICE:497343-2017:TEXT:EN:HTML"}],"annotations":{},"mentions":{}},"text":"Just a few days left to apply for our tender on the efficacy and safety studies on medicines: https://t.co/h9gTQdoO2y","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-01-29T09:30:03.000Z","author_id":"116716199","lang":"en","conversation_id":"957908691608653825","possibly_sensitive":false,"id":"957908691608653825","source":"Sprout Social","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":0,"end":5,"tag":"CHMP"},{"start":19,"end":29,"tag":"medicines"}],"urls":[{"start":71,"end":94,"url":"https://t.co/UiKyUgR2Mi","expanded_url":"http://bit.ly/2DDogR4","display_url":"bit.ly/2DDogR4"},{"start":95,"end":118,"url":"https://t.co/JuR6t9ptJd","expanded_url":"https://twitter.com/EMA_News/status/956866317545549825/photo/1","display_url":"pic.twitter.com/JuR6t9ptJd"}],"annotations":{},"mentions":{}},"text":"#CHMP recommends 7 #medicines for approval at its January 2018 meeting https://t.co/UiKyUgR2Mi https://t.co/JuR6t9ptJd","attachments":{"media_keys":["3_956866314030669824"],"poll_ids":{}},"created_at":"2018-01-26T12:28:02.000Z","author_id":"116716199","lang":"en","conversation_id":"956866317545549825","possibly_sensitive":false,"id":"956866317545549825","source":"Sprout Social","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":12,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":15,"end":24,"tag":"medicine"},{"start":48,"end":60,"tag":"haemophilia"},{"start":137,"end":142,"tag":"CHMP"}],"urls":[{"start":113,"end":136,"url":"https://t.co/eiuTxdmFVB","expanded_url":"http://bit.ly/2DQWlAz","display_url":"bit.ly/2DQWlAz"}],"annotations":{},"mentions":{}},"text":"First-in-class #medicine to prevent bleeding in #haemophilia A patients with inhibitors recommended for approval https://t.co/eiuTxdmFVB #CHMP","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-01-26T12:22:01.000Z","author_id":"116716199","lang":"en","conversation_id":"956864803838070784","possibly_sensitive":false,"id":"956864803838070784","source":"Sprout Social","public_metrics":{"retweet_count":20,"reply_count":0,"like_count":27,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":155,"end":160,"tag":"CHMP"}],"urls":[{"start":131,"end":154,"url":"https://t.co/1lynPta2Np","expanded_url":"http://bit.ly/2DPXfx2","display_url":"bit.ly/2DPXfx2"}],"annotations":{},"mentions":{}},"text":"New enzyme replacement therapy to treat rare genetic disorder alpha-mannosidosis, in children and adults, recommended for approval https://t.co/1lynPta2Np #CHMP","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-01-26T12:15:49.000Z","author_id":"116716199","lang":"en","conversation_id":"956863243053682688","possibly_sensitive":false,"id":"956863243053682688","source":"Sprout Social","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":13,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":25,"end":35,"tag":"medicines"},{"start":114,"end":121,"tag":"health"}],"urls":{},"annotations":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}]},"text":"RT @EU_Health: Falsified #medicines can be ineffective, harmful or even deadly and are a serious threat to public #health. \n\nRead our repor…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-01-26T11:52:11.000Z","author_id":"116716199","lang":"en","conversation_id":"956857295043997696","possibly_sensitive":false,"id":"956857295043997696","source":"TweetDeck","public_metrics":{"retweet_count":31,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"956855876098379777"}]},{"entities":{"hashtags":[{"start":90,"end":94,"tag":"EMA"},{"start":124,"end":134,"tag":"medicines"}],"urls":[{"start":194,"end":217,"url":"https://t.co/1Y9O15l6XW","expanded_url":"http://bit.ly/2DgMYHt","display_url":"bit.ly/2DgMYHt"},{"start":243,"end":266,"url":"https://t.co/n9ZMC9jPav","expanded_url":"https://twitter.com/EMA_News/status/956533623074754562/photo/1","display_url":"pic.twitter.com/n9ZMC9jPav"}],"annotations":{},"mentions":{}},"text":"Regulators, academia,  NGOs, join the second international awareness session organised by #EMA to find out how the European #medicines regulatory network works. There is still time to register: https://t.co/1Y9O15l6XW. Deadline is 16/02/2018. https://t.co/n9ZMC9jPav","attachments":{"media_keys":["16_956533620159606785"],"poll_ids":{}},"created_at":"2018-01-25T14:26:01.000Z","author_id":"116716199","lang":"en","conversation_id":"956533623074754562","possibly_sensitive":false,"id":"956533623074754562","source":"Sprout Social","public_metrics":{"retweet_count":14,"reply_count":0,"like_count":14,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":13,"end":22,"tag":"medicine"},{"start":32,"end":40,"tag":"disease"},{"start":120,"end":129,"tag":"patients"}],"urls":[{"start":160,"end":183,"url":"https://t.co/6RUNLajc9U","expanded_url":"https://www.youtube.com/watch?v=568SI1W-ekE&t=1s","display_url":"youtube.com/watch?v=568SI1…"},{"start":184,"end":207,"url":"https://t.co/7kSzVHMqin","expanded_url":"https://twitter.com/EMA_News/status/956478722533724160/video/1","display_url":"pic.twitter.com/7kSzVHMqin"}],"annotations":[{"start":57,"end":81,"probability":0.6886,"type":"Organization","normalized_text":"European Medicines Agency"}],"mentions":{}},"text":"How is a new #medicine for your #disease approved by the European Medicines Agency? How does a medicine get from lab to #patients? Find out more in this video: https://t.co/6RUNLajc9U https://t.co/7kSzVHMqin","attachments":{"media_keys":["7_956476825357705217"],"poll_ids":{}},"created_at":"2018-01-25T10:47:52.000Z","author_id":"116716199","lang":"en","conversation_id":"956478722533724160","possibly_sensitive":false,"id":"956478722533724160","source":"Twitter Web Client","public_metrics":{"retweet_count":131,"reply_count":0,"like_count":105,"quote_count":10},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":10,"end":18,"tag":"patient"},{"start":46,"end":50,"tag":"EMA"}],"urls":[{"start":100,"end":123,"url":"https://t.co/6QCtmS4Q7W","expanded_url":"https://fmapps.emea.europa.eu/stakeholders/signup.php","display_url":"fmapps.emea.europa.eu/stakeholders/s…"},{"start":124,"end":147,"url":"https://t.co/y9FDFDwUFs","expanded_url":"https://twitter.com/EMA_News/status/956139790818271232/photo/1","display_url":"pic.twitter.com/y9FDFDwUFs"}],"annotations":{},"mentions":{}},"text":"Are you a #patient interested in working with #EMA? Please register your interest and share widely: https://t.co/6QCtmS4Q7W https://t.co/y9FDFDwUFs","attachments":{"media_keys":["3_956139628716871680"],"poll_ids":{}},"created_at":"2018-01-24T12:21:05.000Z","author_id":"116716199","lang":"en","conversation_id":"956139790818271232","possibly_sensitive":false,"id":"956139790818271232","source":"Twitter Web Client","public_metrics":{"retweet_count":66,"reply_count":1,"like_count":34,"quote_count":8},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":12,"end":19,"tag":"pharma"},{"start":56,"end":63,"tag":"Brexit"}],"urls":[{"start":65,"end":88,"url":"https://t.co/U7FpIxTYAZ","expanded_url":"http://bit.ly/2Dse4e5","display_url":"bit.ly/2Dse4e5"}],"annotations":{},"mentions":{}},"text":"EMA surveys #pharma companies on their preparedness for #Brexit: https://t.co/U7FpIxTYAZ","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-01-24T09:34:03.000Z","author_id":"116716199","lang":"en","conversation_id":"956097755696500736","possibly_sensitive":false,"id":"956097755696500736","source":"Sprout Social","public_metrics":{"retweet_count":30,"reply_count":0,"like_count":24,"quote_count":4},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":80,"end":89,"tag":"patients"},{"start":164,"end":174,"tag":"medicines"}],"urls":[{"start":228,"end":251,"url":"https://t.co/8Rt9A3QTle","expanded_url":"http://bit.ly/2F5gMXp","display_url":"bit.ly/2F5gMXp"},{"start":252,"end":275,"url":"https://t.co/88IGHAzeQn","expanded_url":"https://twitter.com/EMA_News/status/955807551869931521/video/1","display_url":"pic.twitter.com/88IGHAzeQn"}],"annotations":[{"start":48,"end":50,"probability":0.3819,"type":"Organization","normalized_text":"EMA"}],"mentions":{}},"text":"We have launched today 3 videos to explain what EMA is and how it works to help #patients. The first one explains that the Agency assesses, supervises and monitors #medicines long before they appear in pharmacies and hospitals. https://t.co/8Rt9A3QTle https://t.co/88IGHAzeQn","attachments":{"media_keys":["7_955804270967836672"],"poll_ids":{}},"created_at":"2018-01-23T14:20:53.000Z","author_id":"116716199","lang":"en","conversation_id":"955807551869931521","possibly_sensitive":false,"id":"955807551869931521","source":"Twitter Web Client","public_metrics":{"retweet_count":115,"reply_count":1,"like_count":104,"quote_count":12},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":167,"end":190,"url":"https://t.co/RG51aYD0Le","expanded_url":"http://bit.ly/2DvdKLE","display_url":"bit.ly/2DvdKLE"},{"start":191,"end":214,"url":"https://t.co/rtAHHyuhTz","expanded_url":"https://twitter.com/EMA_News/status/955767822860341248/photo/1","display_url":"pic.twitter.com/rtAHHyuhTz"}],"annotations":{},"mentions":{}},"text":"In 2017, EMA recommended 92 medicines for approval, including 35 with a new active substance. Check out our “Human medicines highlights” interactive infographic here: https://t.co/RG51aYD0Le https://t.co/rtAHHyuhTz","attachments":{"media_keys":["3_955767819248975872"],"poll_ids":{}},"created_at":"2018-01-23T11:43:00.000Z","author_id":"116716199","lang":"en","conversation_id":"955767822860341248","possibly_sensitive":false,"id":"955767822860341248","source":"Sprout Social","public_metrics":{"retweet_count":98,"reply_count":0,"like_count":98,"quote_count":6},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":71,"end":81,"tag":"medicines"},{"start":107,"end":112,"tag":"CHMP"}],"urls":[{"start":83,"end":106,"url":"https://t.co/RpUmSyQSRn","expanded_url":"http://bit.ly/2BmukM8","display_url":"bit.ly/2BmukM8"}],"annotations":{},"mentions":{}},"text":"What’s on the agenda of the January meeting of our committee for human #medicines? https://t.co/RpUmSyQSRn #CHMP","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-01-22T14:36:31.000Z","author_id":"116716199","lang":"en","conversation_id":"955449101247754240","possibly_sensitive":false,"id":"955449101247754240","source":"Twitter Web Client","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":4,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":84,"end":107,"url":"https://t.co/5AYNhg4Nng","expanded_url":"https://twitter.com/HeretoHelpMDS/status/955373528005701632","display_url":"twitter.com/HeretoHelpMDS/…"}],"annotations":{},"mentions":{}},"text":"We couldn't do our work without the contribution of patients. Thank you, everybody! https://t.co/5AYNhg4Nng","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-01-22T12:16:30.000Z","author_id":"116716199","lang":"en","conversation_id":"955413864228810752","possibly_sensitive":false,"id":"955413864228810752","source":"Twitter Web Client","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":19,"quote_count":0},"referenced_tweets":[{"type":"quoted","id":"955373528005701632"}]},{"entities":{"hashtags":[{"start":13,"end":37,"tag":"AntimicrobialResiatance"},{"start":105,"end":117,"tag":"antibiotics"}],"urls":{},"annotations":{},"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}]},"text":"RT @EFSA_EU: #AntimicrobialResiatance - there are alternatives to reduce, replace and rethink the use of #antibiotics in animals. Find out…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-01-22T09:32:43.000Z","author_id":"116716199","lang":"en","conversation_id":"955372647751266304","possibly_sensitive":false,"id":"955372647751266304","source":"TweetDeck","public_metrics":{"retweet_count":55,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"955371764674113537"}]},{"entities":{"hashtags":[{"start":6,"end":21,"tag":"OrphanMedicine"}],"urls":[{"start":140,"end":163,"url":"https://t.co/J8aPOjCYsd","expanded_url":"http://bit.ly/2mPRvd2","display_url":"bit.ly/2mPRvd2"},{"start":164,"end":187,"url":"https://t.co/m6LXpk7nR1","expanded_url":"https://twitter.com/EMA_News/status/953657792711323648/photo/1","display_url":"pic.twitter.com/m6LXpk7nR1"}],"annotations":[{"start":66,"end":68,"probability":0.4631,"type":"Organization","normalized_text":"EMA"}],"mentions":{}},"text":"Is an #OrphanMedicine still an orphan once it gets on the market? EMA publishes additional reports on decision-making for orphan medicines. https://t.co/J8aPOjCYsd https://t.co/m6LXpk7nR1","attachments":{"media_keys":["3_953657750235598848"],"poll_ids":{}},"created_at":"2018-01-17T15:58:30.000Z","author_id":"116716199","lang":"en","conversation_id":"953657792711323648","possibly_sensitive":false,"id":"953657792711323648","source":"Twitter Web Client","public_metrics":{"retweet_count":75,"reply_count":0,"like_count":55,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":59,"end":69,"tag":"medicines"}],"urls":[{"start":109,"end":132,"url":"https://t.co/X2O1QQdq8H","expanded_url":"http://bit.ly/2B9diAG","display_url":"bit.ly/2B9diAG"}],"annotations":{},"mentions":{}},"text":"Apply for our tender on the efficacy and safety studies on #medicines. Deadline extended to 6 February 2018: https://t.co/X2O1QQdq8H","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-01-17T10:03:05.000Z","author_id":"116716199","lang":"en","conversation_id":"953568350118072320","possibly_sensitive":false,"id":"953568350118072320","source":"Twitter Web Client","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":131,"end":154,"url":"https://t.co/rMxJXL615X","expanded_url":"http://bit.ly/X4lXwT","display_url":"bit.ly/X4lXwT"}],"annotations":{},"mentions":[{"start":0,"end":13,"username":"quequesierra","id":"353926930"}]},"text":"@quequesierra We are very happy to answer your questions. A more effective way for this is via email. Please send us a query here (https://t.co/rMxJXL615X) and we will get back to you with clarifications as soon as possible.","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-01-16T18:04:46.000Z","author_id":"116716199","lang":"en","conversation_id":"953223396745269248","possibly_sensitive":false,"id":"953327180687306754","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":3,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"953322129424109568"}],"in_reply_to_user_id":"353926930"},{"entities":{"hashtags":{},"urls":{},"annotations":{},"mentions":[{"start":0,"end":13,"username":"quequesierra","id":"353926930"}]},"text":"@quequesierra The entire chapter 2 explains the scientific evidence for the initial negative opinion, that’s why there are referrals to the negative benefit/risk balance.","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-01-16T17:02:09.000Z","author_id":"116716199","lang":"en","conversation_id":"953223396745269248","possibly_sensitive":false,"id":"953311424578760706","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"953223396745269248"}],"in_reply_to_user_id":"353926930"},{"entities":{"hashtags":{},"urls":{},"annotations":{},"mentions":[{"start":0,"end":13,"username":"quequesierra","id":"353926930"},{"start":14,"end":27,"username":"quequesierra","id":"353926930"}]},"text":"@quequesierra @quequesierra: This is an assessment report on why EMA recommended a conditional marketing authorisation for Ninlaro (ixazomib), following a re-examination of the Agency’s earlier negative opinion.","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-01-16T17:01:54.000Z","author_id":"116716199","lang":"en","conversation_id":"953223396745269248","possibly_sensitive":false,"id":"953311359189561344","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":3,"quote_count":1},"referenced_tweets":[{"type":"replied_to","id":"953223396745269248"}],"in_reply_to_user_id":"353926930"},{"entities":{"hashtags":[{"start":0,"end":13,"tag":"ClinicalData"}],"urls":[{"start":130,"end":153,"url":"https://t.co/OGwltXCY9y","expanded_url":"http://bit.ly/2DGuzEB","display_url":"bit.ly/2DGuzEB"},{"start":209,"end":232,"url":"https://t.co/RrbjKl3bIv","expanded_url":"https://twitter.com/US_FDA/status/953277089024761856","display_url":"twitter.com/US_FDA/status/…"}],"annotations":[{"start":63,"end":70,"probability":0.4285,"type":"Place","normalized_text":"Atlantic"}],"mentions":{}},"text":"#ClinicalData transparency is progressing on both sides of the Atlantic. Check out EMA’s pioneering initiative launched in 2016 - https://t.co/OGwltXCY9y, it’s good to see others are following a similar path. https://t.co/RrbjKl3bIv","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-01-16T16:32:36.000Z","author_id":"116716199","lang":"en","conversation_id":"953303987553521664","possibly_sensitive":false,"id":"953303987553521664","source":"Twitter Web Client","public_metrics":{"retweet_count":22,"reply_count":0,"like_count":16,"quote_count":2},"referenced_tweets":[{"type":"quoted","id":"953277089024761856"}]},{"entities":{"hashtags":[{"start":29,"end":45,"tag":"OrphanMedicines"}],"urls":[{"start":114,"end":137,"url":"https://t.co/9jjjUPK8ia","expanded_url":"http://bit.ly/2EK5o2V","display_url":"bit.ly/2EK5o2V"},{"start":138,"end":161,"url":"https://t.co/uYb0PAOP1w","expanded_url":"https://twitter.com/EMA_News/status/952924066192740353/photo/1","display_url":"pic.twitter.com/uYb0PAOP1w"}],"annotations":{},"mentions":[{"start":47,"end":61,"username":"bruno_sepodes","id":"3801997829"}]},"text":"Chair of EMA’s committee for #OrphanMedicines, @bruno_sepodes, receives award for outstanding patient engagement: https://t.co/9jjjUPK8ia https://t.co/uYb0PAOP1w","attachments":{"media_keys":["3_952923952355119104"],"poll_ids":{}},"created_at":"2018-01-15T15:22:56.000Z","author_id":"116716199","lang":"en","conversation_id":"952924066192740353","possibly_sensitive":false,"id":"952924066192740353","source":"Twitter Web Client","public_metrics":{"retweet_count":27,"reply_count":8,"like_count":51,"quote_count":3},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":{},"annotations":{},"mentions":[{"start":3,"end":11,"username":"WHOatEU","id":"3042231323"},{"start":41,"end":52,"username":"WHO_Europe","id":"125403342"}]},"text":"RT @WHOatEU: \"Antimicrobial Stewardship\" @WHO_Europe launched online course for clinicians on prescribing and using antibiotics wisely! htt…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-01-15T14:57:13.000Z","author_id":"116716199","lang":"en","conversation_id":"952917596189478912","possibly_sensitive":false,"id":"952917596189478912","source":"Twitter Web Client","public_metrics":{"retweet_count":34,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"952839048082722816"}]},{"entities":{"hashtags":[{"start":66,"end":82,"tag":"OrphanMedicines"},{"start":100,"end":119,"tag":"EURORDISAwards2018"}],"urls":[{"start":121,"end":144,"url":"https://t.co/1VvOJJTwOg","expanded_url":"https://twitter.com/eurordis/status/952838581164367872","display_url":"twitter.com/eurordis/statu…"}],"annotations":{},"mentions":[{"start":19,"end":33,"username":"bruno_sepodes","id":"3801997829"}]},"text":"Congratulations to @bruno_sepodes, the Chair of our Committee for #OrphanMedicines, for winning the #EURORDISAwards2018. https://t.co/1VvOJJTwOg","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-01-15T11:43:37.000Z","author_id":"116716199","lang":"en","conversation_id":"952868873799380993","possibly_sensitive":false,"id":"952868873799380993","source":"Twitter Web Client","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":10,"quote_count":0},"referenced_tweets":[{"type":"quoted","id":"952838581164367872"}]},{"entities":{"hashtags":{},"urls":{},"annotations":[{"start":90,"end":99,"probability":0.6899,"type":"Person","normalized_text":"Guido Rasi"},{"start":113,"end":131,"probability":0.3859,"type":"Person","normalized_text":"Costantino Pitzalis"}],"mentions":[{"start":3,"end":16,"username":"LSE_Italians","id":"3048021519"},{"start":102,"end":111,"username":"EMA_News","id":"116716199"},{"start":133,"end":138,"username":"QMUL","id":"19401276"}]},"text":"RT @LSE_Italians: Personalized medicine: Opportunities, Challenges and Sustainability. W/ Guido Rasi  @EMA_News, Costantino Pitzalis @QMUL…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-01-12T14:51:11.000Z","author_id":"116716199","lang":"en","conversation_id":"951828912061009920","possibly_sensitive":false,"id":"951828912061009920","source":"Twitter Web Client","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"951785226916843520"}]},{"entities":{"hashtags":[{"start":20,"end":38,"tag":"Pharmacovigilance"},{"start":105,"end":110,"tag":"PRAC"}],"urls":[{"start":111,"end":134,"url":"https://t.co/xXeFUekFVJ","expanded_url":"http://bit.ly/2EAg0Bt","display_url":"bit.ly/2EAg0Bt"}],"annotations":{},"mentions":{}},"text":"Highlights from the #Pharmacovigilance Committee's meeting in January 2018: one safety review concluded. #PRAC https://t.co/xXeFUekFVJ","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-01-12T12:55:39.000Z","author_id":"116716199","lang":"en","conversation_id":"951799838210969601","possibly_sensitive":false,"id":"951799838210969601","source":"Twitter Web Client","public_metrics":{"retweet_count":18,"reply_count":2,"like_count":12,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":29,"end":47,"tag":"Pharmacovigilance"},{"start":129,"end":134,"tag":"PRAC"}],"urls":[{"start":105,"end":128,"url":"https://t.co/bpxOQfJALU","expanded_url":"http://bit.ly/2CTyf8K","display_url":"bit.ly/2CTyf8K"}],"annotations":{},"mentions":{}},"text":"What is on the agenda of our #Pharmacovigilance Committee's meeting in January? You can consult it here: https://t.co/bpxOQfJALU #PRAC","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-01-08T17:12:11.000Z","author_id":"116716199","lang":"en","conversation_id":"950414843676327936","possibly_sensitive":false,"id":"950414843676327936","source":"Twitter Web Client","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":9,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":81,"end":104,"url":"https://t.co/fxjnfFHBrg","expanded_url":"https://twitter.com/Wemos/status/950319942167089153","display_url":"twitter.com/Wemos/status/9…"}],"annotations":[{"start":0,"end":11,"probability":0.7759,"type":"Person","normalized_text":"Noël Wathion"}],"mentions":{}},"text":"Noël Wathion, our Deputy Executive Director, will attend the event as a speaker. https://t.co/fxjnfFHBrg","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-01-08T14:43:21.000Z","author_id":"116716199","lang":"en","conversation_id":"950377391079256064","possibly_sensitive":false,"id":"950377391079256064","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":7,"quote_count":0},"referenced_tweets":[{"type":"quoted","id":"950319942167089153"}]},{"entities":{"hashtags":{},"urls":[{"start":96,"end":119,"url":"https://t.co/h9gTQdoO2y","expanded_url":"http://bit.ly/2o3tja7","display_url":"bit.ly/2o3tja7","status":200,"unwound_url":"https://ted.europa.eu/TED/notice/udl?uri=TED:NOTICE:497343-2017:TEXT:EN:HTML"}],"annotations":{},"mentions":{}},"text":"Apply for our tender on the efficacy and safety studies on medicines. Deadline 2 February 2018: https://t.co/h9gTQdoO2y","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-01-08T09:30:03.000Z","author_id":"116716199","lang":"en","conversation_id":"950298546091241473","possibly_sensitive":false,"id":"950298546091241473","source":"Sprout Social","public_metrics":{"retweet_count":18,"reply_count":1,"like_count":8,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":21,"end":31,"tag":"OneHealth"},{"start":92,"end":95,"tag":"TB"},{"start":136,"end":142,"tag":"EndTB"}],"urls":{},"annotations":{},"mentions":{}},"text":"RT @FAOAnimalHealth: #OneHealth approach critical to cut transmission &amp; combat zoonotic #TB across human and animal health sectors. #EndTB…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2018-01-03T15:08:40.000Z","author_id":"116716199","lang":"en","conversation_id":"948571821317722122","possibly_sensitive":false,"id":"948571821317722122","source":"TweetDeck","public_metrics":{"retweet_count":45,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"948563404263915520"}]},{"entities":{"hashtags":[{"start":93,"end":109,"tag":"OrphanMedicines"},{"start":110,"end":129,"tag":"LeavingNoOneBehind"}],"urls":[{"start":69,"end":92,"url":"https://t.co/AL9FrZ19dv","expanded_url":"http://bit.ly/2CQZZ9q","display_url":"bit.ly/2CQZZ9q"},{"start":130,"end":153,"url":"https://t.co/qzU8wuTSiz","expanded_url":"https://twitter.com/EMA_News/status/943866847883079680/photo/1","display_url":"pic.twitter.com/qzU8wuTSiz"}],"annotations":[{"start":35,"end":36,"probability":0.2747,"type":"Organization","normalized_text":"EU"}],"mentions":{}},"text":"Check out our new factsheet on the EU’s orphan designation programme https://t.co/AL9FrZ19dv #OrphanMedicines #LeavingNoOneBehind https://t.co/qzU8wuTSiz","attachments":{"media_keys":["3_943866637958221825"],"poll_ids":{}},"created_at":"2017-12-21T15:32:47.000Z","author_id":"116716199","lang":"en","conversation_id":"943866847883079680","possibly_sensitive":false,"id":"943866847883079680","source":"Twitter Web Client","public_metrics":{"retweet_count":60,"reply_count":2,"like_count":50,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":112,"end":135,"url":"https://t.co/DPtyN8RAkZ","expanded_url":"http://bit.ly/2DoDYjB","display_url":"bit.ly/2DoDYjB"}],"annotations":{},"mentions":{}},"text":"Our Executive Director shares his thoughts on 2017 and outlines some challenges for 2018, Check out his message https://t.co/DPtyN8RAkZ","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-12-21T12:38:22.000Z","author_id":"116716199","lang":"en","conversation_id":"943822954697314304","possibly_sensitive":false,"id":"943822954697314304","source":"Twitter Web Client","public_metrics":{"retweet_count":18,"reply_count":0,"like_count":18,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":137,"end":160,"url":"https://t.co/1Y9O15l6XW","expanded_url":"http://bit.ly/2DgMYHt","display_url":"bit.ly/2DgMYHt"},{"start":161,"end":184,"url":"https://t.co/7Z1NW1zxCP","expanded_url":"https://twitter.com/EMA_News/status/943485367499612160/photo/1","display_url":"pic.twitter.com/7Z1NW1zxCP"}],"annotations":[{"start":13,"end":15,"probability":0.4792,"type":"Organization","normalized_text":"EMA"}],"mentions":{}},"text":"Register for EMA's 2nd international awareness session that will take place on 8-9 March 2018. Registration open until 16 February 2018.\nhttps://t.co/1Y9O15l6XW https://t.co/7Z1NW1zxCP","attachments":{"media_keys":["3_943485294384435203"],"poll_ids":{}},"created_at":"2017-12-20T14:16:55.000Z","author_id":"116716199","lang":"en","conversation_id":"943485367499612160","possibly_sensitive":false,"id":"943485367499612160","source":"Twitter Web Client","public_metrics":{"retweet_count":17,"reply_count":0,"like_count":13,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":58,"end":68,"tag":"medicines"}],"urls":[{"start":75,"end":98,"url":"https://t.co/dwn5a45EfQ","expanded_url":"http://bit.ly/2B4eaYf","display_url":"bit.ly/2B4eaYf"},{"start":99,"end":122,"url":"https://t.co/vDIAf84e7g","expanded_url":"https://twitter.com/EMA_News/status/943439182235611136/photo/1","display_url":"pic.twitter.com/vDIAf84e7g"}],"annotations":{},"mentions":{}},"text":"Find out all about how the European regulatory system for #medicines work: https://t.co/dwn5a45EfQ https://t.co/vDIAf84e7g","attachments":{"media_keys":["3_943439126610800640"],"poll_ids":{}},"created_at":"2017-12-20T11:13:23.000Z","author_id":"116716199","lang":"en","conversation_id":"943439182235611136","possibly_sensitive":false,"id":"943439182235611136","source":"Twitter Web Client","public_metrics":{"retweet_count":52,"reply_count":0,"like_count":49,"quote_count":3},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":{},"annotations":{},"mentions":[{"start":0,"end":13,"username":"EFA_Patients","id":"1299643704"}]},"text":"@EFA_Patients Thank you for your kind words.","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-12-19T15:21:43.000Z","author_id":"116716199","lang":"en","conversation_id":"943119629819445249","possibly_sensitive":false,"id":"943139287779901442","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"943119629819445249"}],"in_reply_to_user_id":"1299643704"},{"entities":{"hashtags":[{"start":25,"end":33,"tag":"patient"},{"start":89,"end":105,"tag":"OrphanMedicines"}],"urls":[{"start":107,"end":130,"url":"https://t.co/1bI1Nf8srD","expanded_url":"http://bit.ly/2AJwCIO","display_url":"bit.ly/2AJwCIO"},{"start":131,"end":154,"url":"https://t.co/KI3KuKFPfU","expanded_url":"https://twitter.com/EMA_News/status/942681602857070592/photo/1","display_url":"pic.twitter.com/KI3KuKFPfU"}],"annotations":{},"mentions":{}},"text":"Just a few days left for #patient organisation representatives to join the Committee for #OrphanMedicines. https://t.co/1bI1Nf8srD https://t.co/KI3KuKFPfU","attachments":{"media_keys":["3_942681600042582016"],"poll_ids":{}},"created_at":"2017-12-18T09:03:02.000Z","author_id":"116716199","lang":"en","conversation_id":"942681602857070592","possibly_sensitive":false,"id":"942681602857070592","source":"Sprout Social","public_metrics":{"retweet_count":18,"reply_count":0,"like_count":16,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":0,"end":5,"tag":"CHMP"},{"start":23,"end":33,"tag":"medicines"},{"start":101,"end":106,"tag":"CHMP"}],"urls":[{"start":77,"end":100,"url":"https://t.co/jKtFJf1leF","expanded_url":"http://bit.ly/2j8IDwN","display_url":"bit.ly/2j8IDwN"},{"start":107,"end":130,"url":"https://t.co/EBdzbSkUWz","expanded_url":"https://twitter.com/EMA_News/status/941646534734680064/photo/1","display_url":"pic.twitter.com/EBdzbSkUWz"}],"annotations":{},"mentions":{}},"text":"#CHMP recommends seven #medicines for approval at its December 2017 meeting: https://t.co/jKtFJf1leF #CHMP https://t.co/EBdzbSkUWz","attachments":{"media_keys":["3_941646532423462914"],"poll_ids":{}},"created_at":"2017-12-15T12:30:03.000Z","author_id":"116716199","lang":"en","conversation_id":"941646534734680064","possibly_sensitive":false,"id":"941646534734680064","source":"Sprout Social","public_metrics":{"retweet_count":25,"reply_count":1,"like_count":20,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":4,"end":20,"tag":"AdvancedTherapy"},{"start":65,"end":79,"tag":"CrohnsDisease"},{"start":105,"end":110,"tag":"CHMP"},{"start":111,"end":116,"tag":"ATMP"}],"urls":[{"start":81,"end":104,"url":"https://t.co/YThNsTWSiY","expanded_url":"http://bit.ly/2ze2aoG","display_url":"bit.ly/2ze2aoG"}],"annotations":{},"mentions":{}},"text":"New #AdvancedTherapy to treat perianal fistulas in patients with #CrohnsDisease: https://t.co/YThNsTWSiY #CHMP #ATMP","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-12-15T12:27:01.000Z","author_id":"116716199","lang":"en","conversation_id":"941645769706299392","possibly_sensitive":false,"id":"941645769706299392","source":"Sprout Social","public_metrics":{"retweet_count":17,"reply_count":1,"like_count":15,"quote_count":4},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":6,"end":17,"tag":"paediatric"},{"start":44,"end":65,"tag":"AdrenalInsufficiency"},{"start":117,"end":122,"tag":"CHMP"}],"urls":[{"start":93,"end":116,"url":"https://t.co/2pyqygHcKl","expanded_url":"http://bit.ly/2j3iCPx","display_url":"bit.ly/2j3iCPx"}],"annotations":{},"mentions":{}},"text":"First #paediatric medicine to treat primary #AdrenalInsufficiency, a rare hormonal disorder: https://t.co/2pyqygHcKl #CHMP","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-12-15T12:23:00.000Z","author_id":"116716199","lang":"en","conversation_id":"941644762603507712","possibly_sensitive":false,"id":"941644762603507712","source":"Sprout Social","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":5,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":17,"end":35,"tag":"hypophosphataemia"},{"start":119,"end":124,"tag":"CHMP"}],"urls":[{"start":95,"end":118,"url":"https://t.co/iXNCl6K46l","expanded_url":"http://bit.ly/2j3NmQx","display_url":"bit.ly/2j3NmQx"}],"annotations":{},"mentions":{}},"text":"New medicine for #hypophosphataemia, a rare bone disease, recommended for conditional approval https://t.co/iXNCl6K46l #CHMP","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-12-15T12:19:01.000Z","author_id":"116716199","lang":"en","conversation_id":"941643756620611584","possibly_sensitive":false,"id":"941643756620611584","source":"Sprout Social","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":8,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":74,"end":97,"url":"https://t.co/Jtb84jW5Sl","expanded_url":"http://bit.ly/2j3bQt0","display_url":"bit.ly/2j3bQt0"}],"annotations":{},"mentions":{}},"text":"Check out the highlights from this week’s meeting of our Management Board https://t.co/Jtb84jW5Sl","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-12-15T10:59:00.000Z","author_id":"116716199","lang":"en","conversation_id":"941623623407882240","possibly_sensitive":false,"id":"941623623407882240","source":"Sprout Social","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":4,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":95,"end":118,"url":"https://t.co/h9gTQdoO2y","expanded_url":"http://bit.ly/2o3tja7","display_url":"bit.ly/2o3tja7"}],"annotations":{},"mentions":{}},"text":"New call for tender on the efficacy and safety studies on medicines. Apply by 2 February 2018. https://t.co/h9gTQdoO2y","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-12-14T11:49:34.000Z","author_id":"116716199","lang":"en","conversation_id":"941273957793222657","possibly_sensitive":false,"id":"941273957793222657","source":"Twitter Web Client","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":4,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":14,"end":21,"tag":"agenda"},{"start":73,"end":83,"tag":"medicines"},{"start":109,"end":114,"tag":"CHMP"}],"urls":[{"start":85,"end":108,"url":"https://t.co/RgTKS1PeLN","expanded_url":"http://bit.ly/2z31zGp","display_url":"bit.ly/2z31zGp"}],"annotations":{},"mentions":{}},"text":"What’s on the #agenda of the December meeting of our committee for human #medicines? https://t.co/RgTKS1PeLN #CHMP","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-12-12T10:08:01.000Z","author_id":"116716199","lang":"en","conversation_id":"940523625576321029","possibly_sensitive":false,"id":"940523625576321029","source":"Sprout Social","public_metrics":{"retweet_count":31,"reply_count":1,"like_count":19,"quote_count":3},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":73,"end":81,"tag":"animals"},{"start":107,"end":118,"tag":"Veterinary"},{"start":119,"end":134,"tag":"noveltherapies"}],"urls":[{"start":83,"end":106,"url":"https://t.co/JS5lLxMBfs","expanded_url":"http://bit.ly/2nLjYUi","display_url":"bit.ly/2nLjYUi"},{"start":135,"end":158,"url":"https://t.co/36rwpJDYrY","expanded_url":"https://twitter.com/EMA_News/status/940218294304411648/photo/1","display_url":"pic.twitter.com/36rwpJDYrY"}],"annotations":{},"mentions":{}},"text":"We have published the first guidance on monoclonal antibodies for use in #animals: https://t.co/JS5lLxMBfs #Veterinary #noveltherapies https://t.co/36rwpJDYrY","attachments":{"media_keys":["3_940217976707432448"],"poll_ids":{}},"created_at":"2017-12-11T13:54:44.000Z","author_id":"116716199","lang":"en","conversation_id":"940218294304411648","possibly_sensitive":false,"id":"940218294304411648","source":"Twitter Web Client","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":21,"quote_count":4},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":29,"end":36,"tag":"health"},{"start":37,"end":47,"tag":"EUfunding"},{"start":78,"end":84,"tag":"H2020"},{"start":85,"end":102,"tag":"EUHealthResearch"}],"urls":[{"start":111,"end":134,"url":"https://t.co/6GRG6bOito","expanded_url":"http://europa.eu/!JJ84dQ","display_url":"europa.eu/!JJ84dQ"}],"annotations":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}]},"text":"RT @EU_Health: Interested in #health #EUfunding? Check out the priorities for #H2020 #EUHealthResearch calls ➡️https://t.co/6GRG6bOito. \nMo…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-12-08T12:15:04.000Z","author_id":"116716199","lang":"en","conversation_id":"939106047821864960","possibly_sensitive":false,"id":"939106047821864960","source":"Twitter Web Client","public_metrics":{"retweet_count":40,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"939082172048330752"}]},{"entities":{"hashtags":{},"urls":[{"start":85,"end":108,"url":"https://t.co/kwKdB3gzf7","expanded_url":"https://twitter.com/EP_Environment/status/938413603807473669","display_url":"twitter.com/EP_Environment…"}],"annotations":[{"start":24,"end":33,"probability":0.9753,"type":"Person","normalized_text":"Guido Rasi"}],"mentions":{}},"text":"Our Executive Director, Guido Rasi, will give a speech at the ENVI meeting tomorrow. https://t.co/kwKdB3gzf7","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-12-06T15:56:32.000Z","author_id":"116716199","lang":"en","conversation_id":"938437007126253568","possibly_sensitive":false,"id":"938437007126253568","source":"Twitter Web Client","public_metrics":{"retweet_count":6,"reply_count":1,"like_count":8,"quote_count":0},"referenced_tweets":[{"type":"quoted","id":"938413603807473669"}]},{"entities":{"hashtags":[{"start":110,"end":125,"tag":"RiskAssessment"}],"urls":{},"annotations":[{"start":49,"end":63,"probability":0.8749,"type":"Person","normalized_text":"Ernesto Liebana"},{"start":77,"end":88,"probability":0.9496,"type":"Person","normalized_text":"Jordi Torren"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"},{"start":71,"end":80,"username":"EMA_News","id":"116716199"}]},"text":"RT @EFSA_EU: Interagency cooperation: our expert Ernesto Liebana &amp; @EMA_News Jordi Torren at workshop for #RiskAssessment &amp; surveillance/mo…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-12-04T14:40:18.000Z","author_id":"116716199","lang":"en","conversation_id":"937693045562183685","possibly_sensitive":false,"id":"937693045562183685","source":"Twitter Web Client","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"937682433662767104"}]},{"entities":{"hashtags":[{"start":9,"end":17,"tag":"patient"},{"start":73,"end":89,"tag":"OrphanMedicines"}],"urls":[{"start":119,"end":142,"url":"https://t.co/1bI1Nf8srD","expanded_url":"http://bit.ly/2AJwCIO","display_url":"bit.ly/2AJwCIO"},{"start":143,"end":166,"url":"https://t.co/G4KvWetEV1","expanded_url":"https://twitter.com/EMA_News/status/937636217151217665/photo/1","display_url":"pic.twitter.com/G4KvWetEV1"}],"annotations":{},"mentions":{}},"text":"Call for #patient organisation representatives to join the Committee for #OrphanMedicines. Deadline: 20 December 2017. https://t.co/1bI1Nf8srD https://t.co/G4KvWetEV1","attachments":{"media_keys":["3_937636082094694400"],"poll_ids":{}},"created_at":"2017-12-04T10:54:29.000Z","author_id":"116716199","lang":"en","conversation_id":"937636217151217665","possibly_sensitive":false,"id":"937636217151217665","source":"Twitter Web Client","public_metrics":{"retweet_count":78,"reply_count":1,"like_count":50,"quote_count":4},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":76,"end":91,"tag":"pharmaceutical"},{"start":124,"end":131,"tag":"Brexit"}],"urls":[{"start":133,"end":156,"url":"https://t.co/N7rdA1lBwe","expanded_url":"http://bit.ly/2AjuvuL","display_url":"bit.ly/2AjuvuL"}],"annotations":{},"mentions":[{"start":37,"end":51,"username":"EU_Commission","id":"157981564"}]},"text":"We have published, together with the @EU_Commission, a Q&amp;A document for #pharmaceutical companies on how to prepare for #Brexit: https://t.co/N7rdA1lBwe","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-12-01T13:26:36.000Z","author_id":"116716199","lang":"en","conversation_id":"936587335839358977","possibly_sensitive":false,"id":"936587335839358977","source":"Twitter Web Client","public_metrics":{"retweet_count":44,"reply_count":2,"like_count":39,"quote_count":12},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":38,"end":56,"tag":"Pharmacovigilance"},{"start":136,"end":141,"tag":"PRAC"}],"urls":[{"start":112,"end":135,"url":"https://t.co/KNlgC3HbYD","expanded_url":"http://bit.ly/2Boh21Z","display_url":"bit.ly/2Boh21Z"}],"annotations":{},"mentions":{}},"text":"See the outcome of the meeting of our #Pharmacovigilance Committee in November. Two new referrals were started. https://t.co/KNlgC3HbYD #PRAC","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-12-01T12:23:20.000Z","author_id":"116716199","lang":"en","conversation_id":"936571413825310721","possibly_sensitive":false,"id":"936571413825310721","source":"Twitter Web Client","public_metrics":{"retweet_count":11,"reply_count":1,"like_count":9,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":136,"end":159,"url":"https://t.co/rMxJXL615X","expanded_url":"http://bit.ly/X4lXwT","display_url":"bit.ly/X4lXwT"}],"annotations":{},"mentions":[{"start":0,"end":15,"username":"GrahamBurgess4","id":"392068833"},{"start":47,"end":57,"username":"MHRAgovuk","id":"330993102"}]},"text":"@GrahamBurgess4 Please report side effects via @MHRAgovuk ‘s Yellow Card Scheme. If you have further questions, please send them to us: https://t.co/rMxJXL615X","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-12-01T11:13:08.000Z","author_id":"116716199","lang":"en","conversation_id":"936520244163735553","possibly_sensitive":false,"id":"936553748431802369","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"936520244163735553"}],"in_reply_to_user_id":"392068833"},{"entities":{"hashtags":[{"start":49,"end":58,"tag":"patients"},{"start":73,"end":83,"tag":"medicines"}],"urls":[{"start":145,"end":168,"url":"https://t.co/JZ2ucqWiH4","expanded_url":"http://bit.ly/2AhIhhp","display_url":"bit.ly/2AhIhhp"},{"start":169,"end":192,"url":"https://t.co/nJgFt7Cn16","expanded_url":"https://twitter.com/EMA_News/status/936193981251235840/photo/1","display_url":"pic.twitter.com/nJgFt7Cn16"}],"annotations":{},"mentions":[{"start":97,"end":111,"username":"EU_Commission","id":"157981564"}]},"text":"Check out the questions and answers document for #patients\non biosimilar #medicines published by @EU_Commission – Now available in 23 languages: https://t.co/JZ2ucqWiH4 https://t.co/nJgFt7Cn16","attachments":{"media_keys":["3_936193128410820608"],"poll_ids":{}},"created_at":"2017-11-30T11:23:33.000Z","author_id":"116716199","lang":"en","conversation_id":"936193981251235840","possibly_sensitive":false,"id":"936193981251235840","source":"Twitter Web Client","public_metrics":{"retweet_count":47,"reply_count":1,"like_count":48,"quote_count":9},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":93,"end":97,"tag":"HIV"}],"urls":{},"annotations":[{"start":111,"end":116,"probability":0.9934,"type":"Place","normalized_text":"Europe"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":16,"end":29,"username":"ECDC_HIVAIDS","id":"2182569746"}]},"text":"RT @EU_Health: .@ECDC_HIVAIDS: New data, persistent problem: over half (51%) of the reported #HIV diagnoses in Europe happen in a late stag…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-11-29T13:44:19.000Z","author_id":"116716199","lang":"en","conversation_id":"935867016816353280","possibly_sensitive":false,"id":"935867016816353280","source":"Twitter Web Client","public_metrics":{"retweet_count":26,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"935551279161634816"}]},{"entities":{"hashtags":[{"start":46,"end":53,"tag":"pharma"},{"start":76,"end":83,"tag":"Brexit"}],"urls":[{"start":84,"end":107,"url":"https://t.co/0JDYQdCbUc","expanded_url":"http://bit.ly/2Bw9LxY","display_url":"bit.ly/2Bw9LxY"}],"annotations":{},"mentions":{}},"text":"We have published additional guidance to help #pharma companies prepare for #Brexit https://t.co/0JDYQdCbUc","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-11-28T12:22:01.000Z","author_id":"116716199","lang":"en","conversation_id":"935483918064734208","possibly_sensitive":false,"id":"935483918064734208","source":"Sprout Social","public_metrics":{"retweet_count":70,"reply_count":1,"like_count":46,"quote_count":10},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":29,"end":47,"tag":"Pharmacovigilance"},{"start":112,"end":117,"tag":"PRAC"}],"urls":[{"start":88,"end":111,"url":"https://t.co/WeEsgaqu4U","expanded_url":"http://bit.ly/2nctJun","display_url":"bit.ly/2nctJun"}],"annotations":{},"mentions":{}},"text":"What is on the agenda of our #Pharmacovigilance Committee meeting this month? See here: https://t.co/WeEsgaqu4U #PRAC","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-11-28T10:14:10.000Z","author_id":"116716199","lang":"en","conversation_id":"935451743391027200","possibly_sensitive":false,"id":"935451743391027200","source":"Twitter Web Client","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":5,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":75,"end":85,"tag":"medicines"}],"urls":[{"start":93,"end":116,"url":"https://t.co/KCLdqZJQSk","expanded_url":"http://bit.ly/2A4ImFm","display_url":"bit.ly/2A4ImFm"},{"start":117,"end":140,"url":"https://t.co/HjabYS6s0Q","expanded_url":"https://twitter.com/EMA_News/status/934094267739529218/photo/1","display_url":"pic.twitter.com/HjabYS6s0Q"}],"annotations":{},"mentions":{}},"text":"ENCePP – Check out the key achievements after 10 years of collaboration in #medicines safety https://t.co/KCLdqZJQSk https://t.co/HjabYS6s0Q","attachments":{"media_keys":["3_934094264505548805"],"poll_ids":{}},"created_at":"2017-11-24T16:20:02.000Z","author_id":"116716199","lang":"en","conversation_id":"934094267739529218","possibly_sensitive":false,"id":"934094267739529218","source":"Sprout Social","public_metrics":{"retweet_count":36,"reply_count":0,"like_count":27,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":69,"end":92,"url":"https://t.co/mh9m4OoMlu","expanded_url":"http://bit.ly/2A5EcgC","display_url":"bit.ly/2A5EcgC"}],"annotations":{},"mentions":[{"start":1,"end":13,"username":"EUombudsman","id":"873777758"}]},"text":".@EUombudsman confirms EMA’s correct handling of declared interests: https://t.co/mh9m4OoMlu","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-11-24T14:45:01.000Z","author_id":"116716199","lang":"en","conversation_id":"934070354661773312","possibly_sensitive":false,"id":"934070354661773312","source":"Sprout Social","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":5,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":93,"end":103,"tag":"medicines"},{"start":108,"end":116,"tag":"patient"},{"start":153,"end":158,"tag":"ATMP"}],"urls":[{"start":129,"end":152,"url":"https://t.co/tHV3LFoLAx","expanded_url":"http://bit.ly/2mYphiN","display_url":"bit.ly/2mYphiN"}],"annotations":{},"mentions":{}},"text":"New guidelines on good manufacturing practices for advanced therapies to ensure high quality #medicines and #patient protection: https://t.co/tHV3LFoLAx #ATMP","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-11-24T13:57:01.000Z","author_id":"116716199","lang":"en","conversation_id":"934058275720630278","possibly_sensitive":false,"id":"934058275720630278","source":"Sprout Social","public_metrics":{"retweet_count":34,"reply_count":0,"like_count":31,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":146,"end":169,"url":"https://t.co/IX3UWWQRbo","expanded_url":"http://bit.ly/2mHWor7","display_url":"bit.ly/2mHWor7"},{"start":170,"end":193,"url":"https://t.co/PPLX9Pg0au","expanded_url":"https://twitter.com/EMA_News/status/933621155633750016/photo/1","display_url":"pic.twitter.com/PPLX9Pg0au"}],"annotations":{},"mentions":{}},"text":"Follow workshop with regulators &amp; the industry on what is (and isn’t) 'prior knowledge' and how it should be used in regulatory applications: https://t.co/IX3UWWQRbo https://t.co/PPLX9Pg0au","attachments":{"media_keys":["3_933621152085295104"],"poll_ids":{}},"created_at":"2017-11-23T09:00:04.000Z","author_id":"116716199","lang":"en","conversation_id":"933621155633750016","possibly_sensitive":false,"id":"933621155633750016","source":"Sprout Social","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":6,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":29,"end":38,"tag":"patients"}],"urls":[{"start":80,"end":103,"url":"https://t.co/Xhc8LOFAw5","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2017/11/news_detail_002858.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"},{"start":104,"end":127,"url":"https://t.co/RU07sVdh8s","expanded_url":"https://twitter.com/EMA_News/status/933276224973148160/photo/1","display_url":"pic.twitter.com/RU07sVdh8s"}],"annotations":[{"start":46,"end":51,"probability":0.9936,"type":"Place","normalized_text":"Europe"}],"mentions":{}},"text":"Better safety monitoring for #patients across Europe is one of EMA's priorities https://t.co/Xhc8LOFAw5 https://t.co/RU07sVdh8s","attachments":{"media_keys":["3_933276176788983809"],"poll_ids":{}},"created_at":"2017-11-22T10:09:26.000Z","author_id":"116716199","lang":"en","conversation_id":"933276224973148160","possibly_sensitive":false,"id":"933276224973148160","source":"Twitter Web Client","public_metrics":{"retweet_count":50,"reply_count":0,"like_count":47,"quote_count":7},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":89,"end":112,"url":"https://t.co/VClZjguh5g","expanded_url":"https://www.youtube.com/watch?v=kGT50snv5yc&feature=youtu.be","display_url":"youtube.com/watch?v=kGT50s…"}],"annotations":[{"start":27,"end":29,"probability":0.4971,"type":"Organization","normalized_text":"EMA"},{"start":78,"end":86,"probability":0.9913,"type":"Place","normalized_text":"Amsterdam"}],"mentions":{}},"text":"Check out the recording of EMA’s press briefing on the Agency’s relocation to Amsterdam: https://t.co/VClZjguh5g","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-11-21T17:05:26.000Z","author_id":"116716199","lang":"en","conversation_id":"933018528046870528","possibly_sensitive":false,"id":"933018528046870528","source":"Twitter Web Client","public_metrics":{"retweet_count":45,"reply_count":1,"like_count":39,"quote_count":3},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":25,"end":48,"url":"https://t.co/6zVlGv1iDj","expanded_url":"http://bit.ly/2mMsmT5","display_url":"bit.ly/2mMsmT5"},{"start":49,"end":72,"url":"https://t.co/HzkIujRuJB","expanded_url":"https://twitter.com/EMA_News/status/932680454758719489/photo/1","display_url":"pic.twitter.com/HzkIujRuJB"}],"annotations":[{"start":15,"end":23,"probability":0.9859,"type":"Place","normalized_text":"Amsterdam"}],"mentions":{}},"text":"EMA to move to Amsterdam https://t.co/6zVlGv1iDj https://t.co/HzkIujRuJB","attachments":{"media_keys":["3_932680450492981248"],"poll_ids":{}},"created_at":"2017-11-20T18:42:03.000Z","author_id":"116716199","lang":"en","conversation_id":"932680454758719489","possibly_sensitive":false,"id":"932680454758719489","source":"Sprout Social","public_metrics":{"retweet_count":820,"reply_count":55,"like_count":686,"quote_count":178},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":{},"annotations":[{"start":14,"end":22,"probability":0.9857,"type":"Place","normalized_text":"Amsterdam"}],"mentions":[{"start":3,"end":12,"username":"EU2017EE","id":"951050205637595137"}]},"text":"RT @EU2017EE: Amsterdam will be the new location of the European Medicines Agency\n\nBackground info on the relocation of the UK-based EU age…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-11-20T17:13:45.000Z","author_id":"116716199","lang":"en","conversation_id":"932658234569224192","possibly_sensitive":false,"id":"932658234569224192","source":"TweetDeck","public_metrics":{"retweet_count":1448,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"932657662638153735"}]},{"entities":{"hashtags":[{"start":88,"end":100,"tag":"antibiotics"},{"start":115,"end":119,"tag":"AMR"},{"start":144,"end":167,"tag":"KeepAntibioticsWorking"}],"urls":[{"start":120,"end":143,"url":"https://t.co/j5GGjA7otl","expanded_url":"http://bit.ly/2mBdsPj","display_url":"bit.ly/2mBdsPj"}],"annotations":{},"mentions":[{"start":14,"end":21,"username":"US_FDA","id":"208120290"}]},"text":"EMA, PMDA and @US_FDA take further steps to align their approaches to the evaluation of #antibiotics to help fight #AMR https://t.co/j5GGjA7otl #KeepAntibioticsWorking","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-11-17T14:50:01.000Z","author_id":"116716199","lang":"en","conversation_id":"931534897491120128","possibly_sensitive":false,"id":"931534897491120128","source":"Sprout Social","public_metrics":{"retweet_count":26,"reply_count":3,"like_count":23,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":74,"end":83,"tag":"vaccines"}],"urls":[{"start":94,"end":117,"url":"https://t.co/xLJhF8KKEt","expanded_url":"http://bit.ly/2zKhpa2","display_url":"bit.ly/2zKhpa2"}],"annotations":[{"start":0,"end":2,"probability":0.6234,"type":"Organization","normalized_text":"EMA"}],"mentions":{}},"text":"EMA agrees new proposals to facilitate the availability of new veterinary #vaccines in the EU https://t.co/xLJhF8KKEt","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-11-17T09:22:01.000Z","author_id":"116716199","lang":"en","conversation_id":"931452353278038016","possibly_sensitive":false,"id":"931452353278038016","source":"Sprout Social","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":5,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":0,"end":6,"tag":"PRIME"},{"start":86,"end":91,"tag":"SMEs"}],"urls":[{"start":62,"end":85,"url":"https://t.co/MJWkjPTFbm","expanded_url":"http://bit.ly/1RNe7kK","display_url":"bit.ly/1RNe7kK"},{"start":92,"end":115,"url":"https://t.co/W5zE2S3mic","expanded_url":"https://twitter.com/EMA_News/status/931105675094175744/photo/1","display_url":"pic.twitter.com/W5zE2S3mic"}],"annotations":{},"mentions":{}},"text":"#PRIME eligibility was granted to three requests in November. https://t.co/MJWkjPTFbm #SMEs https://t.co/W5zE2S3mic","attachments":{"media_keys":["3_931105632215846913"],"poll_ids":{}},"created_at":"2017-11-16T10:24:26.000Z","author_id":"116716199","lang":"en","conversation_id":"931105675094175744","possibly_sensitive":false,"id":"931105675094175744","source":"Twitter Web Client","public_metrics":{"retweet_count":17,"reply_count":0,"like_count":19,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":68,"end":78,"tag":"medicines"}],"urls":[{"start":94,"end":117,"url":"https://t.co/I1h3gV9O7x","expanded_url":"http://bit.ly/2mu0Byl","display_url":"bit.ly/2mu0Byl"}],"annotations":[{"start":0,"end":2,"probability":0.728,"type":"Organization","normalized_text":"EMA"}],"mentions":{}},"text":"EMA launches new action plan to make the product information for EU #medicines easier to read https://t.co/I1h3gV9O7x","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-11-15T16:01:02.000Z","author_id":"116716199","lang":"en","conversation_id":"930827993357996032","possibly_sensitive":false,"id":"930827993357996032","source":"Sprout Social","public_metrics":{"retweet_count":44,"reply_count":0,"like_count":45,"quote_count":4},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":17,"end":38,"tag":"AntibioticResistance"},{"start":64,"end":87,"tag":"KeepAntibioticsWorking"}],"urls":[{"start":40,"end":63,"url":"https://t.co/1QK8SYBBJV","expanded_url":"http://bit.ly/2mteKMg","display_url":"bit.ly/2mteKMg"},{"start":88,"end":111,"url":"https://t.co/Wh8fM9HavL","expanded_url":"https://twitter.com/EMA_News/status/930755581056573440/photo/1","display_url":"pic.twitter.com/Wh8fM9HavL"}],"annotations":{},"mentions":{}},"text":"How do you fight #AntibioticResistance? https://t.co/1QK8SYBBJV\n#KeepAntibioticsWorking https://t.co/Wh8fM9HavL","attachments":{"media_keys":["3_930754207057154048"],"poll_ids":{}},"created_at":"2017-11-15T11:13:17.000Z","author_id":"116716199","lang":"en","conversation_id":"930755581056573440","possibly_sensitive":false,"id":"930755581056573440","source":"Twitter Web Client","public_metrics":{"retweet_count":53,"reply_count":0,"like_count":38,"quote_count":4},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":72,"end":93,"tag":"AntibioticResistance"},{"start":120,"end":143,"tag":"KeepAntibioticsWorking"},{"start":144,"end":154,"tag":"OneHealth"}],"urls":[{"start":95,"end":118,"url":"https://t.co/oOKCfSHX0C","expanded_url":"http://bit.ly/2zx4urT","display_url":"bit.ly/2zx4urT"},{"start":155,"end":178,"url":"https://t.co/s49a7DrLMz","expanded_url":"https://twitter.com/EMA_News/status/930743682894106624/photo/1","display_url":"pic.twitter.com/s49a7DrLMz"}],"annotations":{},"mentions":{}},"text":"Report: there is more evidence on the link between antibiotic use &amp; #AntibioticResistance: https://t.co/oOKCfSHX0C \n#KeepAntibioticsWorking #OneHealth https://t.co/s49a7DrLMz","attachments":{"media_keys":["3_930743603428843520"],"poll_ids":{}},"created_at":"2017-11-15T10:26:01.000Z","author_id":"116716199","lang":"en","conversation_id":"930743682894106624","possibly_sensitive":false,"id":"930743682894106624","source":"Twitter Web Client","public_metrics":{"retweet_count":21,"reply_count":0,"like_count":7,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":51,"end":75,"tag":"AntibioticAwarenessWeek"}],"urls":[{"start":95,"end":118,"url":"https://t.co/qLxYl9aprA","expanded_url":"https://youtu.be/Biw-5Jx64jE","display_url":"youtu.be/Biw-5Jx64jE"}],"annotations":{},"mentions":[{"start":3,"end":18,"username":"V_Andriukaitis","id":"575269517"}]},"text":"RT @V_Andriukaitis: Tomorrow we will mark European #AntibioticAwarenessWeek \nTune in CET 9:00  https://t.co/qLxYl9aprA \nAsk questions with…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-11-14T15:15:41.000Z","author_id":"116716199","lang":"en","conversation_id":"930454194267525127","possibly_sensitive":false,"id":"930454194267525127","source":"Twitter Web Client","public_metrics":{"retweet_count":53,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"930444255088214016"}]},{"entities":{"hashtags":[{"start":115,"end":138,"tag":"KeepAntibioticsWorking"},{"start":139,"end":160,"tag":"AntibioticResistance"},{"start":161,"end":171,"tag":"OneHealth"}],"urls":[{"start":91,"end":114,"url":"https://t.co/odVAKkptb1","expanded_url":"http://bit.ly/2zCAE4X","display_url":"bit.ly/2zCAE4X"},{"start":172,"end":195,"url":"https://t.co/YdXBW2jhLW","expanded_url":"https://twitter.com/EMA_News/status/930405211314802689/photo/1","display_url":"pic.twitter.com/YdXBW2jhLW"}],"annotations":[{"start":57,"end":62,"probability":0.9953,"type":"Place","normalized_text":"Europe"}],"mentions":{}},"text":"EMA's report: Sales of antibiotics for use in animals in Europe fell by 13.4% (2011- 2015)\nhttps://t.co/odVAKkptb1 #KeepAntibioticsWorking #AntibioticResistance #OneHealth https://t.co/YdXBW2jhLW","attachments":{"media_keys":["3_930405208588505089"],"poll_ids":{}},"created_at":"2017-11-14T12:01:03.000Z","author_id":"116716199","lang":"en","conversation_id":"930405211314802689","possibly_sensitive":false,"id":"930405211314802689","source":"Sprout Social","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":7,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":97,"end":120,"tag":"KeepAntibioticsWorking"}],"urls":{},"annotations":[{"start":36,"end":68,"probability":0.8279,"type":"Other","normalized_text":"European Antibiotic Awareness Day"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"},{"start":70,"end":78,"username":"EAAD_EU","id":"1725283578"}]},"text":"RT @EFSA_EU: Mark your calendar for European Antibiotic Awareness Day @EAAD_EU, 18 November 2017 #KeepAntibioticsWorking #AntimicrobialResi…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-11-14T11:59:20.000Z","author_id":"116716199","lang":"en","conversation_id":"930404779767091205","possibly_sensitive":false,"id":"930404779767091205","source":"Twitter Web Client","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"930375225430089728"}]},{"entities":{"hashtags":[{"start":81,"end":102,"tag":"AntibioticResistance"},{"start":103,"end":113,"tag":"OneHealth"},{"start":138,"end":161,"tag":"KeepAntibioticsWorking"}],"urls":[{"start":114,"end":137,"url":"https://t.co/l5OZcFDvRR","expanded_url":"http://bit.ly/2zCSOn8","display_url":"bit.ly/2zCSOn8"},{"start":162,"end":185,"url":"https://t.co/RasxWBLIE3","expanded_url":"https://twitter.com/EMA_News/status/930359666701471744/photo/1","display_url":"pic.twitter.com/RasxWBLIE3"}],"annotations":{},"mentions":{}},"text":"Patients &amp; healthcare professionals need to be involved in the fight against #AntibioticResistance #OneHealth\nhttps://t.co/l5OZcFDvRR #KeepAntibioticsWorking https://t.co/RasxWBLIE3","attachments":{"media_keys":["3_930359664063205376"],"poll_ids":{}},"created_at":"2017-11-14T09:00:04.000Z","author_id":"116716199","lang":"en","conversation_id":"930359666701471744","possibly_sensitive":false,"id":"930359666701471744","source":"Sprout Social","public_metrics":{"retweet_count":31,"reply_count":0,"like_count":26,"quote_count":3},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":70,"end":74,"tag":"EMA"}],"urls":[{"start":75,"end":98,"url":"https://t.co/ogAgMCg4ew","expanded_url":"http://goo.gl/c929p8","display_url":"goo.gl/c929p8"},{"start":99,"end":122,"url":"https://t.co/augZoXBvi2","expanded_url":"https://twitter.com/EUnetHTA/status/930091726735335424/photo/1","display_url":"pic.twitter.com/augZoXBvi2"}],"annotations":[{"start":14,"end":16,"probability":0.5219,"type":"Person","normalized_text":"EMA"},{"start":22,"end":29,"probability":0.4516,"type":"Person","normalized_text":"EUnetHTA"}],"mentions":[{"start":3,"end":12,"username":"EUnetHTA","id":"56493220"}]},"text":"RT @EUnetHTA: EMA and EUnetHTA finalise joint work plan for 2017-2020 #EMA https://t.co/ogAgMCg4ew https://t.co/augZoXBvi2","attachments":{"media_keys":["3_930091621911285760"],"poll_ids":{}},"created_at":"2017-11-13T16:33:09.000Z","author_id":"116716199","lang":"en","conversation_id":"930111301010980864","possibly_sensitive":false,"id":"930111301010980864","source":"TweetDeck","public_metrics":{"retweet_count":24,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"930091726735335424"}]},{"entities":{"hashtags":[{"start":8,"end":17,"tag":"EUnetHTA"}],"urls":[{"start":57,"end":80,"url":"https://t.co/uoemYd7ZIQ","expanded_url":"http://bit.ly/2zzlcqr","display_url":"bit.ly/2zzlcqr"}],"annotations":[{"start":0,"end":2,"probability":0.3272,"type":"Person","normalized_text":"EMA"}],"mentions":{}},"text":"EMA and #EUnetHTA publish joint work plan for 2017-2020: https://t.co/uoemYd7ZIQ","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-11-13T16:15:02.000Z","author_id":"116716199","lang":"en","conversation_id":"930106740544364544","possibly_sensitive":false,"id":"930106740544364544","source":"Sprout Social","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":9,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":0,"end":21,"tag":"AntibioticResistance"},{"start":120,"end":143,"tag":"KeepAntibioticsWorking"}],"urls":[{"start":96,"end":119,"url":"https://t.co/ltK9LXJy03","expanded_url":"http://bit.ly/2jmTczO","display_url":"bit.ly/2jmTczO"},{"start":144,"end":167,"url":"https://t.co/PEzy38n8m1","expanded_url":"https://twitter.com/EMA_News/status/930092767824547840/video/1","display_url":"pic.twitter.com/PEzy38n8m1"}],"annotations":[{"start":68,"end":70,"probability":0.3572,"type":"Organization","normalized_text":"EMA"}],"mentions":{}},"text":"#AntibioticResistance is a challenge for everyone. See the views of EMA’s stakeholders on this: https://t.co/ltK9LXJy03 #KeepAntibioticsWorking https://t.co/PEzy38n8m1","attachments":{"media_keys":["7_930092272120729602"],"poll_ids":{}},"created_at":"2017-11-13T15:19:30.000Z","author_id":"116716199","lang":"en","conversation_id":"930092767824547840","possibly_sensitive":false,"id":"930092767824547840","source":"Twitter Web Client","public_metrics":{"retweet_count":41,"reply_count":0,"like_count":28,"quote_count":4},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":42,"end":63,"tag":"AntibioticResistance"},{"start":88,"end":111,"tag":"KeepAntibioticsWorking"}],"urls":[{"start":64,"end":87,"url":"https://t.co/YvLacRvIyY","expanded_url":"http://bit.ly/2zEEx7a","display_url":"bit.ly/2zEEx7a"},{"start":112,"end":135,"url":"https://t.co/XfH2AYSiPE","expanded_url":"https://twitter.com/EMA_News/status/930071504494227456/photo/1","display_url":"pic.twitter.com/XfH2AYSiPE"}],"annotations":[{"start":4,"end":5,"probability":0.7487,"type":"Organization","normalized_text":"EU"}],"mentions":{}},"text":"How EU agencies support the fight against #AntibioticResistance\nhttps://t.co/YvLacRvIyY #KeepAntibioticsWorking https://t.co/XfH2AYSiPE","attachments":{"media_keys":["3_930071481698136064"],"poll_ids":{}},"created_at":"2017-11-13T13:55:01.000Z","author_id":"116716199","lang":"en","conversation_id":"930071504494227456","possibly_sensitive":false,"id":"930071504494227456","source":"Twitter Web Client","public_metrics":{"retweet_count":77,"reply_count":0,"like_count":60,"quote_count":6},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":33,"end":56,"tag":"KeepAntibioticsWorking"}],"urls":{},"annotations":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}]},"text":"RT @EU_Health: What do you do to #KeepAntibioticsWorking? Join the campaign between 13 and 19 November, by posting your own messages, pictu…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-11-10T17:10:29.000Z","author_id":"116716199","lang":"en","conversation_id":"929033532239962115","possibly_sensitive":false,"id":"929033532239962115","source":"Twitter Web Client","public_metrics":{"retweet_count":48,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"929024416691949569"}]},{"entities":{"hashtags":[{"start":0,"end":5,"tag":"CHMP"},{"start":20,"end":30,"tag":"medicines"}],"urls":[{"start":74,"end":97,"url":"https://t.co/gAr7m3RGiV","expanded_url":"http://bit.ly/2maJaTr","display_url":"bit.ly/2maJaTr"},{"start":98,"end":121,"url":"https://t.co/ylYx19JyFF","expanded_url":"https://twitter.com/EMA_News/status/928963206307082240/photo/1","display_url":"pic.twitter.com/ylYx19JyFF"}],"annotations":{},"mentions":{}},"text":"#CHMP recommends 10 #medicines for approval at its November 2017 meeting: https://t.co/gAr7m3RGiV https://t.co/ylYx19JyFF","attachments":{"media_keys":["3_928963204172017664"],"poll_ids":{}},"created_at":"2017-11-10T12:31:02.000Z","author_id":"116716199","lang":"en","conversation_id":"928963206307082240","possibly_sensitive":false,"id":"928963206307082240","source":"Sprout Social","public_metrics":{"retweet_count":29,"reply_count":0,"like_count":16,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":4,"end":13,"tag":"medicine"},{"start":114,"end":119,"tag":"CHMP"}],"urls":[{"start":90,"end":113,"url":"https://t.co/wbsomDDeLI","expanded_url":"http://bit.ly/2zsrw2U","display_url":"bit.ly/2zsrw2U"}],"annotations":{},"mentions":{}},"text":"New #medicine for rare inflammatory condition of the oesophagus recommended for approval: https://t.co/wbsomDDeLI #CHMP","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-11-10T12:29:01.000Z","author_id":"116716199","lang":"en","conversation_id":"928962698188029953","possibly_sensitive":false,"id":"928962698188029953","source":"Sprout Social","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":4,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":4,"end":13,"tag":"medicine"},{"start":52,"end":61,"tag":"StemCell"},{"start":132,"end":137,"tag":"CHMP"}],"urls":[{"start":108,"end":131,"url":"https://t.co/nksPeXYhi5","expanded_url":"http://bit.ly/2zsKlD9","display_url":"bit.ly/2zsKlD9"}],"annotations":{},"mentions":{}},"text":"New #medicine to prevent cytomegalovirus disease in #StemCell transplant patients recommended for approval: https://t.co/nksPeXYhi5 #CHMP","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-11-10T12:27:01.000Z","author_id":"116716199","lang":"en","conversation_id":"928962195739824133","possibly_sensitive":false,"id":"928962195739824133","source":"Sprout Social","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":10,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":0,"end":5,"tag":"CHMP"},{"start":36,"end":45,"tag":"medicine"},{"start":50,"end":68,"tag":"multipleSclerosis"}],"urls":[{"start":70,"end":93,"url":"https://t.co/uk4SBz7emB","expanded_url":"http://bit.ly/2zqCaax","display_url":"bit.ly/2zqCaax"}],"annotations":{},"mentions":{}},"text":"#CHMP recommends for approval a new #medicine for #multipleSclerosis: https://t.co/uk4SBz7emB","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-11-10T12:25:01.000Z","author_id":"116716199","lang":"en","conversation_id":"928961691596890112","possibly_sensitive":false,"id":"928961691596890112","source":"Sprout Social","public_metrics":{"retweet_count":24,"reply_count":0,"like_count":19,"quote_count":3},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":14,"end":21,"tag":"agenda"},{"start":73,"end":83,"tag":"medicines"},{"start":109,"end":114,"tag":"CHMP"}],"urls":[{"start":85,"end":108,"url":"https://t.co/7SMN1gGb5v","expanded_url":"http://bit.ly/2ziflpe","display_url":"bit.ly/2ziflpe"}],"annotations":{},"mentions":{}},"text":"Check out the #agenda of the November meeting of our committee for human #medicines: https://t.co/7SMN1gGb5v #CHMP","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-11-06T13:56:01.000Z","author_id":"116716199","lang":"en","conversation_id":"927535040464080896","possibly_sensitive":false,"id":"927535040464080896","source":"Sprout Social","public_metrics":{"retweet_count":16,"reply_count":1,"like_count":13,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":48,"end":58,"tag":"medicines"}],"urls":[{"start":98,"end":121,"url":"https://t.co/zavojoKYF3","expanded_url":"http://bit.ly/2zUgG2j","display_url":"bit.ly/2zUgG2j"}],"annotations":{},"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}]},"text":"EU-@US_FDA mutual recognition of inspections of #medicines manufacturers enters operational phase https://t.co/zavojoKYF3","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-10-31T16:07:29.000Z","author_id":"116716199","lang":"en","conversation_id":"925393801673355266","possibly_sensitive":false,"id":"925393801673355266","source":"Twitter Web Client","public_metrics":{"retweet_count":29,"reply_count":2,"like_count":26,"quote_count":3},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":15,"end":24,"tag":"vaccines"},{"start":29,"end":39,"tag":"medicines"}],"urls":[{"start":115,"end":138,"url":"https://t.co/w7CSEu295U","expanded_url":"http://bit.ly/2yYbdLc","display_url":"bit.ly/2yYbdLc"}],"annotations":{},"mentions":{}},"text":"How to develop #vaccines and #medicines for respiratory syncytial virus infection – New guideline for consultation https://t.co/w7CSEu295U","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-10-30T16:00:10.000Z","author_id":"116716199","lang":"en","conversation_id":"925029571417853952","possibly_sensitive":false,"id":"925029571417853952","source":"Sprout Social","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":8,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":4,"end":22,"tag":"Pharmacovigilance"},{"start":109,"end":114,"tag":"PRAC"}],"urls":[{"start":85,"end":108,"url":"https://t.co/BzgGpqNx0G","expanded_url":"http://bit.ly/2zUxYNN","display_url":"bit.ly/2zUxYNN"}],"annotations":{},"mentions":{}},"text":"Our #Pharmacovigilance Committee started 2 referrals this month &amp; concluded one: https://t.co/BzgGpqNx0G #PRAC","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-10-27T11:24:10.000Z","author_id":"116716199","lang":"en","conversation_id":"923872950201315328","possibly_sensitive":false,"id":"923872950201315328","source":"Twitter Web Client","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":1,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":22,"end":46,"tag":"AntimicrobialResistance"}],"urls":[{"start":111,"end":134,"url":"https://t.co/j2G5moYxjY","expanded_url":"http://bit.ly/2lg2uOC","display_url":"bit.ly/2lg2uOC"},{"start":135,"end":158,"url":"https://t.co/2vMu0iivd6","expanded_url":"https://twitter.com/EMA_News/status/923551549103771648/photo/1","display_url":"pic.twitter.com/2vMu0iivd6"}],"annotations":{},"mentions":[{"start":83,"end":91,"username":"EFSA_EU","id":"84582815"},{"start":93,"end":101,"username":"ECDC_EU","id":"204752573"}]},"text":"Measuring progress on #AntimicrobialResistance needs indicators – check opinion by @EFSA_EU, @ECDC_EU and EMA: https://t.co/j2G5moYxjY https://t.co/2vMu0iivd6","attachments":{"media_keys":["3_923551546381438977"],"poll_ids":{}},"created_at":"2017-10-26T14:07:02.000Z","author_id":"116716199","lang":"en","conversation_id":"923551549103771648","possibly_sensitive":false,"id":"923551549103771648","source":"Sprout Social","public_metrics":{"retweet_count":53,"reply_count":0,"like_count":40,"quote_count":3},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":56,"end":67,"tag":"Paediatric"},{"start":116,"end":125,"tag":"children"},{"start":128,"end":138,"tag":"medicines"}],"urls":{},"annotations":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":15,"end":30,"username":"V_Andriukaitis","id":"575269517"},{"start":31,"end":45,"username":"EU_Commission","id":"157981564"},{"start":46,"end":55,"username":"EMA_News","id":"116716199"}]},"text":"RT @EU_Health: @V_Andriukaitis @EU_Commission @EMA_News #Paediatric investigation plans are the 1st step to develop #children's #medicines:…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-10-26T11:03:16.000Z","author_id":"116716199","lang":"en","conversation_id":"923505303798370305","possibly_sensitive":false,"id":"923505303798370305","source":"Twitter Web Client","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"923502145755844608"}]},{"entities":{"hashtags":[{"start":56,"end":59,"tag":"EU"},{"start":60,"end":75,"tag":"ClinicalTrials"}],"urls":{},"annotations":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":15,"end":30,"username":"V_Andriukaitis","id":"575269517"},{"start":31,"end":45,"username":"EU_Commission","id":"157981564"},{"start":46,"end":55,"username":"EMA_News","id":"116716199"}]},"text":"RT @EU_Health: @V_Andriukaitis @EU_Commission @EMA_News #EU #ClinicalTrials that include children increased by 50%: more evidence-based inf…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-10-26T10:46:14.000Z","author_id":"116716199","lang":"en","conversation_id":"923501015021903872","possibly_sensitive":false,"id":"923501015021903872","source":"Twitter Web Client","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"923498067948638208"}]},{"entities":{"hashtags":[{"start":75,"end":91,"tag":"childrenshealth"},{"start":92,"end":109,"tag":"childrenmedicine"}],"urls":[{"start":112,"end":135,"url":"https://t.co/z69nXMt3f4","expanded_url":"http://europa.eu/rapid/press-release_IP-17-4121_en.htm","display_url":"europa.eu/rapid/press-re…"}],"annotations":{},"mentions":[{"start":3,"end":18,"username":"V_Andriukaitis","id":"575269517"}]},"text":"RT @V_Andriukaitis: Report is out. I’m committed to give all my energy for #childrenshealth #childrenmedicine ➡️https://t.co/z69nXMt3f4 htt…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-10-26T10:35:41.000Z","author_id":"116716199","lang":"en","conversation_id":"923498360732086272","possibly_sensitive":false,"id":"923498360732086272","source":"Twitter Web Client","public_metrics":{"retweet_count":14,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"923495792794578944"}]},{"entities":{"hashtags":[{"start":19,"end":28,"tag":"children"},{"start":31,"end":41,"tag":"medicines"},{"start":97,"end":100,"tag":"EU"},{"start":101,"end":112,"tag":"Paediatric"}],"urls":{},"annotations":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}]},"text":"RT @EU_Health: 260 #children's #medicines developed in the past 10 ys - report on progress since #EU #Paediatric Regulation adopted https:/…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-10-26T10:11:49.000Z","author_id":"116716199","lang":"en","conversation_id":"923492355591766017","possibly_sensitive":false,"id":"923492355591766017","source":"Twitter Web Client","public_metrics":{"retweet_count":37,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"923492245675872257"}]},{"entities":{"hashtags":[{"start":32,"end":35,"tag":"EU"},{"start":36,"end":47,"tag":"Paediatric"}],"urls":{},"annotations":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}]},"text":"RT @EU_Health: 10 years ago the #EU #Paediatric regulation came into force. Stay tuned on 26/10 for our report on progress made in #childre…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-10-24T15:57:27.000Z","author_id":"116716199","lang":"en","conversation_id":"922854558723866624","possibly_sensitive":false,"id":"922854558723866624","source":"Twitter Web Client","public_metrics":{"retweet_count":41,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"922849333430620160"}]},{"entities":{"hashtags":[{"start":19,"end":28,"tag":"patients"},{"start":33,"end":57,"tag":"healthcareprofessionals"}],"urls":[{"start":114,"end":137,"url":"https://t.co/g550Wsj6Y9","expanded_url":"http://bit.ly/2zMxbhF","display_url":"bit.ly/2zMxbhF","status":403,"unwound_url":"http://bit.ly/2zMxbhF"}],"annotations":{},"mentions":{}},"text":"Hear the voices of #patients and #healthcareprofessionals engaged in the Agency’s work for better decision-making https://t.co/g550Wsj6Y9","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-10-24T13:45:01.000Z","author_id":"116716199","lang":"en","conversation_id":"922821232185298945","possibly_sensitive":false,"id":"922821232185298945","source":"Sprout Social","public_metrics":{"retweet_count":50,"reply_count":0,"like_count":38,"quote_count":5},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":118,"end":134,"tag":"HealthierEurope"}],"urls":[{"start":94,"end":117,"url":"https://t.co/a1A0paMiYu","expanded_url":"http://www.emcdda.europa.eu/publications/manuals/health-and-social-responses-to-drug-problems-a-european-guide_en","display_url":"emcdda.europa.eu/publications/m…"}],"annotations":{},"mentions":[{"start":3,"end":10,"username":"EMCDDA","id":"50638521"}]},"text":"RT @EMCDDA: Just published: 'Health and social responses to drug problems: a European guide': https://t.co/a1A0paMiYu #HealthierEurope #LxA…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-10-24T09:27:21.000Z","author_id":"116716199","lang":"en","conversation_id":"922756389138829312","possibly_sensitive":false,"id":"922756389138829312","source":"TweetDeck","public_metrics":{"retweet_count":40,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"922756221970632704"}]},{"entities":{"hashtags":[{"start":32,"end":50,"tag":"Pharmacovigilance"},{"start":107,"end":112,"tag":"PRAC"}],"urls":[{"start":83,"end":106,"url":"https://t.co/8rLUBXhSQh","expanded_url":"http://bit.ly/2yKKP6r","display_url":"bit.ly/2yKKP6r"}],"annotations":{},"mentions":{}},"text":"See what's on the agenda of the #Pharmacovigilance Committee's meeting in October: https://t.co/8rLUBXhSQh #PRAC","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-10-24T09:16:33.000Z","author_id":"116716199","lang":"en","conversation_id":"922753669686288384","possibly_sensitive":false,"id":"922753669686288384","source":"Twitter Web Client","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":4,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":23,"end":34,"tag":"OpenCTData"}],"urls":[{"start":89,"end":112,"url":"https://t.co/z1bA0RXC9I","expanded_url":"http://bit.ly/2yY3k8E","display_url":"bit.ly/2yY3k8E"},{"start":113,"end":136,"url":"https://t.co/gq7k3MfFxL","expanded_url":"https://twitter.com/EMA_News/status/921414471557500928/photo/1","display_url":"pic.twitter.com/gq7k3MfFxL"}],"annotations":{},"mentions":{}},"text":"1st anniversary of the #OpenCTData initiative – check out the figures and user feedback: https://t.co/z1bA0RXC9I https://t.co/gq7k3MfFxL","attachments":{"media_keys":["3_921414468625510401"],"poll_ids":{}},"created_at":"2017-10-20T16:35:03.000Z","author_id":"116716199","lang":"en","conversation_id":"921414471557500928","possibly_sensitive":false,"id":"921414471557500928","source":"Sprout Social","public_metrics":{"retweet_count":37,"reply_count":0,"like_count":20,"quote_count":4},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":64,"end":82,"tag":"AdvancedTherapies"}],"urls":[{"start":84,"end":107,"url":"https://t.co/MwrYG8j3S3","expanded_url":"http://bit.ly/2yVrCAk","display_url":"bit.ly/2yVrCAk"}],"annotations":{},"mentions":[{"start":4,"end":14,"username":"EU_Health","id":"606325697"}]},"text":"New @EU_Health and EMA action plan to foster the development of #AdvancedTherapies: https://t.co/MwrYG8j3S3","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-10-20T11:50:00.000Z","author_id":"116716199","lang":"en","conversation_id":"921342737399664640","possibly_sensitive":false,"id":"921342737399664640","source":"Sprout Social","public_metrics":{"retweet_count":17,"reply_count":0,"like_count":13,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":41,"end":53,"tag":"raredisease"}],"urls":[{"start":54,"end":77,"url":"https://t.co/W6Q1ieTS95","expanded_url":"http://download.eurordis.org.s3.amazonaws.com/documents/pdf/Brochure_EN.pdf","display_url":"download.eurordis.org.s3.amazonaws.com/documents/pdf/…"},{"start":78,"end":101,"url":"https://t.co/LBMYRUAA1e","expanded_url":"https://twitter.com/eurordis/status/921293163914031104/photo/1","display_url":"pic.twitter.com/LBMYRUAA1e"}],"annotations":{},"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}]},"text":"RT @eurordis: Check out our new leaflet! #raredisease https://t.co/W6Q1ieTS95 https://t.co/LBMYRUAA1e","attachments":{"media_keys":["3_921292755091054592"],"poll_ids":{}},"created_at":"2017-10-20T08:55:21.000Z","author_id":"116716199","lang":"en","conversation_id":"921298782851125248","possibly_sensitive":false,"id":"921298782851125248","source":"TweetDeck","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"921293163914031104"}]},{"entities":{"hashtags":[{"start":97,"end":107,"tag":"valproate"},{"start":117,"end":127,"tag":"FACSaware"}],"urls":{},"annotations":[{"start":80,"end":92,"probability":0.6036,"type":"Person","normalized_text":"Dr June Raine"}],"mentions":[{"start":3,"end":13,"username":"facsaware","id":"1539712658"},{"start":55,"end":65,"username":"MHRAgovuk","id":"330993102"},{"start":66,"end":75,"username":"EMA_News","id":"116716199"}]},"text":"RT @facsaware: It has been a pleasure to work with the @MHRAgovuk @EMA_News and Dr June Raine on #valproate Toolkit.\n#FACSaware https://t.c…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-10-19T17:16:27.000Z","author_id":"116716199","lang":"en","conversation_id":"921062499818057729","possibly_sensitive":false,"id":"921062499818057729","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"921045758647984128"}]},{"entities":{"hashtags":[{"start":11,"end":19,"tag":"BigData"},{"start":45,"end":54,"tag":"patients"},{"start":85,"end":100,"tag":"DataProtection"}],"urls":[{"start":117,"end":140,"url":"https://t.co/qA1dYf6O2o","expanded_url":"http://bit.ly/2yz9wmg","display_url":"bit.ly/2yz9wmg"},{"start":141,"end":164,"url":"https://t.co/N3rPNehUlA","expanded_url":"https://twitter.com/EMA_News/status/921010308470198272/photo/1","display_url":"pic.twitter.com/N3rPNehUlA"}],"annotations":{},"mentions":{}},"text":"How to use #BigData ethically for benefit of #patients – one of the topics of our EU #DataProtection officer meeting https://t.co/qA1dYf6O2o https://t.co/N3rPNehUlA","attachments":{"media_keys":["3_921008138983264257"],"poll_ids":{}},"created_at":"2017-10-19T13:49:03.000Z","author_id":"116716199","lang":"en","conversation_id":"921010308470198272","possibly_sensitive":false,"id":"921010308470198272","source":"Twitter Web Client","public_metrics":{"retweet_count":55,"reply_count":1,"like_count":60,"quote_count":7},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":0,"end":6,"tag":"PRIME"}],"urls":[{"start":56,"end":79,"url":"https://t.co/JhY8gPYsOv","expanded_url":"http://bit.ly/2hP3MuW","display_url":"bit.ly/2hP3MuW"},{"start":80,"end":103,"url":"https://t.co/gVGQUza8JZ","expanded_url":"https://twitter.com/EMA_News/status/920953932154834944/photo/1","display_url":"pic.twitter.com/gVGQUza8JZ"}],"annotations":{},"mentions":{}},"text":"#PRIME eligibility granted for 3 treatments in October: https://t.co/JhY8gPYsOv https://t.co/gVGQUza8JZ","attachments":{"media_keys":["3_920953929973710848"],"poll_ids":{}},"created_at":"2017-10-19T10:05:02.000Z","author_id":"116716199","lang":"en","conversation_id":"920953932154834944","possibly_sensitive":false,"id":"920953932154834944","source":"Sprout Social","public_metrics":{"retweet_count":20,"reply_count":0,"like_count":13,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":92,"end":115,"url":"https://t.co/AjHgDJDgW2","expanded_url":"http://bit.ly/2hMeFOf","display_url":"bit.ly/2hMeFOf"},{"start":116,"end":139,"url":"https://t.co/qZ5T131blu","expanded_url":"https://twitter.com/Consalud_es/status/920643223906856960","display_url":"twitter.com/Consalud_es/st…"}],"annotations":{},"mentions":[{"start":22,"end":34,"username":"EUombudsman","id":"873777758"}]},"text":"¡Sí, son seguras! The @EUombudsman found no maladministration in EMA’s HPV vaccines review: https://t.co/AjHgDJDgW2 https://t.co/qZ5T131blu","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-10-18T15:47:08.000Z","author_id":"116716199","lang":"es","conversation_id":"920677634450784258","possibly_sensitive":false,"id":"920677634450784258","source":"TweetDeck","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":6,"quote_count":0},"referenced_tweets":[{"type":"quoted","id":"920643223906856960"}]},{"entities":{"hashtags":[{"start":88,"end":91,"tag":"EU"},{"start":92,"end":102,"tag":"languages"}],"urls":[{"start":104,"end":127,"url":"https://t.co/Cxa1homrne","expanded_url":"http://bit.ly/2okZPAc","display_url":"bit.ly/2okZPAc"}],"annotations":[{"start":45,"end":69,"probability":0.3718,"type":"Organization","normalized_text":"European Medicines Agency"}],"mentions":[{"start":3,"end":13,"username":"kardamyla","id":"59722141"},{"start":71,"end":80,"username":"EMA_News","id":"116716199"}]},"text":"RT @kardamyla: Do you want to know about the European Medicines Agency @EMA_News in all #EU #languages? https://t.co/Cxa1homrne https://t.c…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-10-18T13:46:36.000Z","author_id":"116716199","lang":"en","conversation_id":"920647301147840513","possibly_sensitive":false,"id":"920647301147840513","source":"TweetDeck","public_metrics":{"retweet_count":14,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"920646774997610496"}]},{"entities":{"hashtags":{},"urls":[{"start":85,"end":108,"url":"https://t.co/AjHgDJDgW2","expanded_url":"http://bit.ly/2hMeFOf","display_url":"bit.ly/2hMeFOf"},{"start":109,"end":132,"url":"https://t.co/Mv6ZQOlUtv","expanded_url":"https://twitter.com/EllaWeggen/status/920597858046398465","display_url":"twitter.com/EllaWeggen/sta…"}],"annotations":{},"mentions":[{"start":9,"end":21,"username":"EUombudsman","id":"873777758"}]},"text":"Thorough @EUombudsman review found no maladministration with our HPV vaccines review https://t.co/AjHgDJDgW2 https://t.co/Mv6ZQOlUtv","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-10-18T12:03:13.000Z","author_id":"116716199","lang":"en","conversation_id":"920621287021711360","possibly_sensitive":false,"id":"920621287021711360","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":7,"quote_count":0},"referenced_tweets":[{"type":"quoted","id":"920597858046398465"}]},{"entities":{"hashtags":[{"start":31,"end":36,"tag":"EAAD"},{"start":63,"end":84,"tag":"AntibioticResistance"}],"urls":[{"start":107,"end":130,"url":"https://t.co/sGKuxf5lAu","expanded_url":"http://bit.ly/1Mk4MkS","display_url":"bit.ly/1Mk4MkS"}],"annotations":{},"mentions":[{"start":3,"end":11,"username":"EAAD_EU","id":"1725283578"}]},"text":"RT @EAAD_EU: Check out the new #EAAD website: new design &amp; #AntibioticResistance awareness resources! \nhttps://t.co/sGKuxf5lAu https://t.co…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-10-17T15:22:48.000Z","author_id":"116716199","lang":"en","conversation_id":"920309124474294272","possibly_sensitive":false,"id":"920309124474294272","source":"TweetDeck","public_metrics":{"retweet_count":59,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"920307266158505984"}]},{"entities":{"hashtags":[{"start":121,"end":134,"tag":"vaccineswork"}],"urls":[{"start":97,"end":120,"url":"https://t.co/AjHgDJDgW2","expanded_url":"http://bit.ly/2hMeFOf","display_url":"bit.ly/2hMeFOf"}],"annotations":{},"mentions":[{"start":4,"end":16,"username":"EUombudsman","id":"873777758"}]},"text":"The @EUombudsman concluded that EMA’s safety review of HPV vaccines was complete and independent https://t.co/AjHgDJDgW2 #vaccineswork","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-10-17T13:55:01.000Z","author_id":"116716199","lang":"en","conversation_id":"920287032672509953","possibly_sensitive":false,"id":"920287032672509953","source":"Sprout Social","public_metrics":{"retweet_count":30,"reply_count":0,"like_count":30,"quote_count":5},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":35,"end":42,"tag":"Brexit"}],"urls":[{"start":68,"end":91,"url":"https://t.co/UDzB985QF4","expanded_url":"http://bit.ly/2yrUcaR","display_url":"bit.ly/2yrUcaR"}],"annotations":[{"start":0,"end":2,"probability":0.4072,"type":"Organization","normalized_text":"EMA"}],"mentions":{}},"text":"EMA’s Business Continuity Plan for #Brexit has just been published: https://t.co/UDzB985QF4","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-10-16T15:51:23.000Z","author_id":"116716199","lang":"en","conversation_id":"919953932033626112","possibly_sensitive":false,"id":"919953932033626112","source":"Twitter Web Client","public_metrics":{"retweet_count":67,"reply_count":0,"like_count":35,"quote_count":4},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":4,"end":10,"tag":"ESVAC"},{"start":44,"end":56,"tag":"antibiotics"},{"start":130,"end":134,"tag":"AMR"}],"urls":[{"start":106,"end":129,"url":"https://t.co/MoN4QbkoGA","expanded_url":"http://bit.ly/2hJLGdQ","display_url":"bit.ly/2hJLGdQ"},{"start":135,"end":158,"url":"https://t.co/RQmHNfdMDz","expanded_url":"https://twitter.com/EMA_News/status/919918367670124544/photo/1","display_url":"pic.twitter.com/RQmHNfdMDz"}],"annotations":{},"mentions":{}},"text":"New #ESVAC report provides data on sales of #antibiotics for animal use in 30 European countries in 2015: https://t.co/MoN4QbkoGA #AMR https://t.co/RQmHNfdMDz","attachments":{"media_keys":["3_919918364671205389"],"poll_ids":{}},"created_at":"2017-10-16T13:30:04.000Z","author_id":"116716199","lang":"en","conversation_id":"919918367670124544","possibly_sensitive":false,"id":"919918367670124544","source":"Sprout Social","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":9,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":67,"end":74,"tag":"cancer"},{"start":108,"end":112,"tag":"BMJ"}],"urls":[{"start":113,"end":136,"url":"https://t.co/YsoFQxqh8d","expanded_url":"http://bit.ly/2hF5MpM","display_url":"bit.ly/2hF5MpM"},{"start":137,"end":160,"url":"https://t.co/S1wUbUhOPV","expanded_url":"https://twitter.com/ICR_London/status/918057341555302401","display_url":"twitter.com/ICR_London/sta…"}],"annotations":[{"start":20,"end":22,"probability":0.478,"type":"Organization","normalized_text":"ICR"}],"mentions":{}},"text":"We are happy to see ICR contribution to the debate on evidence for #cancer medicines. We responded today to #BMJ https://t.co/YsoFQxqh8d https://t.co/S1wUbUhOPV","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-10-13T14:37:34.000Z","author_id":"116716199","lang":"en","conversation_id":"918848191818330112","possibly_sensitive":false,"id":"918848191818330112","source":"Twitter Web Client","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":16,"quote_count":3},"referenced_tweets":[{"type":"quoted","id":"918057341555302401"}]},{"entities":{"hashtags":[{"start":77,"end":81,"tag":"BMJ"},{"start":98,"end":105,"tag":"cancer"}],"urls":[{"start":116,"end":139,"url":"https://t.co/7JocinKklY","expanded_url":"http://bit.ly/2zldVaU","display_url":"bit.ly/2zldVaU"}],"annotations":{},"mentions":{}},"text":"Science&amp;standards should serve patients, not vice versa. Our response to #BMJ on evidence for #cancer medicines https://t.co/7JocinKklY","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-10-13T12:58:01.000Z","author_id":"116716199","lang":"en","conversation_id":"918823139076988928","possibly_sensitive":false,"id":"918823139076988928","source":"Twitter Web Client","public_metrics":{"retweet_count":41,"reply_count":1,"like_count":42,"quote_count":10},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":0,"end":5,"tag":"CHMP"},{"start":21,"end":30,"tag":"medicine"}],"urls":[{"start":72,"end":95,"url":"https://t.co/5H0EcDnqRj","expanded_url":"http://bit.ly/2hF8OdJ","display_url":"bit.ly/2hF8OdJ"},{"start":96,"end":119,"url":"https://t.co/GIwRDwI5W7","expanded_url":"https://twitter.com/EMA_News/status/918797220589084674/photo/1","display_url":"pic.twitter.com/GIwRDwI5W7"}],"annotations":{},"mentions":{}},"text":"#CHMP recommends one #medicine for approval at its October 2017 meeting https://t.co/5H0EcDnqRj https://t.co/GIwRDwI5W7","attachments":{"media_keys":["3_918797217867087873"],"poll_ids":{}},"created_at":"2017-10-13T11:15:02.000Z","author_id":"116716199","lang":"en","conversation_id":"918797220589084674","possibly_sensitive":false,"id":"918797220589084674","source":"Sprout Social","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":12,"quote_count":3},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":38,"end":46,"tag":"obesity"},{"start":53,"end":62,"tag":"diabetes"},{"start":75,"end":88,"tag":"HeartFailure"}],"urls":{},"annotations":{},"mentions":[{"start":3,"end":18,"username":"EUScienceInnov","id":"193301414"}]},"text":"RT @EUScienceInnov: Understanding how #obesity &amp; #diabetes can lead to #HeartFailure opened way for better treatments https://t.co/uHYaOr4A…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-10-11T16:20:10.000Z","author_id":"116716199","lang":"en","conversation_id":"918149232816730112","possibly_sensitive":false,"id":"918149232816730112","source":"TweetDeck","public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"918148110697852931"}]},{"entities":{"hashtags":[{"start":29,"end":40,"tag":"healthcare"},{"start":98,"end":102,"tag":"AMR"}],"urls":[{"start":109,"end":132,"url":"https://t.co/heAAThJsEx","expanded_url":"http://bit.ly/2kGwtiF","display_url":"bit.ly/2kGwtiF"}],"annotations":{},"mentions":[{"start":3,"end":16,"username":"HAImedicines","id":"429122255"},{"start":70,"end":79,"username":"EMA_News","id":"116716199"}]},"text":"RT @HAImedicines: Patient or #healthcare pro? Find all materials from @EMA_News's info session on #AMR here: https://t.co/heAAThJsEx #antib…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-10-11T16:03:42.000Z","author_id":"116716199","lang":"en","conversation_id":"918145090652114944","possibly_sensitive":false,"id":"918145090652114944","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"918130983068688384"}]},{"entities":{"hashtags":{},"urls":[{"start":55,"end":78,"url":"https://t.co/dAZC4qUku6","expanded_url":"http://ow.ly/eHV530fK2ac","display_url":"ow.ly/eHV530fK2ac"},{"start":79,"end":102,"url":"https://t.co/9dcqojTqNr","expanded_url":"https://twitter.com/EP_ThinkTank/status/918009570508836864","display_url":"twitter.com/EP_ThinkTank/s…"}],"annotations":{},"mentions":[{"start":25,"end":37,"username":"Europarl_EN","id":"36329597"}]},"text":"Therapies for the future @Europarl_EN- watch live here https://t.co/dAZC4qUku6 https://t.co/9dcqojTqNr","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-10-11T12:40:13.000Z","author_id":"116716199","lang":"en","conversation_id":"918093881538957312","possibly_sensitive":false,"id":"918093881538957312","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":8,"quote_count":1},"referenced_tweets":[{"type":"quoted","id":"918009570508836864"}]},{"entities":{"hashtags":{},"urls":[{"start":61,"end":84,"url":"https://t.co/hrSNWURzb3","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/events/2017/09/event_detail_001506.jsp&mid=WC0b01ac058004d5c3","display_url":"ema.europa.eu/ema/index.jsp?…"}],"annotations":{},"mentions":[{"start":3,"end":12,"username":"pbyrne82","id":"2834844207"},{"start":43,"end":52,"username":"EMA_News","id":"116716199"}]},"text":"RT @pbyrne82: Video &amp; presentations of @EMA_News  on AMR https://t.co/hrSNWURzb3","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-10-11T12:26:30.000Z","author_id":"116716199","lang":"en","conversation_id":"918090429068922880","possibly_sensitive":false,"id":"918090429068922880","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"918027713784565762"}]},{"entities":{"hashtags":[{"start":16,"end":31,"tag":"30000followers"},{"start":35,"end":43,"tag":"Twitter"},{"start":45,"end":54,"tag":"ThankYou"},{"start":83,"end":93,"tag":"milestone"}],"urls":[{"start":94,"end":117,"url":"https://t.co/Q4wZLx4GpW","expanded_url":"https://twitter.com/EMA_News/status/918056094169264128/photo/1","display_url":"pic.twitter.com/Q4wZLx4GpW"}],"annotations":{},"mentions":{}},"text":"We have reached #30000followers on #Twitter! #ThankYou for helping us achieve this #milestone https://t.co/Q4wZLx4GpW","attachments":{"media_keys":["3_918056092181004288"],"poll_ids":{}},"created_at":"2017-10-11T10:10:04.000Z","author_id":"116716199","lang":"en","conversation_id":"918056094169264128","possibly_sensitive":false,"id":"918056094169264128","source":"Sprout Social","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":34,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":35,"end":46,"tag":"excipients"}],"urls":[{"start":47,"end":70,"url":"https://t.co/UfykyOqxtD","expanded_url":"http://bit.ly/2yVB6Y6","display_url":"bit.ly/2yVB6Y6"}],"annotations":{},"mentions":{}},"text":"New safety advice available for 15 #excipients https://t.co/UfykyOqxtD","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-10-10T09:30:02.000Z","author_id":"116716199","lang":"en","conversation_id":"917683632227184640","possibly_sensitive":false,"id":"917683632227184640","source":"Sprout Social","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":3,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":14,"end":21,"tag":"agenda"},{"start":72,"end":82,"tag":"medicines"},{"start":108,"end":113,"tag":"CHMP"}],"urls":[{"start":84,"end":107,"url":"https://t.co/QiByzcRCmV","expanded_url":"http://bit.ly/2xtpJpn","display_url":"bit.ly/2xtpJpn"}],"annotations":{},"mentions":{}},"text":"What’s on the #agenda of the October meeting of our committee for human #medicines? https://t.co/QiByzcRCmV #CHMP","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-10-09T11:37:01.000Z","author_id":"116716199","lang":"en","conversation_id":"917353201925591042","possibly_sensitive":false,"id":"917353201925591042","source":"Sprout Social","public_metrics":{"retweet_count":9,"reply_count":2,"like_count":3,"quote_count":3},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":21,"end":36,"tag":"EudraVigilance"}],"urls":[{"start":110,"end":133,"url":"https://t.co/zbfNj7xxZP","expanded_url":"http://bit.ly/2yLEd56","display_url":"bit.ly/2yLEd56"},{"start":134,"end":157,"url":"https://t.co/famR8yebw9","expanded_url":"https://twitter.com/EMA_News/status/917344651538989058/photo/1","display_url":"pic.twitter.com/famR8yebw9"}],"annotations":{},"mentions":{}},"text":"Countdown to the new #EudraVigilance: some EMA IT systems will be unavailable between 8 and 21 November 2017: https://t.co/zbfNj7xxZP https://t.co/famR8yebw9","attachments":{"media_keys":["3_917344649018146817"],"poll_ids":{}},"created_at":"2017-10-09T11:03:03.000Z","author_id":"116716199","lang":"en","conversation_id":"917344651538989058","possibly_sensitive":false,"id":"917344651538989058","source":"Sprout Social","public_metrics":{"retweet_count":14,"reply_count":0,"like_count":11,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":44,"end":56,"tag":"sideEffects"}],"urls":[{"start":68,"end":91,"url":"https://t.co/XW8l92k69i","expanded_url":"http://bit.ly/2wAznrj","display_url":"bit.ly/2wAznrj"},{"start":92,"end":115,"url":"https://t.co/6wUNGm1Xp0","expanded_url":"https://twitter.com/EMA_News/status/917299856024236032/photo/1","display_url":"pic.twitter.com/6wUNGm1Xp0"}],"annotations":{},"mentions":{}},"text":"Last day to participate in our survey about #sideEffects reporting: https://t.co/XW8l92k69i https://t.co/6wUNGm1Xp0","attachments":{"media_keys":["3_917299853205454848"],"poll_ids":{}},"created_at":"2017-10-09T08:05:02.000Z","author_id":"116716199","lang":"en","conversation_id":"917299856024236032","possibly_sensitive":false,"id":"917299856024236032","source":"Sprout Social","public_metrics":{"retweet_count":41,"reply_count":2,"like_count":23,"quote_count":5},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":54,"end":66,"tag":"vaccination"},{"start":84,"end":91,"tag":"Health"},{"start":106,"end":115,"tag":"EHFG2017"}],"urls":{},"annotations":{},"mentions":[{"start":3,"end":18,"username":"V_Andriukaitis","id":"575269517"}]},"text":"RT @V_Andriukaitis: Glad to announce shortlisted NGOs #vaccination champions for EU #Health Award 2017 in #EHFG2017 \n➡️https://t.co/3URpNQD…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-10-06T12:05:11.000Z","author_id":"116716199","lang":"en","conversation_id":"916273125054124033","possibly_sensitive":false,"id":"916273125054124033","source":"TweetDeck","public_metrics":{"retweet_count":28,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"916245204277059584"}]},{"entities":{"hashtags":{},"urls":[{"start":67,"end":90,"url":"https://t.co/yQ6i8sNIPd","expanded_url":"http://bit.ly/2yLYQhl","display_url":"bit.ly/2yLYQhl"}],"annotations":{},"mentions":{}},"text":"See the highlights of this week’s meeting of our Management Board: https://t.co/yQ6i8sNIPd","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-10-06T10:56:34.000Z","author_id":"116716199","lang":"en","conversation_id":"916255859700916226","possibly_sensitive":false,"id":"916255859700916226","source":"TweetDeck","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":6,"quote_count":3},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":26,"end":36,"tag":"valproate"},{"start":37,"end":54,"tag":"EMAPublicHearing"}],"urls":[{"start":88,"end":111,"url":"https://t.co/ql21IcaDNm","expanded_url":"http://bit.ly/2xjxKNp","display_url":"bit.ly/2xjxKNp"},{"start":112,"end":135,"url":"https://t.co/v6shVaTMsp","expanded_url":"https://twitter.com/EMA_News/status/915915825902649344/photo/1","display_url":"pic.twitter.com/v6shVaTMsp"}],"annotations":{},"mentions":{}},"text":"What a doctor says on the #valproate #EMAPublicHearing. What are your thoughts on this? https://t.co/ql21IcaDNm https://t.co/v6shVaTMsp","attachments":{"media_keys":["3_915914937200988160"],"poll_ids":{}},"created_at":"2017-10-05T12:25:24.000Z","author_id":"116716199","lang":"en","conversation_id":"915915825902649344","possibly_sensitive":false,"id":"915915825902649344","source":"Twitter Web Client","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":3,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":24,"end":34,"tag":"valproate"},{"start":35,"end":52,"tag":"EMAPublicHearing"}],"urls":[{"start":86,"end":109,"url":"https://t.co/ql21IcaDNm","expanded_url":"http://bit.ly/2xjxKNp","display_url":"bit.ly/2xjxKNp"},{"start":110,"end":133,"url":"https://t.co/cP4wrVBYoC","expanded_url":"https://twitter.com/EMA_News/status/915882415452803073/photo/1","display_url":"pic.twitter.com/cP4wrVBYoC"}],"annotations":{},"mentions":[{"start":1,"end":16,"username":"LindaMcAvanMEP","id":"166509226"}]},"text":".@LindaMcAvanMEP on the #valproate #EMAPublicHearing. What are your thoughts on this? https://t.co/ql21IcaDNm https://t.co/cP4wrVBYoC","attachments":{"media_keys":["3_915882361795104768"],"poll_ids":{}},"created_at":"2017-10-05T10:12:38.000Z","author_id":"116716199","lang":"en","conversation_id":"915882415452803073","possibly_sensitive":false,"id":"915882415452803073","source":"Twitter Web Client","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":12,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":37,"end":45,"tag":"BigData"},{"start":67,"end":77,"tag":"medicines"}],"urls":[{"start":114,"end":137,"url":"https://t.co/TJGYNWbTzD","expanded_url":"http://bit.ly/2flCQ9b","display_url":"bit.ly/2flCQ9b"},{"start":138,"end":161,"url":"https://t.co/R9gOMuB4RJ","expanded_url":"https://twitter.com/EMA_News/status/915536237955633152/photo/1","display_url":"pic.twitter.com/R9gOMuB4RJ"}],"annotations":{},"mentions":{}},"text":"What are the challenges presented by #BigData in the regulation of #medicines? Take our survey before 20 October: https://t.co/TJGYNWbTzD https://t.co/R9gOMuB4RJ","attachments":{"media_keys":["3_915536234260213763"],"poll_ids":{}},"created_at":"2017-10-04T11:17:03.000Z","author_id":"116716199","lang":"en","conversation_id":"915536237955633152","possibly_sensitive":false,"id":"915536237955633152","source":"Sprout Social","public_metrics":{"retweet_count":32,"reply_count":1,"like_count":18,"quote_count":4},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":78,"end":85,"tag":"Brexit"}],"urls":[{"start":86,"end":109,"url":"https://t.co/EmQ6Pgx7qZ","expanded_url":"http://bit.ly/2yHkEdS","display_url":"bit.ly/2yHkEdS"}],"annotations":[{"start":0,"end":2,"probability":0.5802,"type":"Organization","normalized_text":"EMA"}],"mentions":{}},"text":"EMA publishes comments on the 19 Member States’ bids to host the Agency after #Brexit https://t.co/EmQ6Pgx7qZ","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-10-04T09:15:03.000Z","author_id":"116716199","lang":"en","conversation_id":"915505534970810368","possibly_sensitive":false,"id":"915505534970810368","source":"Sprout Social","public_metrics":{"retweet_count":65,"reply_count":3,"like_count":37,"quote_count":14},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":42,"end":53,"tag":"Veterinary"}],"urls":[{"start":72,"end":95,"url":"https://t.co/cRcZDvPGyU","expanded_url":"http://bit.ly/2g7oZAb","display_url":"bit.ly/2g7oZAb"}],"annotations":{},"mentions":{}},"text":"The agenda for the October meeting of our #Veterinary Committee is out: https://t.co/cRcZDvPGyU","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-10-03T13:20:12.000Z","author_id":"116716199","lang":"en","conversation_id":"915204841592512513","possibly_sensitive":false,"id":"915204841592512513","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":41,"end":52,"tag":"NobelPrize"},{"start":53,"end":62,"tag":"Medicine"}],"urls":[{"start":78,"end":101,"url":"https://t.co/EiSg9q6bYq","expanded_url":"http://goo.gl/z9yUUX","display_url":"goo.gl/z9yUUX"}],"annotations":{},"mentions":[{"start":3,"end":14,"username":"NobelPrize","id":"16465385"}]},"text":"RT @NobelPrize: Read more about the 2017 #NobelPrize #Medicine Press release: https://t.co/EiSg9q6bYq Advanced info: https://t.co/02Kgxpkzc…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-10-02T12:16:19.000Z","author_id":"116716199","lang":"en","conversation_id":"914826374862589952","possibly_sensitive":false,"id":"914826374862589952","source":"TweetDeck","public_metrics":{"retweet_count":955,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"914785997560451073"}]},{"entities":{"hashtags":[{"start":49,"end":61,"tag":"sideEffects"}],"urls":[{"start":73,"end":96,"url":"https://t.co/XW8l92k69i","expanded_url":"http://bit.ly/2wAznrj","display_url":"bit.ly/2wAznrj"},{"start":97,"end":120,"url":"https://t.co/4OuNattUqm","expanded_url":"https://twitter.com/EMA_News/status/914796359869493248/photo/1","display_url":"pic.twitter.com/4OuNattUqm"}],"annotations":{},"mentions":{}},"text":"One more week to participate in our survey about #sideEffects reporting: https://t.co/XW8l92k69i https://t.co/4OuNattUqm","attachments":{"media_keys":["3_914796356090261504"],"poll_ids":{}},"created_at":"2017-10-02T10:17:02.000Z","author_id":"116716199","lang":"en","conversation_id":"914796359869493248","possibly_sensitive":false,"id":"914796359869493248","source":"Sprout Social","public_metrics":{"retweet_count":36,"reply_count":0,"like_count":26,"quote_count":3},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":0,"end":17,"tag":"EMAPublicHearing"},{"start":90,"end":108,"tag":"Pharmacovigilance"}],"urls":[{"start":121,"end":144,"url":"https://t.co/qUf2VC4zCA","expanded_url":"http://bit.ly/2yM1k08","display_url":"bit.ly/2yM1k08"}],"annotations":{},"mentions":{}},"text":"#EMAPublicHearing &amp; a new re-examination are the highlights of the Oct meeting of our #Pharmacovigilance Committee:  https://t.co/qUf2VC4zCA","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-09-29T14:40:33.000Z","author_id":"116716199","lang":"en","conversation_id":"913775511335260160","possibly_sensitive":false,"id":"913775511335260160","source":"Twitter Web Client","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":9,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":32,"end":49,"tag":"EMAPublicHearing"},{"start":53,"end":63,"tag":"valproate"}],"urls":[{"start":109,"end":132,"url":"https://t.co/vK07qTQVGh","expanded_url":"http://bit.ly/2tSFzcX","display_url":"bit.ly/2tSFzcX"}],"annotations":{},"mentions":{}},"text":"Thanks to everybody who came to #EMAPublicHearing on #valproate. Hearing directly from patients is important https://t.co/vK07qTQVGh","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-09-26T17:38:00.000Z","author_id":"116716199","lang":"en","conversation_id":"912733005713723393","possibly_sensitive":false,"id":"912733005713723393","source":"TweetDeck","public_metrics":{"retweet_count":20,"reply_count":3,"like_count":30,"quote_count":6},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":{},"annotations":[{"start":124,"end":131,"probability":0.8779,"type":"Organization","normalized_text":"BBC News"}],"mentions":[{"start":3,"end":18,"username":"LindaMcAvanMEP","id":"166509226"},{"start":59,"end":68,"username":"EMA_News","id":"116716199"}]},"text":"RT @LindaMcAvanMEP: Pleased to attend public hearing today @EMA_News. Epilepsy drug's safety reviewed over pregnancy risk - BBC News https:…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-09-26T14:51:45.000Z","author_id":"116716199","lang":"en","conversation_id":"912691165090197504","possibly_sensitive":false,"id":"912691165090197504","source":"TweetDeck","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"912688701481897984"}]},{"entities":{"hashtags":[{"start":50,"end":67,"tag":"EMAPublicHearing"},{"start":71,"end":81,"tag":"valproate"}],"urls":[{"start":108,"end":131,"url":"https://t.co/VCKIEfi2pv","expanded_url":"http://bit.ly/2xvtIFC","display_url":"bit.ly/2xvtIFC"},{"start":132,"end":155,"url":"https://t.co/6IsceX7wI0","expanded_url":"https://twitter.com/apesac1/status/912660154545573889","display_url":"twitter.com/apesac1/status…"}],"annotations":[{"start":21,"end":22,"probability":0.3853,"type":"Place","normalized_text":"EU"}],"mentions":{}},"text":"Patients from across EU share their experience at #EMAPublicHearing on #valproate. Join the live broadcast: https://t.co/VCKIEfi2pv https://t.co/6IsceX7wI0","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-09-26T13:01:11.000Z","author_id":"116716199","lang":"en","conversation_id":"912663341310595073","possibly_sensitive":false,"id":"912663341310595073","source":"TweetDeck","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":12,"quote_count":0},"referenced_tweets":[{"type":"quoted","id":"912660154545573889"}]},{"entities":{"hashtags":{},"urls":{},"annotations":{},"mentions":[{"start":3,"end":18,"username":"epilepsyaction","id":"17411532"},{"start":20,"end":32,"username":"ClarePelham","id":"773723659"},{"start":40,"end":56,"username":"epilepsysociety","id":"87454049"},{"start":63,"end":78,"username":"epilepsyaction","id":"17411532"},{"start":91,"end":100,"username":"EMA_News","id":"116716199"}]},"text":"RT @epilepsyaction: @ClarePelham giving @epilepsysociety &amp; @epilepsyaction evidence at @EMA_News hearing: \"If nothing changes, this will be…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-09-26T12:50:31.000Z","author_id":"116716199","lang":"en","conversation_id":"912660656133935105","possibly_sensitive":false,"id":"912660656133935105","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"912659288732119040"}]},{"entities":{"hashtags":{},"urls":{},"annotations":{},"mentions":[{"start":3,"end":17,"username":"DisabilityFed","id":"1946452789"},{"start":19,"end":31,"username":"karen_keely","id":"297306966"},{"start":62,"end":71,"username":"EMA_News","id":"116716199"},{"start":96,"end":104,"username":"TheHPRA","id":"780795318778470400"},{"start":123,"end":137,"username":"SimonHarrisTD","id":"21117425"}]},"text":"RT @DisabilityFed: @karen_keely s profoundly moving speech at @EMA_News PRAC review welcomed by @TheHPRA and chair of PRAC @SimonHarrisTD B…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-09-26T12:36:00.000Z","author_id":"116716199","lang":"en","conversation_id":"912657004463783938","possibly_sensitive":false,"id":"912657004463783938","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"912655638681079808"}]},{"entities":{"hashtags":[{"start":54,"end":71,"tag":"EMAPublicHearing"},{"start":79,"end":97,"tag":"pharmacovigilance"},{"start":101,"end":111,"tag":"Valproate"}],"urls":{},"annotations":{},"mentions":[{"start":3,"end":8,"username":"PGEU","id":"459292439"},{"start":15,"end":27,"username":"J_Svarcaite","id":"799545645069725696"},{"start":31,"end":40,"username":"EMA_News","id":"116716199"}]},"text":"RT @PGEU: With @J_Svarcaite at @EMA_News at the first #EMAPublicHearing on the #pharmacovigilance of #Valproate. Read more: https://t.co/jj…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-09-26T11:25:23.000Z","author_id":"116716199","lang":"en","conversation_id":"912639232304435200","possibly_sensitive":false,"id":"912639232304435200","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"912625018290556929"}]},{"entities":{"hashtags":[{"start":25,"end":42,"tag":"EMAPublicHearing"},{"start":46,"end":56,"tag":"valproate"}],"urls":[{"start":106,"end":129,"url":"https://t.co/VCKIEfi2pv","expanded_url":"http://bit.ly/2xvtIFC","display_url":"bit.ly/2xvtIFC"},{"start":130,"end":153,"url":"https://t.co/bxklhHFcW0","expanded_url":"https://twitter.com/EMA_News/status/912602660062351360/photo/1","display_url":"pic.twitter.com/bxklhHFcW0"}],"annotations":[{"start":97,"end":98,"probability":0.819,"type":"Place","normalized_text":"UK"}],"mentions":{}},"text":"If you cannot attend the #EMAPublicHearing on #valproate, join our live broadcast today at 12:45 UK time: https://t.co/VCKIEfi2pv https://t.co/bxklhHFcW0","attachments":{"media_keys":["3_912602656295628805"],"poll_ids":{}},"created_at":"2017-09-26T09:00:04.000Z","author_id":"116716199","lang":"en","conversation_id":"912602660062351360","possibly_sensitive":false,"id":"912602660062351360","source":"Sprout Social","public_metrics":{"retweet_count":21,"reply_count":3,"like_count":22,"quote_count":5},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":0,"end":17,"tag":"EMAPublicHearing"},{"start":21,"end":31,"tag":"valproate"}],"urls":[{"start":83,"end":106,"url":"https://t.co/HorUvrgWGw","expanded_url":"http://bit.ly/2xt9aOk","display_url":"bit.ly/2xt9aOk"}],"annotations":[{"start":74,"end":75,"probability":0.8407,"type":"Place","normalized_text":"UK"}],"mentions":{}},"text":"#EMAPublicHearing on #valproate. Follow the live broadcast today at 12:45 UK time: https://t.co/HorUvrgWGw","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-09-26T08:51:23.000Z","author_id":"116716199","lang":"en","conversation_id":"912600476260212736","possibly_sensitive":false,"id":"912600476260212736","source":"TweetDeck","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":10,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":46,"end":64,"tag":"pharmacovigilance"}],"urls":[{"start":99,"end":122,"url":"https://t.co/EUzzCGAmat","expanded_url":"http://bit.ly/2fMpcsC","display_url":"bit.ly/2fMpcsC"}],"annotations":{},"mentions":{}},"text":"You can check now what's on the agenda of the #pharmacovigilance committee's meeting in September: https://t.co/EUzzCGAmat","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-09-25T16:48:30.000Z","author_id":"116716199","lang":"en","conversation_id":"912358157078450176","possibly_sensitive":false,"id":"912358157078450176","source":"Twitter Web Client","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":10,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":20,"end":30,"tag":"valproate"},{"start":31,"end":48,"tag":"EMAPublicHearing"}],"urls":[{"start":113,"end":136,"url":"https://t.co/xUoYHblHxl","expanded_url":"http://bit.ly/2xwhFI9","display_url":"bit.ly/2xwhFI9"},{"start":137,"end":160,"url":"https://t.co/8Wh3U0dI5r","expanded_url":"https://twitter.com/EMA_News/status/912256624257052673/photo/1","display_url":"pic.twitter.com/8Wh3U0dI5r"}],"annotations":[{"start":104,"end":105,"probability":0.8159,"type":"Place","normalized_text":"UK"}],"mentions":{}},"text":"One more day to the #valproate #EMAPublicHearing. You can see the live broadcast here tomorrow at 12:45 UK time: https://t.co/xUoYHblHxl https://t.co/8Wh3U0dI5r","attachments":{"media_keys":["3_912256621199241217"],"poll_ids":{}},"created_at":"2017-09-25T10:05:02.000Z","author_id":"116716199","lang":"en","conversation_id":"912256624257052673","possibly_sensitive":false,"id":"912256624257052673","source":"Sprout Social","public_metrics":{"retweet_count":18,"reply_count":2,"like_count":21,"quote_count":3},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":89,"end":99,"tag":"valproate"}],"urls":{},"annotations":{},"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"}]},"text":"RT @MHRAgovuk: Our toolkit helps healthcare professionals discuss the potential risks of #valproate with women &amp; girls. Learn more: https:/…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-09-22T17:35:33.000Z","author_id":"116716199","lang":"en","conversation_id":"911282834907811842","possibly_sensitive":false,"id":"911282834907811842","source":"TweetDeck","public_metrics":{"retweet_count":37,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"911282459513360384"}]},{"entities":{"hashtags":[{"start":44,"end":61,"tag":"EMAPublicHearing"},{"start":65,"end":75,"tag":"valproate"}],"urls":[{"start":95,"end":118,"url":"https://t.co/nc3GpqLkOG","expanded_url":"http://bit.ly/2xl5rCg","display_url":"bit.ly/2xl5rCg"}],"annotations":{},"mentions":{}},"text":"The agenda and list of participants for the #EMAPublicHearing on #valproate are now available: https://t.co/nc3GpqLkOG","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-09-22T13:26:59.000Z","author_id":"116716199","lang":"en","conversation_id":"911220283540934656","possibly_sensitive":false,"id":"911220283540934656","source":"Twitter Web Client","public_metrics":{"retweet_count":16,"reply_count":0,"like_count":20,"quote_count":4},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":42,"end":50,"tag":"BigData"},{"start":77,"end":87,"tag":"medicines"}],"urls":[{"start":107,"end":130,"url":"https://t.co/TJGYNWbTzD","expanded_url":"http://bit.ly/2flCQ9b","display_url":"bit.ly/2flCQ9b"},{"start":131,"end":154,"url":"https://t.co/6D4yPwWrih","expanded_url":"https://twitter.com/EMA_News/status/911202430976774145/photo/1","display_url":"pic.twitter.com/6D4yPwWrih"}],"annotations":{},"mentions":{}},"text":"Complete our survey and help us develop a #BigData strategy for the European #medicines regulatory network https://t.co/TJGYNWbTzD https://t.co/6D4yPwWrih","attachments":{"media_keys":["3_911202428522979328"],"poll_ids":{}},"created_at":"2017-09-22T12:16:03.000Z","author_id":"116716199","lang":"en","conversation_id":"911202430976774145","possibly_sensitive":false,"id":"911202430976774145","source":"Sprout Social","public_metrics":{"retweet_count":40,"reply_count":0,"like_count":26,"quote_count":3},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":56,"end":62,"tag":"PSURs"}],"urls":[{"start":106,"end":129,"url":"https://t.co/KtQgjCNu86","expanded_url":"http://bit.ly/2fjS0vx","display_url":"bit.ly/2fjS0vx"},{"start":130,"end":153,"url":"https://t.co/W2zvMJHs4q","expanded_url":"https://twitter.com/EMA_News/status/911138017854836736/photo/1","display_url":"pic.twitter.com/W2zvMJHs4q"}],"annotations":{},"mentions":{}},"text":"Online Q&amp;A session on how to improve the content of #PSURs starts now – Join the live broadcast here: https://t.co/KtQgjCNu86 https://t.co/W2zvMJHs4q","attachments":{"media_keys":["3_911138015828779015"],"poll_ids":{}},"created_at":"2017-09-22T08:00:06.000Z","author_id":"116716199","lang":"en","conversation_id":"911138017854836736","possibly_sensitive":false,"id":"911138017854836736","source":"Sprout Social","public_metrics":{"retweet_count":7,"reply_count":1,"like_count":13,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":42,"end":48,"tag":"PSURs"}],"urls":[{"start":117,"end":140,"url":"https://t.co/PQFdRz8tjB","expanded_url":"http://bit.ly/2wNvEta","display_url":"bit.ly/2wNvEta"},{"start":141,"end":164,"url":"https://t.co/rhwyY11kNy","expanded_url":"https://twitter.com/EMA_News/status/910836039333416962/photo/1","display_url":"pic.twitter.com/rhwyY11kNy"}],"annotations":[{"start":109,"end":110,"probability":0.4495,"type":"Place","normalized_text":"UK"}],"mentions":{}},"text":"Training on how to improve the content of #PSURs - No prior registration required, join here tomorrow at 9am UK time https://t.co/PQFdRz8tjB https://t.co/rhwyY11kNy","attachments":{"media_keys":["3_910836036464369666"],"poll_ids":{}},"created_at":"2017-09-21T12:00:08.000Z","author_id":"116716199","lang":"en","conversation_id":"910836039333416962","possibly_sensitive":false,"id":"910836039333416962","source":"Sprout Social","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":10,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":19,"end":29,"tag":"medicines"},{"start":46,"end":52,"tag":"PRIME"}],"urls":[{"start":74,"end":97,"url":"https://t.co/kFIb8XQB0s","expanded_url":"http://bit.ly/2xwkbOq","display_url":"bit.ly/2xwkbOq"},{"start":98,"end":121,"url":"https://t.co/tESlcrBvoc","expanded_url":"https://twitter.com/EMA_News/status/910786942043852801/photo/1","display_url":"pic.twitter.com/tESlcrBvoc"}],"annotations":{},"mentions":{}},"text":"Find out about the #medicines accepted in our #PRIME scheme in September: https://t.co/kFIb8XQB0s https://t.co/tESlcrBvoc","attachments":{"media_keys":["3_910786938856030208"],"poll_ids":{}},"created_at":"2017-09-21T08:45:03.000Z","author_id":"116716199","lang":"en","conversation_id":"910786942043852801","possibly_sensitive":false,"id":"910786942043852801","source":"Sprout Social","public_metrics":{"retweet_count":20,"reply_count":0,"like_count":12,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":51,"end":61,"tag":"medicines"}],"urls":[{"start":98,"end":121,"url":"https://t.co/cfNsr2MD2b","expanded_url":"http://bit.ly/2xe5srW","display_url":"bit.ly/2xe5srW"}],"annotations":[{"start":0,"end":13,"probability":0.4182,"type":"Organization","normalized_text":"Pre-submission"}],"mentions":[{"start":84,"end":96,"username":"EUombudsman","id":"873777758"}]},"text":"Pre-submission meetings help development of better #medicines – check our letter to @EUombudsman: https://t.co/cfNsr2MD2b","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-09-20T16:34:13.000Z","author_id":"116716199","lang":"en","conversation_id":"910542624364400640","possibly_sensitive":false,"id":"910542624364400640","source":"Twitter Web Client","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":11,"quote_count":4},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":26,"end":38,"tag":"sideEffects"},{"start":42,"end":52,"tag":"medicines"}],"urls":[{"start":92,"end":115,"url":"https://t.co/XW8l92BH0Q","expanded_url":"http://bit.ly/2wAznrj","display_url":"bit.ly/2wAznrj"},{"start":116,"end":139,"url":"https://t.co/we7yr9oLi3","expanded_url":"https://twitter.com/EMA_News/status/910507854548811776/photo/1","display_url":"pic.twitter.com/we7yr9oLi3"}],"annotations":{},"mentions":{}},"text":"Do you know how to report #sideEffects of #medicines? Take the survey in your own language: https://t.co/XW8l92BH0Q https://t.co/we7yr9oLi3","attachments":{"media_keys":["3_910507851554029568"],"poll_ids":{}},"created_at":"2017-09-20T14:16:03.000Z","author_id":"116716199","lang":"en","conversation_id":"910507854548811776","possibly_sensitive":false,"id":"910507854548811776","source":"Sprout Social","public_metrics":{"retweet_count":29,"reply_count":0,"like_count":25,"quote_count":5},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":36,"end":60,"tag":"AntimicrobialResistance"},{"start":123,"end":127,"tag":"AMR"}],"urls":[{"start":99,"end":122,"url":"https://t.co/Ossenu3HwP","expanded_url":"http://bit.ly/2h7h6uk","display_url":"bit.ly/2h7h6uk"},{"start":128,"end":151,"url":"https://t.co/hlBo9HMbxU","expanded_url":"https://twitter.com/EMA_News/status/910048327802216450/photo/1","display_url":"pic.twitter.com/hlBo9HMbxU"}],"annotations":{},"mentions":[{"start":10,"end":18,"username":"ECDC_EU","id":"204752573"}]},"text":"EMA &amp; @ECDC_EU joint meeting on #AntimicrobialResistance starts now – Join the live broadcast: https://t.co/Ossenu3HwP #AMR https://t.co/hlBo9HMbxU","attachments":{"media_keys":["3_910048324278874112"],"poll_ids":{}},"created_at":"2017-09-19T07:50:03.000Z","author_id":"116716199","lang":"en","conversation_id":"910048327802216450","possibly_sensitive":false,"id":"910048327802216450","source":"Sprout Social","public_metrics":{"retweet_count":23,"reply_count":1,"like_count":29,"quote_count":8},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":74,"end":80,"tag":"PSURs"},{"start":106,"end":124,"tag":"pharmacovigilance"}],"urls":[{"start":82,"end":105,"url":"https://t.co/2ZuZNlsgdr","expanded_url":"http://bit.ly/2f8PTr0","display_url":"bit.ly/2f8PTr0"},{"start":125,"end":148,"url":"https://t.co/egLBrBVoQx","expanded_url":"https://twitter.com/EMA_News/status/909787608951205888/photo/1","display_url":"pic.twitter.com/egLBrBVoQx"}],"annotations":{},"mentions":{}},"text":"Join the online Q&amp;A session on 22.09 on how to improve the content of #PSURs: https://t.co/2ZuZNlsgdr #pharmacovigilance https://t.co/egLBrBVoQx","attachments":{"media_keys":["3_909787605998354432"],"poll_ids":{}},"created_at":"2017-09-18T14:34:03.000Z","author_id":"116716199","lang":"en","conversation_id":"909787608951205888","possibly_sensitive":false,"id":"909787608951205888","source":"Sprout Social","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":5,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":24,"end":37,"tag":"EUregulatory"},{"start":49,"end":59,"tag":"medicines"}],"urls":[{"start":91,"end":114,"url":"https://t.co/M36Nl7Ksc0","expanded_url":"http://bit.ly/2uV1XV7","display_url":"bit.ly/2uV1XV7"},{"start":115,"end":138,"url":"https://t.co/gsH3FbrMY3","expanded_url":"https://twitter.com/EMA_News/status/909688462160334849/photo/1","display_url":"pic.twitter.com/gsH3FbrMY3"}],"annotations":{},"mentions":{}},"text":"Find out more about the #EUregulatory system for #medicines – Join the live broadcast now: https://t.co/M36Nl7Ksc0 https://t.co/gsH3FbrMY3","attachments":{"media_keys":["3_909688458901196802"],"poll_ids":{}},"created_at":"2017-09-18T08:00:05.000Z","author_id":"116716199","lang":"en","conversation_id":"909688462160334849","possibly_sensitive":false,"id":"909688462160334849","source":"Sprout Social","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":9,"quote_count":3},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":0,"end":5,"tag":"CHMP"},{"start":20,"end":30,"tag":"medicines"}],"urls":[{"start":74,"end":97,"url":"https://t.co/NGVU7TzA16","expanded_url":"http://bit.ly/2h70LG6","display_url":"bit.ly/2h70LG6"},{"start":98,"end":121,"url":"https://t.co/tBMErKngI8","expanded_url":"https://twitter.com/EMA_News/status/908657911529918465/photo/1","display_url":"pic.twitter.com/tBMErKngI8"}],"annotations":{},"mentions":{}},"text":"#CHMP recommends 13 #medicines for approval at its September 2017 meeting https://t.co/NGVU7TzA16 https://t.co/tBMErKngI8","attachments":{"media_keys":["3_908657910003113984"],"poll_ids":{}},"created_at":"2017-09-15T11:45:02.000Z","author_id":"116716199","lang":"en","conversation_id":"908657911529918465","possibly_sensitive":false,"id":"908657911529918465","source":"Sprout Social","public_metrics":{"retweet_count":44,"reply_count":0,"like_count":20,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":0,"end":9,"tag":"Patients"},{"start":14,"end":25,"tag":"healthcare"},{"start":83,"end":95,"tag":"sideEffects"},{"start":99,"end":109,"tag":"medicines"}],"urls":[{"start":110,"end":133,"url":"https://t.co/XW8l92k69i","expanded_url":"http://bit.ly/2wAznrj","display_url":"bit.ly/2wAznrj"},{"start":134,"end":157,"url":"https://t.co/CoGbAiOPmY","expanded_url":"https://twitter.com/EMA_News/status/908303077530390529/photo/1","display_url":"pic.twitter.com/CoGbAiOPmY"}],"annotations":{},"mentions":{}},"text":"#Patients and #healthcare professionals: Participate in our survey about reporting #sideEffects of #medicines https://t.co/XW8l92k69i https://t.co/CoGbAiOPmY","attachments":{"media_keys":["3_908303074770305024"],"poll_ids":{}},"created_at":"2017-09-14T12:15:03.000Z","author_id":"116716199","lang":"en","conversation_id":"908303077530390529","possibly_sensitive":false,"id":"908303077530390529","source":"Sprout Social","public_metrics":{"retweet_count":49,"reply_count":4,"like_count":35,"quote_count":6},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":106,"end":111,"tag":"PSUR"}],"urls":[{"start":113,"end":136,"url":"https://t.co/c6yfLTCIig","expanded_url":"http://bit.ly/2wNJ8VP","display_url":"bit.ly/2wNJ8VP"},{"start":137,"end":160,"url":"https://t.co/7LCfduWAYM","expanded_url":"https://twitter.com/EMA_News/status/908255261898526720/photo/1","display_url":"pic.twitter.com/7LCfduWAYM"}],"annotations":{},"mentions":{}},"text":"Save the date! Training on 22.09 led by a professional joint panel of industry and regulatory speakers on #PSUR: https://t.co/c6yfLTCIig https://t.co/7LCfduWAYM","attachments":{"media_keys":["3_908255259620806657"],"poll_ids":{}},"created_at":"2017-09-14T09:05:03.000Z","author_id":"116716199","lang":"en","conversation_id":"908255261898526720","possibly_sensitive":false,"id":"908255261898526720","source":"Sprout Social","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":4,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":26,"end":37,"tag":"veterinary"}],"urls":[{"start":100,"end":123,"url":"https://t.co/pMh00Iue9f","expanded_url":"http://bit.ly/2fZ4lVO","display_url":"bit.ly/2fZ4lVO"},{"start":124,"end":147,"url":"https://t.co/ThcEx6wjD3","expanded_url":"https://twitter.com/EMA_News/status/907904448927813632/photo/1","display_url":"pic.twitter.com/ThcEx6wjD3"}],"annotations":{},"mentions":{}},"text":"How do effective and safe #veterinary medicines benefit public health? Find out in our new leaflet: https://t.co/pMh00Iue9f https://t.co/ThcEx6wjD3","attachments":{"media_keys":["3_907904445895270400"],"poll_ids":{}},"created_at":"2017-09-13T09:51:03.000Z","author_id":"116716199","lang":"en","conversation_id":"907904448927813632","possibly_sensitive":false,"id":"907904448927813632","source":"Sprout Social","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":9,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":55,"end":79,"tag":"AntimicrobialResistance"},{"start":140,"end":144,"tag":"AMR"}],"urls":[{"start":116,"end":139,"url":"https://t.co/eJ1sdIokW5","expanded_url":"http://bit.ly/2wXyqcG","display_url":"bit.ly/2wXyqcG"},{"start":145,"end":168,"url":"https://t.co/spQEkdhoci","expanded_url":"https://twitter.com/EMA_News/status/907597191212138497/photo/1","display_url":"pic.twitter.com/spQEkdhoci"}],"annotations":{},"mentions":[{"start":10,"end":18,"username":"ECDC_EU","id":"204752573"}]},"text":"EMA &amp; @ECDC_EU are organising a meeting to discuss #AntimicrobialResistance on 19.09. Join our live broadcast   https://t.co/eJ1sdIokW5 #AMR https://t.co/spQEkdhoci","attachments":{"media_keys":["3_907597188489912320"],"poll_ids":{}},"created_at":"2017-09-12T13:30:07.000Z","author_id":"116716199","lang":"en","conversation_id":"907597191212138497","possibly_sensitive":false,"id":"907597191212138497","source":"Sprout Social","public_metrics":{"retweet_count":44,"reply_count":0,"like_count":31,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":14,"end":21,"tag":"agenda"},{"start":74,"end":84,"tag":"medicines"},{"start":110,"end":115,"tag":"CHMP"}],"urls":[{"start":86,"end":109,"url":"https://t.co/r6lC9OA2Y3","expanded_url":"http://bit.ly/2w0coZX","display_url":"bit.ly/2w0coZX"}],"annotations":{},"mentions":{}},"text":"What’s on the #agenda of the September meeting of our committee for human #medicines? https://t.co/r6lC9OA2Y3 #CHMP","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-09-11T16:57:01.000Z","author_id":"116716199","lang":"en","conversation_id":"907286872849833984","possibly_sensitive":false,"id":"907286872849833984","source":"Sprout Social","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":7,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":23,"end":36,"tag":"EUregulatory"},{"start":48,"end":58,"tag":"medicines"}],"urls":[{"start":111,"end":134,"url":"https://t.co/i177lDRqNn","expanded_url":"http://bit.ly/2wUaZB2","display_url":"bit.ly/2wUaZB2"},{"start":135,"end":158,"url":"https://t.co/sYsMe8U2vG","expanded_url":"https://twitter.com/EMA_News/status/907186971591761920/photo/1","display_url":"pic.twitter.com/sYsMe8U2vG"}],"annotations":{},"mentions":{}},"text":"Time to understand the #EUregulatory system for #medicines – Join the live broadcast on 18 &amp; 19 September: https://t.co/i177lDRqNn https://t.co/sYsMe8U2vG","attachments":{"media_keys":["3_907186969087639553"],"poll_ids":{}},"created_at":"2017-09-11T10:20:03.000Z","author_id":"116716199","lang":"en","conversation_id":"907186971591761920","possibly_sensitive":false,"id":"907186971591761920","source":"Sprout Social","public_metrics":{"retweet_count":62,"reply_count":0,"like_count":41,"quote_count":4},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":60,"end":66,"tag":"PSURs"},{"start":126,"end":133,"tag":"pharma"}],"urls":[{"start":102,"end":125,"url":"https://t.co/dlhjIhiVT6","expanded_url":"http://bit.ly/2f8chRo","display_url":"bit.ly/2f8chRo"},{"start":134,"end":157,"url":"https://t.co/XBTWpAuiBR","expanded_url":"https://twitter.com/EMA_News/status/906141836527489024/photo/1","display_url":"pic.twitter.com/XBTWpAuiBR"}],"annotations":{},"mentions":{}},"text":"Do you have questions on how to improve the content of your #PSURs? Join our webinar on 22 September: https://t.co/dlhjIhiVT6 #pharma https://t.co/XBTWpAuiBR","attachments":{"media_keys":["3_906141833939509248"],"poll_ids":{}},"created_at":"2017-09-08T13:07:03.000Z","author_id":"116716199","lang":"en","conversation_id":"906141836527489024","possibly_sensitive":false,"id":"906141836527489024","source":"Sprout Social","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":10,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":0,"end":9,"tag":"Patients"},{"start":38,"end":50,"tag":"sideEffects"},{"start":54,"end":64,"tag":"medicines"},{"start":124,"end":136,"tag":"sideEffects"}],"urls":[{"start":100,"end":123,"url":"https://t.co/XW8l92k69i","expanded_url":"http://bit.ly/2wAznrj","display_url":"bit.ly/2wAznrj"},{"start":137,"end":160,"url":"https://t.co/06YrHys3j7","expanded_url":"https://twitter.com/EMA_News/status/905720311445893120/photo/1","display_url":"pic.twitter.com/06YrHys3j7"}],"annotations":{},"mentions":{}},"text":"#Patients: have you ever reported any #sideEffects of #medicines? Take our survey before 9 October: https://t.co/XW8l92k69i #sideEffects https://t.co/06YrHys3j7","attachments":{"media_keys":["3_905720308883013632"],"poll_ids":{}},"created_at":"2017-09-07T09:12:04.000Z","author_id":"116716199","lang":"en","conversation_id":"905720311445893120","possibly_sensitive":false,"id":"905720311445893120","source":"Sprout Social","public_metrics":{"retweet_count":44,"reply_count":2,"like_count":27,"quote_count":7},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":51,"end":60,"tag":"patients"}],"urls":[{"start":77,"end":100,"url":"https://t.co/tgu0z9Q51h","expanded_url":"http://bit.ly/2uJx3fb","display_url":"bit.ly/2uJx3fb"},{"start":101,"end":124,"url":"https://t.co/FZtwUHJqbU","expanded_url":"https://twitter.com/EMA_News/status/905051652947939328/photo/1","display_url":"pic.twitter.com/FZtwUHJqbU"}],"annotations":{},"mentions":{}},"text":"Every patient matters – Find out how EMA addresses #patients’ medical needs: https://t.co/tgu0z9Q51h https://t.co/FZtwUHJqbU","attachments":{"media_keys":["3_905051650070425600"],"poll_ids":{}},"created_at":"2017-09-05T12:55:03.000Z","author_id":"116716199","lang":"en","conversation_id":"905051652947939328","possibly_sensitive":false,"id":"905051652947939328","source":"Sprout Social","public_metrics":{"retweet_count":34,"reply_count":0,"like_count":31,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":26,"end":36,"tag":"medicines"},{"start":37,"end":49,"tag":"sideEffects"},{"start":92,"end":101,"tag":"patients"},{"start":102,"end":113,"tag":"healthcare"},{"start":114,"end":128,"tag":"patientsafety"}],"urls":[{"start":68,"end":91,"url":"https://t.co/XW8l92k69i","expanded_url":"http://bit.ly/2wAznrj","display_url":"bit.ly/2wAznrj"},{"start":129,"end":152,"url":"https://t.co/R5NAewSUu8","expanded_url":"https://twitter.com/EMA_News/status/904699330589806593/photo/1","display_url":"pic.twitter.com/R5NAewSUu8"}],"annotations":{},"mentions":{}},"text":"Do you know how to report #medicines #sideEffects? Take our survey: https://t.co/XW8l92k69i #patients #healthcare #patientsafety https://t.co/R5NAewSUu8","attachments":{"media_keys":["3_904699327267782656"],"poll_ids":{}},"created_at":"2017-09-04T13:35:03.000Z","author_id":"116716199","lang":"en","conversation_id":"904699330589806593","possibly_sensitive":false,"id":"904699330589806593","source":"Sprout Social","public_metrics":{"retweet_count":71,"reply_count":1,"like_count":52,"quote_count":16},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":13,"end":31,"tag":"pharmacovigilance"},{"start":108,"end":113,"tag":"PRAC"}],"urls":[{"start":84,"end":107,"url":"https://t.co/AgrICTAi9o","expanded_url":"http://bit.ly/2vxGiUZ","display_url":"bit.ly/2vxGiUZ"}],"annotations":{},"mentions":{}},"text":"See what our #pharmacovigilance committee has decided during its meeting in August: https://t.co/AgrICTAi9o #PRAC","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-09-01T14:37:02.000Z","author_id":"116716199","lang":"en","conversation_id":"903627765383081984","possibly_sensitive":false,"id":"903627765383081984","source":"Sprout Social","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":12,"quote_count":3},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":28,"end":46,"tag":"pharmacovigilance"},{"start":102,"end":107,"tag":"PRAC"}],"urls":[{"start":78,"end":101,"url":"https://t.co/iMMvFp90ZU","expanded_url":"http://bit.ly/2iEvA98","display_url":"bit.ly/2iEvA98"}],"annotations":{},"mentions":{}},"text":"What's on the agenda of our #pharmacovigilance committee's meeting in August? https://t.co/iMMvFp90ZU #PRAC","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-08-29T16:35:01.000Z","author_id":"116716199","lang":"en","conversation_id":"902570294891741184","possibly_sensitive":false,"id":"902570294891741184","source":"Sprout Social","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":10,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":21,"end":34,"tag":"AnimalHealth"}],"urls":[{"start":59,"end":82,"url":"https://t.co/Xpt43G1dHM","expanded_url":"http://bit.ly/2ij21d7","display_url":"bit.ly/2ij21d7"},{"start":83,"end":106,"url":"https://t.co/80Y87UWWtm","expanded_url":"https://twitter.com/EMA_News/status/902468127161769984/photo/1","display_url":"pic.twitter.com/80Y87UWWtm"}],"annotations":{},"mentions":{}},"text":"EMA works to protect #AnimalHealth across the EU. See how: https://t.co/Xpt43G1dHM https://t.co/80Y87UWWtm","attachments":{"media_keys":["3_902468124569550853"],"poll_ids":{}},"created_at":"2017-08-29T09:49:03.000Z","author_id":"116716199","lang":"en","conversation_id":"902468127161769984","possibly_sensitive":false,"id":"902468127161769984","source":"Sprout Social","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":13,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":79,"end":102,"url":"https://t.co/TRnqyo80Up","expanded_url":"http://bit.ly/2wNdDKU","display_url":"bit.ly/2wNdDKU"}],"annotations":{},"mentions":[{"start":0,"end":14,"username":"fairyfaye1986","id":"276417855"}]},"text":"@fairyfaye1986 You can find all the information and the application form here: https://t.co/TRnqyo80Up","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-08-25T14:43:28.000Z","author_id":"116716199","lang":"en","conversation_id":"900995675663499264","possibly_sensitive":false,"id":"901092670659072000","source":"TweetDeck","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"901082647530795010"}],"in_reply_to_user_id":"276417855"},{"entities":{"hashtags":[{"start":27,"end":44,"tag":"EMAPublicHearing"},{"start":49,"end":61,"tag":"HaveYourSay"},{"start":65,"end":75,"tag":"valproate"}],"urls":[{"start":76,"end":99,"url":"https://t.co/6JgN0FGxMd","expanded_url":"https://twitter.com/EMA_News/status/900995675663499264/photo/1","display_url":"pic.twitter.com/6JgN0FGxMd"}],"annotations":{},"mentions":{}},"text":"Last day to register! Join #EMAPublicHearing and #HaveYourSay on #valproate https://t.co/6JgN0FGxMd","attachments":{"media_keys":["3_900995672668651520"],"poll_ids":{}},"created_at":"2017-08-25T08:18:03.000Z","author_id":"116716199","lang":"en","conversation_id":"900995675663499264","possibly_sensitive":false,"id":"900995675663499264","source":"Sprout Social","public_metrics":{"retweet_count":17,"reply_count":1,"like_count":10,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":0,"end":12,"tag":"WeAreHiring"},{"start":115,"end":122,"tag":"EUjobs"}],"urls":[{"start":91,"end":114,"url":"https://t.co/PRLE3sHlLm","expanded_url":"http://bit.ly/2w5OV5G","display_url":"bit.ly/2w5OV5G"},{"start":123,"end":146,"url":"https://t.co/iCC1KUHCrF","expanded_url":"https://twitter.com/EMA_News/status/900703498081325058/photo/1","display_url":"pic.twitter.com/iCC1KUHCrF"}],"annotations":{},"mentions":{}},"text":"#WeAreHiring a Head of Stakeholders and Communication Division. Apply before 14 September: https://t.co/PRLE3sHlLm #EUjobs https://t.co/iCC1KUHCrF","attachments":{"media_keys":["3_900703496139227137"],"poll_ids":{}},"created_at":"2017-08-24T12:57:02.000Z","author_id":"116716199","lang":"en","conversation_id":"900703498081325058","possibly_sensitive":false,"id":"900703498081325058","source":"Sprout Social","public_metrics":{"retweet_count":14,"reply_count":0,"like_count":8,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":68,"end":91,"url":"https://t.co/AMURhH7muD","expanded_url":"http://bit.ly/2g5b2FW","display_url":"bit.ly/2g5b2FW"}],"annotations":{},"mentions":[{"start":1,"end":8,"username":"US_FDA","id":"208120290"},{"start":48,"end":58,"username":"EU_Health","id":"606325697"}]},"text":".@US_FDA to share full inspections reports with @EU_Health and EMA: https://t.co/AMURhH7muD","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-08-23T11:31:01.000Z","author_id":"116716199","lang":"en","conversation_id":"900319459965100032","possibly_sensitive":false,"id":"900319459965100032","source":"Sprout Social","public_metrics":{"retweet_count":49,"reply_count":0,"like_count":33,"quote_count":4},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":28,"end":38,"tag":"valproate"},{"start":39,"end":56,"tag":"EMAPublicHearing"}],"urls":[{"start":57,"end":80,"url":"https://t.co/ERsFraEjs7","expanded_url":"http://bit.ly/2h8oYis","display_url":"bit.ly/2h8oYis"}],"annotations":{},"mentions":{}},"text":"2 more days to register for #valproate #EMAPublicHearing https://t.co/ERsFraEjs7","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-08-23T09:16:00.000Z","author_id":"116716199","lang":"en","conversation_id":"900285485691658240","possibly_sensitive":false,"id":"900285485691658240","source":"Sprout Social","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":5,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":7,"end":18,"tag":"veterinary"},{"start":116,"end":129,"tag":"AnimalHealth"}],"urls":[{"start":92,"end":115,"url":"https://t.co/NsOiYqmZ0l","expanded_url":"http://bit.ly/2ijoGpw","display_url":"bit.ly/2ijoGpw"},{"start":130,"end":153,"url":"https://t.co/sDmwFCjqfQ","expanded_url":"https://twitter.com/EMA_News/status/899628418538635264/photo/1","display_url":"pic.twitter.com/sDmwFCjqfQ"}],"annotations":{},"mentions":{}},"text":"Better #veterinary medicines for healthier animals and people. Check out EMA’s new leaflet: https://t.co/NsOiYqmZ0l #AnimalHealth https://t.co/sDmwFCjqfQ","attachments":{"media_keys":["3_899628415870935040"],"poll_ids":{}},"created_at":"2017-08-21T13:45:03.000Z","author_id":"116716199","lang":"en","conversation_id":"899628418538635264","possibly_sensitive":false,"id":"899628418538635264","source":"Sprout Social","public_metrics":{"retweet_count":14,"reply_count":0,"like_count":11,"quote_count":3},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":27,"end":37,"tag":"valproate"},{"start":38,"end":55,"tag":"EMAPublicHearing"}],"urls":[{"start":74,"end":97,"url":"https://t.co/rwj9T5PyZe","expanded_url":"http://bit.ly/2eSHKd9","display_url":"bit.ly/2eSHKd9"},{"start":98,"end":121,"url":"https://t.co/oEc3P4D8dQ","expanded_url":"https://twitter.com/EMA_News/status/899581517869043714/photo/1","display_url":"pic.twitter.com/oEc3P4D8dQ"}],"annotations":{},"mentions":{}},"text":"Those who can’t attend the #valproate #EMAPublicHearing can watch it live https://t.co/rwj9T5PyZe https://t.co/oEc3P4D8dQ","attachments":{"media_keys":["3_899581515503357952"],"poll_ids":{}},"created_at":"2017-08-21T10:38:41.000Z","author_id":"116716199","lang":"en","conversation_id":"899581517869043714","possibly_sensitive":false,"id":"899581517869043714","source":"Sprout Social","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":10,"quote_count":3},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":0,"end":11,"tag":"DidYouKnow"},{"start":14,"end":23,"tag":"Patients"}],"urls":[{"start":81,"end":104,"url":"https://t.co/zHCx955E4C","expanded_url":"http://bit.ly/2uJcqQd","display_url":"bit.ly/2uJcqQd"},{"start":105,"end":128,"url":"https://t.co/hLbGNYCMu4","expanded_url":"https://twitter.com/EMA_News/status/898531183482605568/photo/1","display_url":"pic.twitter.com/hLbGNYCMu4"}],"annotations":{},"mentions":{}},"text":"#DidYouKnow - #Patients and their needs are at the core of all EMA’s activities: https://t.co/zHCx955E4C https://t.co/hLbGNYCMu4","attachments":{"media_keys":["3_898531181083344896"],"poll_ids":{}},"created_at":"2017-08-18T13:05:02.000Z","author_id":"116716199","lang":"en","conversation_id":"898531183482605568","possibly_sensitive":false,"id":"898531183482605568","source":"Sprout Social","public_metrics":{"retweet_count":23,"reply_count":0,"like_count":22,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":12,"end":29,"tag":"EMAPublicHearing"},{"start":86,"end":96,"tag":"valproate"}],"urls":[{"start":97,"end":120,"url":"https://t.co/mkdzpnmvRA","expanded_url":"http://bit.ly/2eSLueI","display_url":"bit.ly/2eSLueI"}],"annotations":{},"mentions":{}},"text":"How does an #EMAPublicHearing work? Watch the video. Join us on 26 Sept to talk about #valproate https://t.co/mkdzpnmvRA","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-08-17T14:14:01.000Z","author_id":"116716199","lang":"en","conversation_id":"898186153064574978","possibly_sensitive":false,"id":"898186153064574978","source":"Sprout Social","public_metrics":{"retweet_count":11,"reply_count":1,"like_count":14,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":44,"end":55,"tag":"veterinary"},{"start":65,"end":74,"tag":"Bravecto"},{"start":100,"end":105,"tag":"CVMP"},{"start":106,"end":119,"tag":"animalHealth"}],"urls":[{"start":76,"end":99,"url":"https://t.co/sZZmGLXVXu","expanded_url":"http://bit.ly/2i9ifp8","display_url":"bit.ly/2i9ifp8"}],"annotations":[{"start":4,"end":6,"probability":0.3454,"type":"Person","normalized_text":"EMA"}],"mentions":{}},"text":"See EMA’s conclusions after a review of the #veterinary medicine #Bravecto: https://t.co/sZZmGLXVXu #CVMP #animalHealth","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-08-17T11:03:01.000Z","author_id":"116716199","lang":"en","conversation_id":"898138086382731264","possibly_sensitive":false,"id":"898138086382731264","source":"Sprout Social","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":3,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":33,"end":43,"tag":"valproate"},{"start":44,"end":61,"tag":"EMAPublicHearing"}],"urls":[{"start":62,"end":85,"url":"https://t.co/FX8rwLT9ww","expanded_url":"https://twitter.com/EMA_News/status/897385638068195328/photo/1","display_url":"pic.twitter.com/FX8rwLT9ww"}],"annotations":{},"mentions":{}},"text":"10 more days to register for the #valproate #EMAPublicHearing https://t.co/FX8rwLT9ww","attachments":{"media_keys":["3_897385634398052352"],"poll_ids":{}},"created_at":"2017-08-15T09:13:03.000Z","author_id":"116716199","lang":"en","conversation_id":"897385638068195328","possibly_sensitive":false,"id":"897385638068195328","source":"Sprout Social","public_metrics":{"retweet_count":27,"reply_count":5,"like_count":24,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":0,"end":12,"tag":"WeAreHiring"},{"start":33,"end":55,"tag":"DatabaseAdministrator"}],"urls":[{"start":83,"end":106,"url":"https://t.co/TrTWsg5Uzg","expanded_url":"http://bit.ly/2uU3w2v","display_url":"bit.ly/2uU3w2v"},{"start":107,"end":130,"url":"https://t.co/0u4vURcZV7","expanded_url":"https://twitter.com/EMA_News/status/897080398487932928/photo/1","display_url":"pic.twitter.com/0u4vURcZV7"}],"annotations":{},"mentions":{}},"text":"#WeAreHiring! Join our team as a #DatabaseAdministrator. Apply before 4 September: https://t.co/TrTWsg5Uzg https://t.co/0u4vURcZV7","attachments":{"media_keys":["3_897080396407382017"],"poll_ids":{}},"created_at":"2017-08-14T13:00:08.000Z","author_id":"116716199","lang":"en","conversation_id":"897080398487932928","possibly_sensitive":false,"id":"897080398487932928","source":"Sprout Social","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":10,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":13,"end":30,"tag":"EMAPublicHearing"},{"start":34,"end":44,"tag":"valproate"},{"start":72,"end":88,"tag":"BipolarDisorder"}],"urls":[{"start":89,"end":112,"url":"https://t.co/tqJ2tW216F","expanded_url":"http://bit.ly/2u9bqbg","display_url":"bit.ly/2u9bqbg"},{"start":113,"end":136,"url":"https://t.co/zVP2HTYsd0","expanded_url":"https://twitter.com/EMA_News/status/897047510316965888/photo/1","display_url":"pic.twitter.com/zVP2HTYsd0"}],"annotations":{},"mentions":{}},"text":"Register for #EMAPublicHearing on #valproate. Deadline: 25 August 2017. #BipolarDisorder https://t.co/tqJ2tW216F https://t.co/zVP2HTYsd0","attachments":{"media_keys":["3_897047163167023104"],"poll_ids":{}},"created_at":"2017-08-14T10:49:27.000Z","author_id":"116716199","lang":"en","conversation_id":"897047510316965888","possibly_sensitive":false,"id":"897047510316965888","source":"Twitter Web Client","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":11,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":21,"end":30,"tag":"patients"},{"start":34,"end":41,"tag":"Europe"}],"urls":[{"start":70,"end":93,"url":"https://t.co/CaO1IyZnpH","expanded_url":"http://bit.ly/2uJbTxH","display_url":"bit.ly/2uJbTxH"},{"start":94,"end":117,"url":"https://t.co/t7OLfFP5vb","expanded_url":"https://twitter.com/EMA_News/status/895629564357074944/photo/1","display_url":"pic.twitter.com/t7OLfFP5vb"}],"annotations":{},"mentions":{}},"text":"How does EMA benefit #patients in #Europe? Check out our new leaflet: https://t.co/CaO1IyZnpH https://t.co/t7OLfFP5vb","attachments":{"media_keys":["3_895629560791695363"],"poll_ids":{}},"created_at":"2017-08-10T12:55:02.000Z","author_id":"116716199","lang":"en","conversation_id":"895629564357074944","possibly_sensitive":false,"id":"895629564357074944","source":"Sprout Social","public_metrics":{"retweet_count":34,"reply_count":1,"like_count":24,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":0,"end":9,"tag":"EUreport"},{"start":60,"end":81,"tag":"AntibioticResistance"},{"start":106,"end":113,"tag":"JIACRA"}],"urls":[{"start":82,"end":105,"url":"https://t.co/Eeh3IqVq8C","expanded_url":"http://bit.ly/2h7GG5M","display_url":"bit.ly/2h7GG5M"},{"start":114,"end":137,"url":"https://t.co/xuqMaEUeKh","expanded_url":"https://twitter.com/EMA_News/status/895582254587576320/photo/1","display_url":"pic.twitter.com/xuqMaEUeKh"}],"annotations":{},"mentions":{}},"text":"#EUreport: more evidence on link between antibiotic use and #AntibioticResistance https://t.co/Eeh3IqVq8C #JIACRA https://t.co/xuqMaEUeKh","attachments":{"media_keys":["3_895582251492048896"],"poll_ids":{}},"created_at":"2017-08-10T09:47:03.000Z","author_id":"116716199","lang":"en","conversation_id":"895582254587576320","possibly_sensitive":false,"id":"895582254587576320","source":"Sprout Social","public_metrics":{"retweet_count":59,"reply_count":1,"like_count":35,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":16,"end":33,"tag":"EMAPublicHearing"},{"start":95,"end":105,"tag":"valproate"}],"urls":[{"start":71,"end":94,"url":"https://t.co/DEdAlgXkSF","expanded_url":"http://bit.ly/2h7ESd5","display_url":"bit.ly/2h7ESd5"}],"annotations":{},"mentions":{}},"text":"All speakers at #EMAPublicHearing need to respond to these 3 questions https://t.co/DEdAlgXkSF #valproate","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-08-09T14:10:01.000Z","author_id":"116716199","lang":"en","conversation_id":"895286046472245248","possibly_sensitive":false,"id":"895286046472245248","source":"Sprout Social","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":9,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":0,"end":12,"tag":"WeAreHiring"},{"start":115,"end":122,"tag":"EUjobs"}],"urls":[{"start":91,"end":114,"url":"https://t.co/PRLE3sHlLm","expanded_url":"http://bit.ly/2w5OV5G","display_url":"bit.ly/2w5OV5G"},{"start":123,"end":146,"url":"https://t.co/6FknO0c7TC","expanded_url":"https://twitter.com/EMA_News/status/894905292596662272/photo/1","display_url":"pic.twitter.com/6FknO0c7TC"}],"annotations":{},"mentions":{}},"text":"#WeAreHiring a Head of Stakeholders and Communication Division. Apply before 14 September: https://t.co/PRLE3sHlLm #EUjobs https://t.co/6FknO0c7TC","attachments":{"media_keys":["3_894905289903702016"],"poll_ids":{}},"created_at":"2017-08-08T12:57:02.000Z","author_id":"116716199","lang":"en","conversation_id":"894905292596662272","possibly_sensitive":false,"id":"894905292596662272","source":"Sprout Social","public_metrics":{"retweet_count":22,"reply_count":0,"like_count":13,"quote_count":3},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":65,"end":88,"url":"https://t.co/CNj9auMWCE","expanded_url":"http://bit.ly/2uCfGNe","display_url":"bit.ly/2uCfGNe"}],"annotations":[{"start":0,"end":2,"probability":0.5721,"type":"Organization","normalized_text":"EMA"},{"start":52,"end":62,"probability":0.9764,"type":"Place","normalized_text":"East Africa"}],"mentions":{}},"text":"EMA supports regulatory harmonisation activities in East Africa: https://t.co/CNj9auMWCE","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-08-08T10:32:01.000Z","author_id":"116716199","lang":"en","conversation_id":"894868794098712576","possibly_sensitive":false,"id":"894868794098712576","source":"Sprout Social","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":14,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":67,"end":70,"tag":"EU"},{"start":71,"end":81,"tag":"trademark"}],"urls":[{"start":83,"end":106,"url":"https://t.co/58WZ68r4df","expanded_url":"http://bit.ly/2hCqA4s","display_url":"bit.ly/2hCqA4s"}],"annotations":{},"mentions":[{"start":107,"end":114,"username":"EU_IPO","id":"70650192"}]},"text":"EMA’s platform for post-authorisation studies is now registered as #EU #trademark: https://t.co/58WZ68r4df @EU_IPO","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-08-07T12:40:01.000Z","author_id":"116716199","lang":"en","conversation_id":"894538619775574017","possibly_sensitive":false,"id":"894538619775574017","source":"Sprout Social","public_metrics":{"retweet_count":27,"reply_count":0,"like_count":19,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":21,"end":31,"tag":"valproate"},{"start":32,"end":49,"tag":"EMAPublicHearing"}],"urls":[{"start":80,"end":103,"url":"https://t.co/TXlcKdO8Bv","expanded_url":"http://bit.ly/2h7UoWj","display_url":"bit.ly/2h7UoWj"}],"annotations":{},"mentions":{}},"text":"How can you join the #valproate #EMAPublicHearing? Here’s all you need to know: https://t.co/TXlcKdO8Bv","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-08-07T11:06:00.000Z","author_id":"116716199","lang":"en","conversation_id":"894514962219102208","possibly_sensitive":false,"id":"894514962219102208","source":"Sprout Social","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":8,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":27,"end":37,"tag":"valproate"},{"start":38,"end":55,"tag":"EMAPublicHearing"}],"urls":[{"start":94,"end":117,"url":"https://t.co/iFEPKvwgRR","expanded_url":"http://bit.ly/2h8nS6k","display_url":"bit.ly/2h8nS6k"},{"start":118,"end":141,"url":"https://t.co/7AmXZsRSmA","expanded_url":"https://twitter.com/EMA_News/status/893110216413282304/photo/1","display_url":"pic.twitter.com/7AmXZsRSmA"}],"annotations":{},"mentions":{}},"text":"Interested to take part in #valproate #EMAPublicHearing? Register now as speaker or observer: https://t.co/iFEPKvwgRR https://t.co/7AmXZsRSmA","attachments":{"media_keys":["3_893110213414240260"],"poll_ids":{}},"created_at":"2017-08-03T14:04:03.000Z","author_id":"116716199","lang":"en","conversation_id":"893110216413282304","possibly_sensitive":false,"id":"893110216413282304","source":"Sprout Social","public_metrics":{"retweet_count":17,"reply_count":0,"like_count":17,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":0,"end":19,"tag":"PublicConsultation"},{"start":44,"end":59,"tag":"antimicrobials"},{"start":63,"end":74,"tag":"veterinary"},{"start":75,"end":84,"tag":"medicine"}],"urls":[{"start":117,"end":140,"url":"https://t.co/1k5gsTcBHW","expanded_url":"http://bit.ly/2eU3Qfb","display_url":"bit.ly/2eU3Qfb"}],"annotations":{},"mentions":{}},"text":"#PublicConsultation on the off-label use of #antimicrobials in #veterinary #medicine. Have your say until 31.01.2018 https://t.co/1k5gsTcBHW","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-08-02T09:39:00.000Z","author_id":"116716199","lang":"en","conversation_id":"892681128229949441","possibly_sensitive":false,"id":"892681128229949441","source":"Sprout Social","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":4,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":17,"end":24,"tag":"Brexit"}],"urls":[{"start":58,"end":81,"url":"https://t.co/iPsMpJtOsu","expanded_url":"http://bit.ly/2uSnP3k","display_url":"bit.ly/2uSnP3k"}],"annotations":[{"start":0,"end":2,"probability":0.4514,"type":"Organization","normalized_text":"EMA"}],"mentions":{}},"text":"EMA prepares for #Brexit with a business continuity plan: https://t.co/iPsMpJtOsu","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-08-01T17:02:02.000Z","author_id":"116716199","lang":"en","conversation_id":"892430232329826304","possibly_sensitive":false,"id":"892430232329826304","source":"Sprout Social","public_metrics":{"retweet_count":80,"reply_count":3,"like_count":63,"quote_count":7},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":107,"end":123,"tag":"ReflectionPaper"}],"urls":[{"start":83,"end":106,"url":"https://t.co/RV7CIvD1BZ","expanded_url":"http://bit.ly/2tV8OuV","display_url":"bit.ly/2tV8OuV"},{"start":124,"end":147,"url":"https://t.co/V85IEOwZrB","expanded_url":"https://twitter.com/EMA_News/status/892350557633032193/photo/1","display_url":"pic.twitter.com/V85IEOwZrB"}],"annotations":{},"mentions":{}},"text":"How can medicine developers better address the needs of older people? Let us know: https://t.co/RV7CIvD1BZ #ReflectionPaper https://t.co/V85IEOwZrB","attachments":{"media_keys":["3_892350476473315329"],"poll_ids":{}},"created_at":"2017-08-01T11:45:26.000Z","author_id":"116716199","lang":"en","conversation_id":"892350557633032193","possibly_sensitive":false,"id":"892350557633032193","source":"Twitter Web Client","public_metrics":{"retweet_count":14,"reply_count":0,"like_count":16,"quote_count":3},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":70,"end":87,"tag":"EMAPublicHearing"},{"start":112,"end":122,"tag":"valproate"}],"urls":[{"start":88,"end":111,"url":"https://t.co/mkdzpnmvRA","expanded_url":"http://bit.ly/2eSLueI","display_url":"bit.ly/2eSLueI"}],"annotations":{},"mentions":{}},"text":"How does a public hearing work? See this video to find out more about #EMAPublicHearing https://t.co/mkdzpnmvRA #valproate","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-08-01T09:03:01.000Z","author_id":"116716199","lang":"en","conversation_id":"892309683297542144","possibly_sensitive":false,"id":"892309683297542144","source":"Sprout Social","public_metrics":{"retweet_count":18,"reply_count":0,"like_count":15,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":27,"end":40,"tag":"ClinicalData"},{"start":82,"end":91,"tag":"feedback"}],"urls":[{"start":41,"end":64,"url":"https://t.co/Ndo1m0skCV","expanded_url":"http://bit.ly/2t655e6","display_url":"bit.ly/2t655e6"},{"start":93,"end":116,"url":"https://t.co/ILLAwMuLdw","expanded_url":"http://bit.ly/2t655uC","display_url":"bit.ly/2t655uC"},{"start":138,"end":161,"url":"https://t.co/Vo7DU0YOsY","expanded_url":"https://twitter.com/EMA_News/status/891991092203270145/photo/1","display_url":"pic.twitter.com/Vo7DU0YOsY"}],"annotations":{},"mentions":{}},"text":"Explore our new website on #ClinicalData https://t.co/Ndo1m0skCV and send us your #feedback: https://t.co/ILLAwMuLdw. Deadline: 31 August https://t.co/Vo7DU0YOsY","attachments":{"media_keys":["3_891991089850101760"],"poll_ids":{}},"created_at":"2017-07-31T11:57:03.000Z","author_id":"116716199","lang":"en","conversation_id":"891991092203270145","possibly_sensitive":false,"id":"891991092203270145","source":"Sprout Social","public_metrics":{"retweet_count":19,"reply_count":1,"like_count":13,"quote_count":3},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":0,"end":19,"tag":"PublicConsultation"},{"start":40,"end":50,"tag":"guideline"},{"start":54,"end":76,"tag":"PersonalisedMedicines"}],"urls":[{"start":121,"end":144,"url":"https://t.co/8AJGfPZY1T","expanded_url":"http://bit.ly/2eUugxA","display_url":"bit.ly/2eUugxA"}],"annotations":{},"mentions":{}},"text":"#PublicConsultation - help us develop a #guideline on #PersonalisedMedicines &amp; companion diagnostics. Deadline 31.10 https://t.co/8AJGfPZY1T","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-07-28T14:19:01.000Z","author_id":"116716199","lang":"en","conversation_id":"890939654526177281","possibly_sensitive":false,"id":"890939654526177281","source":"Sprout Social","public_metrics":{"retweet_count":16,"reply_count":0,"like_count":12,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":13,"end":31,"tag":"WorldHepatitisDay"},{"start":72,"end":81,"tag":"patients"},{"start":93,"end":103,"tag":"medicines"}],"urls":[{"start":104,"end":127,"url":"https://t.co/8MTp0XnUzA","expanded_url":"https://twitter.com/EMA_News/status/890844784247570432/photo/1","display_url":"pic.twitter.com/8MTp0XnUzA"}],"annotations":[{"start":0,"end":2,"probability":0.4752,"type":"Organization","normalized_text":"EMA"}],"mentions":{}},"text":"EMA supports #WorldHepatitisDay - fostering innovation and facilitating #patients' access to #medicines https://t.co/8MTp0XnUzA","attachments":{"media_keys":["3_890844781642825732"],"poll_ids":{}},"created_at":"2017-07-28T08:02:02.000Z","author_id":"116716199","lang":"en","conversation_id":"890844784247570432","possibly_sensitive":false,"id":"890844784247570432","source":"Sprout Social","public_metrics":{"retweet_count":38,"reply_count":1,"like_count":32,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":0,"end":9,"tag":"EUreport"},{"start":60,"end":81,"tag":"AntibioticResistance"}],"urls":[{"start":82,"end":105,"url":"https://t.co/y5OUrTIDYW","expanded_url":"http://bit.ly/2vLxxTE","display_url":"bit.ly/2vLxxTE"},{"start":106,"end":129,"url":"https://t.co/ZjLgWGe0e4","expanded_url":"https://twitter.com/EMA_News/status/890515571959312385/photo/1","display_url":"pic.twitter.com/ZjLgWGe0e4"}],"annotations":{},"mentions":{}},"text":"#EUreport: more evidence on link between antibiotic use and #AntibioticResistance https://t.co/y5OUrTIDYW https://t.co/ZjLgWGe0e4","attachments":{"media_keys":["3_890514895711719424"],"poll_ids":{}},"created_at":"2017-07-27T10:13:51.000Z","author_id":"116716199","lang":"en","conversation_id":"890515571959312385","possibly_sensitive":false,"id":"890515571959312385","source":"Twitter Web Client","public_metrics":{"retweet_count":44,"reply_count":1,"like_count":23,"quote_count":5},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":0,"end":19,"tag":"PublicConsultation"},{"start":57,"end":73,"tag":"aminoglycosides"}],"urls":[{"start":107,"end":130,"url":"https://t.co/ePzTq4pVE4","expanded_url":"http://bit.ly/2uWX3rB","display_url":"bit.ly/2uWX3rB"}],"annotations":{},"mentions":{}},"text":"#PublicConsultation - What do you think about the use of #aminoglycosides in animals? Deadline: 31 October https://t.co/ePzTq4pVE4","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-07-26T13:05:01.000Z","author_id":"116716199","lang":"en","conversation_id":"890196256424943616","possibly_sensitive":false,"id":"890196256424943616","source":"Sprout Social","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":3,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":74,"end":89,"tag":"clinicaltrials"}],"urls":[{"start":100,"end":123,"url":"https://t.co/hA1VMKrFCF","expanded_url":"http://bit.ly/2uTEapg","display_url":"bit.ly/2uTEapg"}],"annotations":{},"mentions":{}},"text":"We have revised our guideline to ensure that participants in 1st-in-human #clinicaltrials stay safe https://t.co/hA1VMKrFCF","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-07-25T15:00:19.000Z","author_id":"116716199","lang":"en","conversation_id":"889862884456574976","possibly_sensitive":false,"id":"889862884456574976","source":"Sprout Social","public_metrics":{"retweet_count":32,"reply_count":0,"like_count":26,"quote_count":4},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":15,"end":19,"tag":"AMR"},{"start":27,"end":39,"tag":"antibiotics"},{"start":47,"end":50,"tag":"EU"},{"start":84,"end":93,"tag":"EUfunded"},{"start":106,"end":130,"tag":"antimicrobialresistance"}],"urls":{},"annotations":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}]},"text":"RT @EU_Health: #AMR: 7% of #antibiotics in the #EU are taken without prescription - #EUfunded ARNA report #antimicrobialresistance https://…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-07-24T09:48:11.000Z","author_id":"116716199","lang":"en","conversation_id":"889421947565744128","possibly_sensitive":false,"id":"889421947565744128","source":"Twitter Web Client","public_metrics":{"retweet_count":40,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"888698908951621632"}]},{"entities":{"hashtags":[{"start":0,"end":5,"tag":"CHMP"},{"start":19,"end":28,"tag":"medicine"}],"urls":[{"start":86,"end":109,"url":"https://t.co/9SZPIoZogv","expanded_url":"http://bit.ly/2vHCQ5F","display_url":"bit.ly/2vHCQ5F"}],"annotations":{},"mentions":{}},"text":"#CHMP approves new #medicine for rare form of eye allergy in children &amp; teenagers https://t.co/9SZPIoZogv","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-07-21T12:00:08.000Z","author_id":"116716199","lang":"en","conversation_id":"888367990605058049","possibly_sensitive":false,"id":"888367990605058049","source":"Sprout Social","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":12,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":0,"end":5,"tag":"CHMP"},{"start":20,"end":30,"tag":"medicines"}],"urls":[{"start":69,"end":92,"url":"https://t.co/XsnLff4kK9","expanded_url":"http://bit.ly/2gPCt6s","display_url":"bit.ly/2gPCt6s"},{"start":93,"end":116,"url":"https://t.co/srtNDuzc01","expanded_url":"https://twitter.com/EMA_News/status/888359660486635520/photo/1","display_url":"pic.twitter.com/srtNDuzc01"}],"annotations":{},"mentions":{}},"text":"#CHMP recommends 11 #medicines for approval at its July 2017 meeting https://t.co/XsnLff4kK9 https://t.co/srtNDuzc01","attachments":{"media_keys":["3_888359658481532928"],"poll_ids":{}},"created_at":"2017-07-21T11:27:02.000Z","author_id":"116716199","lang":"en","conversation_id":"888359660486635520","possibly_sensitive":false,"id":"888359660486635520","source":"Sprout Social","public_metrics":{"retweet_count":27,"reply_count":1,"like_count":17,"quote_count":6},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":57,"end":70,"tag":"EUregulatory"},{"start":82,"end":92,"tag":"medicines"}],"urls":[{"start":94,"end":117,"url":"https://t.co/Su9hFjlkdX","expanded_url":"http://bit.ly/2uriwsV","display_url":"bit.ly/2uriwsV"},{"start":118,"end":141,"url":"https://t.co/5FpAPtGZzT","expanded_url":"https://twitter.com/EMA_News/status/887651049728823297/photo/1","display_url":"pic.twitter.com/5FpAPtGZzT"}],"annotations":{},"mentions":{}},"text":"Attend our awareness session for a full insight into the #EUregulatory system for #medicines: https://t.co/Su9hFjlkdX https://t.co/5FpAPtGZzT","attachments":{"media_keys":["3_887651030820937728"],"poll_ids":{}},"created_at":"2017-07-19T12:31:16.000Z","author_id":"116716199","lang":"en","conversation_id":"887651049728823297","possibly_sensitive":false,"id":"887651049728823297","source":"Twitter Web Client","public_metrics":{"retweet_count":29,"reply_count":0,"like_count":19,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":8,"end":22,"tag":"YoungPatients"}],"urls":[{"start":76,"end":99,"url":"https://t.co/jMPRUHniHW","expanded_url":"http://bit.ly/2tpmRws","display_url":"bit.ly/2tpmRws"},{"start":100,"end":123,"url":"https://t.co/Y2BNRSyrsc","expanded_url":"https://twitter.com/EMA_News/status/887630612953276416/photo/1","display_url":"pic.twitter.com/Y2BNRSyrsc"}],"annotations":{},"mentions":{}},"text":"How can #YoungPatients under 18 contribute to EMA’s activities? Learn more: https://t.co/jMPRUHniHW https://t.co/Y2BNRSyrsc","attachments":{"media_keys":["3_887630609958412288"],"poll_ids":{}},"created_at":"2017-07-19T11:10:04.000Z","author_id":"116716199","lang":"en","conversation_id":"887630612953276416","possibly_sensitive":false,"id":"887630612953276416","source":"Sprout Social","public_metrics":{"retweet_count":19,"reply_count":0,"like_count":16,"quote_count":4},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":33,"end":46,"tag":"ClinicalData"},{"start":90,"end":99,"tag":"feedback"}],"urls":[{"start":48,"end":71,"url":"https://t.co/Ndo1m0skCV","expanded_url":"http://bit.ly/2t655e6","display_url":"bit.ly/2t655e6"},{"start":108,"end":131,"url":"https://t.co/ILLAwMuLdw","expanded_url":"http://bit.ly/2t655uC","display_url":"bit.ly/2t655uC"},{"start":132,"end":155,"url":"https://t.co/tmwu0m2Xtk","expanded_url":"https://twitter.com/EMA_News/status/887310248381480960/photo/1","display_url":"pic.twitter.com/tmwu0m2Xtk"}],"annotations":{},"mentions":{}},"text":"Have you used our new website on #ClinicalData: https://t.co/Ndo1m0skCV? Take part in our #feedback survey: https://t.co/ILLAwMuLdw https://t.co/tmwu0m2Xtk","attachments":{"media_keys":["3_887310245982117889"],"poll_ids":{}},"created_at":"2017-07-18T13:57:03.000Z","author_id":"116716199","lang":"en","conversation_id":"887310248381480960","possibly_sensitive":false,"id":"887310248381480960","source":"Sprout Social","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":12,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":29,"end":39,"tag":"valproate"},{"start":40,"end":57,"tag":"EMAPublicHearing"}],"urls":[{"start":85,"end":108,"url":"https://t.co/tqJ2tW216F","expanded_url":"http://bit.ly/2u9bqbg","display_url":"bit.ly/2u9bqbg"},{"start":109,"end":132,"url":"https://t.co/BDYZQWOVwz","expanded_url":"https://twitter.com/EMA_News/status/887227288294739968/photo/1","display_url":"pic.twitter.com/BDYZQWOVwz"}],"annotations":{},"mentions":{}},"text":"Register today to attend the #valproate #EMAPublicHearing. Deadline: 25 August 2017. https://t.co/tqJ2tW216F https://t.co/BDYZQWOVwz","attachments":{"media_keys":["3_887227218262405121"],"poll_ids":{}},"created_at":"2017-07-18T08:27:24.000Z","author_id":"116716199","lang":"en","conversation_id":"887227288294739968","possibly_sensitive":false,"id":"887227288294739968","source":"Twitter Web Client","public_metrics":{"retweet_count":15,"reply_count":1,"like_count":8,"quote_count":3},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":10,"end":16,"tag":"PRIME"},{"start":99,"end":109,"tag":"medicines"}],"urls":[{"start":110,"end":133,"url":"https://t.co/Tdq6uyn0WE","expanded_url":"http://bit.ly/2txJVV4","display_url":"bit.ly/2txJVV4"}],"annotations":{},"mentions":{}},"text":"1 year of #PRIME: see feedback from stakeholders on our scheme to support development of promising #medicines https://t.co/Tdq6uyn0WE","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-07-17T14:13:15.000Z","author_id":"116716199","lang":"en","conversation_id":"886951937052168192","possibly_sensitive":false,"id":"886951937052168192","source":"Twitter Web Client","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":7,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":73,"end":78,"tag":"CHMP"}],"urls":[{"start":94,"end":117,"url":"https://t.co/v6FisHcl4O","expanded_url":"http://bit.ly/2thZncR","display_url":"bit.ly/2thZncR"}],"annotations":{},"mentions":{}},"text":"The #agenda of this week's meeting of our committee for human medicines (#CHMP) is available: https://t.co/v6FisHcl4O","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-07-17T11:20:12.000Z","author_id":"116716199","lang":"en","conversation_id":"886908388524818432","possibly_sensitive":false,"id":"886908388524818432","source":"Sprout Social","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":8,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":31,"end":42,"tag":"veterinary"},{"start":43,"end":53,"tag":"medicines"},{"start":64,"end":69,"tag":"CVMP"}],"urls":[{"start":82,"end":105,"url":"https://t.co/l80PKk48gv","expanded_url":"http://bit.ly/2tn2Fq6","display_url":"bit.ly/2tn2Fq6"}],"annotations":{},"mentions":{}},"text":"See the recommendations of our #veterinary #medicines committee #CVMP this month: https://t.co/l80PKk48gv","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-07-14T15:31:54.000Z","author_id":"116716199","lang":"en","conversation_id":"885884565641887744","possibly_sensitive":false,"id":"885884565641887744","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":3,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":55,"end":60,"tag":"PRAC"}],"urls":[{"start":61,"end":84,"url":"https://t.co/toVyMl42zn","expanded_url":"http://bit.ly/2vg2ePI","display_url":"bit.ly/2vg2ePI"},{"start":85,"end":108,"url":"https://t.co/nP91HntXCL","expanded_url":"https://twitter.com/EMA_News/status/885489265999826944/photo/1","display_url":"pic.twitter.com/nP91HntXCL"}],"annotations":{},"mentions":{}},"text":"Join EMA’s Pharmacovigilance Risk Assessment Committee #PRAC https://t.co/toVyMl42zn https://t.co/nP91HntXCL","attachments":{"media_keys":["3_885488966044200960"],"poll_ids":{}},"created_at":"2017-07-13T13:21:07.000Z","author_id":"116716199","lang":"en","conversation_id":"885489265999826944","possibly_sensitive":false,"id":"885489265999826944","source":"Twitter Web Client","public_metrics":{"retweet_count":31,"reply_count":0,"like_count":16,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":18,"end":35,"tag":"EMAPublicHearing"}],"urls":[{"start":89,"end":112,"url":"https://t.co/VAJyeObFxv","expanded_url":"http://bit.ly/2tPz0Yx","display_url":"bit.ly/2tPz0Yx"}],"annotations":[{"start":50,"end":54,"probability":0.5436,"type":"Place","normalized_text":"13h00"}],"mentions":{}},"text":"@Tobeworthtowait .#EMAPublicHearing will start at 13h00. It will be broadcast live here: https://t.co/VAJyeObFxv","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-07-13T10:49:50.000Z","author_id":"116716199","lang":"en","conversation_id":"885450127917404160","possibly_sensitive":false,"id":"885451197280288768","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"885450127917404160"}],"in_reply_to_user_id":"1385425470"},{"entities":{"hashtags":[{"start":21,"end":38,"tag":"EMAPublicHearing"},{"start":82,"end":92,"tag":"valproate"}],"urls":[{"start":58,"end":81,"url":"https://t.co/tqJ2tW216F","expanded_url":"http://bit.ly/2u9bqbg","display_url":"bit.ly/2u9bqbg"},{"start":93,"end":116,"url":"https://t.co/dj4bDtHKvs","expanded_url":"https://twitter.com/EMA_News/status/885416613851394048/photo/1","display_url":"pic.twitter.com/dj4bDtHKvs"}],"annotations":{},"mentions":{}},"text":"You can register for #EMAPublicHearing by 25 August 2017: https://t.co/tqJ2tW216F #valproate https://t.co/dj4bDtHKvs","attachments":{"media_keys":["3_885415728081506305"],"poll_ids":{}},"created_at":"2017-07-13T08:32:25.000Z","author_id":"116716199","lang":"en","conversation_id":"885416613851394048","possibly_sensitive":false,"id":"885416613851394048","source":"Twitter Web Client","public_metrics":{"retweet_count":19,"reply_count":0,"like_count":12,"quote_count":4},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":17,"end":26,"tag":"patients"}],"urls":[{"start":116,"end":139,"url":"https://t.co/8LCYSDMsnI","expanded_url":"http://bit.ly/2tQGHNR","display_url":"bit.ly/2tQGHNR"},{"start":140,"end":163,"url":"https://t.co/vg4LXqAKyx","expanded_url":"https://twitter.com/EMA_News/status/885093409630941188/photo/1","display_url":"pic.twitter.com/vg4LXqAKyx"}],"annotations":[{"start":0,"end":2,"probability":0.5237,"type":"Organization","normalized_text":"EMA"}],"mentions":{}},"text":"EMA engages with #patients, consumers and healthcare professionals all along the medicines lifecycle. Find out how: https://t.co/8LCYSDMsnI https://t.co/vg4LXqAKyx","attachments":{"media_keys":["3_885093407458299904"],"poll_ids":{}},"created_at":"2017-07-12T11:08:07.000Z","author_id":"116716199","lang":"en","conversation_id":"885093409630941188","possibly_sensitive":false,"id":"885093409630941188","source":"Sprout Social","public_metrics":{"retweet_count":30,"reply_count":0,"like_count":30,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":33,"end":50,"tag":"EMAPublicHearing"},{"start":51,"end":61,"tag":"valproate"}],"urls":[{"start":62,"end":85,"url":"https://t.co/tqJ2tW216F","expanded_url":"http://bit.ly/2u9bqbg","display_url":"bit.ly/2u9bqbg"},{"start":86,"end":109,"url":"https://t.co/8pmJuskdCR","expanded_url":"https://twitter.com/EMA_News/status/884737211211673604/photo/1","display_url":"pic.twitter.com/8pmJuskdCR"}],"annotations":{},"mentions":{}},"text":"Save the date! 26 September 2017 #EMAPublicHearing #valproate https://t.co/tqJ2tW216F https://t.co/8pmJuskdCR","attachments":{"media_keys":["3_884737017422241792"],"poll_ids":{}},"created_at":"2017-07-11T11:32:43.000Z","author_id":"116716199","lang":"en","conversation_id":"884737211211673604","possibly_sensitive":false,"id":"884737211211673604","source":"Twitter Web Client","public_metrics":{"retweet_count":40,"reply_count":0,"like_count":21,"quote_count":6},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":28,"end":39,"tag":"veterinary"},{"start":69,"end":74,"tag":"CVMP"}],"urls":[{"start":75,"end":98,"url":"https://t.co/RuULkzbuxF","expanded_url":"http://bit.ly/2tGg4LW","display_url":"bit.ly/2tGg4LW"}],"annotations":{},"mentions":{}},"text":"What's on the agenda of our #veterinary committee's meeting in July? #CVMP https://t.co/RuULkzbuxF","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-07-10T13:50:11.000Z","author_id":"116716199","lang":"en","conversation_id":"884409416358952961","possibly_sensitive":false,"id":"884409416358952961","source":"Twitter Web Client","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":22,"end":40,"tag":"pharmacovigilance"},{"start":103,"end":108,"tag":"PRAC"}],"urls":[{"start":78,"end":101,"url":"https://t.co/w7BYUJg0wP","expanded_url":"http://bit.ly/2tZ3pqt","display_url":"bit.ly/2tZ3pqt"}],"annotations":{},"mentions":{}},"text":"Our highlights of the #pharmacovigilance committee's meeting in July are out: https://t.co/w7BYUJg0wP  #PRAC","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-07-07T11:44:37.000Z","author_id":"116716199","lang":"en","conversation_id":"883290653572182016","possibly_sensitive":false,"id":"883290653572182016","source":"Twitter Web Client","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":8,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":0,"end":11,"tag":"DidYouKnow"}],"urls":[{"start":114,"end":137,"url":"https://t.co/F0nWfkmuvX","expanded_url":"http://bit.ly/2tR1P6G","display_url":"bit.ly/2tR1P6G"},{"start":138,"end":161,"url":"https://t.co/Yun57pFzuq","expanded_url":"https://twitter.com/EMA_News/status/882963608203907074/photo/1","display_url":"pic.twitter.com/Yun57pFzuq"}],"annotations":{},"mentions":{}},"text":"#DidYouKnow? In 2016, 142 patients &amp; 106 healthcare professionals made their voices heard at EMA’s workshops: https://t.co/F0nWfkmuvX https://t.co/Yun57pFzuq","attachments":{"media_keys":["3_882963604835753984"],"poll_ids":{}},"created_at":"2017-07-06T14:05:03.000Z","author_id":"116716199","lang":"en","conversation_id":"882963608203907074","possibly_sensitive":false,"id":"882963608203907074","source":"Sprout Social","public_metrics":{"retweet_count":28,"reply_count":0,"like_count":29,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":33,"end":46,"tag":"ClinicalData"},{"start":97,"end":111,"tag":"helpUsImprove"}],"urls":[{"start":48,"end":71,"url":"https://t.co/Ndo1m0skCV","expanded_url":"http://bit.ly/2t655e6","display_url":"bit.ly/2t655e6"},{"start":113,"end":136,"url":"https://t.co/ILLAwMuLdw","expanded_url":"http://bit.ly/2t655uC","display_url":"bit.ly/2t655uC"},{"start":137,"end":160,"url":"https://t.co/1xdBdP0fnV","expanded_url":"https://twitter.com/EMA_News/status/882190764398325760/photo/1","display_url":"pic.twitter.com/1xdBdP0fnV"}],"annotations":{},"mentions":{}},"text":"Have you used our new website on #ClinicalData: https://t.co/Ndo1m0skCV? Fill in this survey and #helpUsImprove: https://t.co/ILLAwMuLdw https://t.co/1xdBdP0fnV","attachments":{"media_keys":["3_882190761432825857"],"poll_ids":{}},"created_at":"2017-07-04T10:54:03.000Z","author_id":"116716199","lang":"en","conversation_id":"882190764398325760","possibly_sensitive":false,"id":"882190764398325760","source":"Sprout Social","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":3,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":85,"end":103,"tag":"accesstomedicines"}],"urls":[{"start":117,"end":140,"url":"https://t.co/TXHC4jI2hE","expanded_url":"http://bit.ly/2slcSnv","display_url":"bit.ly/2slcSnv"}],"annotations":{},"mentions":[{"start":8,"end":17,"username":"EUnetHTA","id":"56493220"}]},"text":"EMA and @EUnetHTA step up interaction and launch parallel consultation to facilitate #accesstomedicines for patients https://t.co/TXHC4jI2hE","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-07-04T08:11:11.000Z","author_id":"116716199","lang":"en","conversation_id":"882149780423684096","possibly_sensitive":false,"id":"882149780423684096","source":"TweetDeck","public_metrics":{"retweet_count":44,"reply_count":2,"like_count":26,"quote_count":3},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":28,"end":46,"tag":"pharmacovigilance"},{"start":100,"end":105,"tag":"PRAC"}],"urls":[{"start":76,"end":99,"url":"https://t.co/uPmHaovMyH","expanded_url":"http://bit.ly/2t99OgY","display_url":"bit.ly/2t99OgY"}],"annotations":{},"mentions":{}},"text":"What's on the agenda of our #pharmacovigilance committee's meeting in July? https://t.co/uPmHaovMyH #PRAC","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-07-03T15:53:15.000Z","author_id":"116716199","lang":"en","conversation_id":"881903672812240902","possibly_sensitive":false,"id":"881903672812240902","source":"Twitter Web Client","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":10,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":69,"end":77,"tag":"Gaucher"},{"start":88,"end":101,"tag":"RareDiseases"}],"urls":[{"start":115,"end":138,"url":"https://t.co/n2zj4grIF6","expanded_url":"http://bit.ly/2sxMcUM","display_url":"bit.ly/2sxMcUM"}],"annotations":{},"mentions":[{"start":14,"end":21,"username":"US_FDA","id":"208120290"}]},"text":"See EMA &amp; @US_FDA strategy to boost development of medicines for #Gaucher and other #RareDiseases in children: https://t.co/n2zj4grIF6","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-07-03T09:06:25.000Z","author_id":"116716199","lang":"en","conversation_id":"881801291223183360","possibly_sensitive":false,"id":"881801291223183360","source":"Twitter Web Client","public_metrics":{"retweet_count":21,"reply_count":0,"like_count":16,"quote_count":4},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":13,"end":37,"tag":"AntimicrobialResistance"},{"start":69,"end":81,"tag":"EUAMRaction"}],"urls":[{"start":107,"end":130,"url":"https://t.co/jbhbNCyD4Q","expanded_url":"http://bit.ly/2kL8Uon","display_url":"bit.ly/2kL8Uon"}],"annotations":[{"start":41,"end":46,"probability":0.9957,"type":"Place","normalized_text":"Europe"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}]},"text":"RT @EFSA_EU: #AntimicrobialResistance in Europe, country by country. #EUAMRaction Check out our data viz:  https://t.co/jbhbNCyD4Q https://…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-06-30T14:36:34.000Z","author_id":"116716199","lang":"en","conversation_id":"880797211931664385","possibly_sensitive":false,"id":"880797211931664385","source":"Twitter Web Client","public_metrics":{"retweet_count":43,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"880455133125070848"}]},{"entities":{"hashtags":[{"start":91,"end":94,"tag":"EU"},{"start":105,"end":117,"tag":"EUAMRaction"}],"urls":{},"annotations":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}]},"text":"RT @EU_Health: Antimicrobial Resistance (AMR) = 25,000 deaths &amp; €1.5 billion losses in #EU / y - new #EUAMRaction Plan to tackle it https:/…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-06-29T14:58:11.000Z","author_id":"116716199","lang":"en","conversation_id":"880440266309685248","possibly_sensitive":false,"id":"880440266309685248","source":"Twitter Web Client","public_metrics":{"retweet_count":340,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"880384901618552833"}]},{"entities":{"hashtags":[{"start":9,"end":21,"tag":"EUAMRaction"},{"start":38,"end":62,"tag":"AntimicrobialResistance"}],"urls":[{"start":81,"end":104,"url":"https://t.co/WZKjnUx7tX","expanded_url":"http://bit.ly/2tnRUrT","display_url":"bit.ly/2tnRUrT"},{"start":105,"end":128,"url":"https://t.co/c417PR3uop","expanded_url":"https://twitter.com/EMA_News/status/880401125211598850/photo/1","display_url":"pic.twitter.com/c417PR3uop"}],"annotations":{},"mentions":{}},"text":"Why does #EUAMRaction matter? Because #AntimicrobialResistance is a real threat: https://t.co/WZKjnUx7tX https://t.co/c417PR3uop","attachments":{"media_keys":["3_880400579633262594"],"poll_ids":{}},"created_at":"2017-06-29T12:22:39.000Z","author_id":"116716199","lang":"en","conversation_id":"880401125211598850","possibly_sensitive":false,"id":"880401125211598850","source":"Twitter Web Client","public_metrics":{"retweet_count":22,"reply_count":0,"like_count":20,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":0,"end":24,"tag":"AntimicrobialResistance"},{"start":81,"end":85,"tag":"AMR"},{"start":86,"end":98,"tag":"EUAMRaction"}],"urls":[{"start":100,"end":123,"url":"https://t.co/WZKjnUx7tX","expanded_url":"http://bit.ly/2tnRUrT","display_url":"bit.ly/2tnRUrT"},{"start":124,"end":147,"url":"https://t.co/i6bXAFvjDh","expanded_url":"https://twitter.com/EMA_News/status/880374056020840448/photo/1","display_url":"pic.twitter.com/i6bXAFvjDh"}],"annotations":{},"mentions":[{"start":26,"end":40,"username":"EU_Commission","id":"157981564"}]},"text":"#AntimicrobialResistance: @EU_Commission steps us the fight with new Action Plan #AMR #EUAMRaction: https://t.co/WZKjnUx7tX https://t.co/i6bXAFvjDh","attachments":{"media_keys":["3_880373618605252609"],"poll_ids":{}},"created_at":"2017-06-29T10:35:06.000Z","author_id":"116716199","lang":"en","conversation_id":"880374056020840448","possibly_sensitive":false,"id":"880374056020840448","source":"Twitter Web Client","public_metrics":{"retweet_count":35,"reply_count":1,"like_count":34,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":19,"end":29,"tag":"medicines"},{"start":46,"end":52,"tag":"PRIME"}],"urls":[{"start":69,"end":92,"url":"https://t.co/hFaBbL1097","expanded_url":"http://bit.ly/2tpfgOi","display_url":"bit.ly/2tpfgOi"},{"start":93,"end":116,"url":"https://t.co/xfu6cZMJ63","expanded_url":"https://twitter.com/EMA_News/status/880342836226523136/photo/1","display_url":"pic.twitter.com/xfu6cZMJ63"}],"annotations":{},"mentions":{}},"text":"Find out about the #medicines accepted in our #PRIME scheme in June: https://t.co/hFaBbL1097 https://t.co/xfu6cZMJ63","attachments":{"media_keys":["3_880342833554575361"],"poll_ids":{}},"created_at":"2017-06-29T08:31:02.000Z","author_id":"116716199","lang":"en","conversation_id":"880342836226523136","possibly_sensitive":false,"id":"880342836226523136","source":"Sprout Social","public_metrics":{"retweet_count":18,"reply_count":0,"like_count":6,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":53,"end":62,"tag":"patients"},{"start":67,"end":78,"tag":"healthcare"}],"urls":[{"start":94,"end":117,"url":"https://t.co/LCSQirJ7YK","expanded_url":"http://bit.ly/2thaZfw","display_url":"bit.ly/2thaZfw"},{"start":118,"end":141,"url":"https://t.co/nn0LjYhZut","expanded_url":"https://twitter.com/EMA_News/status/879633410553262080/photo/1","display_url":"pic.twitter.com/nn0LjYhZut"}],"annotations":{},"mentions":{}},"text":"In 2016, more than 1100 of EMA’s activities involved #patients and #healthcare professionals: https://t.co/LCSQirJ7YK https://t.co/nn0LjYhZut","attachments":{"media_keys":["3_879633408200065025"],"poll_ids":{}},"created_at":"2017-06-27T09:32:02.000Z","author_id":"116716199","lang":"en","conversation_id":"879633410553262080","possibly_sensitive":false,"id":"879633410553262080","source":"Sprout Social","public_metrics":{"retweet_count":22,"reply_count":0,"like_count":12,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":23,"end":32,"tag":"StemCell"}],"urls":[{"start":74,"end":97,"url":"https://t.co/7y7GXreUV6","expanded_url":"http://bit.ly/2t2ZrvM","display_url":"bit.ly/2t2ZrvM"},{"start":98,"end":121,"url":"https://t.co/pHcKvvCkhg","expanded_url":"https://twitter.com/EMA_News/status/878258642318876672/photo/1","display_url":"pic.twitter.com/pHcKvvCkhg"}],"annotations":{},"mentions":{}},"text":"The first guidance for #StemCell therapies in animals has been published: https://t.co/7y7GXreUV6 https://t.co/pHcKvvCkhg","attachments":{"media_keys":["3_878258340287184896"],"poll_ids":{}},"created_at":"2017-06-23T14:29:12.000Z","author_id":"116716199","lang":"en","conversation_id":"878258642318876672","possibly_sensitive":false,"id":"878258642318876672","source":"Twitter Web Client","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":9,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":0,"end":5,"tag":"CHMP"},{"start":19,"end":29,"tag":"medicines"}],"urls":[{"start":69,"end":92,"url":"https://t.co/eDZ2rvgHGu","expanded_url":"http://bit.ly/2t1I8Mb","display_url":"bit.ly/2t1I8Mb"},{"start":93,"end":116,"url":"https://t.co/2YIvncWryT","expanded_url":"https://twitter.com/EMA_News/status/878213560257712128/photo/1","display_url":"pic.twitter.com/2YIvncWryT"}],"annotations":{},"mentions":{}},"text":"#CHMP recommends 8 #medicines for approval at its June 2017 meeting: https://t.co/eDZ2rvgHGu https://t.co/2YIvncWryT","attachments":{"media_keys":["3_878213557434761216"],"poll_ids":{}},"created_at":"2017-06-23T11:30:03.000Z","author_id":"116716199","lang":"en","conversation_id":"878213560257712128","possibly_sensitive":false,"id":"878213560257712128","source":"Sprout Social","public_metrics":{"retweet_count":25,"reply_count":1,"like_count":13,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":8,"end":18,"tag":"medicines"},{"start":60,"end":71,"tag":"hepatitisC"},{"start":97,"end":102,"tag":"CHMP"},{"start":103,"end":107,"tag":"HCV"}],"urls":[{"start":73,"end":96,"url":"https://t.co/8Fn50vU9e5","expanded_url":"http://bit.ly/2t1XEI2","display_url":"bit.ly/2t1XEI2"}],"annotations":{},"mentions":{}},"text":"Two new #medicines recommended for the treatment of chronic #hepatitisC: https://t.co/8Fn50vU9e5 #CHMP #HCV","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-06-23T11:25:24.000Z","author_id":"116716199","lang":"en","conversation_id":"878212388972937217","possibly_sensitive":false,"id":"878212388972937217","source":"Sprout Social","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":6,"quote_count":4},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":13,"end":22,"tag":"feedback"},{"start":30,"end":43,"tag":"ClinicalData"}],"urls":[{"start":53,"end":76,"url":"https://t.co/Ndo1m0skCV","expanded_url":"http://bit.ly/2t655e6","display_url":"bit.ly/2t655e6"},{"start":113,"end":136,"url":"https://t.co/ILLAwMuLdw","expanded_url":"http://bit.ly/2t655uC","display_url":"bit.ly/2t655uC"},{"start":137,"end":160,"url":"https://t.co/XWIuLlaC6S","expanded_url":"https://twitter.com/EMA_News/status/877832296702894081/photo/1","display_url":"pic.twitter.com/XWIuLlaC6S"}],"annotations":{},"mentions":{}},"text":"We want your #feedback on our #ClinicalData website: https://t.co/Ndo1m0skCV  – Fill in our survey by 31 August: https://t.co/ILLAwMuLdw https://t.co/XWIuLlaC6S","attachments":{"media_keys":["3_877832293376606208"],"poll_ids":{}},"created_at":"2017-06-22T10:15:03.000Z","author_id":"116716199","lang":"en","conversation_id":"877832296702894081","possibly_sensitive":false,"id":"877832296702894081","source":"Sprout Social","public_metrics":{"retweet_count":14,"reply_count":0,"like_count":9,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":11,"end":30,"tag":"VeterinaryVaccines"}],"urls":[{"start":109,"end":132,"url":"https://t.co/WmLMRKuY6g","expanded_url":"http://bit.ly/2rlJgFp","display_url":"bit.ly/2rlJgFp"},{"start":133,"end":156,"url":"https://t.co/egTBsnW0fN","expanded_url":"https://twitter.com/EMA_News/status/877485011112534016/photo/1","display_url":"pic.twitter.com/egTBsnW0fN"}],"annotations":{},"mentions":{}},"text":"In 2016, 5 #VeterinaryVaccines were recommended for approval to prevent infections in food producing animals https://t.co/WmLMRKuY6g https://t.co/egTBsnW0fN","attachments":{"media_keys":["3_877485007060647936"],"poll_ids":{}},"created_at":"2017-06-21T11:15:04.000Z","author_id":"116716199","lang":"en","conversation_id":"877485011112534016","possibly_sensitive":false,"id":"877485011112534016","source":"Sprout Social","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":3,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":73,"end":78,"tag":"CHMP"}],"urls":[{"start":94,"end":117,"url":"https://t.co/tgGQPx8bfR","expanded_url":"http://bit.ly/2sKqQ61","display_url":"bit.ly/2sKqQ61"}],"annotations":{},"mentions":{}},"text":"The #agenda of this week's meeting of our committee for human medicines (#CHMP) is available: https://t.co/tgGQPx8bfR","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-06-19T13:01:37.000Z","author_id":"116716199","lang":"en","conversation_id":"876787050686631936","possibly_sensitive":false,"id":"876787050686631936","source":"Sprout Social","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":14,"end":25,"tag":"Veterinary"},{"start":133,"end":138,"tag":"CVMP"}],"urls":[{"start":109,"end":132,"url":"https://t.co/ndX8nbKsN6","expanded_url":"http://bit.ly/2tb2qjk","display_url":"bit.ly/2tb2qjk"}],"annotations":{},"mentions":{}},"text":"Committee for #Veterinary Medicines recommends 3 new vaccines for approval. Check out all opinions from June https://t.co/ndX8nbKsN6 #CVMP","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-06-16T16:37:03.000Z","author_id":"116716199","lang":"en","conversation_id":"875754100809510919","possibly_sensitive":false,"id":"875754100809510919","source":"Sprout Social","public_metrics":{"retweet_count":8,"reply_count":1,"like_count":6,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":67,"end":90,"url":"https://t.co/YgnAT4OWwo","expanded_url":"http://bit.ly/2t9CfJN","display_url":"bit.ly/2t9CfJN"}],"annotations":{},"mentions":{}},"text":"See the highlights of this week’s meeting of our Management Board: https://t.co/YgnAT4OWwo","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-06-16T13:27:44.000Z","author_id":"116716199","lang":"en","conversation_id":"875706457794150401","possibly_sensitive":false,"id":"875706457794150401","source":"Sprout Social","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":2,"quote_count":3},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":25,"end":38,"tag":"ClinicalData"}],"urls":[{"start":48,"end":71,"url":"https://t.co/Ndo1m0skCV","expanded_url":"http://bit.ly/2t655e6","display_url":"bit.ly/2t655e6"},{"start":106,"end":129,"url":"https://t.co/ILLAwMuLdw","expanded_url":"http://bit.ly/2t655uC","display_url":"bit.ly/2t655uC"},{"start":130,"end":153,"url":"https://t.co/haiNd1bizV","expanded_url":"https://twitter.com/EMA_News/status/875352236674732032/photo/1","display_url":"pic.twitter.com/haiNd1bizV"}],"annotations":{},"mentions":{}},"text":"What do you think of our #ClinicalData website: https://t.co/Ndo1m0skCV? Fill in our survey by 31 August: https://t.co/ILLAwMuLdw https://t.co/haiNd1bizV","attachments":{"media_keys":["3_875352233369522176"],"poll_ids":{}},"created_at":"2017-06-15T14:00:11.000Z","author_id":"116716199","lang":"en","conversation_id":"875352236674732032","possibly_sensitive":false,"id":"875352236674732032","source":"Sprout Social","public_metrics":{"retweet_count":17,"reply_count":0,"like_count":7,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":24,"end":38,"tag":"SafetySignals"}],"urls":[{"start":98,"end":121,"url":"https://t.co/WmLMRKuY6g","expanded_url":"http://bit.ly/2rlJgFp","display_url":"bit.ly/2rlJgFp"},{"start":122,"end":145,"url":"https://t.co/NypaESeueW","expanded_url":"https://twitter.com/EMA_News/status/875294573014265856/photo/1","display_url":"pic.twitter.com/NypaESeueW"}],"annotations":{},"mentions":{}},"text":"What happened to the 94 #SafetySignals on medicines assessed in 2016? Check out our annual report https://t.co/WmLMRKuY6g https://t.co/NypaESeueW","attachments":{"media_keys":["3_875294570551980032"],"poll_ids":{}},"created_at":"2017-06-15T10:11:03.000Z","author_id":"116716199","lang":"en","conversation_id":"875294573014265856","possibly_sensitive":false,"id":"875294573014265856","source":"Sprout Social","public_metrics":{"retweet_count":35,"reply_count":0,"like_count":16,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":36,"end":45,"tag":"patients"}],"urls":[{"start":112,"end":135,"url":"https://t.co/lY1LHpIiC5","expanded_url":"http://bit.ly/29BbanN","display_url":"bit.ly/29BbanN"}],"annotations":{},"mentions":{}},"text":"Get involved! EMA collaborates with #patients and their organisations at all stages of the medicines lifecycle: https://t.co/lY1LHpIiC5","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-06-14T09:30:02.000Z","author_id":"116716199","lang":"en","conversation_id":"874921864333864960","possibly_sensitive":false,"id":"874921864333864960","source":"Sprout Social","public_metrics":{"retweet_count":25,"reply_count":1,"like_count":30,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":97,"end":121,"tag":"AntimicrobialResistance"},{"start":122,"end":139,"tag":"HealthRegulation"}],"urls":[{"start":73,"end":96,"url":"https://t.co/5PbHP6bOEV","expanded_url":"http://bit.ly/2sTqU0b","display_url":"bit.ly/2sTqU0b"}],"annotations":[{"start":23,"end":27,"probability":0.9725,"type":"Place","normalized_text":"Japan"}],"mentions":[{"start":5,"end":12,"username":"US_FDA","id":"208120290"}]},"text":"EMA, @US_FDA &amp; PMDA in Japan enhance development of new antibiotics: https://t.co/5PbHP6bOEV #AntimicrobialResistance #HealthRegulation","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-06-12T10:51:03.000Z","author_id":"116716199","lang":"en","conversation_id":"874217479610015749","possibly_sensitive":false,"id":"874217479610015749","source":"Sprout Social","public_metrics":{"retweet_count":27,"reply_count":0,"like_count":7,"quote_count":3},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":0,"end":9,"tag":"Workshop"},{"start":45,"end":75,"tag":"PulmonaryArterialHypertension"}],"urls":[{"start":107,"end":130,"url":"https://t.co/n299X0574G","expanded_url":"http://bit.ly/2sbF5AD","display_url":"bit.ly/2sbF5AD"},{"start":131,"end":154,"url":"https://t.co/D0gjf2MiyS","expanded_url":"https://twitter.com/EMA_News/status/874170671252856833/photo/1","display_url":"pic.twitter.com/D0gjf2MiyS"}],"annotations":{},"mentions":{}},"text":"#Workshop: Addressing needs of children with #PulmonaryArterialHypertension – Join the live broadcast now: https://t.co/n299X0574G https://t.co/D0gjf2MiyS","attachments":{"media_keys":["3_874170669159731201"],"poll_ids":{}},"created_at":"2017-06-12T07:45:03.000Z","author_id":"116716199","lang":"en","conversation_id":"874170671252856833","possibly_sensitive":false,"id":"874170671252856833","source":"Sprout Social","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":4,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":27,"end":45,"tag":"pharmacovigilance"},{"start":99,"end":104,"tag":"PRAC"}],"urls":[{"start":75,"end":98,"url":"https://t.co/TKZVI40k2M","expanded_url":"http://bit.ly/2r9GYhh","display_url":"bit.ly/2r9GYhh"}],"annotations":{},"mentions":{}},"text":"Read the highlights of the #pharmacovigilance committee's meeting in June: https://t.co/TKZVI40k2M #PRAC","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-06-09T15:59:57.000Z","author_id":"116716199","lang":"en","conversation_id":"873208051070881793","possibly_sensitive":false,"id":"873208051070881793","source":"Twitter Web Client","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":3,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":4,"end":22,"tag":"pharmacovigilance"},{"start":103,"end":108,"tag":"PRAC"},{"start":109,"end":119,"tag":"valproate"}],"urls":[{"start":79,"end":102,"url":"https://t.co/TKZVI40k2M","expanded_url":"http://bit.ly/2r9GYhh","display_url":"bit.ly/2r9GYhh"}],"annotations":{},"mentions":{}},"text":"Our #pharmacovigilance committee has set the date of its first public hearing: https://t.co/TKZVI40k2M #PRAC #valproate","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-06-09T15:55:49.000Z","author_id":"116716199","lang":"en","conversation_id":"873207011286110208","possibly_sensitive":false,"id":"873207011286110208","source":"Twitter Web Client","public_metrics":{"retweet_count":14,"reply_count":1,"like_count":13,"quote_count":4},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":8,"end":28,"tag":"MedicineEarlyAccess"},{"start":36,"end":45,"tag":"patients"}],"urls":[{"start":108,"end":131,"url":"https://t.co/oikSIK5Kcl","expanded_url":"http://bit.ly/2kdlVDM","display_url":"bit.ly/2kdlVDM"},{"start":132,"end":155,"url":"https://t.co/9vvlJU7C71","expanded_url":"https://twitter.com/EMA_News/status/872804159891935232/photo/1","display_url":"pic.twitter.com/9vvlJU7C71"}],"annotations":{},"mentions":{}},"text":"How has #MedicineEarlyAccess helped #patients in 2006-2016? Learn more on conditional market authorisation: https://t.co/oikSIK5Kcl https://t.co/9vvlJU7C71","attachments":{"media_keys":["3_872804157169717249"],"poll_ids":{}},"created_at":"2017-06-08T13:15:02.000Z","author_id":"116716199","lang":"en","conversation_id":"872804159891935232","possibly_sensitive":false,"id":"872804159891935232","source":"Sprout Social","public_metrics":{"retweet_count":39,"reply_count":0,"like_count":17,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":21,"end":27,"tag":"PRIME"}],"urls":[{"start":110,"end":133,"url":"https://t.co/ZpWrv35wpI","expanded_url":"http://bit.ly/2qK0Pmv","display_url":"bit.ly/2qK0Pmv"},{"start":134,"end":157,"url":"https://t.co/4X2vLRizYr","expanded_url":"https://twitter.com/EMA_News/status/872479428739293185/photo/1","display_url":"pic.twitter.com/4X2vLRizYr"}],"annotations":{},"mentions":{}},"text":"First anniversary of #PRIME: video recording and presentations of meeting with stakeholders are now available https://t.co/ZpWrv35wpI https://t.co/4X2vLRizYr","attachments":{"media_keys":["3_872479354634240001"],"poll_ids":{}},"created_at":"2017-06-07T15:44:40.000Z","author_id":"116716199","lang":"en","conversation_id":"872479428739293185","possibly_sensitive":false,"id":"872479428739293185","source":"Twitter Web Client","public_metrics":{"retweet_count":14,"reply_count":0,"like_count":11,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":24,"end":36,"tag":"biosimilars"}],"urls":[{"start":97,"end":120,"url":"https://t.co/WmLMRKuY6g","expanded_url":"http://bit.ly/2rlJgFp","display_url":"bit.ly/2rlJgFp"},{"start":121,"end":144,"url":"https://t.co/yDGWNHAeR5","expanded_url":"https://twitter.com/EMA_News/status/872440513445736449/photo/1","display_url":"pic.twitter.com/yDGWNHAeR5"}],"annotations":{},"mentions":{}},"text":"14 applications for new #biosimilars were received in 2016 – the highest number in a year so far https://t.co/WmLMRKuY6g https://t.co/yDGWNHAeR5","attachments":{"media_keys":["3_872440511029583872"],"poll_ids":{}},"created_at":"2017-06-07T13:10:02.000Z","author_id":"116716199","lang":"en","conversation_id":"872440513445736449","possibly_sensitive":false,"id":"872440513445736449","source":"Sprout Social","public_metrics":{"retweet_count":22,"reply_count":0,"like_count":13,"quote_count":3},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":0,"end":9,"tag":"Workshop"},{"start":45,"end":75,"tag":"PulmonaryArterialHypertension"}],"urls":[{"start":113,"end":136,"url":"https://t.co/fYnnxOxVEY","expanded_url":"http://bit.ly/2qY0tZR","display_url":"bit.ly/2qY0tZR"},{"start":137,"end":160,"url":"https://t.co/ncA9Q3p3yn","expanded_url":"https://twitter.com/EMA_News/status/872089516701560833/photo/1","display_url":"pic.twitter.com/ncA9Q3p3yn"}],"annotations":{},"mentions":{}},"text":"#Workshop: Addressing needs of children with #PulmonaryArterialHypertension – Join the live broadcast on 12 June https://t.co/fYnnxOxVEY https://t.co/ncA9Q3p3yn","attachments":{"media_keys":["3_872089044645236740"],"poll_ids":{}},"created_at":"2017-06-06T13:55:18.000Z","author_id":"116716199","lang":"en","conversation_id":"872089516701560833","possibly_sensitive":false,"id":"872089516701560833","source":"Twitter Web Client","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":7,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":40,"end":58,"tag":"Pharmacovigilance"},{"start":110,"end":115,"tag":"PRAC"}],"urls":[{"start":86,"end":109,"url":"https://t.co/SH4aO8vus1","expanded_url":"http://bit.ly/2qXIXFc","display_url":"bit.ly/2qXIXFc"}],"annotations":{},"mentions":{}},"text":"You can consult the draft agenda of the #Pharmacovigilance Committee meeting in June: https://t.co/SH4aO8vus1 #PRAC","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-06-06T13:35:19.000Z","author_id":"116716199","lang":"en","conversation_id":"872084490344181760","possibly_sensitive":false,"id":"872084490344181760","source":"Twitter Web Client","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":5,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":63,"end":85,"tag":"PersonalisedMedicines"}],"urls":[{"start":87,"end":110,"url":"https://t.co/QPuFKkiu0h","expanded_url":"http://bit.ly/2rqxM4g","display_url":"bit.ly/2rqxM4g"},{"start":111,"end":134,"url":"https://t.co/waliTDFtJ7","expanded_url":"https://twitter.com/EMA_News/status/870219380562382848/photo/1","display_url":"pic.twitter.com/waliTDFtJ7"}],"annotations":{},"mentions":{}},"text":"What are the main challenges and opportunities in the field of #PersonalisedMedicines? https://t.co/QPuFKkiu0h https://t.co/waliTDFtJ7","attachments":{"media_keys":["3_870219377118859265"],"poll_ids":{}},"created_at":"2017-06-01T10:04:02.000Z","author_id":"116716199","lang":"en","conversation_id":"870219380562382848","possibly_sensitive":false,"id":"870219380562382848","source":"Sprout Social","public_metrics":{"retweet_count":29,"reply_count":0,"like_count":16,"quote_count":3},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":108,"end":131,"url":"https://t.co/kX3nzCM5wa","expanded_url":"http://bit.ly/2rF5BSQ","display_url":"bit.ly/2rF5BSQ"}],"annotations":[{"start":79,"end":80,"probability":0.8767,"type":"Place","normalized_text":"UK"}],"mentions":{}},"text":"We’ve published the first in a series of Q+As to help industry prepare for the UK’s withdrawal from the EU: https://t.co/kX3nzCM5wa","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-05-31T16:25:01.000Z","author_id":"116716199","lang":"en","conversation_id":"869952867901165568","possibly_sensitive":false,"id":"869952867901165568","source":"Sprout Social","public_metrics":{"retweet_count":58,"reply_count":1,"like_count":28,"quote_count":12},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":0,"end":5,"tag":"SMEs"}],"urls":[{"start":47,"end":70,"url":"https://t.co/YV1dL2zgB3","expanded_url":"http://bit.ly/2rEpFVi","display_url":"bit.ly/2rEpFVi"},{"start":107,"end":130,"url":"https://t.co/UlYNmJZbKn","expanded_url":"http://bit.ly/2rEpCZC","display_url":"bit.ly/2rEpCZC"}],"annotations":{},"mentions":{}},"text":"#SMEs are drivers of pharmaceutical innovation https://t.co/YV1dL2zgB3. We support them with these actions https://t.co/UlYNmJZbKn","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-05-31T13:40:01.000Z","author_id":"116716199","lang":"en","conversation_id":"869911346195832832","possibly_sensitive":false,"id":"869911346195832832","source":"Sprout Social","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":8,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":46,"end":49,"tag":"EU"},{"start":50,"end":62,"tag":"traineeship"},{"start":133,"end":140,"tag":"EUjobs"}],"urls":[{"start":71,"end":94,"url":"https://t.co/yVieVQGpsU","expanded_url":"http://bit.ly/2sa263M","display_url":"bit.ly/2sa263M"},{"start":141,"end":164,"url":"https://t.co/4LINv5670F","expanded_url":"https://twitter.com/EMA_News/status/869879894825500673/photo/1","display_url":"pic.twitter.com/4LINv5670F"}],"annotations":[{"start":124,"end":125,"probability":0.6765,"type":"Place","normalized_text":"UK"}],"mentions":{}},"text":"You are still on time to apply for a 6 months #EU #traineeship at EMA: https://t.co/yVieVQGpsU. Deadline: 1 June (midnight, UK Time) #EUjobs https://t.co/4LINv5670F","attachments":{"media_keys":["3_869879891331764225"],"poll_ids":{}},"created_at":"2017-05-31T11:35:03.000Z","author_id":"116716199","lang":"en","conversation_id":"869879894825500673","possibly_sensitive":false,"id":"869879894825500673","source":"Sprout Social","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":8,"quote_count":4},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":88,"end":111,"url":"https://t.co/RbTvP1wiJz","expanded_url":"http://bit.ly/2r4tn78","display_url":"bit.ly/2r4tn78"},{"start":112,"end":135,"url":"https://t.co/qBUcGo3xuu","expanded_url":"https://twitter.com/EMA_News/status/869828802746122240/photo/1","display_url":"pic.twitter.com/qBUcGo3xuu"}],"annotations":{},"mentions":{}},"text":"Communication@EMA – how are we doing? Last day to participate in our perception survey: https://t.co/RbTvP1wiJz https://t.co/qBUcGo3xuu","attachments":{"media_keys":["3_869828800158195713"],"poll_ids":{}},"created_at":"2017-05-31T08:12:01.000Z","author_id":"116716199","lang":"en","conversation_id":"869828802746122240","possibly_sensitive":false,"id":"869828802746122240","source":"Sprout Social","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":4,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":2,"end":20,"tag":"AdvancedTherapies"},{"start":31,"end":39,"tag":"therapy"}],"urls":[{"start":106,"end":129,"url":"https://t.co/WmLMRKuY6g","expanded_url":"http://bit.ly/2rlJgFp","display_url":"bit.ly/2rlJgFp"},{"start":130,"end":153,"url":"https://t.co/fW2HCQYTOj","expanded_url":"https://twitter.com/EMA_News/status/869586207369555968/photo/1","display_url":"pic.twitter.com/fW2HCQYTOj"}],"annotations":{},"mentions":{}},"text":"2 #AdvancedTherapies, one gene #therapy and one cell-based therapy, were recommended for approval in 2016 https://t.co/WmLMRKuY6g https://t.co/fW2HCQYTOj","attachments":{"media_keys":["3_869586204815106049"],"poll_ids":{}},"created_at":"2017-05-30T16:08:02.000Z","author_id":"116716199","lang":"en","conversation_id":"869586207369555968","possibly_sensitive":false,"id":"869586207369555968","source":"Sprout Social","public_metrics":{"retweet_count":26,"reply_count":0,"like_count":12,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":46,"end":49,"tag":"EU"},{"start":50,"end":62,"tag":"traineeship"},{"start":133,"end":140,"tag":"EUjobs"}],"urls":[{"start":71,"end":94,"url":"https://t.co/yVieVQY0Ru","expanded_url":"http://bit.ly/2sa263M","display_url":"bit.ly/2sa263M"},{"start":141,"end":164,"url":"https://t.co/WArchD9eZI","expanded_url":"https://twitter.com/EMA_News/status/869549971397279744/photo/1","display_url":"pic.twitter.com/WArchD9eZI"}],"annotations":[{"start":124,"end":125,"probability":0.6765,"type":"Place","normalized_text":"UK"}],"mentions":{}},"text":"You are still on time to apply for a 6 months #EU #traineeship at EMA: https://t.co/yVieVQY0Ru. Deadline: 1 June (midnight, UK Time) #EUjobs https://t.co/WArchD9eZI","attachments":{"media_keys":["3_869549965072257024"],"poll_ids":{}},"created_at":"2017-05-30T13:44:03.000Z","author_id":"116716199","lang":"en","conversation_id":"869549971397279744","possibly_sensitive":false,"id":"869549971397279744","source":"Sprout Social","public_metrics":{"retweet_count":23,"reply_count":0,"like_count":14,"quote_count":5},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":110,"end":133,"url":"https://t.co/RbTvP1wiJz","expanded_url":"http://bit.ly/2r4tn78","display_url":"bit.ly/2r4tn78"},{"start":134,"end":157,"url":"https://t.co/NaRFZiY0yc","expanded_url":"https://twitter.com/EMA_News/status/869466414981185536/photo/1","display_url":"pic.twitter.com/NaRFZiY0yc"}],"annotations":{},"mentions":{}},"text":"Communication@EMA – how are we doing? Still on time to participate in our perception survey. Deadline 31 May: https://t.co/RbTvP1wiJz https://t.co/NaRFZiY0yc","attachments":{"media_keys":["3_869466412586221568"],"poll_ids":{}},"created_at":"2017-05-30T08:12:01.000Z","author_id":"116716199","lang":"en","conversation_id":"869466414981185536","possibly_sensitive":false,"id":"869466414981185536","source":"Sprout Social","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":5,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":39,"end":51,"tag":"biosimilars"},{"start":126,"end":140,"tag":"BiosimilarsEU"}],"urls":[{"start":102,"end":125,"url":"https://t.co/AvTwT7bPiA","expanded_url":"http://bit.ly/2s6I8qE","display_url":"bit.ly/2s6I8qE"},{"start":141,"end":164,"url":"https://t.co/Jp6ZgzF7CU","expanded_url":"https://twitter.com/EMA_News/status/869207964959297536/photo/1","display_url":"pic.twitter.com/Jp6ZgzF7CU"}],"annotations":[{"start":4,"end":5,"probability":0.7084,"type":"Organization","normalized_text":"EU"}],"mentions":{}},"text":"The EU has pioneered the regulation of #biosimilars since 2006. Learn more about biosimilar medicines https://t.co/AvTwT7bPiA #BiosimilarsEU https://t.co/Jp6ZgzF7CU","attachments":{"media_keys":["3_869207962216038400"],"poll_ids":{}},"created_at":"2017-05-29T15:05:02.000Z","author_id":"116716199","lang":"en","conversation_id":"869207964959297536","possibly_sensitive":false,"id":"869207964959297536","source":"Sprout Social","public_metrics":{"retweet_count":26,"reply_count":0,"like_count":18,"quote_count":3},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":113,"end":136,"url":"https://t.co/RbTvP1wiJz","expanded_url":"http://bit.ly/2r4tn78","display_url":"bit.ly/2r4tn78"},{"start":137,"end":160,"url":"https://t.co/TsbEjcwsXa","expanded_url":"https://twitter.com/EMA_News/status/869185062172078083/photo/1","display_url":"pic.twitter.com/TsbEjcwsXa"}],"annotations":{},"mentions":{}},"text":"Communication@EMA – how are we doing? Only 3 days left to participate in our perception survey. Deadline 31 May: https://t.co/RbTvP1wiJz https://t.co/TsbEjcwsXa","attachments":{"media_keys":["3_869185059777007617"],"poll_ids":{}},"created_at":"2017-05-29T13:34:02.000Z","author_id":"116716199","lang":"en","conversation_id":"869185062172078083","possibly_sensitive":false,"id":"869185062172078083","source":"Sprout Social","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":23,"end":41,"tag":"Pharmacovigilance"},{"start":45,"end":48,"tag":"EU"}],"urls":{},"annotations":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":65,"end":74,"username":"EMA_News","id":"116716199"}]},"text":"RT @EU_Health: Report: #Pharmacovigilance in #EU countries &amp; @EMA_News concerning medicinal products for human use (2012 – 2014) https://t.…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-05-29T10:37:19.000Z","author_id":"116716199","lang":"en","conversation_id":"869140589639589889","possibly_sensitive":false,"id":"869140589639589889","source":"Twitter Web Client","public_metrics":{"retweet_count":25,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"868761345814089728"}]},{"entities":{"hashtags":[{"start":13,"end":19,"tag":"PRIME"},{"start":35,"end":51,"tag":"OrphanMedicines"},{"start":99,"end":112,"tag":"RareDiseases"}],"urls":[{"start":75,"end":98,"url":"https://t.co/20y9rmAvEb","expanded_url":"http://bit.ly/2ryuNad","display_url":"bit.ly/2ryuNad"},{"start":113,"end":136,"url":"https://t.co/slKSfyoSd6","expanded_url":"https://twitter.com/EMA_News/status/867734512981221376/photo/1","display_url":"pic.twitter.com/slKSfyoSd6"}],"annotations":{},"mentions":{}},"text":"12 months of #PRIME in figures: 12 #OrphanMedicines accepted in the scheme https://t.co/20y9rmAvEb #RareDiseases https://t.co/slKSfyoSd6","attachments":{"media_keys":["3_867734509625724928"],"poll_ids":{}},"created_at":"2017-05-25T13:30:04.000Z","author_id":"116716199","lang":"en","conversation_id":"867734512981221376","possibly_sensitive":false,"id":"867734512981221376","source":"Sprout Social","public_metrics":{"retweet_count":16,"reply_count":0,"like_count":7,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":65,"end":74,"tag":"patients"}],"urls":[{"start":117,"end":140,"url":"https://t.co/WmLMRKuY6g","expanded_url":"http://bit.ly/2rlJgFp","display_url":"bit.ly/2rlJgFp"},{"start":141,"end":164,"url":"https://t.co/JBBTnDZvUC","expanded_url":"https://twitter.com/EMA_News/status/867682662026182656/photo/1","display_url":"pic.twitter.com/JBBTnDZvUC"}],"annotations":{},"mentions":{}},"text":"In 2016, almost 50000 reports on side effects came directly from #patients. Find more info in our 2016 annual report https://t.co/WmLMRKuY6g https://t.co/JBBTnDZvUC","attachments":{"media_keys":["3_867682659455074304"],"poll_ids":{}},"created_at":"2017-05-25T10:04:02.000Z","author_id":"116716199","lang":"en","conversation_id":"867682662026182656","possibly_sensitive":false,"id":"867682662026182656","source":"Sprout Social","public_metrics":{"retweet_count":26,"reply_count":0,"like_count":11,"quote_count":8},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":73,"end":87,"tag":"HelpUsImprove"}],"urls":[{"start":88,"end":111,"url":"https://t.co/BpY3qdnpFm","expanded_url":"https://twitter.com/EMA_News/status/867674107327991808/photo/1","display_url":"pic.twitter.com/BpY3qdnpFm"}],"annotations":{},"mentions":{}},"text":"Tell us your thoughts via the new comment box available on our webpages. #HelpUsImprove https://t.co/BpY3qdnpFm","attachments":{"media_keys":["3_867674104123580416"],"poll_ids":{}},"created_at":"2017-05-25T09:30:02.000Z","author_id":"116716199","lang":"en","conversation_id":"867674107327991808","possibly_sensitive":false,"id":"867674107327991808","source":"Sprout Social","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":4,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":91,"end":114,"url":"https://t.co/RbTvP1wiJz","expanded_url":"http://bit.ly/2r4tn78","display_url":"bit.ly/2r4tn78"},{"start":115,"end":138,"url":"https://t.co/4WL78xeVnx","expanded_url":"https://twitter.com/EMA_News/status/867654223378382848/photo/1","display_url":"pic.twitter.com/4WL78xeVnx"}],"annotations":{},"mentions":{}},"text":"Communication@EMA – how are we doing? Take part in our perception survey. Deadline 31 May: https://t.co/RbTvP1wiJz https://t.co/4WL78xeVnx","attachments":{"media_keys":["3_867654221038047232"],"poll_ids":{}},"created_at":"2017-05-25T08:11:01.000Z","author_id":"116716199","lang":"en","conversation_id":"867654223378382848","possibly_sensitive":false,"id":"867654223378382848","source":"Sprout Social","public_metrics":{"retweet_count":8,"reply_count":1,"like_count":3,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":19,"end":29,"tag":"medicines"},{"start":46,"end":52,"tag":"PRIME"}],"urls":[{"start":68,"end":91,"url":"https://t.co/oSiFVI6RHW","expanded_url":"http://bit.ly/2rhkHxv","display_url":"bit.ly/2rhkHxv"},{"start":92,"end":115,"url":"https://t.co/OVvdXbsqPf","expanded_url":"https://twitter.com/EMA_News/status/867409926766854145/photo/1","display_url":"pic.twitter.com/OVvdXbsqPf"}],"annotations":{},"mentions":{}},"text":"Find out about the #medicines accepted in our #PRIME scheme in May: https://t.co/oSiFVI6RHW https://t.co/OVvdXbsqPf","attachments":{"media_keys":["3_867409923520516098"],"poll_ids":{}},"created_at":"2017-05-24T16:00:16.000Z","author_id":"116716199","lang":"en","conversation_id":"867409926766854145","possibly_sensitive":false,"id":"867409926766854145","source":"Sprout Social","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":6,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":67,"end":81,"tag":"antimicrobial"}],"urls":[{"start":105,"end":128,"url":"https://t.co/94m4hjzYqM","expanded_url":"http://bit.ly/2qOIW4S","display_url":"bit.ly/2qOIW4S"}],"annotations":[{"start":14,"end":19,"probability":0.447,"type":"Organization","normalized_text":"EC-EMA"}],"mentions":[{"start":129,"end":139,"username":"EU_Health","id":"606325697"}]},"text":"New report on EC-EMA workshop about benefits of collecting data on #antimicrobial consumption in animals https://t.co/94m4hjzYqM @EU_Health","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-05-24T15:22:49.000Z","author_id":"116716199","lang":"en","conversation_id":"867400500748189696","possibly_sensitive":false,"id":"867400500748189696","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":13,"end":19,"tag":"PRIME"}],"urls":[{"start":77,"end":100,"url":"https://t.co/20y9rmAvEb","expanded_url":"http://bit.ly/2ryuNad","display_url":"bit.ly/2ryuNad"},{"start":101,"end":124,"url":"https://t.co/MjGFeSZwUQ","expanded_url":"https://twitter.com/EMA_News/status/867304923788193792/photo/1","display_url":"pic.twitter.com/MjGFeSZwUQ"}],"annotations":{},"mentions":{}},"text":"12 months of #PRIME in a nutshell: 6 cancer medicines accepted in the scheme https://t.co/20y9rmAvEb https://t.co/MjGFeSZwUQ","attachments":{"media_keys":["3_867304920374022144"],"poll_ids":{}},"created_at":"2017-05-24T09:03:02.000Z","author_id":"116716199","lang":"en","conversation_id":"867304923788193792","possibly_sensitive":false,"id":"867304923788193792","source":"Sprout Social","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":8,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":70,"end":93,"url":"https://t.co/c060qoqhUN","expanded_url":"http://bit.ly/2rdChmb","display_url":"bit.ly/2rdChmb"},{"start":94,"end":117,"url":"https://t.co/bUD5MvlexP","expanded_url":"https://twitter.com/EMA_News/status/867050000001454080/photo/1","display_url":"pic.twitter.com/bUD5MvlexP"}],"annotations":{},"mentions":{}},"text":"EMA - a model for a regulatory Agency for the East African Community? https://t.co/c060qoqhUN https://t.co/bUD5MvlexP","attachments":{"media_keys":["3_867049996776067074"],"poll_ids":{}},"created_at":"2017-05-23T16:10:03.000Z","author_id":"116716199","lang":"en","conversation_id":"867050000001454080","possibly_sensitive":false,"id":"867050000001454080","source":"Sprout Social","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":9,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":19,"end":25,"tag":"PRIME"},{"start":41,"end":59,"tag":"AdvancedTherapies"}],"urls":[{"start":83,"end":106,"url":"https://t.co/20y9rmAvEb","expanded_url":"http://bit.ly/2ryuNad","display_url":"bit.ly/2ryuNad"},{"start":107,"end":130,"url":"https://t.co/Ihx4BHXUOE","expanded_url":"https://twitter.com/EMA_News/status/866973239188369408/photo/1","display_url":"pic.twitter.com/Ihx4BHXUOE"}],"annotations":{},"mentions":{}},"text":"First 12 months of #PRIME in figures: 12 #AdvancedTherapies accepted in the scheme https://t.co/20y9rmAvEb https://t.co/Ihx4BHXUOE","attachments":{"media_keys":["3_866973235828731905"],"poll_ids":{}},"created_at":"2017-05-23T11:05:02.000Z","author_id":"116716199","lang":"en","conversation_id":"866973239188369408","possibly_sensitive":false,"id":"866973239188369408","source":"Sprout Social","public_metrics":{"retweet_count":17,"reply_count":0,"like_count":9,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":91,"end":114,"url":"https://t.co/RbTvP1wiJz","expanded_url":"http://bit.ly/2r4tn78","display_url":"bit.ly/2r4tn78"},{"start":115,"end":138,"url":"https://t.co/TjiTFSV9Hr","expanded_url":"https://twitter.com/EMA_News/status/866928693482074112/photo/1","display_url":"pic.twitter.com/TjiTFSV9Hr"}],"annotations":{},"mentions":{}},"text":"Communication@EMA – how are we doing? Take part in our perception survey. Deadline 31 May: https://t.co/RbTvP1wiJz https://t.co/TjiTFSV9Hr","attachments":{"media_keys":["3_866928691271667714"],"poll_ids":{}},"created_at":"2017-05-23T08:08:01.000Z","author_id":"116716199","lang":"en","conversation_id":"866928693482074112","possibly_sensitive":false,"id":"866928693482074112","source":"Sprout Social","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":2,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":53,"end":68,"tag":"EudraVigilance"},{"start":76,"end":88,"tag":"SideEffects"}],"urls":[{"start":89,"end":112,"url":"https://t.co/ZXo2OlANKp","expanded_url":"http://bit.ly/2qMSAoZ","display_url":"bit.ly/2qMSAoZ","status":403,"unwound_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2017/05/news_detail_002752.jsp&mid=WC0b01ac058004d5c1"}],"annotations":[{"start":0,"end":21,"probability":0.5397,"type":"Organization","normalized_text":"EMA's Management Board"}],"mentions":{}},"text":"EMA's Management Board gives green light for the new #EudraVigilance system #SideEffects https://t.co/ZXo2OlANKp","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-05-22T14:53:36.000Z","author_id":"116716199","lang":"en","conversation_id":"866668370820837376","possibly_sensitive":false,"id":"866668370820837376","source":"Twitter Web Client","public_metrics":{"retweet_count":29,"reply_count":0,"like_count":15,"quote_count":5},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":4,"end":20,"tag":"AdvancedTherapy"},{"start":111,"end":116,"tag":"CHMP"}],"urls":[{"start":87,"end":110,"url":"https://t.co/Tyyj5BJuiX","expanded_url":"http://bit.ly/2qZwvVb","display_url":"bit.ly/2qZwvVb"}],"annotations":{},"mentions":{}},"text":"New #AdvancedTherapy to repair cartilage defects in the knee recommended for approval: https://t.co/Tyyj5BJuiX #CHMP","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-05-19T11:43:05.000Z","author_id":"116716199","lang":"en","conversation_id":"865533262952677378","possibly_sensitive":false,"id":"865533262952677378","source":"Sprout Social","public_metrics":{"retweet_count":10,"reply_count":1,"like_count":6,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":4,"end":13,"tag":"medicine"},{"start":85,"end":90,"tag":"CHMP"},{"start":91,"end":104,"tag":"RareDiseases"}],"urls":[{"start":61,"end":84,"url":"https://t.co/1aPCeRArsy","expanded_url":"http://bit.ly/2qZgOx0","display_url":"bit.ly/2qZgOx0"}],"annotations":{},"mentions":{}},"text":"New #medicine for rare eye disease recommended for approval: https://t.co/1aPCeRArsy #CHMP #RareDiseases","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-05-19T11:41:56.000Z","author_id":"116716199","lang":"en","conversation_id":"865532974736982020","possibly_sensitive":false,"id":"865532974736982020","source":"Sprout Social","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":6,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":0,"end":5,"tag":"CHMP"},{"start":20,"end":30,"tag":"medicines"}],"urls":[{"start":69,"end":92,"url":"https://t.co/dl9NUAxV6e","expanded_url":"http://bit.ly/2ryHQZ6","display_url":"bit.ly/2ryHQZ6"},{"start":93,"end":116,"url":"https://t.co/4wfBgddPcN","expanded_url":"https://twitter.com/EMA_News/status/865532334866538497/photo/1","display_url":"pic.twitter.com/4wfBgddPcN"}],"annotations":{},"mentions":{}},"text":"#CHMP recommends 11 #medicines for approval at its May 2017 meeting: https://t.co/dl9NUAxV6e https://t.co/4wfBgddPcN","attachments":{"media_keys":["3_865532332073074688"],"poll_ids":{}},"created_at":"2017-05-19T11:39:24.000Z","author_id":"116716199","lang":"en","conversation_id":"865532334866538497","possibly_sensitive":false,"id":"865532334866538497","source":"Sprout Social","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":14,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":19,"end":25,"tag":"PRIME"}],"urls":[{"start":38,"end":61,"url":"https://t.co/20y9rmS6vJ","expanded_url":"http://bit.ly/2ryuNad","display_url":"bit.ly/2ryuNad"},{"start":62,"end":85,"url":"https://t.co/EuhmWMtGk2","expanded_url":"https://twitter.com/EMA_News/status/865513839462305794/photo/1","display_url":"pic.twitter.com/EuhmWMtGk2"}],"annotations":{},"mentions":{}},"text":"First 12 months of #PRIME in figures: https://t.co/20y9rmS6vJ https://t.co/EuhmWMtGk2","attachments":{"media_keys":["3_865512784611508225"],"poll_ids":{}},"created_at":"2017-05-19T10:25:54.000Z","author_id":"116716199","lang":"en","conversation_id":"865513839462305794","possibly_sensitive":false,"id":"865513839462305794","source":"TweetDeck","public_metrics":{"retweet_count":27,"reply_count":0,"like_count":18,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":14,"end":20,"tag":"PRIME"}],"urls":{},"annotations":[{"start":0,"end":11,"probability":0.992,"type":"Person","normalized_text":"Rob Hemmings"}],"mentions":{}},"text":"Rob Hemmings: #PRIME is about addressing patients unmet needs -I would like to see medicines tackling the issue of antimicrobial resistance","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-05-19T09:22:05.000Z","author_id":"116716199","lang":"en","conversation_id":"865497780147470337","possibly_sensitive":false,"id":"865497780147470337","source":"TweetDeck","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":5,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":85,"end":91,"tag":"PRIME"}],"urls":[{"start":141,"end":164,"url":"https://t.co/a48EX7AVM8","expanded_url":"https://twitter.com/EMA_News/status/865492540518146049/photo/1","display_url":"pic.twitter.com/a48EX7AVM8"}],"annotations":[{"start":0,"end":11,"probability":0.9918,"type":"Person","normalized_text":"Rob Hemmings"}],"mentions":{}},"text":"Rob Hemmings, Scientific Advice Working Party Chair: we are happy with the number of #PRIME requests received, in line with our expectations https://t.co/a48EX7AVM8","attachments":{"media_keys":["3_865483765279096832"],"poll_ids":{}},"created_at":"2017-05-19T09:01:16.000Z","author_id":"116716199","lang":"en","conversation_id":"865492540518146049","possibly_sensitive":false,"id":"865492540518146049","source":"TweetDeck","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":3,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":49,"end":55,"tag":"PRIME"}],"urls":{},"annotations":[{"start":0,"end":2,"probability":0.6314,"type":"Organization","normalized_text":"EMA"},{"start":23,"end":32,"probability":0.6722,"type":"Person","normalized_text":"Guido Rasi"}],"mentions":{}},"text":"EMA Executive Director Guido Rasi opens meeting: #PRIME is bringing our community of stakeholders together to address the needs of patients","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-05-19T08:11:18.000Z","author_id":"116716199","lang":"en","conversation_id":"865479965944406016","possibly_sensitive":false,"id":"865479965944406016","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":1,"like_count":3,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":21,"end":27,"tag":"PRIME"}],"urls":[{"start":102,"end":125,"url":"https://t.co/ZpWrv2NV18","expanded_url":"http://bit.ly/2qK0Pmv","display_url":"bit.ly/2qK0Pmv"},{"start":126,"end":149,"url":"https://t.co/7li2gpQcgU","expanded_url":"https://twitter.com/EMA_News/status/865475873595457536/photo/1","display_url":"pic.twitter.com/7li2gpQcgU"}],"annotations":{},"mentions":{}},"text":"First anniversary of #PRIME: watch now our meeting with stakeholders on the experience gained so far: https://t.co/ZpWrv2NV18 https://t.co/7li2gpQcgU","attachments":{"media_keys":["3_865475870860877825"],"poll_ids":{}},"created_at":"2017-05-19T07:55:02.000Z","author_id":"116716199","lang":"en","conversation_id":"865475873595457536","possibly_sensitive":false,"id":"865475873595457536","source":"Sprout Social","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":2,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":39,"end":48,"tag":"patients"},{"start":53,"end":64,"tag":"healthcare"},{"start":85,"end":107,"tag":"PersonalisedMedicines"}],"urls":[{"start":109,"end":132,"url":"https://t.co/QPuFKk0T8J","expanded_url":"http://bit.ly/2rqxM4g","display_url":"bit.ly/2rqxM4g"},{"start":133,"end":156,"url":"https://t.co/FFoBdiT2Yg","expanded_url":"https://twitter.com/EMA_News/status/864844717527379968/photo/1","display_url":"pic.twitter.com/FFoBdiT2Yg"}],"annotations":{},"mentions":{}},"text":"Read the report from our workshop with #patients and #healthcare professionals about #PersonalisedMedicines: https://t.co/QPuFKk0T8J https://t.co/FFoBdiT2Yg","attachments":{"media_keys":["3_864844714574356480"],"poll_ids":{}},"created_at":"2017-05-17T14:07:03.000Z","author_id":"116716199","lang":"en","conversation_id":"864844717527379968","possibly_sensitive":false,"id":"864844717527379968","source":"Sprout Social","public_metrics":{"retweet_count":29,"reply_count":0,"like_count":18,"quote_count":5},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":98,"end":108,"tag":"medicines"}],"urls":[{"start":109,"end":132,"url":"https://t.co/WmLMRKuY6g","expanded_url":"http://bit.ly/2rlJgFp","display_url":"bit.ly/2rlJgFp"},{"start":133,"end":156,"url":"https://t.co/Gil4zxCZ9Y","expanded_url":"https://twitter.com/EMA_News/status/864829109888835585/photo/1","display_url":"pic.twitter.com/Gil4zxCZ9Y"}],"annotations":{},"mentions":{}},"text":"1800 people registered to our clinical data website in 2016 to have access to clinical reports on #medicines https://t.co/WmLMRKuY6g https://t.co/Gil4zxCZ9Y","attachments":{"media_keys":["3_864829106961039364"],"poll_ids":{}},"created_at":"2017-05-17T13:05:02.000Z","author_id":"116716199","lang":"en","conversation_id":"864829109888835585","possibly_sensitive":false,"id":"864829109888835585","source":"Sprout Social","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":6,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":47,"end":51,"tag":"PVC"},{"start":52,"end":65,"tag":"plasticisers"},{"start":70,"end":80,"tag":"bloodbags"}],"urls":[{"start":82,"end":105,"url":"https://t.co/L6ahUIXpl7","expanded_url":"http://bit.ly/2pG0yRt","display_url":"bit.ly/2pG0yRt"},{"start":106,"end":129,"url":"https://t.co/PnprlmtrXi","expanded_url":"https://twitter.com/edqm_news/status/864462567112134656","display_url":"twitter.com/edqm_news/stat…"}],"annotations":{},"mentions":[{"start":1,"end":11,"username":"edqm_news","id":"2242197968"}]},"text":".@edqm_news wants your feedback on alternative #PVC #plasticisers for #bloodbags: https://t.co/L6ahUIXpl7 https://t.co/PnprlmtrXi","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-05-16T16:57:06.000Z","author_id":"116716199","lang":"en","conversation_id":"864525123688296449","possibly_sensitive":false,"id":"864525123688296449","source":"Twitter Web Client","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":3,"quote_count":0},"referenced_tweets":[{"type":"quoted","id":"864462567112134656"}]},{"entities":{"hashtags":[{"start":21,"end":27,"tag":"PRIME"}],"urls":[{"start":88,"end":111,"url":"https://t.co/ZpWrv35wpI","expanded_url":"http://bit.ly/2qK0Pmv","display_url":"bit.ly/2qK0Pmv"},{"start":112,"end":135,"url":"https://t.co/jFSFrBf65G","expanded_url":"https://twitter.com/EMA_News/status/864389965597347840/photo/1","display_url":"pic.twitter.com/jFSFrBf65G"}],"annotations":{},"mentions":{}},"text":"First anniversary of #PRIME: join live broadcast on experience gained so far on 19 May: https://t.co/ZpWrv35wpI https://t.co/jFSFrBf65G","attachments":{"media_keys":["3_864155891305730049"],"poll_ids":{}},"created_at":"2017-05-16T08:00:02.000Z","author_id":"116716199","lang":"en","conversation_id":"864389965597347840","possibly_sensitive":false,"id":"864389965597347840","source":"TweetDeck","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":6,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":73,"end":78,"tag":"CHMP"}],"urls":[{"start":94,"end":117,"url":"https://t.co/fERvVBk1mj","expanded_url":"http://bit.ly/2qo778a","display_url":"bit.ly/2qo778a"}],"annotations":{},"mentions":{}},"text":"The #agenda of this week's meeting of our committee for human medicines (#CHMP) is available: https://t.co/fERvVBk1mj","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-05-15T16:16:18.000Z","author_id":"116716199","lang":"en","conversation_id":"864152470603386881","possibly_sensitive":false,"id":"864152470603386881","source":"TweetDeck","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":{},"annotations":{},"mentions":[{"start":0,"end":8,"username":"Bontrop","id":"3148384150"}]},"text":"@Bontrop Please send us your question (press@ema.europa.eu) and we will get back to you as soon as possible.","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-05-15T16:13:25.000Z","author_id":"116716199","lang":"en","conversation_id":"863012807213817858","possibly_sensitive":false,"id":"864151742816112641","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"863012807213817858"}],"in_reply_to_user_id":"3148384150"},{"entities":{"hashtags":[{"start":44,"end":55,"tag":"Veterinary"},{"start":106,"end":111,"tag":"CVMP"}],"urls":[{"start":82,"end":105,"url":"https://t.co/4e758yNmkk","expanded_url":"http://bit.ly/2qn2cVf","display_url":"bit.ly/2qn2cVf"}],"annotations":{},"mentions":{}},"text":"Check out the opinions of our Committee for #Veterinary Medicines' meeting in May https://t.co/4e758yNmkk #CVMP","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-05-15T11:35:32.000Z","author_id":"116716199","lang":"en","conversation_id":"864081810485063681","possibly_sensitive":false,"id":"864081810485063681","source":"Twitter Web Client","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":91,"end":114,"url":"https://t.co/RbTvP1wiJz","expanded_url":"http://bit.ly/2r4tn78","display_url":"bit.ly/2r4tn78"},{"start":115,"end":138,"url":"https://t.co/SK2q5eGOQz","expanded_url":"https://twitter.com/EMA_News/status/863061203865567232/photo/1","display_url":"pic.twitter.com/SK2q5eGOQz"}],"annotations":{},"mentions":{}},"text":"Communication@EMA – how are we doing? Take part in our perception survey. Deadline 31 May: https://t.co/RbTvP1wiJz https://t.co/SK2q5eGOQz","attachments":{"media_keys":["3_862962714888605697"],"poll_ids":{}},"created_at":"2017-05-12T16:00:00.000Z","author_id":"116716199","lang":"en","conversation_id":"863061203865567232","possibly_sensitive":false,"id":"863061203865567232","source":"TweetDeck","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":3,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":91,"end":114,"url":"https://t.co/RbTvP1eHS1","expanded_url":"http://bit.ly/2r4tn78","display_url":"bit.ly/2r4tn78"},{"start":115,"end":138,"url":"https://t.co/nttTKOYKUR","expanded_url":"https://twitter.com/EMA_News/status/862588404856492036/photo/1","display_url":"pic.twitter.com/nttTKOYKUR"}],"annotations":{},"mentions":{}},"text":"Communication@EMA – how are we doing? Take part in our perception survey. Deadline 31 May: https://t.co/RbTvP1eHS1 https://t.co/nttTKOYKUR","attachments":{"media_keys":["3_862588195673919490"],"poll_ids":{}},"created_at":"2017-05-11T08:41:16.000Z","author_id":"116716199","lang":"en","conversation_id":"862588404856492036","possibly_sensitive":false,"id":"862588404856492036","source":"TweetDeck","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":3,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":92,"end":99,"tag":"Health"}],"urls":[{"start":101,"end":124,"url":"https://t.co/I01ZGYjkQ6","expanded_url":"http://bit.ly/2pj3dAi","display_url":"bit.ly/2pj3dAi"},{"start":125,"end":148,"url":"https://t.co/Z0pCuRGfo3","expanded_url":"https://twitter.com/EMA_News/status/862235526811746305/photo/1","display_url":"pic.twitter.com/Z0pCuRGfo3"}],"annotations":{},"mentions":{}},"text":"EMA 2016 annual report published - read about key achievements to protect public and animal #Health: https://t.co/I01ZGYjkQ6 https://t.co/Z0pCuRGfo3","attachments":{"media_keys":["3_862233665740439552"],"poll_ids":{}},"created_at":"2017-05-10T09:19:03.000Z","author_id":"116716199","lang":"en","conversation_id":"862235526811746305","possibly_sensitive":false,"id":"862235526811746305","source":"TweetDeck","public_metrics":{"retweet_count":39,"reply_count":1,"like_count":37,"quote_count":5},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":109,"end":132,"url":"https://t.co/PXIKAnRU3w","expanded_url":"http://bit.ly/176ZhkW","display_url":"bit.ly/176ZhkW"}],"annotations":{},"mentions":[{"start":0,"end":11,"username":"spyhistory","id":"3345374145"},{"start":12,"end":19,"username":"US_FDA","id":"208120290"}]},"text":"@spyhistory @US_FDA Please send us your question and we will get back to you with more details on edaravone: https://t.co/PXIKAnRU3w","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-05-08T16:34:13.000Z","author_id":"116716199","lang":"en","conversation_id":"861309872129937410","possibly_sensitive":false,"id":"861620264546820096","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"861309872129937410"}],"in_reply_to_user_id":"3345374145"},{"entities":{"hashtags":[{"start":22,"end":31,"tag":"patients"}],"urls":[{"start":116,"end":139,"url":"https://t.co/hXaHnkgrYk","expanded_url":"http://bit.ly/2qJEZze","display_url":"bit.ly/2qJEZze"}],"annotations":{},"mentions":{}},"text":"Report concludes that #patients should continue to be involved in discussions on benefits &amp; risks of medicines: https://t.co/hXaHnkgrYk","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-05-08T15:44:53.000Z","author_id":"116716199","lang":"en","conversation_id":"861607847481790466","possibly_sensitive":false,"id":"861607847481790466","source":"Twitter Web Client","public_metrics":{"retweet_count":53,"reply_count":1,"like_count":39,"quote_count":6},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":18,"end":36,"tag":"pharmacovigilance"},{"start":103,"end":108,"tag":"PRAC"}],"urls":[{"start":79,"end":102,"url":"https://t.co/WrS4Gh2p0E","expanded_url":"http://bit.ly/2q7ss8R","display_url":"bit.ly/2q7ss8R"}],"annotations":{},"mentions":{}},"text":"Highlights of the #pharmacovigilance committee's meeting in May are published: https://t.co/WrS4Gh2p0E #PRAC","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-05-05T15:26:45.000Z","author_id":"116716199","lang":"en","conversation_id":"860516120608034816","possibly_sensitive":false,"id":"860516120608034816","source":"Twitter Web Client","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":5,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":108,"end":122,"tag":"BiosimilarsEU"}],"urls":[{"start":84,"end":107,"url":"https://t.co/d2aLHkiodx","expanded_url":"http://bit.ly/2p4kcGz","display_url":"bit.ly/2p4kcGz"}],"annotations":{},"mentions":{}},"text":"We have published a new guide on biosimilar medicines for healthcare professionals: https://t.co/d2aLHkiodx #BiosimilarsEU","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-05-05T11:54:29.000Z","author_id":"116716199","lang":"en","conversation_id":"860462701390303232","possibly_sensitive":false,"id":"860462701390303232","source":"TweetDeck","public_metrics":{"retweet_count":54,"reply_count":1,"like_count":34,"quote_count":9},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":18,"end":26,"tag":"patient"}],"urls":[{"start":95,"end":118,"url":"https://t.co/1rhUfFgyT9","expanded_url":"http://bit.ly/1RY814z","display_url":"bit.ly/1RY814z"},{"start":119,"end":142,"url":"https://t.co/i6V5vpUwpF","expanded_url":"https://twitter.com/EMA_News/status/860153870319857664/photo/1","display_url":"pic.twitter.com/i6V5vpUwpF"}],"annotations":[{"start":53,"end":77,"probability":0.6705,"type":"Organization","normalized_text":"European Medicines Agency"}],"mentions":{}},"text":"Get involved as a #patient expert in the work of the European Medicines Agency. Register here: https://t.co/1rhUfFgyT9 https://t.co/i6V5vpUwpF","attachments":{"media_keys":["3_860153823108755456"],"poll_ids":{}},"created_at":"2017-05-04T15:27:18.000Z","author_id":"116716199","lang":"en","conversation_id":"860153870319857664","possibly_sensitive":false,"id":"860153870319857664","source":"Twitter Web Client","public_metrics":{"retweet_count":40,"reply_count":2,"like_count":20,"quote_count":3},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":24,"end":42,"tag":"Pharmacovigilance"},{"start":100,"end":105,"tag":"PRAC"}],"urls":[{"start":76,"end":99,"url":"https://t.co/TBSZQxazT1","expanded_url":"http://bit.ly/2pXf9Yc","display_url":"bit.ly/2pXf9Yc"}],"annotations":{},"mentions":{}},"text":"The draft agenda of the #Pharmacovigilance Committee meeting in May is out: https://t.co/TBSZQxazT1 #PRAC","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-05-03T10:28:32.000Z","author_id":"116716199","lang":"en","conversation_id":"859716298342846464","possibly_sensitive":false,"id":"859716298342846464","source":"Twitter Web Client","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":8,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":0,"end":13,"tag":"VaccinesWork"},{"start":14,"end":29,"tag":"ImmunizeEurope"}],"urls":[{"start":30,"end":53,"url":"https://t.co/ZUATYig3Oc","expanded_url":"http://bit.ly/2q9RX5h","display_url":"bit.ly/2q9RX5h"},{"start":54,"end":77,"url":"https://t.co/Iy7050tytf","expanded_url":"https://twitter.com/EMA_News/status/857883975142060032/photo/1","display_url":"pic.twitter.com/Iy7050tytf"}],"annotations":{},"mentions":{}},"text":"#VaccinesWork #ImmunizeEurope https://t.co/ZUATYig3Oc https://t.co/Iy7050tytf","attachments":{"media_keys":["3_857883758787272704"],"poll_ids":{}},"created_at":"2017-04-28T09:07:33.000Z","author_id":"116716199","lang":"und","conversation_id":"857883975142060032","possibly_sensitive":false,"id":"857883975142060032","source":"Twitter Web Client","public_metrics":{"retweet_count":18,"reply_count":1,"like_count":15,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":0,"end":13,"tag":"VaccinesWork"},{"start":14,"end":29,"tag":"ImmunizeEurope"}],"urls":[{"start":30,"end":53,"url":"https://t.co/vJkCOPlLEy","expanded_url":"http://bit.ly/2qdF1LR","display_url":"bit.ly/2qdF1LR"},{"start":54,"end":77,"url":"https://t.co/pSOSwdnOVt","expanded_url":"https://twitter.com/EMA_News/status/857614970036604928/photo/1","display_url":"pic.twitter.com/pSOSwdnOVt"}],"annotations":{},"mentions":{}},"text":"#VaccinesWork #ImmunizeEurope https://t.co/vJkCOPlLEy https://t.co/pSOSwdnOVt","attachments":{"media_keys":["3_857614553139613696"],"poll_ids":{}},"created_at":"2017-04-27T15:18:37.000Z","author_id":"116716199","lang":"und","conversation_id":"857614970036604928","possibly_sensitive":false,"id":"857614970036604928","source":"Twitter Web Client","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":8,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":82,"end":95,"tag":"VaccinesWork"},{"start":96,"end":111,"tag":"ImmunizeEurope"}],"urls":[{"start":112,"end":135,"url":"https://t.co/ZUATYig3Oc","expanded_url":"http://bit.ly/2q9RX5h","display_url":"bit.ly/2q9RX5h"},{"start":136,"end":159,"url":"https://t.co/hXhVhEvSg1","expanded_url":"https://twitter.com/EMA_News/status/857532813901475840/photo/1","display_url":"pic.twitter.com/hXhVhEvSg1"}],"annotations":{},"mentions":{}},"text":"Patients, parents, everyone can get involved in the monitoring of vaccine safety! #VaccinesWork #ImmunizeEurope https://t.co/ZUATYig3Oc https://t.co/hXhVhEvSg1","attachments":{"media_keys":["3_857532489866375168"],"poll_ids":{}},"created_at":"2017-04-27T09:52:09.000Z","author_id":"116716199","lang":"en","conversation_id":"857532813901475840","possibly_sensitive":false,"id":"857532813901475840","source":"Twitter Web Client","public_metrics":{"retweet_count":18,"reply_count":0,"like_count":10,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":24,"end":32,"tag":"measles"},{"start":85,"end":93,"tag":"vaccine"}],"urls":{},"annotations":{},"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}]},"text":"RT @ECDC_EU: &gt;95% of #measles cases in 2016 were unvaccinated. 2 doses of measles #vaccine are needed to ensure full protection. https://t.…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-04-27T08:13:48.000Z","author_id":"116716199","lang":"en","conversation_id":"857508062558552064","possibly_sensitive":false,"id":"857508062558552064","source":"Twitter Web Client","public_metrics":{"retweet_count":41,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"856433160032223233"}]},{"entities":{"hashtags":[{"start":59,"end":73,"tag":"antimicrobial"},{"start":97,"end":101,"tag":"AMR"},{"start":102,"end":105,"tag":"EU"},{"start":106,"end":113,"tag":"health"},{"start":114,"end":125,"tag":"foodsafety"}],"urls":{},"annotations":{},"mentions":[{"start":3,"end":11,"username":"Food_EU","id":"2874880006"},{"start":28,"end":37,"username":"EMA_News","id":"116716199"}]},"text":"RT @Food_EU: Event today w. @EMA_News - Data collection on #antimicrobial consumption in animals #AMR #EU #health #foodsafety https://t.co/…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-04-26T16:29:12.000Z","author_id":"116716199","lang":"en","conversation_id":"857270344574541824","possibly_sensitive":false,"id":"857270344574541824","source":"TweetDeck","public_metrics":{"retweet_count":20,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"857159253689344002"}]},{"entities":{"hashtags":[{"start":19,"end":29,"tag":"medicines"},{"start":46,"end":52,"tag":"PRIME"}],"urls":[{"start":70,"end":93,"url":"https://t.co/feD2iMFgvO","expanded_url":"http://bit.ly/2q825yY","display_url":"bit.ly/2q825yY"},{"start":94,"end":117,"url":"https://t.co/HhZHOwICP7","expanded_url":"https://twitter.com/EMA_News/status/857269062338048000/photo/1","display_url":"pic.twitter.com/HhZHOwICP7"}],"annotations":{},"mentions":{}},"text":"Find out about the #medicines accepted in our #PRIME scheme in April: https://t.co/feD2iMFgvO https://t.co/HhZHOwICP7","attachments":{"media_keys":["3_857268142787235841"],"poll_ids":{}},"created_at":"2017-04-26T16:24:06.000Z","author_id":"116716199","lang":"en","conversation_id":"857269062338048000","possibly_sensitive":false,"id":"857269062338048000","source":"TweetDeck","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":16,"quote_count":3},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":99,"end":112,"tag":"VaccinesWork"},{"start":113,"end":128,"tag":"ImmunizeEurope"}],"urls":[{"start":74,"end":97,"url":"https://t.co/vJkCOPlLEy","expanded_url":"http://bit.ly/2qdF1LR","display_url":"bit.ly/2qdF1LR"},{"start":129,"end":152,"url":"https://t.co/K0gKcO3Yz6","expanded_url":"https://twitter.com/EMA_News/status/857235345833959424/photo/1","display_url":"pic.twitter.com/K0gKcO3Yz6"}],"annotations":{},"mentions":{}},"text":"Keeping children and adults safe with vaccines is a joint responsibility: https://t.co/vJkCOPlLEy  #VaccinesWork #ImmunizeEurope https://t.co/K0gKcO3Yz6","attachments":{"media_keys":["3_857235279614181376"],"poll_ids":{}},"created_at":"2017-04-26T14:10:07.000Z","author_id":"116716199","lang":"en","conversation_id":"857235345833959424","possibly_sensitive":false,"id":"857235345833959424","source":"Twitter Web Client","public_metrics":{"retweet_count":14,"reply_count":0,"like_count":8,"quote_count":3},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":131,"end":144,"tag":"VaccinesWork"}],"urls":[{"start":107,"end":130,"url":"https://t.co/vJkCOPlLEy","expanded_url":"http://bit.ly/2qdF1LR","display_url":"bit.ly/2qdF1LR"},{"start":145,"end":168,"url":"https://t.co/jg2nFnmcL8","expanded_url":"https://twitter.com/EMA_News/status/857182501177094148/photo/1","display_url":"pic.twitter.com/jg2nFnmcL8"}],"annotations":{},"mentions":{}},"text":"A doctor, a researcher &amp; a regulatory body’s representative shared their thoughts on vaccine hesitancy https://t.co/vJkCOPlLEy #VaccinesWork https://t.co/jg2nFnmcL8","attachments":{"media_keys":["3_857182160603815936"],"poll_ids":{}},"created_at":"2017-04-26T10:40:08.000Z","author_id":"116716199","lang":"en","conversation_id":"857182501177094148","possibly_sensitive":false,"id":"857182501177094148","source":"Twitter Web Client","public_metrics":{"retweet_count":20,"reply_count":0,"like_count":12,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":85,"end":98,"tag":"vaccineswork"},{"start":99,"end":114,"tag":"ImmunizeEurope"}],"urls":[{"start":115,"end":138,"url":"https://t.co/ZUATYig3Oc","expanded_url":"http://bit.ly/2q9RX5h","display_url":"bit.ly/2q9RX5h"},{"start":139,"end":162,"url":"https://t.co/bKgDCT3bD9","expanded_url":"https://twitter.com/EMA_News/status/856873063824150529/photo/1","display_url":"pic.twitter.com/bKgDCT3bD9"}],"annotations":{},"mentions":{}},"text":"Let's not forget: some major human diseases are under control thanks to immunisation #vaccineswork #ImmunizeEurope https://t.co/ZUATYig3Oc https://t.co/bKgDCT3bD9","attachments":{"media_keys":["3_856873042995236865"],"poll_ids":{}},"created_at":"2017-04-25T14:10:33.000Z","author_id":"116716199","lang":"en","conversation_id":"856873063824150529","possibly_sensitive":false,"id":"856873063824150529","source":"Twitter Web Client","public_metrics":{"retweet_count":56,"reply_count":0,"like_count":49,"quote_count":3},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":47,"end":60,"tag":"vaccineswork"},{"start":61,"end":76,"tag":"ImmunizeEurope"}],"urls":[{"start":77,"end":100,"url":"https://t.co/ZUATYig3Oc","expanded_url":"http://bit.ly/2q9RX5h","display_url":"bit.ly/2q9RX5h"},{"start":101,"end":124,"url":"https://t.co/vBTfBUAb9J","expanded_url":"https://twitter.com/EMA_News/status/856818554955591680/photo/1","display_url":"pic.twitter.com/vBTfBUAb9J"}],"annotations":[{"start":15,"end":45,"probability":0.4027,"type":"Other","normalized_text":"European Immunization Week 2017"}],"mentions":{}},"text":"We support the European Immunization Week 2017 #vaccineswork #ImmunizeEurope https://t.co/ZUATYig3Oc https://t.co/vBTfBUAb9J","attachments":{"media_keys":["3_856818049911017472"],"poll_ids":{}},"created_at":"2017-04-25T10:33:57.000Z","author_id":"116716199","lang":"en","conversation_id":"856818554955591680","possibly_sensitive":false,"id":"856818554955591680","source":"Twitter Web Client","public_metrics":{"retweet_count":36,"reply_count":0,"like_count":26,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":99,"end":105,"tag":"Jakab"},{"start":130,"end":143,"tag":"vaccineswork"}],"urls":[{"start":106,"end":129,"url":"https://t.co/Ceq2qFjG8g","expanded_url":"http://europa.eu/!HF78bJ","display_url":"europa.eu/!HF78bJ"}],"annotations":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":74,"end":89,"username":"V_Andriukaitis","id":"575269517"}]},"text":"RT @EU_Health: Benefits of vaccines are a fact, not an opinion: statement @V_Andriukaitis &amp; Z. #Jakab https://t.co/Ceq2qFjG8g #vaccineswork…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-04-24T12:59:06.000Z","author_id":"116716199","lang":"en","conversation_id":"856492696243982336","possibly_sensitive":false,"id":"856492696243982336","source":"Twitter Web Client","public_metrics":{"retweet_count":116,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"856485327619469314"}]},{"entities":{"hashtags":[{"start":20,"end":33,"tag":"VaccinesWork"},{"start":105,"end":120,"tag":"ImmunizeEurope"}],"urls":{},"annotations":{},"mentions":[{"start":3,"end":18,"username":"WHO_Europe_VPI","id":"561122363"}]},"text":"RT @WHO_Europe_VPI: #VaccinesWork to save lives. An estimated 2-3 million deaths are prevented each year #ImmunizeEurope https://t.co/JkLqs…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-04-24T08:01:58.000Z","author_id":"116716199","lang":"en","conversation_id":"856417919017902080","possibly_sensitive":false,"id":"856417919017902080","source":"Twitter Web Client","public_metrics":{"retweet_count":66,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"855790546891165697"}]},{"entities":{"hashtags":[{"start":6,"end":15,"tag":"medicine"},{"start":101,"end":113,"tag":"RareDisease"}],"urls":[{"start":76,"end":99,"url":"https://t.co/9Noa0Obk5K","expanded_url":"http://bit.ly/2pmket3","display_url":"bit.ly/2pmket3"}],"annotations":{},"mentions":{}},"text":"First #medicine for spinal muscular atrophy (SMA) recommended for approval: https://t.co/9Noa0Obk5K  #RareDisease","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-04-21T17:51:05.000Z","author_id":"116716199","lang":"en","conversation_id":"855479014814777344","possibly_sensitive":false,"id":"855479014814777344","source":"TweetDeck","public_metrics":{"retweet_count":37,"reply_count":1,"like_count":39,"quote_count":5},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":6,"end":15,"tag":"medicine"},{"start":114,"end":119,"tag":"CHMP"},{"start":120,"end":133,"tag":"RareDiseases"}],"urls":[{"start":90,"end":113,"url":"https://t.co/ivjwIQreIY","expanded_url":"http://bit.ly/2oZIu0U","display_url":"bit.ly/2oZIu0U"}],"annotations":{},"mentions":{}},"text":"First #medicine for rare neurodegenerative disorder in children recommended for approval: https://t.co/ivjwIQreIY #CHMP #RareDiseases","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-04-21T17:23:50.000Z","author_id":"116716199","lang":"en","conversation_id":"855472157006188544","possibly_sensitive":false,"id":"855472157006188544","source":"TweetDeck","public_metrics":{"retweet_count":20,"reply_count":0,"like_count":11,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":0,"end":5,"tag":"CHMP"},{"start":20,"end":30,"tag":"medicines"}],"urls":[{"start":71,"end":94,"url":"https://t.co/vXzY1Ccg72","expanded_url":"http://bit.ly/2oZSW8Q","display_url":"bit.ly/2oZSW8Q"},{"start":95,"end":118,"url":"https://t.co/Z0rTLdQFzx","expanded_url":"https://twitter.com/EMA_News/status/855472018589929472/photo/1","display_url":"pic.twitter.com/Z0rTLdQFzx"}],"annotations":{},"mentions":{}},"text":"#CHMP recommends 11 #medicines for approval at its April 2017 meeting: https://t.co/vXzY1Ccg72 https://t.co/Z0rTLdQFzx","attachments":{"media_keys":["3_855468993175597056"],"poll_ids":{}},"created_at":"2017-04-21T17:23:17.000Z","author_id":"116716199","lang":"en","conversation_id":"855472018589929472","possibly_sensitive":false,"id":"855472018589929472","source":"TweetDeck","public_metrics":{"retweet_count":23,"reply_count":0,"like_count":13,"quote_count":4},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":51,"end":62,"tag":"veterinary"}],"urls":[{"start":92,"end":115,"url":"https://t.co/7Z4b8KXGni","expanded_url":"http://bit.ly/2p2yYvX","display_url":"bit.ly/2p2yYvX"}],"annotations":{},"mentions":{}},"text":"Revised guidelines to encourage the development of #veterinary medicines are now published: https://t.co/7Z4b8KXGni","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-04-21T10:43:25.000Z","author_id":"116716199","lang":"en","conversation_id":"855371385744625664","possibly_sensitive":false,"id":"855371385744625664","source":"Twitter Web Client","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":7,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":73,"end":78,"tag":"CHMP"}],"urls":[{"start":94,"end":117,"url":"https://t.co/leRJMylrye","expanded_url":"http://bit.ly/2pOAxuE","display_url":"bit.ly/2pOAxuE"}],"annotations":{},"mentions":{}},"text":"The #agenda of this week's meeting of our committee for human medicines (#CHMP) is available: https://t.co/leRJMylrye","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-04-18T14:18:37.000Z","author_id":"116716199","lang":"en","conversation_id":"854338381341499392","possibly_sensitive":false,"id":"854338381341499392","source":"TweetDeck","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":8,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":56,"end":67,"tag":"veterinary"},{"start":68,"end":78,"tag":"medicines"}],"urls":[{"start":100,"end":123,"url":"https://t.co/qhbhZTnd6q","expanded_url":"http://bit.ly/2nUZUtB","display_url":"bit.ly/2nUZUtB"}],"annotations":{},"mentions":{}},"text":"The #agenda of this week's meeting of our committee for #veterinary #medicines (CVMP) is available: https://t.co/qhbhZTnd6q","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-04-10T16:15:28.000Z","author_id":"116716199","lang":"en","conversation_id":"851468683356590080","possibly_sensitive":false,"id":"851468683356590080","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":7,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":45,"end":55,"tag":"medicines"}],"urls":[{"start":57,"end":80,"url":"https://t.co/u08fJygofk","expanded_url":"http://bit.ly/2nT7THG","display_url":"bit.ly/2nT7THG"}],"annotations":{},"mentions":{}},"text":"How to report irregularities that may affect #medicines: https://t.co/u08fJygofk","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-04-10T09:26:43.000Z","author_id":"116716199","lang":"en","conversation_id":"851365817656725504","possibly_sensitive":false,"id":"851365817656725504","source":"TweetDeck","public_metrics":{"retweet_count":24,"reply_count":0,"like_count":10,"quote_count":3},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":22,"end":40,"tag":"pharmacovigilance"},{"start":115,"end":120,"tag":"PRAC"}],"urls":[{"start":91,"end":114,"url":"https://t.co/q0yCJhMDII","expanded_url":"http://bit.ly/2o9NZLF","display_url":"bit.ly/2o9NZLF"}],"annotations":{},"mentions":{}},"text":"The highlights of the #pharmacovigilance committee's meeting in April have been published: https://t.co/q0yCJhMDII #PRAC","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-04-07T11:21:17.000Z","author_id":"116716199","lang":"en","conversation_id":"850307487840563201","possibly_sensitive":false,"id":"850307487840563201","source":"Twitter Web Client","public_metrics":{"retweet_count":14,"reply_count":0,"like_count":6,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":94,"end":112,"tag":"pharmacovigilance"}],"urls":[{"start":70,"end":93,"url":"https://t.co/RtgLnOd0lB","expanded_url":"http://bit.ly/2o0GN2T","display_url":"bit.ly/2o0GN2T"}],"annotations":{},"mentions":{}},"text":"Check out our new guidance to improve periodic safety update reports: https://t.co/RtgLnOd0lB #pharmacovigilance","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-04-06T11:22:38.000Z","author_id":"116716199","lang":"en","conversation_id":"849945440023871488","possibly_sensitive":false,"id":"849945440023871488","source":"Twitter Web Client","public_metrics":{"retweet_count":23,"reply_count":0,"like_count":7,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":18,"end":30,"tag":"RareDisease"}],"urls":[{"start":69,"end":92,"url":"https://t.co/5M9rVQfmSQ","expanded_url":"http://bit.ly/2oMrlaL","display_url":"bit.ly/2oMrlaL"}],"annotations":[{"start":0,"end":1,"probability":0.4789,"type":"Organization","normalized_text":"EU"}],"mentions":[{"start":49,"end":61,"username":"EUombudsman","id":"873777758"}]},"text":"EU cooperation on #RareDisease honoured with new @EUombudsman prize: https://t.co/5M9rVQfmSQ","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-04-06T10:51:37.000Z","author_id":"116716199","lang":"en","conversation_id":"849937634331852800","possibly_sensitive":false,"id":"849937634331852800","source":"TweetDeck","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":8,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":{},"annotations":[{"start":55,"end":60,"probability":0.9975,"type":"Place","normalized_text":"London"}],"mentions":[{"start":0,"end":12,"username":"RainerThiel","id":"49917846"}]},"text":"@RainerThiel We are recruiting for our headquarters in London.","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-04-04T14:38:03.000Z","author_id":"116716199","lang":"en","conversation_id":"849256094820126722","possibly_sensitive":false,"id":"849269841739612161","source":"Twitter Web Client","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"849267123839021061"}],"in_reply_to_user_id":"49917846"},{"entities":{"hashtags":[{"start":34,"end":52,"tag":"Pharmacovigilance"},{"start":104,"end":109,"tag":"PRAC"}],"urls":[{"start":80,"end":103,"url":"https://t.co/YXW85DCxYl","expanded_url":"http://bit.ly/2nAkkrJ","display_url":"bit.ly/2nAkkrJ"}],"annotations":{},"mentions":{}},"text":"Check out the draft agenda of the #Pharmacovigilance Committee meeting in April https://t.co/YXW85DCxYl #PRAC","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-04-04T14:30:25.000Z","author_id":"116716199","lang":"en","conversation_id":"849267918248583169","possibly_sensitive":false,"id":"849267918248583169","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":43,"end":50,"tag":"EUjobs"}],"urls":[{"start":19,"end":42,"url":"https://t.co/eRvGnx0kJJ","expanded_url":"http://bit.ly/1zp7JIe","display_url":"bit.ly/1zp7JIe"},{"start":51,"end":74,"url":"https://t.co/nyeLFOLDSY","expanded_url":"https://twitter.com/EMA_News/status/849256094820126722/photo/1","display_url":"pic.twitter.com/nyeLFOLDSY"}],"annotations":{},"mentions":{}},"text":"We are recruiting! https://t.co/eRvGnx0kJJ #EUjobs https://t.co/nyeLFOLDSY","attachments":{"media_keys":["3_849256062939279360"],"poll_ids":{}},"created_at":"2017-04-04T13:43:26.000Z","author_id":"116716199","lang":"en","conversation_id":"849256094820126722","possibly_sensitive":false,"id":"849256094820126722","source":"Twitter Web Client","public_metrics":{"retweet_count":21,"reply_count":1,"like_count":11,"quote_count":3},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":118,"end":129,"tag":"EUacademia"}],"urls":[{"start":94,"end":117,"url":"https://t.co/9U7Yta59UQ","expanded_url":"http://bit.ly/2n3Iq2m","display_url":"bit.ly/2n3Iq2m"},{"start":130,"end":153,"url":"https://t.co/rDb1iT0fWI","expanded_url":"https://twitter.com/EMA_News/status/848860913453150208/photo/1","display_url":"pic.twitter.com/rDb1iT0fWI"}],"annotations":{},"mentions":{}},"text":"Stronger collaboration with academia: see new framework and action plan for the next 3 years: https://t.co/9U7Yta59UQ #EUacademia https://t.co/rDb1iT0fWI","attachments":{"media_keys":["3_848860655671267329"],"poll_ids":{}},"created_at":"2017-04-03T11:33:07.000Z","author_id":"116716199","lang":"en","conversation_id":"848860913453150208","possibly_sensitive":false,"id":"848860913453150208","source":"TweetDeck","public_metrics":{"retweet_count":38,"reply_count":1,"like_count":33,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":19,"end":29,"tag":"medicines"},{"start":46,"end":52,"tag":"PRIME"}],"urls":[{"start":70,"end":93,"url":"https://t.co/xSnG0MixaF","expanded_url":"http://bit.ly/2nAqSK1","display_url":"bit.ly/2nAqSK1"},{"start":94,"end":117,"url":"https://t.co/EMlKaqhSy4","expanded_url":"https://twitter.com/EMA_News/status/847131535878828032/photo/1","display_url":"pic.twitter.com/EMlKaqhSy4"}],"annotations":{},"mentions":{}},"text":"Find out about the #medicines accepted in our #PRIME scheme in March: https://t.co/xSnG0MixaF https://t.co/EMlKaqhSy4","attachments":{"media_keys":["3_847131349064585216"],"poll_ids":{}},"created_at":"2017-03-29T17:01:11.000Z","author_id":"116716199","lang":"en","conversation_id":"847131535878828032","possibly_sensitive":false,"id":"847131535878828032","source":"Twitter Web Client","public_metrics":{"retweet_count":28,"reply_count":1,"like_count":13,"quote_count":5},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":36,"end":44,"tag":"measles"},{"start":85,"end":93,"tag":"Romania"},{"start":100,"end":106,"tag":"Italy"}],"urls":[{"start":107,"end":130,"url":"https://t.co/PGuesgh7pT","expanded_url":"http://bit.ly/2nv6IRO","display_url":"bit.ly/2nv6IRO"}],"annotations":[{"start":58,"end":63,"probability":0.9962,"type":"Place","normalized_text":"Europe"}],"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}]},"text":"RT @WHO_Europe: The largest current #measles outbreaks in Europe are taking place in #Romania &amp; #Italy https://t.co/PGuesgh7pT #VaccinesWor…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-03-28T14:48:36.000Z","author_id":"116716199","lang":"en","conversation_id":"846735783079936000","possibly_sensitive":false,"id":"846735783079936000","source":"Twitter Web Client","public_metrics":{"retweet_count":22,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"846701159586975745"}]},{"entities":{"hashtags":[{"start":58,"end":76,"tag":"pharmacovigilance"}],"urls":[{"start":90,"end":113,"url":"https://t.co/XZZFdXcLqp","expanded_url":"http://bit.ly/2o9B3U9","display_url":"bit.ly/2o9B3U9"}],"annotations":{},"mentions":{}},"text":"See the report on our workshop on measuring the impact of #pharmacovigilance activities:  https://t.co/XZZFdXcLqp","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-03-27T14:21:50.000Z","author_id":"116716199","lang":"en","conversation_id":"846366659271147520","possibly_sensitive":false,"id":"846366659271147520","source":"TweetDeck","public_metrics":{"retweet_count":30,"reply_count":1,"like_count":19,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":{},"annotations":[{"start":62,"end":71,"probability":0.8866,"type":"Person","normalized_text":"Guido RASI"}],"mentions":[{"start":3,"end":17,"username":"EuropeanFiles","id":"4185381851"},{"start":73,"end":82,"username":"EMA_News","id":"116716199"}]},"text":"RT @EuropeanFiles: \"Keeping the focus on patients’ wellbeing\" Guido RASI @EMA_News statement on our Medicines of the Future issue. https://…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-03-24T12:10:38.000Z","author_id":"116716199","lang":"en","conversation_id":"845246474455842816","possibly_sensitive":false,"id":"845246474455842816","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"845236113564483584"}]},{"entities":{"hashtags":[{"start":0,"end":5,"tag":"CHMP"},{"start":19,"end":29,"tag":"medicines"}],"urls":[{"start":70,"end":93,"url":"https://t.co/wQ8CXIT6xJ","expanded_url":"http://bit.ly/2mXXuKk","display_url":"bit.ly/2mXXuKk"},{"start":94,"end":117,"url":"https://t.co/WmnTZZBA0d","expanded_url":"https://twitter.com/EMA_News/status/845245461497888769/photo/1","display_url":"pic.twitter.com/WmnTZZBA0d"}],"annotations":{},"mentions":{}},"text":"#CHMP recommends 6 #medicines for approval at its March 2017 meeting: https://t.co/wQ8CXIT6xJ https://t.co/WmnTZZBA0d","attachments":{"media_keys":["3_845245297794146304"],"poll_ids":{}},"created_at":"2017-03-24T12:06:36.000Z","author_id":"116716199","lang":"en","conversation_id":"845245461497888769","possibly_sensitive":false,"id":"845245461497888769","source":"TweetDeck","public_metrics":{"retweet_count":23,"reply_count":2,"like_count":13,"quote_count":5},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":69,"end":74,"tag":"EU60"}],"urls":[{"start":75,"end":98,"url":"https://t.co/25GqRruzru","expanded_url":"https://twitter.com/EUCouncil/status/844232159581765632","display_url":"twitter.com/EUCouncil/stat…"}],"annotations":{},"mentions":{}},"text":"Let's celebrate 60 years of European peace and progress on Saturday! #EU60 https://t.co/25GqRruzru","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-03-24T11:32:29.000Z","author_id":"116716199","lang":"en","conversation_id":"845236876478963712","possibly_sensitive":false,"id":"845236876478963712","source":"Twitter Web Client","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":10,"quote_count":0},"referenced_tweets":[{"type":"quoted","id":"844232159581765632"}]},{"entities":{"hashtags":[{"start":46,"end":50,"tag":"flu"},{"start":51,"end":59,"tag":"vaccine"}],"urls":[{"start":83,"end":106,"url":"https://t.co/fEm73un8Mh","expanded_url":"http://bit.ly/2nKI9RO","display_url":"bit.ly/2nKI9RO"}],"annotations":{},"mentions":{}},"text":"EU recommendations for the 2017/2018 seasonal #flu #vaccine composition published: https://t.co/fEm73un8Mh","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-03-24T10:27:53.000Z","author_id":"116716199","lang":"en","conversation_id":"845220619088265220","possibly_sensitive":false,"id":"845220619088265220","source":"TweetDeck","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":6,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":8,"end":16,"tag":"BigData"},{"start":25,"end":38,"tag":"PublicHealth"}],"urls":[{"start":100,"end":123,"url":"https://t.co/B13bdGuvUy","expanded_url":"http://bit.ly/2mvTXas","display_url":"bit.ly/2mvTXas"}],"annotations":{},"mentions":{}},"text":"How can #BigData benefit #PublicHealth? New task force will look into this and establish a roadmap. https://t.co/B13bdGuvUy","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-03-23T12:12:53.000Z","author_id":"116716199","lang":"en","conversation_id":"844884655920812032","possibly_sensitive":false,"id":"844884655920812032","source":"Sprout Social","public_metrics":{"retweet_count":33,"reply_count":0,"like_count":22,"quote_count":3},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":[{"start":76,"end":99,"url":"https://t.co/w5MU91bCAc","expanded_url":"http://bit.ly/2mvINCO","display_url":"bit.ly/2mvINCO"},{"start":100,"end":123,"url":"https://t.co/bh1wBzHFpY","expanded_url":"https://twitter.com/EMA_News/status/844861376375865344/photo/1","display_url":"pic.twitter.com/bh1wBzHFpY"}],"annotations":{},"mentions":{}},"text":"We have just launched a call for experts in anonymisation of clinical data: https://t.co/w5MU91bCAc https://t.co/bh1wBzHFpY","attachments":{"media_keys":["3_844861373129474049"],"poll_ids":{}},"created_at":"2017-03-23T10:40:23.000Z","author_id":"116716199","lang":"en","conversation_id":"844861376375865344","possibly_sensitive":false,"id":"844861376375865344","source":"Sprout Social","public_metrics":{"retweet_count":19,"reply_count":1,"like_count":9,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":57,"end":62,"tag":"EU60"}],"urls":[{"start":103,"end":126,"url":"https://t.co/AXUTikN9Rw","expanded_url":"http://www.europa-eu60.com/","display_url":"europa-eu60.com"},{"start":127,"end":150,"url":"https://t.co/1EfV3FCwun","expanded_url":"https://twitter.com/EMA_News/status/844850798999744512/photo/1","display_url":"pic.twitter.com/1EfV3FCwun"}],"annotations":{},"mentions":{}},"text":"I'm celebrating peace, democracy and solidarity with the #EU60 filter on my profile photo, you can too https://t.co/AXUTikN9Rw https://t.co/1EfV3FCwun","attachments":{"media_keys":["3_844850796353142785"],"poll_ids":{}},"created_at":"2017-03-23T09:58:21.000Z","author_id":"116716199","lang":"en","conversation_id":"844850798999744512","possibly_sensitive":false,"id":"844850798999744512","source":"erased13534770","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":8,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":21,"end":27,"tag":"PRIME"}],"urls":[{"start":111,"end":134,"url":"https://t.co/D0sc173IVz","expanded_url":"http://bit.ly/2nBHqSK","display_url":"bit.ly/2nBHqSK"},{"start":135,"end":158,"url":"https://t.co/dw6kmSAGS3","expanded_url":"https://twitter.com/EMA_News/status/844558693714837504/photo/1","display_url":"pic.twitter.com/dw6kmSAGS3"}],"annotations":{},"mentions":{}},"text":"First anniversary of #PRIME: register now for meeting on experience so far or follow live broadcast on 19 May: https://t.co/D0sc173IVz https://t.co/dw6kmSAGS3","attachments":{"media_keys":["3_844545818002669569"],"poll_ids":{}},"created_at":"2017-03-22T14:37:38.000Z","author_id":"116716199","lang":"en","conversation_id":"844558693714837504","possibly_sensitive":false,"id":"844558693714837504","source":"TweetDeck","public_metrics":{"retweet_count":19,"reply_count":0,"like_count":10,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":73,"end":78,"tag":"CHMP"}],"urls":[{"start":94,"end":117,"url":"https://t.co/anMKIfNTtz","expanded_url":"http://bit.ly/2nebfrI","display_url":"bit.ly/2nebfrI"}],"annotations":{},"mentions":{}},"text":"The #agenda of this week's meeting of our committee for human medicines (#CHMP) is available: https://t.co/anMKIfNTtz","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-03-20T14:24:51.000Z","author_id":"116716199","lang":"en","conversation_id":"843830703213219841","possibly_sensitive":false,"id":"843830703213219841","source":"TweetDeck","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":9,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":18,"end":36,"tag":"AdvancedTherapies"}],"urls":[{"start":142,"end":165,"url":"https://t.co/N8iuOgFWha","expanded_url":"https://twitter.com/EMA_News/status/842320275752517633/photo/1","display_url":"pic.twitter.com/N8iuOgFWha"}],"annotations":[{"start":65,"end":77,"probability":0.9671,"type":"Person","normalized_text":"Ilona Reischl"}],"mentions":[{"start":132,"end":141,"username":"agesnews","id":"223456379"}]},"text":"Our Committee for #AdvancedTherapies elected its new vice-chair: Ilona Reischl from the Austrian Agency for Health&amp;Food Safety. @agesnews https://t.co/N8iuOgFWha","attachments":{"media_keys":["3_842320057770381314"],"poll_ids":{}},"created_at":"2017-03-16T10:22:57.000Z","author_id":"116716199","lang":"en","conversation_id":"842320275752517633","possibly_sensitive":false,"id":"842320275752517633","source":"Twitter Web Client","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":15,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":49,"end":58,"tag":"medicine"},{"start":118,"end":130,"tag":"raredisease"}],"urls":[{"start":94,"end":117,"url":"https://t.co/dnx4DU2egp","expanded_url":"http://bit.ly/2nmdJ5d","display_url":"bit.ly/2nmdJ5d"}],"annotations":{},"mentions":{}},"text":"The #agenda of this week's meeting of our orphan #medicine committee (COMP) is now published: https://t.co/dnx4DU2egp #raredisease","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-03-13T16:22:19.000Z","author_id":"116716199","lang":"en","conversation_id":"841323549805694977","possibly_sensitive":false,"id":"841323549805694977","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":5,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":29,"end":47,"tag":"pharmacovigilance"},{"start":102,"end":107,"tag":"PRAC"}],"urls":[{"start":78,"end":101,"url":"https://t.co/DEvITeSZVs","expanded_url":"http://bit.ly/2m8L6Xp","display_url":"bit.ly/2m8L6Xp"}],"annotations":{},"mentions":{}},"text":"Check out the outcome of the #pharmacovigilance committee's meeting in March: https://t.co/DEvITeSZVs #PRAC","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-03-10T18:04:12.000Z","author_id":"116716199","lang":"en","conversation_id":"840262023585894401","possibly_sensitive":false,"id":"840262023585894401","source":"Twitter Web Client","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":9,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":109,"end":122,"tag":"globalhealth"}],"urls":[{"start":85,"end":108,"url":"https://t.co/swfWSK8Tbn","expanded_url":"http://bit.ly/2mqHS3b","display_url":"bit.ly/2mqHS3b"}],"annotations":[{"start":0,"end":2,"probability":0.671,"type":"Organization","normalized_text":"EMA"}],"mentions":{}},"text":"EMA experts meet with African regulators to discuss opportunities for collaboration: https://t.co/swfWSK8Tbn #globalhealth","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-03-10T12:10:19.000Z","author_id":"116716199","lang":"en","conversation_id":"840172964888875012","possibly_sensitive":false,"id":"840172964888875012","source":"TweetDeck","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":18,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":0,"end":21,"tag":"PersonalisedMedicine"}],"urls":[{"start":117,"end":140,"url":"https://t.co/bnP4R622LU","expanded_url":"http://bit.ly/2mwmPOQ","display_url":"bit.ly/2mwmPOQ"},{"start":141,"end":164,"url":"https://t.co/QuCcufVAel","expanded_url":"https://twitter.com/EMA_News/status/839067364943609857/photo/1","display_url":"pic.twitter.com/QuCcufVAel"}],"annotations":{},"mentions":{}},"text":"#PersonalisedMedicine workshop: follow discussion with patients, consumers and healthcare professionals on 14 March: https://t.co/bnP4R622LU https://t.co/QuCcufVAel","attachments":{"media_keys":["3_839065278881415168"],"poll_ids":{}},"created_at":"2017-03-07T10:57:03.000Z","author_id":"116716199","lang":"en","conversation_id":"839067364943609857","possibly_sensitive":false,"id":"839067364943609857","source":"TweetDeck","public_metrics":{"retweet_count":22,"reply_count":2,"like_count":17,"quote_count":6},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":21,"end":39,"tag":"pharmacovigilance"},{"start":103,"end":108,"tag":"PRAC"}],"urls":[{"start":79,"end":102,"url":"https://t.co/WdqksFOVvz","expanded_url":"http://bit.ly/2mXKBAY","display_url":"bit.ly/2mXKBAY"}],"annotations":{},"mentions":{}},"text":"Draft agenda for the #pharmacovigilance committee meeting on 6-9 March is out: https://t.co/WdqksFOVvz #PRAC","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-03-06T17:42:44.000Z","author_id":"116716199","lang":"en","conversation_id":"838807070229020672","possibly_sensitive":false,"id":"838807070229020672","source":"Twitter Web Client","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":14,"end":24,"tag":"medicines"},{"start":41,"end":47,"tag":"PRIME"}],"urls":[{"start":70,"end":93,"url":"https://t.co/MJWkjPTFbm","expanded_url":"http://bit.ly/1RNe7kK","display_url":"bit.ly/1RNe7kK"},{"start":94,"end":117,"url":"https://t.co/6a83J6vepC","expanded_url":"https://twitter.com/EMA_News/status/836953135247687680/photo/1","display_url":"pic.twitter.com/6a83J6vepC"}],"annotations":{},"mentions":{}},"text":"Check out the #medicines accepted in our #PRIME scheme this February: https://t.co/MJWkjPTFbm https://t.co/6a83J6vepC","attachments":{"media_keys":["3_836953028787843078"],"poll_ids":{}},"created_at":"2017-03-01T14:55:51.000Z","author_id":"116716199","lang":"en","conversation_id":"836953135247687680","possibly_sensitive":false,"id":"836953135247687680","source":"Twitter Web Client","public_metrics":{"retweet_count":19,"reply_count":0,"like_count":9,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":{},"urls":{},"annotations":{},"mentions":[{"start":3,"end":17,"username":"EU_Commission","id":"157981564"}]},"text":"RT @EU_Commission: How will European Reference Networks improve the lives of patients? What medical areas are covered? https://t.co/bhCtzVq…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-02-28T13:22:52.000Z","author_id":"116716199","lang":"en","conversation_id":"836567345892065281","possibly_sensitive":false,"id":"836567345892065281","source":"TweetDeck","public_metrics":{"retweet_count":61,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"836534138844950529"}]},{"entities":{"hashtags":{},"urls":{},"annotations":[{"start":33,"end":40,"probability":0.441,"type":"Organization","normalized_text":"Facebook"}],"mentions":[{"start":3,"end":18,"username":"rarediseaseday","id":"19982434"},{"start":29,"end":32,"username":"FT","id":"18949452"},{"start":113,"end":128,"username":"V_Andriukaitis","id":"575269517"}]},"text":"RT @rarediseaseday: Join the @FT Facebook Live at 3pm (UTC) and put your questions to EU Commissioner for Health @V_Andriukaitis #RareDisea…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-02-28T11:30:43.000Z","author_id":"116716199","lang":"en","conversation_id":"836539121459937286","possibly_sensitive":false,"id":"836539121459937286","source":"TweetDeck","public_metrics":{"retweet_count":30,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"836523891900178433"}]},{"entities":{"hashtags":[{"start":4,"end":12,"tag":"minutes"},{"start":127,"end":132,"tag":"COMP"}],"urls":[{"start":103,"end":126,"url":"https://t.co/LOrh5osGfj","expanded_url":"http://bit.ly/2mDqruZ","display_url":"bit.ly/2mDqruZ"}],"annotations":[{"start":58,"end":82,"probability":0.5824,"type":"Organization","normalized_text":"Orphan Medicinal Products"}],"mentions":{}},"text":"The #minutes of the Jan 2017 meeting of our Committee for Orphan Medicinal Products are now published: https://t.co/LOrh5osGfj #COMP","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-02-27T18:15:40.000Z","author_id":"116716199","lang":"en","conversation_id":"836278643722694656","possibly_sensitive":false,"id":"836278643722694656","source":"TweetDeck","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":3,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":89,"end":94,"tag":"Data"},{"start":98,"end":122,"tag":"AntimicrobialResistance"},{"start":123,"end":131,"tag":"DataViz"}],"urls":{},"annotations":{},"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}]},"text":"RT @EFSA_EU: Bacteria in humans, animals &amp; food continue to show resistance. Explore #Data on #AntimicrobialResistance #DataViz https://t.c…","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-02-24T16:02:12.000Z","author_id":"116716199","lang":"en","conversation_id":"835157892059779072","possibly_sensitive":false,"id":"835157892059779072","source":"Twitter Web Client","public_metrics":{"retweet_count":33,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"retweeted","id":"834802516567146496"}]},{"entities":{"hashtags":[{"start":4,"end":13,"tag":"medicine"},{"start":67,"end":72,"tag":"CHMP"},{"start":98,"end":111,"tag":"RareDiseases"}],"urls":[{"start":74,"end":97,"url":"https://t.co/38zI4u3wCR","expanded_url":"http://bit.ly/2kTQSQU","display_url":"bit.ly/2kTQSQU"}],"annotations":{},"mentions":{}},"text":"New #medicine for parathyroid disorder recommended for approval by #CHMP: https://t.co/38zI4u3wCR #RareDiseases","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-02-24T13:47:37.000Z","author_id":"116716199","lang":"en","conversation_id":"835124023717675009","possibly_sensitive":false,"id":"835124023717675009","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":1,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":0,"end":5,"tag":"CHMP"},{"start":19,"end":29,"tag":"medicines"}],"urls":[{"start":73,"end":96,"url":"https://t.co/vJH8wCSoai","expanded_url":"http://bit.ly/2kTWUkl","display_url":"bit.ly/2kTWUkl"},{"start":97,"end":120,"url":"https://t.co/bf5M9c2N4W","expanded_url":"https://twitter.com/EMA_News/status/835099730564763648/photo/1","display_url":"pic.twitter.com/bf5M9c2N4W"}],"annotations":{},"mentions":{}},"text":"#CHMP recommends 6 #medicines for approval at its February 2017 meeting: https://t.co/vJH8wCSoai https://t.co/bf5M9c2N4W","attachments":{"media_keys":["3_835099503808110593"],"poll_ids":{}},"created_at":"2017-02-24T12:11:05.000Z","author_id":"116716199","lang":"en","conversation_id":"835099730564763648","possibly_sensitive":false,"id":"835099730564763648","source":"TweetDeck","public_metrics":{"retweet_count":21,"reply_count":0,"like_count":13,"quote_count":3},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":30,"end":47,"tag":"AdaptivePathways"}],"urls":[{"start":76,"end":99,"url":"https://t.co/FFfZfF5jT8","expanded_url":"http://bit.ly/2lOEgdi","display_url":"bit.ly/2lOEgdi"},{"start":100,"end":123,"url":"https://t.co/qTHWyjl4N1","expanded_url":"http://bit.ly/2ggK0Jn","display_url":"bit.ly/2ggK0Jn"},{"start":124,"end":147,"url":"https://t.co/7bfX51G0ws","expanded_url":"https://twitter.com/EMA_News/status/834799715652890624/photo/1","display_url":"pic.twitter.com/7bfX51G0ws"}],"annotations":{},"mentions":{}},"text":"Report and video recording of #AdaptivePathways workshop are now available: https://t.co/FFfZfF5jT8 https://t.co/qTHWyjl4N1 https://t.co/7bfX51G0ws","attachments":{"media_keys":["3_834798604812427265"],"poll_ids":{}},"created_at":"2017-02-23T16:18:56.000Z","author_id":"116716199","lang":"en","conversation_id":"834799715652890624","possibly_sensitive":false,"id":"834799715652890624","source":"TweetDeck","public_metrics":{"retweet_count":34,"reply_count":0,"like_count":16,"quote_count":2},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":73,"end":78,"tag":"CHMP"}],"urls":[{"start":94,"end":117,"url":"https://t.co/Nbht4hQaMs","expanded_url":"http://bit.ly/2m0f7Nw","display_url":"bit.ly/2m0f7Nw"}],"annotations":{},"mentions":{}},"text":"The #agenda of this week's meeting of our committee for human medicines (#CHMP) is available: https://t.co/Nbht4hQaMs","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-02-20T13:05:33.000Z","author_id":"116716199","lang":"en","conversation_id":"833663882950504448","possibly_sensitive":false,"id":"833663882950504448","source":"TweetDeck","public_metrics":{"retweet_count":6,"reply_count":1,"like_count":2,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":20,"end":30,"tag":"guideline"},{"start":49,"end":64,"tag":"clinicaltrials"}],"urls":[{"start":113,"end":136,"url":"https://t.co/OQKAnK2rYq","expanded_url":"http://bit.ly/2fBxzW5","display_url":"bit.ly/2fBxzW5"}],"annotations":{},"mentions":{}},"text":"We are revising our #guideline on first-in-human #clinicaltrials. Send your comments until end of February 2017: https://t.co/OQKAnK2rYq","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-02-20T11:54:26.000Z","author_id":"116716199","lang":"en","conversation_id":"833645986912280576","possibly_sensitive":false,"id":"833645986912280576","source":"TweetDeck","public_metrics":{"retweet_count":30,"reply_count":0,"like_count":5,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":6,"end":25,"tag":"MonoclonalAntibody"},{"start":29,"end":40,"tag":"veterinary"}],"urls":[{"start":92,"end":115,"url":"https://t.co/igNKJWLflD","expanded_url":"http://bit.ly/2lrDHG4","display_url":"bit.ly/2lrDHG4"}],"annotations":{},"mentions":{}},"text":"First #MonoclonalAntibody in #veterinary medicines recommended for marketing authorisation: https://t.co/igNKJWLflD","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-02-20T08:30:02.000Z","author_id":"116716199","lang":"en","conversation_id":"833594548882284544","possibly_sensitive":false,"id":"833594548882284544","source":"TweetDeck","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":8,"quote_count":0},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":65,"end":83,"tag":"AccessToDocuments"}],"urls":[{"start":102,"end":125,"url":"https://t.co/iFUOQv2Jds","expanded_url":"http://bit.ly/2kx2qt2","display_url":"bit.ly/2kx2qt2"}],"annotations":{},"mentions":{}},"text":"We invite EMA's stakeholders to comment on the revised policy on #AccessToDocuments. Ddl: 18 May 2017 https://t.co/iFUOQv2Jds","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-02-17T14:57:11.000Z","author_id":"116716199","lang":"en","conversation_id":"832604814349651970","possibly_sensitive":false,"id":"832604814349651970","source":"Twitter Web Client","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":4,"quote_count":1},"referenced_tweets":{}},{"entities":{"hashtags":[{"start":57,"end":65,"tag":"Patient"}],"urls":[{"start":97,"end":120,"url":"https://t.co/e1wVN7Rpqa","expanded_url":"http://bit.ly/2m2zd5H","display_url":"bit.ly/2m2zd5H"}],"annotations":{},"mentions":{}},"text":"Check out observations and recommendations following our #Patient Registries Workshop in October https://t.co/e1wVN7Rpqa","attachments":{"media_keys":{},"poll_ids":{}},"created_at":"2017-02-17T14:34:06.000Z","author_id":"116716199","lang":"en","conversation_id":"832599006316474370","possibly_sensitive":false,"id":"832599006316474370","source":"Twitter Web Client","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":6,"quote_count":1},"referenced_tweets":{}}]
